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Analytical methods for the study of membranes and peptide-membrane 
interactions 
Catherine Jane Pridmore 
This thesis describes analytical work carried out to determine the stability and properties 
of lipid and peptide-lipid systems. 
Matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) and tandem 
mass spectrometry (MSMS) analyses were carried out to establish a validated protocol for 
the complete identification of phospholipids, including the nature of the headgroup and 
acyl chains and the positions of the acyl chains on the glycerol backbone.  Statistical 
differences were observed in the relative intensities of peaks corresponding to the neutral 
loss of the acyl chain from the sn-1 and sn-2 positions of POPE, POPC and OPPC, with a 
preferential cleavage of the chain from the sn-2 position of all three in the absence of 
added salt and a preferential cleavage at the sn-1 position in the presence of sodium or 
lithium ions.  This knowledge was applied to the identification of unknown lipid mixtures 
both of the standard MALDI target plate and directly onto thin layer chromatography 
plates after separation. 
The above techniques, together with other analytical methods including thin layer 
chromatography and dynamic light scattering, were applied to the study and identification 
of lipids modified by actions such as hydrolysis and oxidation under conditions used for 
binding analyses of peptides and small molecules.  Long-term analyses of samples 
containing synthetic melittin and liposomes showed that over time melittin both promotes 
the hydrolysis of liposomal lipids and is itself acylated. 
Analyses of the binding of a prototypical peptide (human neutrophil defensin HNP-2) to 
membranes, using methods that included dichroism and fluorescence spectroscopy, 
demonstrated that HNP-2 dimers act on lipid membranes via a carpet-type mechanism 
and allowed the rate of the formation of bound HNP-2 states to be determined.  HNP-2 
was modeled as a consecutive two-step process following pseudo-first order kinetics.  
The first step (membrane association) was rapid, with a half-life of around 0.5 minutes, 
while the second step (reorientation and partial insertion into the membrane) was slower 
by an order of magnitude. 
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1 INTRODUCTION 
1.1 The cell 
Every living species in composed of cells, from single-celled yeast to complex 
multicellular humans.  Cells can be classed as prokaryotic or eukaryotic by the presence 
(eukaryote) or absence (prokaryote) of a nucleus.  Bacteria are prokaryotic, whether 
single-celled or multicellular, and animals, fungi and plants are eukaryotic.1  Both types of 
cell contain one or more lipid cell membranes.  The outermost of these is the plasma 
membrane.  In eukaryotic cells this is the outer membrane of the cell, while in prokaryotic 
cells it sits beneath the capsule and cell wall (Figure 1.1).  Prokaryotic cells are further 
divided into Gram positive, which have a thick peptidoglycan cell wall outside the plasma 
membrane, and Gram negative, which have a thinner peptidoglycan layer underneath an 
outer membrane of lipopolysaccharides and membrane proteins.  Some bacterial cells 
also have flagellae, filamentous protein appendages which aid the motion of the cells.2 
 
Figure 1.1.  Prokaryotic and eukaryotic cells. 
In 1972, Singer and Nicholson proposed the „fluid mosaic model‟ to elucidate the 
structure of biological membranes.3  The model described two layers of lipids arranged tail 
to tail, interspersed with proteins and carbohydrates (Figure 1.2).  The lipids are free to 
diffuse laterally within each layer, but not to swap between them.  The proteins are either 
„integral‟, spanning the membrane, or „extrinsic‟, bound to the surface.  They perform a 
number of functions, including acting as pumps, gates and enzymes.4 
                                               
 http://schools-wikipedia.org/images/915/91506.png.htm (A non-copyright public domain image from the 
Science Primer (US Federal Government National Centre for Biotechnology Information)) 
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Figure 1.2.  The cell membrane.  Phospholipid bilayer shown in purple and integral and extrinsic membrane 
proteins in red and green respectively. 
1.2 Lipids 
Lipids are amphiphilic species with hydrophilic headgroups and hydrophobic 
tailgroups separated by a cyclopenta[a]phenanthrene, sphinganine or glycerol group.  
They can be classed by their central group, with sterols built around 
cyclopenta[a]phenanthrene, sphingolipids built around sphinganine and 
glycerophospholipids based around glycerol. 
1.2.1 Sterols 
Sterols are a minor component of cell membranes.  They are neutral lipids, based 
on a cyclopenta[a]phenanthrene skeleton with a hydroxyl group at the C-3 position.  
Cholesterol (Figure 1.3) is the most commonly occurring sterol, and is present in all 
erythrocyte (red blood cell) membranes but rarely in prokaryotic cell membranes.4  It 
comprises approximately 30 % of the lipid mass of mammalian cell membranes.5 
 
Figure 1.3.  Structure of cholesterol.  The common sterol cyclopenta[a]phenanthrene skeleton and hydroxyl 
group are shown in red. 
1.2.2 Sphingolipids 
Sphingolipids are based around a sphingosine skeleton attached to an amide and 
either a sugar (glycosphingolipids, Figure 1.4A) or a phosphate group (sphingomyelins, 
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Figure 1.4B).  The phosphate group of sphingomyelin lipids is in turn linked to one of a 
number of groups, usually choline ((CH2)2NMe3). 
 
Figure 1.4.  Structure of A) glycosphingolipids and B) sphingomyelin.  R corresponds to a hydrocarbon chain.  
Sphingosine is shown in blue. 
1.2.3 Glycerophospholipids 
Glycerophospholipids are composed of two acyl chains attached through a 
glycerol linker to a phosphate, which is in turn linked to one of a number of groups (Table 
1.1).  
 
Figure 1.5.  Structure of glycerophospholipids.  R1 and R2 correspond to hydrocarbon chains and R3 
corresponds to one of a number of groups, as described in Table 1.1.  Glycerol is shown in red. 
Glycerophospholipids are the major lipid component of cell membranes, and all 
further discussion of „phospholipids‟ refers to glycerophospholipids.  Table 1.1 shows the 
common phospholipid headgroups.  These headgroups can be zwitterionic (neutral with 
balanced positive and negative charges), positive or negatively charged.  Prokaryotic and 
eukaryotic plasma membranes differ in their phospholipid compositions, with prokaryotic 
membranes containing a higher percentage of negatively charged lipids than those of 
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eukaryotes.  For example, the major phospholipid components of the plasma membrane 
of the Gram-negative bacteria E. coli are phosphoethanolamine (74%) and 
phosphoglycerol (19%), while the main phospholipid components of human liver plasma 
membranes are phosphocholine (44%), phosphoethanolamine (28%), phosphoinositol 
(9%) and phosphoserine (3%) (as % of total lipid composition).6 
Table 1.1.  Phospholipid headgroups. 
Name Abbreviation Net Charge 
(pH 7) 
Structure 
Phosphate PA -1 
P
O-
OH
O
O
 
Phosphocholine PC Neutral 
P
O-
O
O
N+
O
 
Phosphoethanolamine PE Neutral 
P
O-
O
O
NH3
+O
 
Phosphoglycerol PG -1 
OH
OH
P
O-
O
O
O
 
Phospho-L-serine PS -1 
NH3
+
O
O-H
P
O-
O
O
O
 
Phosphoinositol PI -1 HO
OH
OH
OH
OH
P
O
O
O-
O
 
 
The acyl chains of naturally occurring lipid membranes can be saturated or contain 
one or more double bonds.  These double bonds are normally the cis isomers.7  The 
structures, systemic, trivial and shorthand names of some commonly occurring lipid acyl 
chains are shown in Table 1.2.  The shorthand name corresponds to the length of the 
carbon chain followed by the number, position and configuration of the double bonds. 
Table 1.2.  Some commonly occurring acyl chains of phospholipids. 
Structure Systemic Name Trivial 
Name 
Shorthand 
Name 
CH3(CH2)14COO Hexadecanoic Palmitic 16:0 
CH3(CH2)7CH=CH(CH2)7COO Z-9-octadecanoic Oleic 18:1 9c 
CH3(CH2)3(CH2CH=CH)2(CH2)7COO Z,Z-9,12-octadecanoic Linoleic 18:2 9c,12c 
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Phospholipid bilayers exhibit liquid crystalline properties.  With increasing 
temperature or decreasing pressure, bilayers composed of a single phospholipid types 
undergo transitions between gel (Lβ‟), rippled gel (Pβ‟) and liquid crystalline (Lα) phases 
(Figure 1.6).  The first transition is termed pre-transition (Tp) and the second the main 
transition (Tm).
8  The phase transition temperatures of lipids increase with increasing 
chain length, due to the increased van der Waals forces between the chains, and 
decrease with increasing unsaturation due to the disruption to the ordered chain packing 
this causes.9  Lipids with unsaturated acyl chains generally have Tm values below 0   C, 
while those of saturated lipids can be much higher (80 °C for 24:0/24:0-PC).10  The phase 
transition temperatures of mixed phospholipid bilayers depend on the mixing of the 
different lipid types; if the lipids mix ideally then Tm will be the average of those of the 
constituent lipids, whereas if they do not mix ideally the separate lipid components will 
undergo individual transitions.  The binding of antimicrobial peptides to lipid bilayers has 
been shown to be affected by the phase of the lipids, for example the peptide gramicidin 
S does not bind to zwitterionic neutral bilayers below the main phase transition 
temperature, binding only when the bilayer is in a liquid-crystalline state.11 
 
 
Figure 1.6.  Gel (Lβ‟), rippled gel (Pβ‟) and liquid crystalline (Lα) phospholipid phases. 
1.3 Antimicrobial peptides 
Antimicrobial peptides (AMPs) are a form of innate immunity found in virtually all 
living species as a protection against microbes.12  Many are cationic, with a net charge 
between + 2 and + 9, and they usually form amphipathic secondary structures.12 AMPs 
can be classed according to their secondary structures, for example α-helical, β-sheet,  
linear  and loop structures (Figure 1.7).14, 15  They are also grouped into families which 
share similarities such as structure, sections of sequence, disulphide bridges and action, 
along with evolutionary relationships determinable from the location of their genes within 
the genome.16  Table 1.3 contains descriptions and structures of a number of different 
AMPs. 
Lβ’ Pβ’ Lα 
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Figure 1.7.  Secondary structures of A) defensin HNP-3 monomer (56% β-sheet); B) defensin HBD-3 
monomer (11% α-helix, 28% β-sheet); C) magainin-2 monomer (52% α-helix) and D) indolicidin (linear).  
Entries 1DFN, 1KJ6, 1DUM and 1G89 respectively in the Protein Data Bank (http://www.rscb.org/pdb).
17–20
 
Structures displayed using The PyMOL Molecular Graphics System, Version 1.2r1, Schrödinger, LLC 
(www.pymol.org). 
1.3.1 AMP action against different cell types 
AMPs can act against a number of cell types including Gram positive and Gram 
negative bacteria, erythrocytes, fungi, protozoa and viruses.  The examples described in 
Table 1.3 show that not all AMPs have the same activity.  Research using peptides where 
residues have been replaced to alter the structure, hydrophobicity and amphipathicity has 
given an insight into the features which determine the hemolytic, antibacterial and 
antifungal properties of AMPs.  High amphipathicity,21 high hydrophobicity,22 and high 
proportions of either α-helix or β-sheet in the secondary structure have all been observed 
to promote hemolysis while suppressing antimicrobial activity.23, 24  An optimum 
hydrophobicity for antibacterial activity was determined, above and below which activity 
decreased strongly.25  It was also found that positioning a polar lysine residue in the 
centre of the hydrophobic region caused a dramatic improvement in antibacterial activity 
and reduction in hemolytic activity.  Fungal cells are eukaryotic, with a high percentage of 
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PC and PE lipids, but also contain a small percentage of each of PI, PS and 
diphosphatidyl PG lipids, which increases their susceptibility to AMPs above mammalian 
cells.2  Fungal cell plasma membranes are surrounded by a cell wall of cross-linked chitin, 
mannoproteins (mannose-containing proteins), glucans and glycoproteins, which can act 
as a barrier to antimicrobial peptide attack on the membrane.26  It has been proposed that 
if peptides form strong dimers in solution their activity against fungal cells is reduced, 
possibly due to a need to dissociate to pass through the cell wall.27 
The different activities of antimicrobial peptide species toward erythrocytes and 
prokaryotes depending on their hydrophobicity has been explained by reference to the 
mechanism of action of the peptides and the different modes of interaction between the 
peptides and lipid membranes.  Peptide-membrane interactions can either be electrostatic 
(enthalpic) or hydrophobic (entropic).  It has been proposed that when cationic peptides 
interact with anionic membranes the attraction is primarily electrostatic, while interactions 
between peptides, cationic or otherwise, with neutral membranes are dominated by 
hydrophobic effects between the hydrophobic regions of the peptides and the 
hydrocarbon chain region of the bilayer.24  It has also been suggested that more 
hydrophobic peptides penetrate deep into the hydrocarbon region of the bilayer of red 
blood cells during hemolysis, forming pores or channels.25  As described below, when 
interacting with anionic membranes antimicrobial peptides can cause lysis without 
penetrating deeply into the membrane through carpet-like mechanisms (as described in 
Section 1.3.2.3). 
AMPs do not cause the death of viral particles through permeabilization of the cell 
membrane in the same manner as they do with bacterial cells.  The antiviral activity of 
AMPs has been found to be a combination of direct action on the viral particle and indirect 
action via interaction with the viral target cell, depending on the virus and the peptide.28  
Lactoferrin has been found to interact directly with viral particles, including those of feline 
calcivirus, poliovirus and human immunodeficiency virus, through binding to their surface, 
which hinders the interaction of the viral particle with target cells.29–31  Defensin HNP-1 
has been shown to have a dual effect on the viral haemorrhagic septicaemia virus.  The 
peptide binds directly to viral particles to alter their ability to interact with target cells in the 
same manner as lactoferrin, but also hinders the virus through inducing an antiviral 
response in host cells.32 
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Family Peptide Species Target Structure sequence Net Charge (Ph7) Notes Ref 
Magainins Magainin 1 African Clawed 
Frog (Xenopus 
laevis) 
Gram -ve and 
Gram +ve bacteria; 
fungi; protozoa; 
anti-tumour 
α- helical GIGKFLHSAGKFGKAFVGEIMKS + 3   33 
  Magainin 2 African Clawed 
Frog (Xenopus 
laevis) 
Gram -ve and 
Gram +ve bacteria; 
fungi; protozoa; 
anti-tumour 
α- helical GIGKFLHSAKKFGKAFVGEIMNS + 3   33 
Tachyplesins Tachyplesin 
1 
Chinese 
Horseshoe Crab 
(Tachypleus 
tridentatus) 
Gram -ve and 
Gram +ve bacteria; 
fungi 
β-sheet KWCFRVCYRGICYRRCR + 7 Two disulphide 
bridges 
34 
  Tachyplesin 
2 
Chinese 
Horseshoe Crab 
(Tachypleus 
tridentatus) 
Gram -ve and 
gram +ve bacteria; 
fungi 
β-sheet RWCFRVCYRGICYRKCR + 7  35 
Cathelicidins Indolicidin Cattle Gram -ve and 
Gram +ve bacteria; 
fungi; protozoa 
Linear ILPWKWPWWPWRR + 3   20 
  LL-37 Human Gram -ve and 
Gram +ve bacteria; 
fungi; protozoa 
α- helical LLGDFFRKSKEKIGKEFKRIVQRIKD 
FLRNLVPRTES 
+ 6   36 
Defensins HNP-1 Human Gram -ve and 
Gram +ve bacteria; 
fungi; enveloped 
viruses 
β-sheet ACYCRIPACIAGERRYGTCIYQGRL 
WAFCC 
+ 3 Three disulphide 
bridges;  
an α defensin 
37 
  TAP Cattle Gram -ve and 
Gram +ve bacteria; 
fungi 
β-sheet NPVSCVRNKGICVPIRCPGSMKQIG 
TCVGRAVKCCRKK 
+ 9 Three disulphide 
bridges; an insect 
defensin 
37 
  Phormia A Flies Primarily Gram +ve 
bacteria 
β-sheet ATCDLLSGTGINHSACAAHCLLRGN 
RGGYCNGKGVCVCRN 
+ 3 Three disulphide 
bridges; a β 
defensin 
37 
Melittin Melittin 
(Apis 
mellifera) 
Honeybee (Apis 
mellifera) 
Erythrocytes; Gram 
-ve and Gram +ve 
bacteria; fungi 
α- helical GIGAVLKVLTTGLPALISWIKRKRQQ + 5  40, 41, 
42 
Table 1.3.  Descriptions of a number of antimicrobial peptides.
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1.3.2 Modes of action  
Three general models have been proposed for the mode of action of AMPs on 
microbe cells.12  It must be noted that these mechanisms are not universally accepted by 
all researchers in the field of antimicrobial peptide analysis; other mechanisms have been 
proposed, including detergent-type micellization, and some peptides are known to bind 
via different mechanisms depending on the lipid type and buffer conditions.12,13  All of the 
general models initially require the ratio of bound peptide:lipid to reach a threshold value 
(P:L), often termed the „threshold concentration‟. 
1.3.2.1 The barrel stave mechanism 
During this mechanism, the AMPs initially bind to the surface of the cell, 
weakening it, before the hydrophobic portion of the peptide inserts into the outer lipid 
monolayer.  When enough peptides are bound to this degree, they aggregate and push 
through the membrane, forming a „barrel‟-like structure spanning the cell with the peptide 
hydrophobic regions facing the hydrophobic portions of the membrane and hydrophobic 
regions facing inwards, forming a pore through which cell contents can leak, causing cell 
death. 
1.3.2.2 The toroidal pore mechanism 
This mechanism describes the action of peptides which bind to the surface of the 
cell, causing the outer lipid layer to bend in on itself and join up with the inner leaflet, 
giving a pore lined with lipid headgroups interspersed with peptides. 
1.3.2.3 The carpet mechanism 
AMPs employing the carpet mechanism never actually form a pore through the 
membrane.  They initially bind to the surface through electrostatic interactions, then once 
a sufficient number are bound, the interactions of the peptides with the membrane disrupt 
the ordered lipid bilayer to such an extent that it becomes permeable. 
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Figure 1.8.  Binding mechanisms of antimicrobial peptides.  A)  Electrostatic binding of peptide to bilayer 
surface below threshold peptide concentration; B) barrel stave mechanism; C) toroidal pore mechanism; D) 
carpet binding mechanism. 
All of these mechanisms cause permeabilization of the cell membrane, followed by 
the leakage of cell contents and/or the introduction of water by osmosis.  This was initially 
thought to be the cause of cell death by AMPs, but there is evidence that in some cases 
the permeabilization of the cell membrane, though present, is not the actual cause of cell 
death.  In some cases cell death is caused by the inhibition of intracellular processes.  
Defensin human neutrophil peptides have been suggested to attack the plasma 
membrane of bacterial cells and then to cause inhibition of DNA biosynthesis, both of 
which contribute to cell death.43, 44  It has also been observed that 30 minutes after 
addition of defensin peptides to microbial cells, after evidence of widespread cell 
permeabilization has been observed, the cells could recover after re-suspending in 
peptide-free media, therefore cell permeabilization may not be sufficient to cause cell 
death.45 
1.3.3 The study of antimicrobial peptide binding 
There are a number of methods by which the binding of AMPs has been studied 
and from which the binding models were initially suggested.  Analyses of pore formation 
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were initially carried out using electrical measurements and the observation of the 
leakage of fluorescence markers after the addition of peptides to marker-containing 
vesicles.46, 47  The release of fluorescent markers due to pore formation and release due 
to membrane disruption can be distinguished by determining whether the release is 
graded or an all-or-none occurrence.48, 49, 50   If the release is graded, all of the vesicles 
lose some of their contents, suggesting membrane disruption due to a carpet-like model.  
If the release is all-or-none, some of the vesicles release all of their contents and some 
are unaffected.  This can be caused either by pore formation, which requires a certain 
number of peptide molecules to be present on one vesicle and aggregate to form the pore 
and therefore does not occur on every vesicle, or the complete disruption of some 
vesicles in a detergent-like manner (gross vesicle destabilization).  The release of 
different sized markers after the addition of peptides can be used to give an indication of 
pore sizes.49   Fluorescence labelling can be used to follow the insertion of peptides into 
the lipid membrane, by following the blue-shift of, for example, 4-fluoro-7-nitrobenz-2-oxa-
1,-3-diazole (NBD) as it moves from being surrounded by aqueous solution to the more 
hydrophobic environment inside the lipid bilayer.  The shape of binding isotherms can 
then be used to give an idea of whether the peptide monomers aggregate within the 
bilayer.  Straight line isotherms indicate simple adhesion processes, while an increase in 
the slope as the peptide/lipid molar ratio is increased suggests slight aggregation within 
the lipid bilayers.47  Initially the only pore-forming mechanism suggested was the barrel 
stave mechanism.  The toroidal pore mechanism was first proposed to explain the binding 
of the peptide magainin.  Oriented circular dichroism (OCD) had shown the magainin 
helices to be oriented perpendicular to the membrane surface, and neutron scattering 
data showed a pore was being formed.51, 52  The neutron scattering data did not fit a barrel 
stave model however.  Two measurements can be produced from neutron scattering 
analysis to describe an AMP pore, the core radius (the radius of the aqueous solution at 
the centre of the pore, which is treated as a cylinder) and the contact radius (the radius 
from the outer edge of a peptide monomer to the centre of the pore).  For the helical AMP 
alamethicin, the core radius had been calculated as 9 Å and the contact radius 20 Å, 
which correlates with the helix diameter, known from the crystal structure, of 11 Å. 
Alamethicin was clearly forming barrel stave pores.  The core radius of magainin pores 
was calculated as 14 Å from the neutron scattering data, while the contact radius was 
found to be 35.5 Å.  The difference, 20 Å, was much greater than the diameter of the 
magainin helix (11 Å).  Using measurements of the fraction of the membrane surface 
covered by peptide and the contact radius, and calculating the number of bound peptide 
monomers, it was determined that each pore must be composed of 4–7 monomers, which 
was not enough to create a pore of the size calculated from the neutron data.  A toroidal 
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or wormhole-like structure was therefore suggested to explain this, lined with lipid head 
groups interspersed with peptide monomers.  The difference between the core and 
contact radii correlated well with the thickness of a lipid monolayer (approximately 20 Å), 
and, since the peptides would be interspersed with lipids and not in direct contact with 
each other, the presence of only 4–7 peptide monomers in each pore was also 
explained.52  The toroidal pore model has since been proposed to describe the binding of 
other AMPs including protegrin and melittin.53, 54   
The development of analytical techniques over recent years is allowing a much 
greater understanding of the nature of antimicrobial peptide binding.  AMPs are very hard 
to crystallise, due mainly to their amphiphilic nature and tendency to be partially 
disordered in solution, which has caused a major hurdle in understanding their structure 
and binding.  In 2003 the Protein Data Bank (PDB) contained the 3D structures of only 54 
of the 525 AMPs which were thought to be known, according to the authors of the 
Antimicrobial Peptide Database, though 68 had been studied by nuclear magnetic 
resonance (NMR) in membrane-mimetic environments or lipid bilayers.55  High-resolution 
solution state NMR in membrane-mimetic environments has become the most widely-
used method for structure determination of AMPs.56  Other analytical techniques provide 
complimentary information about peptide binding, especially the orientation of peptides 
within the lipid bilayer, which can be determined by, for example, linear dichroism, and 
solid-state NMR of peptides binding to magnetically-oriented lipid bilayers.57  The addition 
of secondary structural information, obtained from solution or crystal structures or by 
circular dichroism, membrane penetration information from, for example, fluorescence 
spectra, and liposome stability effects analysed by dynamic light scattering or 
fluorescence of labelled peptides, provides pictures of the nature of antimicrobial peptide 
binding.  
1.3.4 Linear dichroism as a tool for studying antimicrobial peptides 
Linear dichroism is the difference in absorbance of parallel and perpendicular 
linearly polarised light by an oriented sample (Equation 1.1), and is used to study the 
orientation of species including membrane-bound peptides and proteins. 
                   (1.1) 
In linearly polarised light, the electric field vector oscillates in the same plane 
(Figure 1.9)  
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Figure 1.9.  Parallel and perpendicular linearly polarised electromagnetic radiation. 
Peptides and proteins can contain a number of chromophores, including the 
peptide amide bond, the side chains of aromatic residues and disulphide bonds.  The 
main transitions of the amide bond are the weak, but not strictly forbidden, n–π* transition, 
and two allowed π–π* transitions (Figure 1.10).58 
 
Figure 1.10.  The electronic transitions of the peptide amide bond.  
 These transitions all have transition moments, as do the aromatic amino acids 
tryptophan, tyrosine and phenylalanine.59  Transition moments are vector properties 
describing the intensity and polarization of the transition.  The transition moments of α-
helices, β-sheets, phenylalanine, tryptophan and tyrosine are shown in Figure 1.11. 
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Figure 1.11.  The transition moments of A) an α-helix; B) a β-sheet; C) phenylalanine; D) tryptophan and E) 
tyrosine.
58, 59
  Transition shown in parentheses is weak in intensity. 
 If the transition moment is oriented parallel to the surface of the membrane a 
positive signal is recorded at the wavelength of the transition on the LD spectrum.  If the 
orientation is perpendicular to the surface of the membrane then the signal will be 
negative.  If the sample is not oriented then no net signal will be observed, as the signals 
will cancel out from the interactions of the polarised light with the randomly oriented 
sample molecules.  For the study of membrane peptides and proteins, orientation can be 
achieved through orienting the liposomes to which binding occurs.  The liposomes are 
distorted into ellipses though shear flow in a Couette cell (Figure 1.12).60  The Couette cell 
is composed of two concentric cylinders, between which the sample is placed.  The 
central cylinder is rotated at 3000 rpm during LD experiments, which causes the distortion 
of the liposomes.  
  Introduction 
38 
 
 
Figure 1.12.  Design of LD experiment for the analysis of the binding of membrane proteins to liposomes. 
 In order to calculate the linear dichroism of peptides binding to shear deformed 
liposomes, the distorted liposomes are modelled as in Figure 1.13, where all peptides 
bound to the cylindrical section will be oriented in the same way relative to the polarised 
light.59  By definition the long axis of the liposome is the „parallel‟ orientation and the short 
axis is the „perpendicular‟ orientation.   
 
Figure 1.13.  Illustrations of A) a liposome; B) a shear deformed liposome; C) model of a shear deformed 
liposome with defined perpendicular and parallel axes. 
 Equation 1.2 describes the linear dichroism of peptides bound to liposomes, where 
µ is the transition dipole, α is the angle between the transition moment and the membrane 
normal and S is the scaling factor.  The equation is often described in terms of the 
reduced LD, LDr, which is independent of the concentration of the sample and the 
strength of the transition dipole.  Equation 1.3 is achieved by dividing Equation 1.2 by the 
isotropic absorbance, which is equal to µ2/3 
   
                 
 
         (1.2) 
    
   
  
 
                
 
        (1.3) 
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 Whilst there are uncertainties concerning the mechanisms of peptide binding to 
membranes, circular and in particular linear dichroism spectroscopies (discussed above), 
allied to other methods such as mass spectrometry and fluorescence spectroscopy, have 
the potential to reveal key features of the binding process. The following chapters 
describe experiments conducted to examine the scope of these analytical techniques for 
this purpose.  Initially, the challenge of identifying lipids by mass spectrometric techniques 
is explored.  This is followed by studies of liposome stability in the presence and absence 
of both natural and synthetic samples of a membrane-active peptide (melittin).  The final 
chapter describes investigations into the membrane binding, including characterisation of 
membrane alignment and binding kinetics, of the antimicrobial peptide defensin HNP-2.  
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2 THE IDENTIFICATION OF PHOSPHOLIPIDS BY MASS 
SPECTROMETRY 
2.1 Introduction 
2.1.1 Lipid and bilayer properties 
The properties of cell membranes are influenced by certain features of the lipids 
from which they are composed.  Headgroup composition determines the charge of the 
membrane, which in turn affects the membrane‟s physiological behaviour and interactions 
with other molecules such as peptides and proteins.1  The major phospholipid 
components of the plasma membrane of the gram-negative bacteria E. coli are 
phosphoethanolamine (74% of total lipid composition) and phosphoglycerol (19%), which 
are neutral and negatively charged, respectively, at pH 7 (Table 2.1).  The majority of the 
phospholipid components of human liver plasma membranes are neutral at pH 7, 
including phosphocholine (44%) and phosphoethanolamine (28%), with just a small 
amount of the negative phosphoinositol (9%) and phosphoserine (3%).2   
The bilayer thickness, phase transition and mixing behaviour are features of the 
length and degree of unsaturation of the lipid hydrocarbon chains.3  As can be seen from 
Table 2.1, the bilayer thickness increases by approximately 4 Å for every addition of 
(CH2)2 to the unsaturated acyl chains.  The addition of a double bond reduces the bilayer 
thickness.  The phase transition temperature increases with increasing chain length and 
drops dramatically with increasing unsaturation. 
Table 2.1.  Bilayer properties of saturated phosphocholine lipids.  
 
Lipid Bilayer Thickness      
(hydrocarbon region) (Å) (± 1)4,a 
Tm   (°C)
5 
10:0 15.5 - 
12:0 19.5 -1 
14:0 23 23 
16:0 26 41 
18:0 29.5 55 
18:1 27 -20 
18:2 - -53 
18:3 - -60 
a) Bilayer thickness measurements were obtained by X-ray scattering above the lipid phase transition temperature. 
The position of the double bond of unsaturated lipids is also important, affecting 
the bilayer thickness, the surface area occupied by each lipid molecule and the 
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arrangement of hydrocarbon chains within the bilayer (Table 2.2).6  The surface area per 
molecule increases slowly with the distance of the double bond from the headgroup until 
the double bond is at the middle of the chain (C9 in Table 2.2), then decreases rapidly.  
The bilayer thickness remains stable until the double bond is in the centre of the chain, 
then increases.  These measurements correlate with measurements of the chain order, 
which decreases as the double bond is moved away from the headgroup towards the 
middle of the chain and then increases again as the bond is moved further towards the 
end of the chain.  In lipids with two different acyl chains, the phase transition temperature 
has been shown to decrease as the difference in chain lengths increases, due to the 
decreased attraction between the chains and therefore lower stability of the bilayer.7 
Table 2.2.  Bilayer properties of phosphocholine lipids with C18 chains with no or one double bond.
6 
Double bond 
position 
Area per 
molecule (nm
2
) 
Bilayer thickness 
(P–P) (nm) 
3 0.724 3.72 
5 0.726 3.72 
7 0.728 3.72 
9 (DOPC) 0.731 3.71 
11 0.719 3.77 
13 0.706 3.83 
15 0.686 3.93 
none 0.669 4.02 
 
Due to the strong effects of these different features, it is important to be able to 
fully identify unknown lipids, down to the position of each acyl chain on the central lipid 
glycerol. 
2.1.2 Lipid identification by mass spectrometry 
A number of different mass spectrometers and mass spectrometry techniques 
have been explored in relation to lipid analysis, with the aim of obtaining the maximum 
possible information for lipid identification, especially from samples at low concentrations.  
Different types of matrices have been studied for their suitability for the analysis of lipids 
by matrix-assisted laser desorption/ionisation-mass spectrometry (MALDI-MS).   A solid 
ionic crystal matrix composed of p-nitroaniline and butyric acid was found to be 
particularly suited to the analysis of lipids present in only small quantities, by producing 
strong molecular ion peaks ([M + H]+ for PC and PE lipids, [M + Na]+ for PA, PG and PS 
lipids) in full-scan spectra, with the formation of virtually no other salt adducts and causing 
very little fragmentation.  This gave less complex MS spectra, which is especially 
important when analysing lipid mixtures, and improved tandem mass spectrometry 
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through giving the maximum intensity of parent ions.8  Different isomers of 
dihydroxybenzoic acid (DHB) have also been explored in relation to their suitability for 
phospholipid analysis, though the commonly used 2,5 isomer was found to be best for 
lipid analysis in both positive and negative mode due to it having the optimum acidity 
compared to the other isomers and forming of the smallest crystals and thinnest crystal 
layers.9  The addition of metal salts has been shown to have effects on the product ion 
spectra of lipids analysed using a range of mass spectrometric techniques.  The 
dissociation of PE and PC [lipid + Na]+ product ions by electrospray ionisation-tandem 
mass spectrometry (ESI-MSMS) was demonstrated to achieve greater sensitivity than the 
dissociation of protonated lipids, allowing the characterisation of species present in only 
picomole quantities.10  The analysis of PC lipids by MALDI-post-source decay (MALDI-
PSD) was greatly improved by the addition of NaCl to the sample.  Dissociation of the [M 
+ H]+ parent under these conditions produced a spectrum with only one peak, 
corresponding to [OP(O)2OCH2CH2NMe3]
+, therefore not allowing identification of the acyl 
chains, whereas dissociation of [M + Na]+ produced a product ion spectrum from which 
the acyl chains could be identified.11  MALDI-MSMS analysis of lithium adducts of 
phospholipids has been shown to produce spectra which are more useful for lipid 
identification than those of [M + H]+ and [M + Na]+, with more abundant product ion peaks 
and the presence of pairs of peaks separated by 6 Da corresponding to protonated and 
lithium adducts of fragments.12  It has also been suggested that the addition of a salt to 
lipid mixtures before analysis can improve the identification of the individual lipids by 
separating out overlapping proton and sodium adducts of lipids which may have the same 
mass, such as [18:1/18:2-PC + H]+ and [16:0/18:0-PC + Na]+ (1-oleoyl-2-linoleoyl-sn-3-
phosphocholine and 1-palmitoyl-2-stearolyl-sn-glycero-3-phosphocholine respectively), 
which both have m/z values of 784.58 Da.13  This method works better with metals of 
higher m/z values however, such as Cs+ (132.97 Da), as the lithium adducts of some 
lipids can overlap with the proton adducts of others.13 
 
Figure 2.1.  The sn-1, sn-2 and sn-3 positions on the glycerol backbone of phospholipids, along with the 
hydrocarbon chain sections referred to as R1 and R2. 
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It has been demonstrated that under certain conditions tandem mass spectrometry 
can allow the identification of the arrangement of the two acyl chains at the sn-1 
(stereospecifically numbered-1) and sn-2 positions of the central lipid glycerol (Figure 
2.1).  This can be achieved by comparing the intensity of peaks corresponding to the loss 
of the chain from the sn-1 position with the intensity of those corresponding to the loss of 
the chain from the sn-2 position for analogous fragments.  Under certain conditions a 
difference in intensities has been shown to be diagnostic of the position of the chain.  A 
number of inconsistencies can be observed in the literature referring to the analysis of PC 
and PE lipids in the presence and absence of salts and fragmented by different 
techniques however.10–12, 14–32  Differences can be observed in both the degree of 
fragmentation reported and the relative intensities associated with the fragments.  Reports 
of collision induced dissociation (CID) describe the observation of peaks corresponding to 
the loss of each acyl chain in every case where fragmentation occurred in a sector 
instrument,15, 16, 25, 27, 31, 32 a linear ion trap,21, 23 or a MALDI-TOF/TOF.12, 14, 22  CID in a 
triple quadrupole caused a range of results however: a) no peaks corresponding to the 
cleavage of either acyl chain were observed;18 b) peaks were observed which 
corresponded to the loss of each acyl chain and there were statistical differences in 
intensities of those corresponding to analogous fragmentations at the sn-1 and sn-2 
positions;17, 18, 20, 29 c) peaks were observed which corresponded to the loss of each acyl 
chain but there were no statistical differences in the intensities of those corresponding to 
analogous fragmentations at the sn-1 and sn-2 positions;26 d) a number of peaks 
corresponding to different types of fragmentations at the sn-1 and sn-2 positions were 
observed, and the differences in relative intensities varied between the different fragment 
types.19  Inconsistencies were also observed in the data reported from post source decay 
(PSD) or seamless post source decay (sPSD), where in 50 % of cases peaks 
corresponding to cleavage of the acyl chains were not observed.11, 15, 24  Results reported 
for the fragmentation of [PC + Na]+ lipids highlight the differences observed.  sPSD was 
reported to produce no product ions corresponding to the cleavage at either the sn-1 or 
sn-2 positions,15 yet PSD or CID of [PC + Na]+ in a linear ion trap instrument was shown 
to produce dissociation at the sn-1 and sn-2 positions, with a preferential loss of the chain 
from the sn-1 position observed.11, 23  When the same ion was fragmented by high energy 
CID in a sector instrument however preferential loss of the chain from the sn-2 position 
was observed.27 
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2.1.3 MALDI imaging of lipids and thin layer chromatography plates 
MALDI imaging of lipids is a growing field.  Direct analysis of thin slices of 
biological tissue allows the identification of not only which lipids are present, but also their 
distribution.  This can be used to study diseases which affect lipid production and 
distribution, such as Duchenne muscular dystrophy, which was shown by MALDI imaging 
of mouse muscle tissue to cause differences in certain phosphocholine lipids between 
diseased and healthy muscle.33  MALDI imaging of thin layer chromatography (TLC) 
plates on which lipids have been separated is a more recent development for identifying 
individual lipids from mixtures, and offers advantages over the traditional method of using 
stains to give broad indications of the species which are present on the TLC plate.  The 
separation of lipid mixtures by TLC prior to MALDI analysis also offers advantages for 
lipid identification compared to the direct analysis of the mixture.  The presence of PC 
lipids in samples analysed by MALDI-MS is known to suppress the detection of other lipid 
species, therefore if equal concentrations of different lipid types are present in an 
analysed mixture, peaks corresponding to PC lipids will dominate the mass spectrum.  
This is thought to be due to the increased detection sensitivity of neutral phospholipids, 
such as PC lipids, compared to acidic lipids, with PC lipids having the lowest detection 
limit due to the positive charge of the quaternary ammonium salt.  This means that 
separation of different lipid types before analysis will enhance the detection of non-PC 
lipids.34  A number of different methods have been proposed for the analysis of lipids, and 
non-lipids, separated on TLC plates, from different ways to apply the matrix to the TLC 
plate for direct analysis, to methods of extracting the separated species either to the 
surface of the TLC plate or into a different substrate.35,  36 
2.1.4 MALDI-TOF/TOF MS 
 During MALDI, a laser is fired at a dried mixture of sample and matrix, causing 
both to ablate from a flat conductive surface.  The matrix molecules have a strong 
absorbance at the wavelength of the laser (337 nm), hence will absorb energy from the 
laser radiation and become electronically excited.  Ionised matrix molecules then collide 
with sample molecules and causing the sample molecules to be ionised.  In full scan 
mode, the ions are then accelerated through a potential of 19 kV through the ion optics 
before entering a field-free region.  The polarity of the ion optics determines whether 
positive or negatively charged ions will be extracted and accelerated.  All of the ions with 
the same charge have the same kinetic energy after acceleration (Ek), 19 keV, which 
means that their velocity is dependent on their mass, as shown in Equation 2.1.   Ions 
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with lower masses (m) have greater velocities (v), therefore ions of different mass to 
charge ratio are separated in time.  
   
 
 
                   (2.1) 
In the field free region the ions can undergo metastable decay to produce product ions.  
The product ions travel with the same velocity as the precursor ions from which they were 
formed, but have a lower mass and less kinetic energy. 
  
Figure 2.2.  Schematic diagram of the Bruker Daltonics Autoflex MALDI TOF-TOF mass spectrometer.  
 At the end of the field free region the ions enter the electric field of the reflector.  
The reflector separates the ions, as ions with more kinetic energy will travel further into 
the reflector electric field, taking longer to turn around and exit thus emerging at different 
times relative to the product ions.  The reflector detector can only focus within 
approximately a 30% difference in kinetic energy, therefore only fragments with at least 
70% of the mass of the precursor will be detected.   
 Two types of tandem mass spectrometry can be carried out on the MALDI mass 
spectrometer used for the research described herein.  One is collision induced 
dissociation and the other is LIFT, although both use the LIFT device.  If the LIFT device 
is used the ions are initially only accelerated through 8 kV by the ion optics.  This slows 
the ions down, thus allowing more time for dissociation to occur.  Collision induced 
dissociation occurs if an inert collision gas such as argon is introduced into the collision 
cell situated before the LIFT device (Figure 2.2).  Interactions with the collision gas cause 
the parent ions to undergo different fragmentation than when they fragment through 
metastable decay.  Comparison of the product ion spectra of peptides analysed by LIFT 
and by CID found that a greater proportion of the product ions produced by CID were in 
the lower mass region of the spectrum, and that more internal fragment ions were 
produced by CID.37  A precursor ion selector (PCIS) situated before the LIFT device is 
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used to separate out the required precursor ion and related product ions formed through 
collisions or, in the absence of a collision gas, through metastable decay.  The LIFT 
device is a series of electrodes which raise the kinetic energy of the both the parent and 
daughter ions by 19 keV so that more of the daughter ions have at least 70% of the 
kinetic energy of the parent to enable them to be detected after separation in the reflector.  
As an example, if a precursor ion has 8 keV of kinetic energy, a fragment with 5% of the 
parent mass will have 5% of the kinetic energy of the parent (0.4 keV).  After acceleration 
by 19 keV in the LIFT device the parent will have 27 keV of kinetic energy and the 
daughter will have 19.4 keV, which is now 72% of the kinetic energy of the parent, 
therefore it will be detected after separation in the reflector.38 
2.1.5 The limitations of current methods and scope of this research 
It has been established that product ion spectra of phospholipids can, in some 
cases, reveal the positions of the two acyl chains on the backbone glycerol, although a 
number of discrepancies are apparent within the literature on the topic.  These 
discrepancies mean that the relative intensities of peaks corresponding to the loss of each 
acyl chain reported in one paper may not be extrapolated to interpret data obtained under 
different experimental conditions.  The aim of this work is to establish a validated method 
that could be used for identifying unknown lipids from mixtures, and ultimately to the 
MALDI imaging of lipid bilayers and lipid mixtures separated on TLC plates.  The 
methodology was developed on the basis that the same bilayer or TLC surface could not 
be analysed multiple times, due to the fact that lipid bilayers are very thin and that the 
quantity of lipid brought to the surface of the TLC plate by the addition of the matrix may 
be low.  The method must, if possible, allow all of the molecular ions to be observed in 
one „pass‟ over the surface, and then MSMS analysis could be used on specific areas of 
interest to provide full identification of the lipids.  Determination of the optimum conditions 
depends on a number of factors relating to the analysis, both in terms of the instrument 
used and the systematic protocols deployed.  Key issues are summarised in a–d below:  
 
a) Whether all of the phospholipid classes can be analysed and whether particular 
lipids preferentially produce positive or negative ions. 
b) Establishing the effect of metal salts on MS and MSMS spectra and whether the 
addition of such enhances the spectra in relation to lipid identification. 
c) Determining whether a statistical difference can be observed in the intensities of 
any peaks corresponding to the loss of the acyl chains from the sn-1 and sn-2 positions 
under the conditions established through a) and b). 
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d) The development of a method of carrying out MALDI imaging of TLC plates, and 
the application of the analysis method developed through a) to c) in order to identify 
unknown lipids. 
2.2 Results and discussion 
2.2.1 Lipid analysis by MALDI-MS 
Initially, positive ions of the lipids DOPC, DPPC, POPC, DPPE, POPE, DPPA, 
DOPS and POPG were analysed by MALDI-MS to determine to what degree they could 
be identified.  The MS analysis of each lipid produced peaks corresponding to the 
molecular ion and, in some cases, decomposition fragments (Table 2.3).  The lipids and 
references to „R‟ when discussing fragmentation are described in Figure 2.3.  
O
P
O O
O
R3O
OR1
R2
O
O
sn-1
sn-2
sn-3
POPE/POPC/POPG
R1 = (CH2)14CH3
R2 = (CH2)7CH=CH(CH2)7CH3
DOPC/POPC/DPPC
R3 = CH2CH2
+NMe3
POPE/DPPE
R3 = CH2CH2
+NH3
DOPS
R3 = CH2CH(
+NH3)CO2
DPPA
R3 = OH
POPG
R3 = CH2CH(OH)CH2(OH)
DOPC/DOPS
R1 and R2 = (CH2)7CH=CH(CH2)7CH3
DPPC/DPPA/DPPE
R1 and R2 = (CH2)14CH3
 
Figure 2.3.  Nomenclature used in descriptions of lipids and lipid fragmentation. 
  All of the spectra revealed peaks which allowed the identification of the lipid 
headgroup, either through its neutral loss or through peaks corresponding to the 
headgroup itself.  Two peaks were observed in the spectrum of POPG from which the 
oleoyl chain could be identified (Figure 2.4A), one at m/z 467.3, corresponding to the 
neutral loss of OC(O)CH=CH(CH2)7CH3 from the sn-2 position, and one at m/z 282.3, 
corresponding to [R2COO + H]
+.  Peaks corresponding to the equivalent fragmentation 
involving the palmitoyl chain were not observed.  Neither acyl chain could be identified in 
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the full-scan spectra of the other lipids analysed in positive ion mode, and any 
decomposition species which were used to identify headgoups or acyl chains could not be 
assumed to have been formed during ionisation; the sample may have degraded during 
storage, or the peaks may have been caused by the matrix or contaminants and then 
misidentified.  A matrix-only MS spectrum is shown in Figure 2.4D, and it is apparent from 
this spectrum that a large number of peaks are observed in MS spectra which are not 
related to the sample being analysed, due to the matrix, matrix clusters and any 
contaminants present in the matrix solution or on the target plate.  An example of possible 
misidentification is the peak at m/z 154.0 in all of the spectra.  This is the molecular 
weight of the matrix, 2,5-dihydroxybenzoic acid (DHB), but also corresponds to the 
P(O)2OCH2CH2(OH)CH2OH portion of the headgroup of PG lipids.  Without a matrix blank 
for comparison this peak could be wrongly assigned, and the matrix peak may be 
masking a peak corresponding to this lipid fragment.  For these reasons, MS analysis in 
positive mode with this matrix is not adequate for the complete identification of 
phospholipids. 
 
Figure 2.4.  Full scan MALDI-MS spectra of A) POPG; B) POPC and C) DPPE, and D) a matrix-only 
spectrum.  The samples were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 1:9 (v/v) with 
solutions of DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)) or by spotting just DHB (30 mg/mL) in EtOH/H2O 
(50:50 (v/v)). 
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Table 2.3.  Decomposition products observed in the positive ion MALDI-MS spectra of DOPC, DPPC, DPPE, 
POPE, POPG, DPPA, POPC and DOPS. 
DOPC  DPPC  
m/z Assignment m/z Assignment 
184.1 [OP(O)2OCH2CH2NMe3]
+
  184.3 [OP(O)2OCH2CH2NMe3]
+
 
 786.6 [M + H]
+
  735.4 [M + H]
+
 
POPC  DPPE  
m/z Assignment m/z Assignment 
184.0 [OP(O)2OCH2CH2NMe3]
+
  551.6 [M – OP(O)2OCH2CH2NH3]
+
 
760.7 [M + H]
+
  692.7 [M + H]
+
 
DOPS  DPPA  
m/z Assignment m/z Assignment 
603.7 [M – OP(O)2OCH2CH(NH3)CO2]
+
  551.6 [M – OP(O)2OH + Na]
+
 
788.6 [M + 2H]
+
  671.6 [M + Na + H]
+
 
 POPG   POPE  
m/z Assignment m/z Assignment 
282.3 [R2COO + H]+ 577.6 [M – OP(O)2OCH2CH2NH3]
+
 
467.4 [M – R2COO + H]
+
 592.4 [M – P(O)2OCH2CH2NH3]
+
 
577.6 [M – OP(O)2OCH2CH2(OH)CH2OH]
+
 718.5 [M + H]
+
 
771.4 [M +Na + H]
+
   
 
Table 2.4.  Decomposition products observed in the negative ion MALDI-MS spectra of DPPE, POPE, DOPS, 
POPG and DPPA. 
DPPE POPE 
m/z Assignment m/z Assignment 
675.1 [M – NH3]
-
 437.1 [M – R2COO + H]
-
 
690.6 [M – H]
-
 716.7 [M – H]
-
 
POPG DOPS 
m/z Assignment m/z Assignment 
168.9 [OP(O)2OCH2CH(OH)CH2OH – H]
-
 681.7 [M – OCH2CH(NH3)CO2 – H]
-
 
464.8 [M – R2COO – H]
-
 787.3 [M – H]
-
 
491.3 [M – R1COO – H]
-
   
747.2 [M]
-
   
DPPA   
m/z Assignment   
647.1 [M]
-
   
a) R1 and R2 correspond to the acyl chains at the sn-1 and sn-2 positions respectively 
The negative ions of DOPC, DPPC, POPC, DPPE, POPE, DPPA, DOPS and 
POPG were also analysed by MALDI-MS to determine what structural information could 
be determined.  As shown in Table 2.4, by this method peaks were observed which 
corresponded to the loss of each chain and to the headgroup in the spectrum of POPG.  
A peak corresponding to the loss of the headgroup was observed in the spectrum of 
DOPS, and one corresponding to the neutral loss of the oleoyl chain in the spectrum of 
POPE.  No decomposition products were observed in the spectrum of DPPA, and only the 
neutral loss of NH3 was observed in the spectrum of DPPE.  None of the phosphocholine 
lipids could be ionised in negative mode, which is to be expected given the structure and 
neutral charge of the PC headgroup (Figure 2.3).  Overall, full scan analysis in negative 
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mode was found to be a less informative method of identifying lipids than full scan 
analysis in positive mode, and the lack of ionisation of phosphocholine lipids implied that 
MALDI-MSMS analysis in negative mode would also be unsuitable for the analysis of 
unknown lipids, particularly mixtures. 
2.2.2 MALDI-MS in the absence of a matrix 
 Small molecules can in some cases be analysed without the addition of a matrix, 
giving spectra without interfering matrix peaks.39  This would provide more reliable 
identification of any peaks observed in the MS spectra of lipids and could allow weak 
peaks to be observed which may have been suppressed or overlapped by matrix peaks.  
For this reason, POPG and DPPC were analysed in the absence of a matrix: 1 µL lipid (1 
mg/mL in CHCl3) was spotted onto the target plate and allowed to dry, then initially 
irradiated with a very low laser power.  The laser power was slowly increased to try to find 
the level at which peaks corresponding to the molecular ion or decomposition products 
could be observed, however no peaks corresponding to molecular ions or decomposition 
products were observed even at high laser power. 
2.2.3 Lipid analysis by MALDI-MSMS 
Having concluded that the neither positive nor negative mode MALDI-MS analysis 
provided sufficient information for the identification of all of the lipids, and that, due to the 
lack of ionisation of PC lipids in negative mode, MALDI-MSMS in negative mode would be 
unsuitable, MALDI-MSMS in positive ionisation mode was considered.  This method 
provides more information than MALDI-MS, as product ion spectra of a specific parent ion 
are produced, so all of the peaks observed in the spectrum can be relied upon to have 
originated from the selected ion, without the interference of matrix or contaminants.  
MALDI-MSMS spectra were obtained from [DOPC + H]+, [DPPC + H]+, [DPPA + Na + H]+, 
[DOPS + 2H]+,  [POPE + H]+, [POPG + Na + H]+ and [POPC + H]+.  DPPA and POPG 
were supplied as sodium salts due to their inherent negative charges, and non-sodiated 
parent ions were not observed in the MALDI-MS spectra of either.  The product ions 
observed in the spectra are shown in Table 2.5. 
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Table 2.5.  Product ions observed in the MALDI-MSMS spectra of [DOPC + H]
+
, [POPC + H]
+
, [DPPC + H]
+
, 
[DOPS + 2H]
+
, [POPE + H]
+
, [POPG + Na + H]
+
 and [DPPA + Na + H]
+
. 
[DPPA + Na + H]
+  
[POPC + H]
+
  
m/z Product ion m/z Product ion 
121.0 [OP(O)2OH + Na + 2H]
+
 184.0 [OP(O)2OCH2CH2NMe3]
+
 
239.3 [RCO]
+
 478.2 [M – R2COO]
+
 
415.4 [M + Na – RCOO]
+
 496.2 [M – R2CO + 2H]
+
 
433.4 [M – RCO + Na + 2H]
+
 504.2 [M – R2COO]
+
 
551.7 [M – OP(O)2OH]
+
 522.2 [M – R1CO + 2H]
+
 
573.7 [M + Na – OP(O)2OH –H]
+
 577.4 [M – OP(O)2OCH2CH2NMe3]
+
 
[DOPS + 2H]+  [DOPC + H]
+
  
m/z Product ion m/z Product ion
a
 
184.1 [OP(O)2OCH2CH(NH3)CO2]
+
 184.0 [OP(O)2OCH2CH2NMe3]
+
 
265.3 [RCO]
+
 504.3 [M – RCOO]
+
 
339.4 [M – RCOO – P(O)2OCH2CH(NH3)CO2]
+
 522.2 [M – RCO + 2H]
+
 
506.4 [M – RCOO + H]+ 603.2 [M – OP(O)2OCH2CH2NMe3]
+
 
603.7 [M – OP(O)2OCH2CH(NH3)CO2]
+
   
[POPG + Na + H]
+  
[POPE + H]
+
  
m/z Product ion m/z Product ion 
194.9 [OP(O)2OCH2CH(OH)CH2(OH) + Na + 2H]
+
 282.3 [R2COO + H]
+
 
239.1 [R1CO]
+
 308.3 [R2COOCH2CH2 + H]
+
 
265.1 [R2CO]
+
 436.6 [M – R2COO]+ ]
+
 
415.1 [M– R2CO – OCH2CH(OH)CH2OH +Na + H]
+
 454.3 [M – R2CO + 2H]
+
 
441.1 [M– R1CO – OCH2CH(OH)CH2OH +Na + H]
+
 462.3 [M – R1COO]
+
 
489.1 [M +Na – R2COO]
+
 480.3 [M – R1CO + 2H]
+
 
515.2 [M +Na – R1COO]
+
 577.5 [M – OP(O)2OCH2CH2NH3]
+
 
577.4 [M – OP(O)2OCH2CH(OH)CH2(OH) ]
+
 591.9 [M – P(O)2OCH2CH2NH3]
+
 
599.4 [M – OP(O)2OCH2CH(OH)CH2(OH) + Na – H]
+
   
[DPPC + H]
+
    
m/z Product ion   
183.8 [OP(O)2OCH2CH2NMe3]
+
   
477.8 [M – RCOO]
+
   
495.8 [M – RCO + 2H]
+
   
a) R1 and R2 correspond to the acyl chains and the sn-1 and sn-2 positions respectively 
Each product ion spectrum provided enough information to fully identify the lipids 
analysed, with peaks corresponding to the neutral loss of the headgroup and to the 
neutral loss of each acyl chain observed in the spectrum of each lipid.  Some lipids were 
fragmented more than others.  Only three peaks were observed in the product ion 
spectrum of [DPPC + H]+ from which the lipid could be identified, whereas peaks 
corresponding to five fragments of DOPS were observed.  Some peaks, especially those 
from which the acyl chains could be identified, were very weak.  The effects of the 
addition of metal ions on MSMS spectra were therefore explored, to determine whether 
fragmentation and/or peak intensities could be increased. 
2.2.4 MALDI-MSMS of lipids in presence of metal salts 
2.2.4.1 Analysis of POPE with CaCl2, CuCl2, MgCl2, ZnCl2, LiCl and NaCl 
Initially, the effect of a number of different metal salts on the MS analysis of POPE 
was explored.  Spectra were obtained for POPE with each of CaCl2, CuCl2, MgCl2, ZnCl2, 
LiCl and NaCl and compared to a spectrum obtained in the absence of added salt (Figure 
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2.5 and Table 2.6).  Peaks corresponding to the protonated molecular ion were observed 
at m/z 718.6 in the all of the spectra, however the peak could only be observed weakly in 
the spectra of POPE with magnesium and zinc.  Peaks corresponding to [POPE + Na]+ 
(m/z 740.6), due to Na+ naturally present in the samples, were observed in the spectra 
obtained in the absence of added salt, in the presence of Ca2+, Cu2+ and, to a far lesser 
extent, Zn2+.  Additions of both 63Cu and 65Cu (relative abundance 69:31) to POPE were 
observed in the MS spectrum obtained with CuCl2 at m/z 780.5 and m/z 782.6, 
corresponding to [POPE + 63Cu – H]+ and [POPE + 65Cu – H]+ respectively (Figure 
2.5E).40  The addition of Li+ to POPE generated molecular ion peaks corresponding to 
[POPE + 6Li]+, [POPE + 7Li]+ [POPE – H + 6Li + 7Li]+, and [POPE – H + 27Li]+, though 
[POPE + 6Li]+ and [POPE – H + 6Li + 7Li]+ were present as minor peaks due to the relative 
isotopic abundances of 7.5 and 92.5 for 6Li and 7Li respectively (Figure 2.5B).40  Calcium 
also has a number of isotopes, but the relative abundances of 42Ca, 43Ca, 44Ca, 46Ca and 
48Ca are very low (0.647:0.135:2.07:0.004:0.187) compared to 40Ca (96.9%) and only the 
addition of the most abundant isotope was observed in the MS spectrum of POPE in the 
presence of CaCl2, with a peak at m/z 756.5 corresponding to [POPE + 
40Ca – H]+ (Figure 
2.5D).40  Peaks corresponding to [POPE + Na]+ and [POPE + 2Na – H]+ were observed in 
the spectrum of POPE with NaCl (Figure 2.5C).  The addition of two singly charged metal 
ions to POPE can be attributed to the pKa of the ammonium and phosphate groups, 
which are 9.8 and 1.7 respectively.41  Though POPE has a neutral charge between 
approximately pH 4 and pH 8, the presence of a small population of the negatively 
charged species allows the addition of two singly charged metal ions.  No magnesium or 
zinc adducts of POPE were observed (Figure 2.5F and G respectively).  All of the MS 
spectra revealed peaks corresponding to [M – OP(O)2OCH2CH2NMe3]
+ i.e. loss of the 
metal ion and the headgroup, but there was no evidence of any other decomposition. 
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Figure 2.5.  MALDI-MS spectra of POPE A) in the absence of added salt, and with B) LiCl; C) NaCl; D) CaCl2; 
E) CuCl2; F) MgCl2; and G) ZnCl2.  The samples were prepared by mixing a solution of the lipid in CHCl3 (1 
mg/mL) 1:9 (v/v) with solutions of DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)) or CaCl2 (4.5 mM), CuCl2 (100 
mM), MgCl2 (100 mM), ZnCl2 (100 mM), LiCl (100 mM) or NaCl (100 mM) in EtOH/H2O (50:50 (v/v)) for each 
of the salt adducts respectively. 
MALDI-MSMS analysis was then carried out on [POPE – H + Ca]+, [POPE – H + 
Cu]+, [POPE + Li]+ and [POPE + Na]+, and the resulting product ion spectra compared to 
A 
B
A 
C 
D 
 E 
F 
G 
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that of [POPE + H]+.  It was not possible to isolate the 6Li and 7Li isotope adducts of 
POPE separately for MSMS analysis; discussion of fragments refers only to those 
involving more abundant 7Li isotope.  The main product ions observed in the MSMS 
spectra of [POPE + H]+, [POPE + Li]+, [POPE + Na]+, and [POPE – H + Ca]+ (Figure 2.6) 
are recorded in Table 2.6; the product ion peaks of [POPE – H + Cu]+ were too weak to 
record.  It is possible that the low intensity of the product ions of [POPE – H + Cu]+ was 
due to the two copper isotopes, 63Cu and 65Cu, with relative abundance 69:31, causing 
the signal-to-noise ratio of each fragment to be reduced according to the isotopic 
abundance.40   
Table 2.6.  Product ions observed in the MALDI-MSMS spectra of [POPE + H]
+
, [POPE + Li]
+
, [POPE – H + 
Ca]
+
 and [POPE + Na]
+
. 
[POPE + H]
+
 [POPE + Li]
+
 
m/z Product ion
a 
m/z Product ion 
282.3 [R2COOH]
+
 148.0 [OP(O)2O(CH2)2NH3 + 
7
Li + H]
+
 
308.3 [R2COOCH2CH2]
+
 399.2 [M – R2COO – (CH2)2NH3 + H + 
7
Li]
+
 
436.3 [M – R2COO]
+
 425.2 [M – R1COO – (CH2)2NH3 + H + 
7
Li]
+
 
454.3 [M – R2CO + 2H]
+
 577.2 [M – OP(O)2O(CH2)2NH3]
+
 
462.3 [M – R1COO]
 +
 601.7 [M – P(O)2O(CH2)2NH3 + H + 
7
Li]
+
 
480.3 [M – R1CO + 2H]
+
 681.5 [M – (CH2)2NH3 + 2H + 
7
Li]
+
 
577.5 [M – OP(O)2O(CH2)2NH3]
+
   
591.9 [M – P(O)2O(CH2)2NH3 – 2H]
+
   
[POPE + Na]
+
  [POPE + Ca]+  
m/z Product ion m/z Product ion 
145.9 [P(O)2(CH2)2NH3 – H + Na]
+
 163.9 [P(O)2O(CH2)2NH3 + Ca]
+
 
164.0 [OP(O)2O(CH2)2NH3 + H + Na]
+
 180.0 [OP(O)2O(CH2)2NH3 + Ca]
+
 
239.0 [R1CO]
+
 431.2 [M –  R2COO –  CH2CH2NH3 + Ca]
+
 
265.0 [R2CO]
+
 457.2 [M – R1COO – CH2CH2NH3 + Ca]
+
 
415.0 [M – R2CO – O(CH2)2NH3 + H 
+
 Na]
+
 474.3 [M –  R2COO – 2H + Ca]
+
 
420.4 [M – R2COO – NH3 + 2H]
+
 500.3 [M – R1COO – 2H + Ca]
+
 
441.1 [M – R2COO NH3 – H + Na]
+
 577.5 [M – OP(O)2O(CH2)2NH3]
+
 
446.3 [M – R1COO – NH3 + 2H]
+
   
458.0 [M – R2COO – H + Na]
+
   
466.8 [M – R1COO NH3 – H + Na]
+
   
484.1 [M – R1COO – H + Na]
+
   
577.5 [M – OP(O)2O(CH2)2NH3]
+
   
599.4 [M – OP(O)2O(CH2)2NH3 – H + Na]
+
   
a) R1 and R2 correspond to the acyl chains and the sn-1 and sn-2 positions respectively 
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Figure 2.6.  MALDI-MSMS spectra of A) [POPE + H]
+
; B) [POPE + Na]
+
; C) [POPE + Li]
+
 and D) [POPE – H + 
Ca]
+
.  The samples were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 1:9 (v/v) with solutions 
of DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)) or NaCl (100 mM), LiCl (100 mM) or CaCl2 (4.5 mM) in 
EtOH/H2O (50:50 (v/v)) for each of the salt adducts respectively. 
 [POPE + Li]+, [POPE – H + Ca]+ and [POPE + Na]+ were all shown to give more 
clear product ion spectra than the protonated species.  The peaks corresponding to the 
neutral loss of the acyl chains from the Na+ and Li+ adducts (Figures 2.6B and C 
respectively) had the greatest intensity relative to the peaks corresponding to the 
headgroup or neutral loss of the headgroup, compared to the spectra of the Ca2+ adduct 
(Figure 2.6D) and the protonated lipid (Figure 2.6A).  Further comparisons were therefore 
carried out between POPC and POPE MSMS spectra obtained in the presence and 
absence of LiCl and NaCl to determine which gave the most useful spectrum for lipid 
identification in terms of the amount of fragmentation, the nature of the fragmentations 
and the signal-to-noise ratio. 
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2.2.4.2 MALDI-MS analysis of POPC and POPE in the presence of LiCl and NaCl 
and in the absence of added salt 
 The MALDI-MS spectrum of POPE in the absence of added metal salts showed 
three molecular ions, corresponding to [M + H]+, [M + Na]+ and [M + K]+, in order of 
increasing mass and decreasing intensity (Figure 2.5A).  The spectrum obtained in the 
presence of added Na+ (Figure 2.5C) also contained three molecular ions, corresponding 
to [M + H]+, [M + Na]+ and [M + 2Na – H]+, with the peak corresponding to [M + Na]+ the 
most intense and that corresponding to [M + H]+ the weakest.  In the presence of added 
Li+ (Figure 2.5B), a peak corresponding to [M + H]+ was weak, one corresponding to [M + 
7Li]+ more intense, and one corresponding to [M + 27Li – H]+ more intense again.  This trio 
of peaks was separated by 6 Da each.  The observation of molecular ion peaks separated 
by 6 Da in the presence of lithium may provide a useful visual indication of the masses of 
molecular ions in full scan MS spectra of lipid mixtures.  Minor peaks corresponding to [M 
+ 6Li]+ and [M + 26Li – H]+ were also observed. 
 Hydrogen, sodium and potassium adducted molecular ion peaks were also 
observed in the MALDI-MS spectrum of POPC (Figure 2.7A), again with [M + H]+ the most 
intense and [M + K]+ the weakest.  In the presence of the sodium salt (Figure 2.7C), only 
protonated and singly sodiated molecular ions were observed, with [M + H]+ more intense 
than [M + Na]+.  Similarly, in the spectrum obtained in the presence of the lithium salt 
(Figure 2.7B) only peaks corresponding to [M + H]+, [M + 6Li]+ and [M + 7Li]+ were 
observed, with the peak corresponding to [M + H]+ slightly more intense than that of [M + 
7Li]+ and [M + 6Li]+ present as a minor peak.  The H and 7Li adducts were again separated 
by only 6 Da, making them clearly identifiable.  The observation of only single sodium and 
lithium adducts of POPC, compared to the addition of two metal ions to POPE, is due to 
the phosphocholine headgroup having only one ionisable group at physiological pH, 
allowing only the single metal adducts. 
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Figure 2.7.  MALDI-MS spectra of POPC A) in the absence of added salt, and with B) LiCl and C) NaCl.  The 
samples were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 1:9 (v/v) with solutions of DHB (30 
mg/mL) in EtOH/H2O (50:50 (v/v)) or LiCl (100 mM) or NaCl (100 mM) in EtOH/H2O (50:50 (v/v)). 
2.2.4.3 MALDI-MSMS of POPE in the presence of LiCl and NaCl and in the absence 
of added salt 
The dominant peak in the product ion spectrum of [POPE + H]+ (Figure 2.6A, 
Table 2.6) corresponds to the neutral loss of the headgroup, [M – OP(O)2O(CH2)2NH3]
+, at 
m/z 577.5, and the next most intense corresponds to the neutral loss of P(O)2O(CH2)2NH3 
at m/z 591.9.  Two pairs of peaks were observed which correspond to the loss of the 
palmitoyl or oleoyl chain, [M – RxCOO]+ and [M – RxCO + 2H]
+, and two more peaks were 
observed which correspond to fragments involving the chain from the sn-2 position, 
[R2COOH]
+ and [R2COOCH2CH2]
+, though peaks corresponding to their analogous sn-1 
fragments were not observed.  All of these peaks were very weak in relation to those 
corresponding to fragments involving the loss of the headgroup.  The product ion 
spectrum of the sodium adduct of POPE (Figure 2.6B, Table 2.6) contained a number of 
intense peaks corresponding to the headgroup or to the neutral loss of the headgroup, 
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with and without the sodium ion.  These were observed at m/z 145.9, m/z 164.0, m/z 
577.5 and m/z 599.4, corresponding to [P(O)2(CH2)2NH3 – H + Na]
+, [OP(O)2(CH2)2NH3 + 
H + Na]+, [M – OP(O)2(CH2)2NH3]
+ and [M – OP(O)2O(CH2)2NH3 – H + Na]
+ respectively.  
Four pairs of peaks were observed from which the acyl chains could be identified.  The 
most intense of these pairs corresponds to [M – RxCO – OCH2CH2NH3 + H + Na]
+, at m/z 
415.0 and m/z 441.1 for fragmentation at the sn-2 and sn-1 positions respectively.  The 
other pairs of peaks, corresponding to [RxCO]
+, [M – RxCOO – NH3 + 2H]
+ and [M – 
RxCOO – H + Na]
+, were also relatively intense in relation to the peaks corresponding to 
the presence or loss of the headgroup and when compared with the acyl chain fragment 
peaks in the product ion spectrum of [POPE + H]+.  As with the spectrum of [POPE + 
Na]+, the product ion spectrum of [POPE + Li]+ (Figure 2.6C, Table 2.6) was dominated by 
four peaks corresponding to fragments involving the cleavage of the headgroup, namely 
[OP(O)2O(CH2)2NH3 + Li + H]
+, [M – OP(O)2O(CH2)2NH3]
+, [M – P(O)2O(CH2)2NH3 + H + 
Li]+ and [M – (CH2)2NH3 + 2H + Li]
+ at m/z 147.9, m/z 577.2, m/z 601.7 and m/z 681.5 
respectively.  Only one pair of peaks was observed from which the acyl chains could be 
identified, corresponding to [M – R1COO – (CH2)2NH3 + H + Li]
+ and [M – R2COO – 
(CH2)2NH3 + H + Li]
+ at m/z 425.2 and m/z 399.2 respectively, however these peaks were 
both intense.  Weak peaks could also be observed at m/z 405 and m/z 431.  These are 
double lithium adducts of the [M – RxCOO – (CH2)2NH3 + H + Li]
+ fragments due to 
incomplete isolation of the [POPE + Li]+ parent, despite an isolation window of ± 5 Da. 
2.2.4.4 MALDI-MSMS of POPC in the presence of LiCl and NaCl and in the absence 
of added salt. 
Table 2.7 and Figure 2.8 show the product ion spectra and peak assignments for 
[POPC + H]+, [POPC + Na]+ and [POPC + Li]+.  All of these spectra revealed peaks from 
which the identity of the headgroup and both chains could be determined.  As with the 
analysis of POPE, it was not possible to isolate the 6Li and 7Li isotope adducts of POPC 
separately for MSMS analysis and discussion of fragments refers only to those involving 
more abundant 7Li isotope.  The dominant peak in each spectrum corresponded to 
[OP(O)2(CH2)2NMe3+ 2H]
+, and all spectra also showed peaks corresponding to [M – 
OP(O)2(CH2)2NMe3]
+, which were intense in the spectra of the salt adducts but weak in 
the spectrum obtained in the absence of salt.  In the product ion spectra of [POPC + Na]+ 
and [POPC + Li]+ (Figure 2.8B and C) peaks corresponding to [M – OP(O)2(CH2)2NMe3 – 
H + Na]+ and [M – OP(O)2(CH2)2NMe3 – H + Li]
+ were also observed.  Determination of 
both lipid chains is also essential for lipid identification.  Two pairs of peaks were 
observed in the spectrum of [POPC + H]+ (Figure 2.8A) from which both lipid chains could 
be identified.  The peaks corresponding to [M – R1CO + 2H]
+ and [M – R2CO + 2H]
+ were 
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both relatively intense in comparison to the other peaks in the spectrum.  The spectrum of 
[POPC + Na]+ revealed four pairs of peaks involving the loss of an acyl chain.  Of these, 
[M – R1COO – NMe3 – H + Na]
+ and [M – R2COO – NMe3 – H + Na]
+ were the most 
intense, but were still relatively weak compared to the rest of the spectrum.  The peaks 
corresponding to [RxCO]
+ were particularly weak.  Four pairs of peaks corresponding to 
the loss of an acyl chain were also observed in the spectrum of [POPC + Li]+.  Of these, 
the pairs of peaks corresponding to [M – RxCOO – NMe3 – H + Li]
+, [M – RxCOO]
+ and [M 
– RxCOO – H + Li]
+ were all relatively strong in comparison to the other peaks in the 
spectrum, especially when compared to the peaks corresponding to the loss of an acyl 
chain in the MSMS spectra of POPC obtained with sodium and in the absence of an 
added salt.  Pairs of peaks separated by 6 mass units, corresponding to protonated and 
lithiated fragments, could be observed in the spectrum of [POPC + Li]+ in the same way 
as the molecular ions in the full-scan mass spectra of both lipids.  Examples were 
observed at m/z 478.1 and m/z 484.3, corresponding to [M – R2COO]
+ and [M – R2COO – 
H + Li]+ and m/z 504.4 and m/z 510.3, corresponding to [M – R1COO]
+ and [M – R1COO – 
H + Li]+ respectively.  Peaks could also be observed at m/z 432 and m/z 458 in the 
product ion spectrum of [POPC + Li]+.  These are assigned as metastable due to their 
peak shapes. 
Table 2.7.  Product ions observed in the MALDI-MSMS spectra of [POPC + Li]
+
, [POPC + Na]
+
, and [POPC + 
H]
+
. 
 [POPC + Li]
+
 [POPC + Na]
+
 
 m/z Product ion m/z Product ion 
184.1 [OP(O)2(CH2)2NMe3+ 2H]
+
 183.7 [OP(O)2(CH2)2NMe3+ 2H]
+
 
239.3 [R1CO]
+
 239.3 [R1CO]
+
 
265.1 [R2CO]
+
 265.3 [R2CO]
+
 
425.2 [M – R2COO – NMe3 – H + Li]
+
 441.2 
 
[M – R2COO – NMe3 – H + Na]
+
 
451.2 [M – R1COO – NMe3 – H + Li]
+
 467.2 [M – R1COO – NMe3 – H + Na]
+
 
478.1 [M – R2COO]
+
 478.3 [M – R2COO]
+
 
484.3 [M – R2COO – H + Li]
+
 500.3 [M – R2COO – H + Na]
+
 
504.4 [M – R1COO]
+
 504.3 [M – R1COO]
+
 
510.3 [M – R1COO – H + Li]
+
 526.3  [M – R1COO – H + Na]
+
 
577.0 [M – OP(O)2(CH2)2NMe3]
+
 577.5 [M – OP(O)2(CH2)2NMe3]
+
 
583.5 [M – OP(O)2(CH2)2NMe3 – H + Li]
+
 599.7 [M – OP(O)2(CH2)2NMe3 – H + Na]
+
 
[POPC + H]
+
   
m/z Product ion   
184.1 [OP(O)2(CH2)2NMe3 + 2H]
+
   
478.2 [M – R2COO]
+
   
496.2 [M – R2CO + 2H]
+
   
504.4 [M – R1COO]
+
   
522.2 [M – R1CO + 2H]
+
   
577.0 [M – OP(O)2(CH2)2NMe3]
+
   
a) R1 and R2 correspond to the acyl chains and the sn-1 and sn-2 positions respectively 
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Figure 2.8.  MALDI-MSMS spectra of A) [POPC + H]
+
; B) [POPC + Na]
+
; and C) [POPC + Li]
+
.  The samples 
were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 1:9 (v/v) with solutions of DHB (30 mg/mL) 
in EtOH/H2O (50:50 (v/v)), or NaCl (100 mM) or LiCl (100 mM) in EtOH/H2O (50:50 (v/v)) respectively. 
2.2.4.5 Comparison of POPE and POPC fragmentation in the presence of LiCl, 
NaCl and in the absence of added salt 
For both of the lipids, lithium and sodium adducts gave more useful product ion 
spectra for lipid identification than the spectra of [M + H]+.  This was particularly noticeable 
for the fragments involving the loss of the acyl chains.  Although the presence of salt ions 
did not always cause a greater number of these fragments, they were more intense 
compared to the other peaks in the spectra, in both cases.  The product ion spectrum 
obtained in the presence of Li+ was the most useful of the three obtained for POPC in 
terms of the ease of lipid identification.  Although the same number of fragments involving 
the acyl chains were observed in the spectrum of [POPC + Na]+, the signal-to-noise ratio 
was much better in the spectrum of the lithium adduct.  In the case of POPE, the product 
ion spectrum of [POPE + Na]+ contained more fragments from which the lipid could be 
identified, especially the acyl chains, but they were of no greater intensity than those in 
the spectrum of [POPE + Li]+.  Overall, using the results from both lipids, the addition of 
lithium is more useful than the addition of sodium for the MSMS analysis of lipids.    
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2.2.4.6 The effect of LiCl concentration 
An investigation was carried out into the effects of LiCl concentration on MALDI-
MSMS spectra to determine if there was an optimum concentration for the analysis for 
POPE and POPC.  The normalised intensities of a number of lipid fragments were 
averaged for eight repeat analyses at each of six LiCl concentrations from 5 mM to 100 
mM.  As figures 2.9 and 2.10 show, no statistical differences were observed in the spectra 
of POPE or POPC over the range of concentrations analysed. 
 
Figure 2.9.  Normalized intensities of [POPE + Li]
+
 fragment peaks with varying [LiCl] (5, 10, 20, 30, 50, 100 
mM).  The peaks with m/z 148, m/z 399 , m/z 425 and m/z 577 refer to the fragments [OP(O)2O(CH2)2NH3 + Li 
+ H]
+
, [M – R2COO – (CH2)2NH3 + H + Li]
+
, [M – R1COO – (CH2)2NH3 + H + Li]
+
, and [M – 
OP(O)2O(CH2)2NH3]
+
 respectively.  Error bars represent two times the standard deviation from 8 repeat scans 
in each case. 
 
  The identification of phospholipids by 
  mass spectrometry 
65 
 
 
Figure 2.10.  Normalized intensities of [POPC + Li]
+
 fragment peaks with varying [LiCl] (5, 10, 20, 30, 50, 100 
mM).  The peaks with m/z 184, m/z 425, m/z 451, m/z 478, m/z 484, m/z 504, m/z 510 and m/z 577 refer to 
the fragments [OP(O)2(CH2)2NMe3+ 2H]
+
, [M – R2COO – NMe3 – H + Li]
+
, [M – R1COO – NMe3 – H + Li]
+
, [M 
– R2COO]
+
, [M – R2COO – H + Li]
+
, [M – R1COO]
+
, [M – R1COO – H + Li]
+
 and [M – OP(O)2(CH2)2NMe3]
+
 
respectively.  Error bars represent two times the standard deviation from 8 repeat scans in each case.  R1 and 
R2 are described in Figure 2.3. 
2.2.5 Acyl chain identification 
It has been stated in the literature that in some cases a comparison of the relative 
intensities of peaks corresponding to fragmentations at the sn-1 and sn-2 positions can be 
used to identify which acyl chain is situated at which position on the lipid glycerol 
backbone.10–12, 14–32  In order to determine whether this could be used to identify lipids 
under the conditions found to give the clearest product ion spectra for lipid identification, 
as described in Sections 2.2.3 and 2.2.4, POPC and POPE were each fragmented 24 
times in the presence of LiCl, NaCl and in the absence of added salt to see if statistical 
differences could be observed in the relative intensities of any product ion peaks 
corresponding to losses of the acyl chains.  Although LiCl had been shown to give more 
useful product ion spectra for lipid identification than NaCl, this did not rule out NaCl 
giving as good or better relative intensity data from which the position of the lipid acyl 
chains could be determined. 
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Figure 2.11.  Identities of fragmentations of POPC, OPPC and POPE used for the comparison of relative 
intensities of cleavages at the sn-1 and sn-2 position. 
2.2.5.1 POPE 
Table 2.8 shows all of the fragment types involving the loss of the palmitoyl or 
oleoyl chain from POPE observed in the spectra obtained in the absence of added salt 
and in the presence of either lithium or sodium ions.  For each fragment type, the intensity 
of the peak corresponding to a loss from the sn-1 position has been normalised relative to 
the intensity of the peak corresponding to a loss from the sn-2 position, with the data in 
Table 2.8 and Figure 2.12 showing results averaged from 24 spectra.  Two pairs of 
fragments of [POPE + H]+ were identified, both of which showed a preferential loss from 
the sn-2 position.  For the [i]+ fragments of [POPE + Li]+, a preferential loss of the acyl 
chain from the sn-1 position was observed.  Of the four pairs of peaks corresponding to 
the loss of an acyl chain from [POPE + Na]+, in two cases no difference in relative 
intensities was observed within an error of two times the standard deviation.  For the [i]+ 
fragments, a slight preference for [R1CO]
+ was observed, but this was only just outside 
error.  A clear preference for the loss of the chain from the sn-1 position was observed for 
the [M – ii – iv + 2H]+ fragments however.  A number of points can be made from this 
data.  Firstly, different product ions involving the acyl chains were shown to be formed 
depending on the presence or absence of salt ions, with many more fragments of [POPE 
+ Na]+ observed than of the other two parent ions.  Secondly, the relative intensities were 
different for each type of fragment from each parent ion.  The two pairs of fragments of 
[POPE + H]+ had different relative intensities, as did the four pairs of fragments of [POPE 
+ Na]+, and different relative intensities were observed for the analogous fragments of 
[POPE + Li]+ and [POPE + Na]+, [M – ii – v + H + Li]+ and [M – ii – v + H + Na]+.  Thirdly, in 
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the absence of added salt, preferential losses of the chain from the sn-2 position were 
observed, while in the presence of Na or Li the chain was preferentially lost from the sn-1 
position.  The greatest difference in relative intensity was observed for the [M – i + 2H]+ 
fragment of [POPE + H]+, but at least one fragment type was observed for each parent 
where the acyl chain position could be determined from relative intensities. 
Table 2.8.  Product ions corresponding to the loss of the acyl chain from the sn-1 or sn-2 positions of POPE 
observed in the MALDI-MSMS spectra of [POPE + H]
+
 and [POPE + Li]
+
.  The relative intensities of peaks 
corresponding to the loss of the acyl chains from the sn-1 and sn-2 positions have been normalized with 
respect to one another for each type of fragment. 
 Parent ion Fragment
a 
Relative intensity  
x = 1 
Relative intensity  
x = 2 
a [POPE + H]
+
  [M – ii]
+
 0.43 ± 0.05
b 
0.57 ± 0.05 
b [POPE + H]
+
 [M – i + 2H]
+
 0.28 ± 0.03 0.72 ± 0.03 
c [POPE + Li]
+
  [M – ii – v + H + Li]
+
 0.60 ± 0.05 0.40 ± 0.05 
d [POPE + Na]
+
 [i]
+
 0.57 ± 0.06 0.43 ± 0.06 
e [POPE + Na]
+
 [M – ii – H + Na]
+
 0.56 ± 0.10 0.44 ± 0.10 
f [POPE + Na]
+
 [M – ii – v + H + Na]
+
 0.55 ± 0.05 0.45 ± 0.05 
g [POPE + Na]
+
 [M – ii – iv + 2H]
+
 0.63 ± 0.06 0.37 ± 0.06 
a) x = 1 and x = 2 correspond to sn-1 and sn-2 positions of lipid respectively.   
b) The error corresponds to two times the standard deviation. 
 
Figure 2.12.  The relative intensities of peaks corresponding to loss of the acyl chain from the sn-1 and sn-2 
positions of different types of fragments of POPE from MSMS spectra of [POPE + H]
+
, [POPE + Li]
+
 and 
[POPE + Na]
+
.  The white sections correspond to a loss from sn-1 position, shaded to the sn-2 position.  Refer 
to Table 2.8 for identification of a–g.  The error bars correspond to two times the standard deviation of the 
data. 
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2.2.5.2 POPC 
The data from POPC were analysed in the same way as those of POPE, and the 
relative intensities of all of the peaks corresponding to the loss of an acyl chain from 
[POPC + H]+, [POPC + Li]+ and [POPC + Na]+ are shown in Table 2.9 and Figure 2.13.  
Two types of fragmentation of [POPC + H]+ were observed which involved the loss of an 
acyl chain, [M – ii]+ and [M – i + 2H]+.  No difference in relative intensity was observed 
between the peaks corresponding to [M – R1COO]
+ and [M – R2COO]
+ within the margin 
of error, but a preferential loss from the sn-2 position was observed for the [M – i + 2H]+ 
fragments.  Of the four different types of [POPC + Li]+ fragmentation involving the loss of 
an acyl chain, no difference in intensity within the margin of error was observed between 
the peaks corresponding to [M – ii]+ but the other three fragmentations all showed 
preferential cleavage at the sn-1 position.  Three of the four fragmentations of [POPC + 
Na]+ showed no preferential cleavage at the sn-1 or sn-2 position, and the fourth 
fragmentation showed only a slight preference for the loss of the acyl chain from the sn-1 
position, with a relative intensities of 0.59 ± 0.08 and 0.41 ± 0.08 for [M – R1COO – H + 
Na]+ and [M – R2COO – H + Na]
+ respectively.  As with POPE, differences were observed 
between the fragmentation of the three parents, though the product ions of the sodium 
and lithium adducts were analogous.  The protonated parent ion showed a preferential 
loss from the sn-2 position, while the salt adducts were preferentially cleaved at the sn-1 
position, the same results as observed for the fragmentation of POPE.  Similarly to POPE, 
differences could be observed in the relative intensities of the fragments of the three 
POPC parent ions, but some similarities could also be noted.   
 
The four fragmentations of [POPC + Li]+ and [POPC + Na]+  were analogous, but 
the same relative intensity results were only observed for two pairs of peaks.  The [M – ii 
– H + salt]+ fragmentations showed preferential cleavage at the sn-1 position, though the 
preference was only slight for the fragments of [POPC + Na]+.  There was no preferential 
loss of either acyl chain from either parent ion within the margin of error for the peaks 
corresponding to [M – ii]+.  A preferential loss of the chain from the sn-1 position was 
observed for the other two fragments of [POPC + Li]+, [i]+ and [M – ii – iv – H + Li]+, while 
no preferential loss of either chain was observed for the same two fragmentations of 
[POPC + Na]+.  Peaks corresponding to [M – ii]+ could be observed in all three spectra, 
with no preferential cleavage at the sn-1 or sn-2 positions of any of the parent ions.  The 
greatest difference in relative intensities was observed between the [M – R1CO + 2H]
+ and 
[M – R2CO + 2H]
+ fragments of [POPC + H]+, but the most information was provided by 
the fragmentation of the [POPC + Li]+ parent ion, which produced three pairs of peaks 
where a clear difference in intensity could be observed.  Fragmentation of the [POPC + 
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Na]+ parent ion gave little information from which the positions of the acyl chains on the 
glycerol backbone could be determined. 
Table 2.9.  Product ions corresponding to the loss of the acyl chain from the sn-1 or sn-2 positions of POPC 
observed in the MALDI-MSMS spectra of [POPC + H]
+
 and [POPC + Li]
+
.  The relative intensities of peaks 
corresponding to the loss of the acyl chains from the sn-1 and sn-2 positions have been normalized with 
respect to one another for each type of fragmentation. 
 Parent ion Fragment
a 
Relative intensity  
x = 1 
Relative intensity  
x = 2 
a [POPC + H]
+
  [M – ii]
+
 0.55 ± 0.06
b 
0.45 ± 0.06 
b [POPC + H]
+
 [M – i + 2H]
+
 0.28 ± 0.03 0.72 ± 0.03 
c [POPC + Li]
+
 [i]
+
 0.61 ± 0.04  0.39 ± 0.04 
d [POPC + Li]
+
  [M – ii]
+
 0.53 ± 0.03 0.47 ± 0.03 
e [POPC + Li]
+
  [M – ii – H + Li]
+
 0.64 ± 0.04 0.36 ± 0.04 
f [POPC + Li]
+
 [M – ii – iv – H + Li]
+
 0.64 ± 0.03 0.36 ± 0.03 
g [POPC + Na]
+
 [i]
+
 0.57 ± 0.11 0.43 ± 0.11 
h [POPC + Na]
+
 [M – ii]
+
 0.45 ± 0.10 0.55 ± 0.10 
i [POPC + Na]
+
 [M – ii – H + Na]
+
 0.59 ± 0.08 0.41 ± 0.08 
j [POPC + Na]
+
 [M – ii – iv – H + Na]
+
 0.56 ± 0.10 0.44 ± 0.10 
a) x = 1 and x = 2 correspond to sn-1 and sn-2 positions of lipid respectively.   
b) The error corresponds to two times the standard deviation. 
 
Figure 2.13.  The relative intensities of peaks corresponding to loss of the acyl chain from the sn-1 and sn-2 
positions of different types of fragments of POPC from MSMS spectra of [POPC + H]
+
, [POPC + Li]
+
 and 
[POPC + Na]
+
.  The white sections correspond to a loss from sn-1 position, shaded to the sn-2 position.  Refer 
to Table 2.9 for identification of a–j.  The error bars correspond to two times the standard deviation of the 
data. 
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2.2.5.3 Comparison of POPE and POPC acyl chain fragmentation 
Some similarities could be observed between the results of the fragmentation of 
the two lipids.  [POPE + H]+ and [POPC + H]+ fragmented in analogous ways, producing 
[M – ii]+ and [M – i + 2H]+ ions with comparable relative intensities.  [POPE + Li]+ and 
[POPC + Li]+ produced similar fragments involving the loss of a portion of the headgroups, 
[POPE – ii – v + H + Li]+ and [POPC – ii – iv – H + Li]+, and the relative intensities of the 
peaks were similar for the two parents.  The product ion spectra of [POPE + Na]+ and 
[POPC + Na]+ also showed some similarities, with pairs of peaks corresponding to [i]+ and 
[M – ii – H + Na]+ observed in both spectra. 
 Overall, the positions of the acyl chains could be determined from the product ion 
spectra of POPE in the presence of Li+, Na+ or in the absence of a salt, and for POPC 
they could be clearly determined in the presence or absence of Li+.   
2.2.5.4 Comparison of analysis of POPC by LIFT and CID 
In order to test whether fragmentation by CID produced different relative intensities 
of peaks corresponding to fragmentation at the sn-1 or sn-2 positions from those obtained 
by LIFT, 25 CID spectra were collected of [POPC + H]+ and [POPC + Li]+.  Figure 2.14 
shows CID and LIFT spectra of [POPC + Li]+.  The relative intensities of the fragments 
which involved the loss of an acyl chain are shown in Table 2.10 and Figure 2.15, with the 
relative intensities of the LIFT data for comparison. 
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Figure 2.14.  A) CID and B) LIFT MALDI-MSMS spectra of POPC with lithium.  The samples were prepared 
by mixing a solution of the lipid in CHCl3 (1 mg/mL) 1:9 (v/v) with a solution of LiCl (100 mM) and DHB (30 
mg/mL) in EtOH/H2O (50:50 (v/v)). 
Table 2.10.  Product ions corresponding to the loss of the acyl chain from the sn-1 or sn-2 positions of POPC 
observed in CID and LIFT spectra of [POPC + H]
+
 and [POPC + Li]
+
.  The relative intensities of peaks 
corresponding to the loss of the acyl chains from the sn-1 and sn-2 positions have been normalized with 
respect to one another for each type of fragmentation. 
 
Parent ion Fragmentation 
method 
Fragment
a 
Relative intensity            
x = 1 
Relative intensity     
x = 2 
 [POPC + H]
+
 LIFT [M – ii]
+
 0.55 ± 0.06
b 
0.45 ± 0.06 
a [POPC + H]
+
 CID [M – ii]
+
 0.45 ± 0.16 0.55 ± 0.16 
 [POPC + H]
+
 LIFT [M – i + 2H]
+
 0.28 ± 0.03 0.72 ± 0.03 
b [POPC + H]
+
 CID [M – i + 2H]
+
 0.29 ± 0.08 0.71 ± 0.08 
 [POPC + Li]
+
 LIFT [i]
+
 0.61 ± 0.04  0.39 ± 0.04 
c [POPC + Li]
+
 CID [i]
+
 0.61 ± 0.11  0.39 ± 0.11 
 [POPC + Li]
+
 LIFT [M – ii]
+
 0.53 ± 0.03 0.47 ± 0.03 
d [POPC + Li]
+
 CID [M – ii]
+
 0.53 ± 0.06 0.47 ± 0.06 
 [POPC + Li]
+
 LIFT [M – ii – H + Li]
+
 0.64 ± 0.03 0.36 ± 0.03 
e [POPC + Li]
+
 CID [M – ii – H + Li]
+
 0.59 ± 0.08 0.41 ± 0.08 
 [POPC + Li]
+
 LIFT [M – ii – iv – H + Li]
+
 0.64 ± 0.04 0.36 ± 0.04 
f [POPC + Li]
+
 CID [M – ii – iv – H + Li]
+
 0.50 ± 0.08 0.50 ± 0.08 
a) x = 1 and x = 2 correspond to sn-1 and sn-2 positions of lipid respectively.  
b) The error corresponds to two times the standard deviation.  
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Three observations were made from comparison of the LIFT and CID data.  Firstly, 
the same fragments involving the loss an acyl chain were produced by each 
fragmentation method, in both of the presence and absence of Li+.  This is despite the fact 
that, as can be observed in the CID and LIFT spectra of [POPC + Li]+ in Figure 2.14, CID 
caused more fragmentation of the lipid than LIFT.  Secondly, for all but one fragment type 
the average relative intensities were very similar (ignoring the case of the [M – ii]+ 
fragments of [POPC + H]+ where, although a difference in average relative intensities 
could be observed within an error of two times standard deviation, neither the LIFT or the 
CID data showed statistical differences in relative intensities).  A difference was observed 
between the LIFT and CID results for the [M – ii – iv – H + Li]+ fragments of [POPC + Li]+, 
where a clear preferential loss from the sn-1 position was observed when LIFT was 
carried out but the relative intensities were 0.5:0.5 within the margin of error for fragments 
produced by CID.  The final observation referred to the reproducibility of the relative 
intensities.  The errors of two times the standard deviation were at least twice as great for 
the CID data than for the LIFT data.  This was notable for the [i]+ fragmentation of [POPC 
+ Li]+, where the average relative intensities were the same for fragmentation by LIFT and 
CID, but the variation in the CID data meant that the relative intensities were 0.5:0.5 
within error, while for fragmentation by LIFT the error was smaller and a statistical 
difference could be observed in the relative intensities. 
 
Figure 2.15.  The relative intensities of peaks corresponding to loss of the acyl chain from the sn-1 and sn-2 
positions of different types of fragments of POPC from CID spectra of [POPC + H]
+
 and [POPC + Li]
+
.  The 
white sections correspond to a loss from sn-1 position, shaded to the sn-2 position.  Refer to Table 2.10 for 
identification of a–f.  The error bars correspond to two times the standard deviation of the data. 
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2.2.5.5 Comparison of POPC and OPPC acyl chain fragmentation 
Though the results of the acyl chain fragmentation of POPC and POPE are 
repeatable, in isolation it cannot be proved that the difference in relative intensities is due 
to the position of the chains on the lipid glycerol rather than to the differences in the 
chains themselves.  In order to validate this, 24 MALDI-MSMS spectra of [OPPC + H]+ 
and [OPPC + Li]+ were collected and the results compared to those for [POPC + H]+ and 
[POPC + Li]+ (Figure 2.16 and Table 2.11). 
 
Figure 2.16.  The relative intensities of peaks corresponding to loss of the acyl chain from the sn-1 and sn-2 
positions of different types of fragments of OPPC from MALDI-MSMS spectra of [OPPC + H]
+
 and [OPPC + 
Li]
+
.  The white sections correspond to a loss from sn-1 position, shaded to the sn-2 position.  Refer to Table 
2.11 for identification of a–f.  The error bars correspond to two times the standard deviation of the data. 
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Table 2.11.  Product ions corresponding to the loss of the acyl chain from the sn-1 or sn-2 positions of POPC 
and OPPC observed in the MALDI-MSMS spectra of [POPC + H]
+
, [OPPC + H]
+
, [POPC + Li]
+
and [OPPC + 
Li]
+
.  The relative intensities of peaks corresponding to the loss of the acyl chains from the sn-1 and sn-2 
positions have been normalized with respect to one another for each type of fragmentation. 
 Parent ion Fragment
a 
Relative intensity  
sn-1 cleavage
b 
Relative intensity  
sn-2 cleavage  
a [POPC + H]
+
  [M – ii]
+
 55 ± 6
 
45 ± 6 
a [OPPC + H]
+
 [M – ii]
+
 63 ± 6 37 ± 6 
b [POPC + H]
+
 [M – i + 2H]
+
 28 ± 3 72 ± 3 
b [OPPC + H]
+
 [M – i + 2H]
+
 12 ± 2 88 ± 2 
c [POPC + Li]
+
 [i]
+
 61 ± 4  39 ± 4 
c [OPPC + Li]
+
 [i]
+
 44 ± 4 56 ± 4 
d [POPC + Li]
+
  [M – ii]
+
 53 ± 3 47 ± 3 
d [OPPC + Li]
+
 [M – ii]
+
 58 ± 3 42 ± 3 
e [POPC + Li]
+
  [M – ii – H + Li]
+
 64 ± 4 36 ± 4 
e [OPPC + Li]
+
 [M – ii – H + Li]
+
 79 ± 3 21 ± 3 
f [POPC + Li]
+
 [M – ii – iv – H + Li]
+
 64 ± 3 36 ± 3 
f [OPPC + Li]
+
 [M – ii – iv – H + Li]
+
 76 ± 3 24 ± 3 
a) x = 1 and x = 2 correspond to sn-1 and sn-2 positions of lipid respectively.  
b) The error corresponds to two times the standard deviation. 
2.2.5.5.1 MALDI-MSMS in the absence of added salt 
Two pairs of fragmentations of the protonated POPC and OPPC parents were 
identified which involved the loss of one or other acyl chain.  For the [M – ii]+ 
fragmentation, both lipids showed a greater average loss of the chain from the sn-1 
position, but for POPC the difference in relative intensity was 0.5:0.5 within an error of 2 
times the standard deviation across the 24 repeat analyses.  For the [M – i + 2H]+ 
fragmentation, a clear preferential loss of the chain from the sn-2 position was observed 
for both lipids, but the difference in relative intensities between the loss from the sn-1 
position and that from the sn-2 position was greater for OPPC (12 ± 2:88 ± 2 for OPPC 
compared to 28 ± 3:72 ± 3 for POPC) 
2.2.5.5.2 MALDI-MSMS in the presence of LiCl 
For the [i]+ fragmentation of the lithium adducts of POPC and OPPC, the intensity 
of the peak corresponding to the palmitoyl chain (CH3(CH2)14CO) was greater than that 
corresponding to the oleoyl chain (CH3(CH2)7CH=CH(CH2)7) whether it was fragmented 
from the sn-1 position (POPC) or the sn-2 position (OPPC).   For the [M – ii – H + Li]+ and 
[M – ii – iv – H + Li]+ fragmentations, a clear preferential loss of the chain from the sn-1 
position was observed for both lipids.  A larger difference between the relative intensity of 
the peak corresponding to a loss from the sn-1 position and that corresponding to a loss 
from the sn-2 position was observed for OPPC in both cases.  In the case of the [M – ii]+ 
fragmentation, the average relative intensity over 24 measurements suggested a 
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preferential loss of the chain from the sn-1 position of both lipids, but in the case of POPC 
the magnitude of the standard deviation across the 24 measurements meant that the 
relative intensities were 0.5:0.5 within error. 
2.2.5.5.3 Discussion 
 Overall, the results of the OPPC analysis supported the conclusions from the 
analyses of POPC and POPE.  The same preferential losses from the sn-1 and sn-2 
positions were observed in all but one case, though in two cases the magnitude of the 
standard deviation across the 24 measurements meant that the relative intensities of the 
fragments of POPC were 0.5:0.5 within error where the difference for the fragments of 
OPPC was outside error.  The [M – i + 2H]+ fragments of the protonated parents and [M – 
ii – H + Li]+ and [M – ii – iv – H + Li]+ from the lithium adducts allow unambiguous 
identification of the position of the acyl chain through a preferential loss from the sn-2 
position of the protonated parent and a preferential loss from the sn-1 position of the 
lithium adduct (Table 2.12).  Where a difference in relative intensities was observed, the 
difference was consistently larger for the fragments of OPPC than POPC. 
Table 2.12.  Summarised results of the MALDI-MSMS analyses of POPC and OPPC.  The relative intensities 
of peaks corresponding to cleavages of the acyl chains from the sn-1 and sn-2 positions for different fragment 
types are shown qualitatively.  
Parent ion 
 
Fragment
 
Preferential cleavage 
 
[PC + H]
+
  [M – ii]
+
 =
 
[PC + H]
+
 [M – i + 2H]
+
 sn-2>sn-1 
[PC + Li]
+
  [M – ii]
+
 = 
[PC + Li]
+
  [M – ii – H + Li]
+
 sn-1>sn-2 
[PC + Li]
+
 [M – ii – iv – H + Li]
+
 sn-1>sn-2 
 
2.2.6 The identification of unknown lipids by MALDI-MSMS 
Egg and soybean phosphocholines are natural lipid mixtures extracted from hen 
egg yolks and soya beans respectively.  These mixtures were used to test the lipid 
identification analysis methods developed above, to see how many phosphocholine lipids 
could be identified and to what degree.  The soybean phosphocholine mixture analysed 
for this work was described by the supplier as containing an average of 55% 
phosphocholine lipids, 20% phosphoethanolamine lipids and a number of unquantified 
trace components such as carbohydrates and other lipids.  The fatty acid distribution 
described for soybean PC includes contributions from all lipids present.  The egg 
phosphocholine mixture is described by the supplier as containing 100% phosphocholine 
lipids.  Table 2.13 shows the average contributions of the most common fatty acid 
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components of the two lipids as analysed by the supplier.42, 43  Contributions from trace 
fatty acids make up the remaining 8% and 3% for egg and soybean phosphocholines 
respectively.  The trace fatty acids of egg PC include 20:4, 20:5, 22:5 and 22:6.44 
Table 2.13.  Average relative abundances of the main fatty acids of egg phosphocholine and soybean 
phosphocholine lipids as analysed by the supplier.
42, 43 
Soybean PC  Egg PC  
Acyl chain Relative 
Abundance (%) 
Acyl chain Relative 
Abundance (%) 
16:0 17 16:0 33 
18:0 4 18:0 13 
18:1 9 18:1 31 
18:2 60 18:2 15 
18:3 7   
 
Each lipid mixture was analysed by MALDI-MS and MSMS in the presence of LiCl 
and in the absence of added salt.  All m/z values observed in the MALDI-MS spectra were 
compared to theoretical PC (and PE in the case of soybean PC) [M + H]+ and [M + Li]+ 
ions drawn up from all possible combinations of common and trace acyl chains, to 
determine which should be fragmented by MSMS and to give an idea of lipid identities as 
a starting point to identify the fragments.   
2.2.6.1 Egg PC 
 Figure 2.17 shows the MALDI-MS spectra of egg PC in A) the absence of added 
salt and B) the presence of lithium, centred on the mass region which is likely to include 
phosphocholine lipids. 
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Figure 2.17.  MALDI-MS spectra of egg PC A) in the absence of added salt and B) in the presence of lithium, 
centred on the mass region which is likely to include phosphocholine lipids.  The samples were prepared by 
mixing a solution of the lipid in CHCl3 (1 mg/mL) 2:9 (v/v) with solutions of DHB (30 mg/mL) in EtOH/H2O 
((50:50 (v/v)) or LiCl (100 mM) in EtOH/H2O (50:50 (v/v)). 
2.2.6.1.1 Analyses in the absence of added salt 
Table 2.14 shows the m/z values of the peaks observed in the MALDI-MS 
spectrum of egg PC in the absence of added salt which matched possible phosphocholine 
lipid identities. 
Table 2.14.  The m/z values and possible assignments of peaks observed in the MALDI-MS spectrum of the 
egg phosphocholine lipid mixture obtained in the absence of added salt. 
m/z Possible acyl chain combinations 
758.6 16:0/18:2 + H      
760.6 16:0/18:1 + H      
782.6 18:1/18:3 + H 18:2/18:2 + H 16:0/20:4 + H 16:0/18:1 + Na 
788.6 18:0/18:1 + H      
 
Of the precursor ions examined by MSMS in the absence of added salt, the 
product ion spectra of the ions with m/z 758.6 ([M + H]+ ion) and m/z 788.6 ([M + H]+ ion) 
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did not provide enough information from which the lipids could be identified.  The product 
ion spectrum of the peak at m/z 782.6 ([M + H]+ ion) contained peaks corresponding to 
fragments of all three of the possible PC lipid species shown in Table 2.14, making 
complete identification of the individual lipids impossible.  The product ion spectrum of the 
precursor ion with m/z 760.6 ([M + H]+ ion) contained enough peaks for identification of 
the lipid, as shown in Table 2.15 and Figure 2.17.  Peaks corresponding to 
[OP(O)2O(CH2)2NMe3 + 2 H]
+ and [M – OP(O)2O(CH2)2NMe3]
+ were observed with m/z 
184.3 and m/z 577.6 respectively, which confirmed that the lipid had a PC headgroup .  
The spectrum showed two pairs of peaks corresponding to fragments involving the loss of 
an acyl chain, [M – RxCOO]
+ and [M – RxCO + 2H ]
+, with the m/z values consistent with 
the identification of the two acyl chains as 16:0 and 18:1.  For the [M – RxCOO]
+ 
fragments, the ratio of the intensity of the peak corresponding to the loss of the 16:0 chain 
relative to the peak corresponding to the loss of the 18:1 chain was 0.56:0.44.  This ratio 
was compared to the results for POPC and OPPC summarised in Table 2.12.  The ratio of 
relative intensities of the loss of the chain from the sn-1 position to the loss from the sn-2 
position for this fragmentation was found to be equal within an error of twice the standard 
deviation.  For the other fragment of the unknown lipid, a ratio of 0.11:0.89 was found for 
the relative intensities of the peaks corresponding to [M – R16:0CO + 2H ]
+ and [M – 
R18:1CO + 2H ]
+ respectively.  This fragmentation was found to preferentially cause 
cleavage at the sn-2 position during the analyses of POPC and OPPC.  This suggests 
that the 16:0 chain is at the sn-1 position of the unknown lipid and the 18:1 chain at the 
sn-2 position, making the lipid POPC. 
 
Figure 2.18.  MALDI-MSMS spectrum of unknown lipid of egg PC with m/z 760.6 ([M + H]
+
 ion).  The samples 
were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 2:9 (v/v) with a solution of DHB (30 mg/mL) 
in EtOH/H2O (50:50 (v/v)). 
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Table 2.15.  Product ions corresponding to the loss of an acyl chain observed in the MALDI-MSMS spectrum 
of the unknown phosphocholine lipid of egg PC with m/z 760.6 ([M + H]
+
 ion).  The relative intensities of peaks 
corresponding to cleavages of the 16:0 and 18:1 chains are shown for each fragment type. 
m/z Assignment Relative intensities 
(16:0:18:2) 
504.3 [M – R16:0COO]
+
 
0.56:0.44 
478.3 [M – R18:1COO]
+
 
522.4 [M – R16:0CO + 2H ]
+
 
0.11:0.89 
496.3 [M – R18:1CO + 2H ]
+
 
 
2.2.6.1.2 Analyses in the presence of lithium 
Three peaks which could correspond to phosphocholine lipids were identified in 
the MALDI-MS spectrum of egg PC obtained in the presence of lithium (Table 2.16).  The 
product ion spectrum of the lipid with m/z 788.6 ([M + Li]+ ion) showed peaks 
corresponding to the fragments of a number of lipids, suggesting the presence of both the 
18:1/18:3 and 18:2/18:2 acyl chain combinations, and possibly those of a third lipid due to 
incomplete isolation, so no single lipid could be fully identified.  The product ion spectra of 
the other two lipids did allow identification however, as shown in Tables 2.17 and 2.18 
and Figure 2.19. 
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Figure 2.19.  MALDI-MSMS spectrum of unknown lipids of egg PC with m/z A) 766.6 and B) 794.6 (both [M + 
Li]
+
 ions).  The samples were prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 2:9 (v/v) with a 
solution of LiCl (100 mM) and DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)). 
Table 2.16.  The m/z values and possible assignments of peaks observed in the MALDI-MS spectrum of the 
egg PC lipid mixture obtained in the presence of LiCl. 
m/z Possible acyl chain combinations 
766.6 16:0/18:1 + Li   
788.6 18:1/18:3 + Li 18:2/18:2 + Li 
794.6 18:0/18:1 + Li   
 
The product ion spectrum of the unknown lipid with m/z 766.6 ([M + Li]+ ion) 
(Figure 2.19A) showed peaks with m/z 184.2 and m/z 577.6, corresponding to 
[OP(O)2O(CH2)2NMe3 + 2H]
+ and [M – OP(O)2O(CH2)2NMe3]
+ respectively, confirming that 
the lipid had a phosphocholine headgroup.  Four pairs of peaks were observed in the 
product ion spectrum which corresponded to fragments involving the loss of an acyl chain 
(Figure 2.19A and Table 2.17).  The relative intensities of the peaks corresponding to [M – 
R16:0COO]
+ and [M – R18:1COO]
+ were found to be 0.5:0.5, so these peaks did not allow 
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the positions of the chains to be determined, though they did support the chain identities.  
The other three pairs of peaks ([M – RxCOO – H + Li]
+, [RxCO]
+ and [M – RxCOO – NMe3 
– H + Li]+) all had significant differences in relative intensity for the loss of each chain, so 
they were compared to the data obtained for POPC and OPPC in the presence of lithium 
to identify the chain positions.  The relative intensities of the peaks corresponding to [M – 
R16:0COO – H + Li]
+ and [M – R18:1COO – H + Li]
+ were found to be 0.74:0.26.  For the 
equivalent fragmentation of [POPC + Li]+ and [OPPC + Li]+ a preferential loss of the chain 
from the sn-1 position was observed.  The other two fragmentations of the unknown lipid, 
[RxCO]
+ and [M – RxCOO – NMe3 – H + Li]
+, also both showed a preferential loss of the 
16:0 chain.  The [M – RxCOO – NMe3 – H + Li]
+ fragmentations of [POPC + Li]+ and 
[OPPC + Li]+ showed a preferential loss of the chain from the sn-1 position.  The [RxCO]
+ 
fragment was found to give inconsistent relative intensity results for POPC and OPPC and 
therefore could not be used to identify the position of the acyl chains.  The relative 
intensities of the [M – RxCOO – H + Li]
+ and [M – RxCOO – NMe3 – H + Li]
+ fragments 
identify the 16:0 chain as being at the sn-1 position.  This suggests that the unknown lipid 
is POPC, which supports the conclusion from the analysis in the absence of added salt.   
Table 2.17.  Product ions corresponding to the loss of an acyl chain observed in the MALDI-MSMS spectrum 
of the unknown phosphocholine lipid of egg PC with m/z 766.6 ([M + Li]
+
 ion).  The relative intensities of peaks 
corresponding to cleavages of the 16:0 and 18:1 chains are shown for each fragment type. 
m/z Assignment Relative intensities 
(16:0:18:1) 
504.3 [M – R16:0COO]
+
 
0.50:0.50 
478.3 [M – R18:1COO]
+
 
510.4 [M – R16:0COO – H + Li]
+
 
0.74:0.26 
484.3 [M – R18:1COO – H + Li]
+
 
239.2 [R16:0CO]
+
 
0.60:0.40 
265.3 [R18:1CO]
+
 
451.3 [M – R16:0COO – NMe3 – H + Li]
+
 
0.74:0.26 
425.3 [M – R18:1COO – NMe3 – H + Li]
+
 
 
The product ion spectrum of the unknown lipid with m/z 794.6 ([M + Li]+ ion) 
contained two peaks which confirmed the presence of a phosphocholine headgroup, at 
m/z 184.2 and m/z 605.6, corresponding to [OP(O)2O(CH2)2NMe3 + 2 H]
+ and [M – 
OP(O)2O(CH2)2NMe3]
+ respectively (Figure 2.19B and Table 2.18).  Four pair of peaks 
corresponding to the loss of an acyl chain were observed.  No significant difference in 
relative intensities between the peaks corresponding to losses of the 18:0 and 18:1 chains 
were observed for the [M – RxCOO]
+ or [ RxCO]
+ fragment types.  Both the [M – RxCOO – 
H + Li]+ and [M – RxCOO – NMe3 – H + Li]
+  fragmentations showed a preferential loss of 
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the 18:0 chain.  The analogous fragments of [POPC + Li]+ and [OPPC + Li]+ both showed 
preferential losses of the chain from the sn-1 position.  This suggests that the 18:0 chain 
is at the sn-1 position and that the unknown lipid is 1-stearoyl-2-oleoyl-sn-glycero-3-
phosphocholine (SOPC).   
Table 2.18.  Product ions corresponding to the loss of an acyl chain observed in the MALDI-MSMS spectrum 
of the unknown phosphocholine lipid of egg PC with m/z 794.6 ([M + Li]
+
 ion).  The relative intensities of peaks 
corresponding to cleavages of the 18:0 and 18:1 chains are shown for each fragment type. 
m/z Assignment Relative intensities 
(18:1:18:0) 
506.4 [M – R18:1COO]
+
 
0.49:0.51 
504.3 [M – R18:0COO]
+
 
512.4 [M – R18:1COO – H + Li]
+
 
0.27:0.73 
510.4 [M – R18:0COO – H + Li]
+
 
265.3 [ R18:1CO]
+
 
0.52:0.48 
267.3 [R18:0CO]
+
 
453.3 [M – R18:1COO – NMe3 – H + Li]
+
 
0.34:0.66 
451.3 [M – R18:0COO – NMe3 – H + Li]
+
 
 
Table 2.19 shows the backbone positions of the most common fatty acids of egg 
PC lipids.44  This was used to validate the lipid identities.  The lipids identified by the 
MALDI-MSMS analyses were POPC (16:0/18:1) and SOPC (18:0/18:1).  The data in the 
Table 2.19 shows that for the majority of phosphocholine lipids in egg yolk, the 16:0 chain 
is at the sn-1 position if present.  This supports the identification of the lipid containing 
16:0 and 18:1 chains as POPC.  Furthermore, if the 18:1 chain is present in a lipid of egg 
yolk PC, it is much more likely to be at the sn-2 position than the sn-1 position, supporting 
this identification and that of SOPC.  A greater mole % of the 18:0 chains of egg PC lipids 
occur at the sn-1 position than the sn-2 position.  16:0/18:1 and 18:0/18:1 PC have also 
been identified as major phosphocholine components of egg yolk.45 
 
Table 2.19.  Positions of the most common fatty acids of egg phosphocholine lipids.
44
  
Chain sn-1   
(mol %) 
sn-2   
(mol %) 
16:0 68.8 1.8 
18:0 25.8 1.2 
18:1 4.7 48.9 
18:2 0.2 11.1 
18:3 0.5 - 
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2.2.6.2 Soybean PC 
Soybean PC was analysed in the same way as egg PC, and Figure 2.20 shows 
the mass spectra of the lipid mixture in A) the absence of added salt and B) the presence 
of lithium chloride, centred on the mass region which is likely to include phosphocholine or 
phosphoethanolamine lipids. 
 
Figure 2.20.  MALDI-MS spectra of soy PC A) in the absence of added salt and B) in the presence of lithium, 
centred on the mass region which is likely to include phosphocholine lipids.  The samples were prepared by 
mixing a solution of the lipid in CHCl3 (1 mg/mL) 2:9 (v/v) with solutions of DHB (30 mg/mL) in EtOH/H2O 
(50:50 (v/v)) or LiCl (100 mM) in EtOH/H2O (50:50 (v/v))). 
2.2.6.2.1 Analyses in the absence of added salt 
 Table 2.20 shows the peaks in the MALDI-MS spectrum of soybean PC analysed 
in the absence of added salt which were identified as corresponding to possible PC lipid 
masses.  No peaks corresponding to the masses of possible PE lipids were observed. 
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Table 2.20.  The m/z values and possible assignments of peaks observed in the MALDI-MS spectrum of the 
soybean phosphocholine lipid mixture obtained in the absence of added salt. 
m/z Possible acyl chain combinations 
758.6 16:0/18:2 + H      
782.6 18:1/18:3 + H 18:2/18:2 + H 16:0/20:4 + H 16:0/18:1 + Na 
 
The product ion spectrum of the lipid with m/z 782.6 ([M + H]+) (Figure 2.21B) 
showed only peaks corresponding to the loss of 18:2 acyl chains, [M – R18:2COO]
+ and [M 
– R18:2CO + 2H ]
+ at m/z 502.5 and m/z 520.4 respectively, along with peaks from which 
the PC headgroup could be confirmed at m/z 599.4 and m/z 184.2 corresponding to [M – 
OP(O)2O(CH2)2NMe3]
+ and [OP(O)2O(CH2)2NMe3]
+ respectively.  This suggested that the 
lipid was 1,2-dilinoleoyl-sn-glycero-3-phosphocholine (DLPC).  The lipid with m/z 758.6 
was also identified as a phosphocholine lipid, through peaks corresponding to 
[OP(O)2O(CH2)2NMe3]
+ and [M – OP(O)2O(CH2)2NMe3]
+ at m/z 184.3 and m/z 575.5 
respectively (Figure 2.21A).  The MSMS spectrum of this lipid contained two pairs of 
peaks corresponding to the loss of an acyl chain, as shown in Table 2.21.  No preferential 
loss was observed for either acyl chain for the [M – RxCOO]
+ fragments.  A much greater 
loss of the 18:2 chain than the 16:0 chain was observed for the [M – RxCO + 2H]
+ 
fragmentation.  The equivalent fragmentation of POPC and OPPC showed preferential 
cleavage at the sn-2 position, suggesting that this lipid has the 18:2 chain at the sn-2 
position, which would identify it as 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine 
(PLPC). 
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Figure 2.21.  MALDI-MSMS spectrum of unknown phosphocholine lipids of soy PC with m/z values A) 758.6 
and B) 782.6 (both [M + H]
+
 ions).  The samples were prepared by mixing a solution of the lipid in CHCl3 (1 
mg/mL) 2:9 (v/v) with a solution of DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)). 
Table 2.21.  Product ions corresponding to the loss of an acyl chain observed in the MALDI-MSMS spectrum 
of the unknown phosphocholine lipid of soy PC with m/z 758.6 ([M + H]
+
 ion).  The relative intensities of peaks 
corresponding to cleavages of the 16:0 and 18:2 chains are shown for each fragment type. 
m/z Assignment Relative intensities 
(16:0:18:2) 
502.3 [M – R16:0COO]
+
 
0.50:0.50 
478.3 [M – R18:2COO]
+
 
520.2 [M – R16:0CO + 2H ]
+
 
0.14:0.86 
496.4 [M – R18:2CO + 2H ]
+
 
 
2.2.6.2.2 Analyses in the presence of lithium 
Table 2.22 shows the peaks observed in the full-scan spectrum of soybean PC in 
the presence of lithium which were identified as corresponding to possible PC lipids.  No 
possible PE lipids were identified. 
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Table 2.22.  The m/z values and possible assignments of peaks observed in the MALDI-MS spectrum of the 
soy PC lipid mixture obtained in the presence of LiCl. 
m/z Possible acyl chain combinations 
764.6 16:0/18:2 + H   
788.6 18:1/18:3 + H 18:2/18:2 + H 
 
The spectrum of the lipid with m/z 788.6 ([M + Li]+) showed peaks corresponding 
to the fragments of a number of lipids, suggesting the presence of both the 18:1/18:3 and 
18:2/18:2 acyl chain combinations, and possibly those of a third lipid due to incomplete 
isolation, so no single lipid could be fully identified.  Figure 2.22 shows the product ion 
spectrum of the unknown lipid with m/z 764.6 ([M + Li]+ ion), and Table 2.23 lists the m/z 
values and assignments of four pairs of peaks observed which corresponded to the loss 
of one or other acyl chain.  The presence of a phosphocholine headgroup on the lipid was 
confirmed by the observation of peaks at m/z 184.2 and m/z 575.5 corresponding to 
[OP(O)2O(CH2)2NMe3]
+ and [M – OP(O)2O(CH2)2NMe3]
+ respectively.  A preferential loss 
of the 16:0 chain was observed for the [M – RxCOO]
+, [M – RxCOO – H + Li]
+, and [M – 
RxCOO – NMe3 – H + Li]
+ fragment types, and the peak corresponding to the [R18:2CO]
+ 
fragment had a greater intensity than that of the [R16:0CO]
+ fragment.  The analyses of 
[POPC + Li]+ and [OPPC + Li]+ (Section 2.2.5.5) showed no preferential loss of either 
chain for the [M – RxCOO]
+ fragmentation within an error of twice the standard deviation.  
For the [M – RxCOO – H + Li]
+, and [M – RxCOO – NMe3 – H + Li]
+ fragments, a 
preferential loss of the chain from the sn-1 position was observed, which suggests that 
the 16:0 chain of the unknown lipid is at the sn-1 position.  The analyses of POPC and 
OPPC showed that the relative intensity values of [RxCO]
+ fragments can not be used to 
identify the positions of the acyl chains.  The lipid was therefore identified as 1-palmitoyl-
2-linoleoyl-sn-glycero-3-phosphocholine (PLPC). 
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Table 2.23.  Product ions corresponding to the loss of an acyl chain observed in the MALDI-MSMS spectrum 
of the unknown phosphocholine lipid of soy PC with m/z 764.6 ([M + Li]
+
 ion).  The relative intensities of peaks 
corresponding to cleavages of the 16:0 and 18:2 chains are shown for each fragment type. 
m/z Assignment Relative intensities 
(16:0:18:2) 
502.3 [M – R16:0COO]
+
 
0.55:0.45 
478.3 [M – R18:2COO]
+
 
508.3 [M – R16:0COO – H + Li]
+
 
0.73:0.27 
484.3 [M – R18:2COO – H + Li]
+
 
239.2 [R16:0CO]
+
 
0.40:0.60 
263.2 [R18:2CO]
+
 
449.3 [M – R16:0COO – NMe3 – H + Li]
+
 
0.68:0.32 
425.3 [M – R18:2COO – NMe3 – H + Li]
+
 
 
 
Figure 2.22.  MALDI-MSMS spectrum of unknown phosphocholine lipid of soy PC with m/z 764.6 ([M + Li]
+
 
ion).  The sample was prepared by mixing a solution of the lipid in CHCl3 (1 mg/mL) 2:9 (v/v) with a solution of 
LiCl (100 mM) and DHB (30 mg/mL) in EtOH/H2O (50:50 (v/v)). 
Table 2.24 shows the backbone positions of the most common fatty acids of the 
soybean PC lipids.44  This was used to validate the lipid identities.  Two phosphocholine 
lipids were identified from the MALDI-MS and MSMS spectra of soybean PC, DLPC 
(18:2/18:2) and PLPC (16:0/18:2).  The identification of PLPC is supported by the fact that 
the 16:0 chain is not observed at the sn-2 position of lipids in soybean PC, so this lipid 
can only be PLPC.  DLPC and PLPC have been identified as major components of 
soybean PC.46 
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Table 2.24.  Positions of the most common fatty acids of soybean phosphocholine lipids.
44
  
Chain sn-1   
(mol %) 
sn-2   
(mol %) 
16:0 34.4 - 
18:0 7.6 - 
18:1 30.2 15.8 
18:2 23.8 71.8 
18:3 4.0 13.1 
 
2.2.6.3 MALDI imaging of TLC plates 
The analyses of natural lipid mixtures described in Section 2.2.6 highlight some of 
the difficulties of analysing lipid mixtures by MALDI-MSMS.  Though some of the lipids in 
egg PC and soybean PC were fully identified, some could not be identified due to 
incomplete isolation causing fragments from more than just the lipid of interest to be 
present in the spectrum.  In some cases a number of different lipids had the same 
molecular mass, again causing the fragments of more than one lipid to be present in a 
spectrum and making positive identification of specific lipids difficult, if not impossible, for 
example product ions corresponding to both 18:1/18:3 PC and 18:2/18:2 PC were 
observed in the MSMS spectrum of m/z 788.6 from egg PC.  The possible presence of 
peaks corresponding to fragments of lipids with the same mass also means that 
measuring the relative intensities of the product ion peaks cannot be relied upon to use to 
determine the positions of the acyl chains.  In the case of PC lipids, the addition of lithium 
provides the advantage of a number of pairs of peaks corresponding to the loss of one or 
other acyl chains ([RxCO]
+, [M – RxCOO – NMe3 – H + Li]
+, [M – RxCOO]
+ and [M – 
R2COO – H + Li]
+) compared to the two pairs of peaks observed in spectra obtained in the 
absence of lithium ([M – RxCOO]
+ and [M – R2CO + 2H]
+).  This means that if peaks are 
observed which correspond to fragments of more than one lipid, causing the relative 
intensities of the peaks corresponding to fragmentations at the sn-1 and sn-2 positions to 
be affected for one or two pairs of fragments, it may still be possible to rely on the relative 
intensity data for two or three other pairs of fragments to determine the positions of the 
acyl chains on the glycerol backbone.  These problems could be solved if the individual 
lipids could be separated out before analysis.  One way of doing this is by separating the 
lipids by thin layer chromatography (TLC) and then analysing the plates by MALDI 
imaging. 
Some method development was required before the analysis of lipids separated 
on TLC plates could be carried out.  Firstly, a method of getting the TLC plate into the 
instrument was established.  This was done using a commercial MALDI target plate 
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designed to hold surface modified microscope slides.  A piece of steel, the same size as a 
microscope slide, was modified to accommodate an aluminium-backed TLC plate and a 
strip of conductive double-sided adhesive carbon tape (Figure 2.23).  The depth of the 
channel in which the TLC plate was to be adhered was the same as the combined 
thickness of the TLC plate and the strip of adhesive, as any discrepancy between the 
height of the surface of the TLC plate and the normal surface of a target plate would 
cause loss of mass accuracy.   
 
Figure 2.23.  Diagram of TLC plate holder.  
The next step was to find a way of applying the matrix to the TLC plate which 
would result in successful ionisation of lipid species on the plate.  The MALDI laser cannot 
penetrate the silica layer of the TLC plate, therefore the addition of the matrix must cause 
the sample molecules to travel to the surface of the silica.  The matrix must also not 
cause the sample spots to spread laterally within the plate.47  Three methods were tested 
to see which gave the most even coverage and the best sample spectrum.  A solution of 
DOPC in chloroform was applied to three pieces of TLC plate, run in 25:25:25:10:9 ethyl 
acetate, propan-2-ol, CHCl3, MeOH, 0.25% (w/v) KCl and allowed to dry before the 
application of the matrix as one of three solutions:   
a) DHB (100 mg/mL) in 1:1 acetonitrile/CHCl3 (Figure 2.24A) 
b) DHB (100 mg/mL) in EtOH (Figure 2.24B) 
c) DHB (100 mg/mL) in MeOH (Figure 2.24C) 
 The application method was adapted from that of Fuchs et al, as was the matrix 
concentration and use of 1:1 acetonitrile/water as one of the solvents tested.48  A 
thorough coating of the matrices were applied to the plates by pipette, quickly dried under 
a stream of argon, then another layer applied.  The plates were allowed to dry thoroughly 
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before analysis.  The MALDI images of each TLC plate are shown in Figure 2.24, with the 
areas where peaks corresponding to [DHB]+ (m/z 154.1) were observed in spectra shown 
in yellow, and areas where peaks corresponding to [DOPC + H]+ (m/z 786.6) were 
observed in spectra shown in blue.  Very little matrix or DOPC were observed on the plate 
coated with the matrix in ACN/H2O.  Matrix was observed on the plate where it had been 
applied in MeOH, but very little DOPC was observed.  On the plate where the matrix had 
been applied in EtOH a good coverage of matrix could be observed, along with a clear 
area of DOPC.  This clearly shows that method (b) was the most successful, therefore 
this method was implemented during further experiments.  Soaking the surface of the 
plate in a solution of DHB in ethanol is not expected to cause lateral spreading of lipid 
sample spots, as the standard TLC plate staining protocol involves dipping the plate into a 
solution of phosphomolybdic acid in ethanol, from which no spreading of sample spots is 
observed.  
 
Figure 2.24.  Representative image of MALDI imaging analysis of TLC plates to which DOPC had been 
applied.  DOPC (35 µL, 1 mg/mL in CHCl3) was run with 25:25:25:10:9 ethyl acetate, propan-2-ol, CHCl3, 
MeOH, 0.25% (w/v) KCl, and analysed after the addition of A) DHB (100 mg/mL in ACN/water), B) DHB (100 
mg/mL, EtOH) or C) DHB (100 mg/mL, MeOH) matrix solutions.  Areas where peaks corresponding to [DHB]
+
 
(m/z 154.1) were observed in spectra are shown in yellow, areas where peaks corresponding to [DOPC + H]
+
 
(m/z 786.6) were observed in spectra are shown in blue.   
2.2.6.4 Calibration 
Concerns regarding the accuracy of mass measurement across the TLC plate 
were investigated by calibrating with PEG 600.  Poly(ethylene glycol) 600 (PEG 600) (1 
mg/mL with 100 mM NaCl in 50:50 (v/v) EtOH/H2O) was spotted onto a piece of TLC 
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plate, DHB added using method (b) as above and the plate analysed by MALDI imaging, 
with the aim of calibrating the TLC plate using peaks corresponding to the sodium 
adducts of PEG molecules.  Peaks corresponding to PEG were not observed in the 
resulting spectrum, but a number of other peaks were observed at regular intervals, which 
were found to be DHB/Na clusters.  Peaks corresponding to DHB/Na clusters were 
observed in all TLC plate spectra, and therefore be used for internal calibration of the 
MALDI-MS spectra. 
Table 2.25.  Monoisotopic masses of DHB clusters used for internal calibration of MALDI-MS spectra 
obtained from TLC plates. 
Mass 
(monoisotopic) 
Cluster 
198.9978 [DHB + 2Na – H]
+
 
375.0063 [2DHB + 3Na – 2H]
+
 
551.0149 [3DHB + 4Na – 3H]
+
 
727.0234 [4DHB + 5Na – 4H]
+
 
903.0320 [5DHB + 6Na – 5H]
+
 
 
The imaging method was then applied to a natural lipid mixtures extracted from 
mouse lungs and soybean PC. 
2.2.6.5 Mouse lung lipids 
2.2.6.5.1 Analyses in the absence of added salt 
Figure 2.25 shows two TLC plates on which the mouse lipid solution had been run.  
The plate in Figure 2.25A was stained with phosphomolybdic acid and heat, and that in 
Figure 2.25B imaged after coating with DHB in EtOH.  Though the plates were different 
sizes, the same areas of interest can be observed on both plates.  Any m/z values of 
interest identified from the imaging of the plate were then analysed manually by MALDI-
MSMS to try and identify the lipid that they corresponded to.  The MS and MSMS spectra 
obtained were also compared to spectra obtained for the lipid mixture analysed on the 
standard MALDI target plate without separation.  
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Figure 2.25.  A) TLC plate after separation of mouse lipid mixture (45 µL lipid, 2 mg/mL in 50:50 (v/v) 
MeOH/CHCl3) with 25:25:25:10:9 ethyl acetate, propan-2-ol, CHCL3, MeOH, 0.25% (w/v) KCl and staining 
with PMA (20% w/v in EtOH) and heat.  B)  Representative image of MALDI imaging analysis of TLC plate 
after separation of mouse lipid (concentration and running solvents as A), showing areas where peaks not 
corresponding to [DHB]
+
 or DHB clusters were observed.  The MALDI matrix was applied according to Section 
2.2.6.3 method 2. 
Though MSMS was attempted on a number of species, only one lipid could be 
tentatively identified in the absence of an added salt.  Two product ion spectra were 
obtained from area A (just above where the lipid was spotted on the plate), from parent 
ions with m/z 734.5 and m/z 756.5.  These were identified as phosphocholine lipids from 
the presence of peaks at m/z 184.1 corresponding to [OP(O)2CH2CH2NMe3]
+ in each 
product ion spectrum, but no other structural information could be obtained from the 
spectra.  The lipids appeared to be hydrogen and sodium adducts of the same species, 
due to a mass difference of 22 Da, giving them possible identities of [16:0/16:0-PC + H]+ 
and [16:0/16:0-PC + Na]+, DPPC. 
2.2.6.5.2 Analyses in the presence of lithium 
100 mM LiCl was added to the DHB matrix solution before addition to another TLC 
plate on which the mouse lipids had been separated, in an attempt to improve the quality 
of the MS and MSMS spectra.  Overall, the MS spectra produced from the imaging 
showed much weaker peaks when compared to the spectra obtained in the absence of 
the salt.  A peak was observed at m/z 740.6 in the MS spectra of area A in Figure 2.25B, 
which was tentatively assigned as the lithium adduct of the PC lipid observed in the 
spectra obtained in the absence of an added salt.  Figure 2.26 shows the MALDI-MSMS 
spectrum of this lipid, and Table 2.26 describes the identities of the peaks observed.  The 
phosphocholine headgroup can be identified from peaks corresponding to 
[OP(O)2CH2CH2NMe3]
+ and [M – OP(O)2CH2CH2NMe3]
+, at m/z 184.4 and m/z 551.2, and 
the palmitoyl chain from peaks corresponding to [R16:0CO]
+, [M – R16:0CO + H]
+ and [M – 
R16:0CO + Li]
+ at m/z 239.5, m/z 479.0 and m/z 485.0. 
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Figure 2.26.  MALDI-MSMS spectrum of unknown lipid with m/z 740.6, suggested to correspond to [DPPC + 
Li]
+
.  Spectrum recorded from TLC plate after separation of mouse lipid mixture (45 µL lipid, 2 mg/mL in 50:50 
(v/v) MeOH/CHCl3) with 25:25:25:10:9 ethyl acetate, propan-2-ol, CHCl3, MeOH, 0.25% (w/v) KCl.  The 
MALDI matrix was applied according to Section 2.2.6.3 method 2 with the addition of 100 mM LiCl. 
Table 2.26.  Product ions observed in the MALDI-MSMS spectrum of the unknown lipid with m/z 740.6 ([M + 
Li]
+
 ion) obtained from a TLC plate on which the mouse lipid mixture had  been separated. 
m/z Assignment 
184.4 [OP(O)2CH2CH2NMe3]
+
 
239.5 [R16:0CO]
+ 
479.0 [M – R16:0COO]
+
 
485.0 [M – R16:0COO – H + Li]
+
 
551.2 [M – OP(O)2CH2CH2NMe3]
+
 
 
2.2.6.5.3 Discussion 
The ability to fully identify DPPC from the MSMS spectrum in the presence of 
lithium was an improvement on the tentative assignment from the spectra of the hydrogen 
and sodium adducts.  However, it was not possible to isolate and fragment any other 
species.  In the absence of lithium it was possible to carry out MSMS on a number of 
masses observed in spectra obtained from different regions of the TLC plate, though no 
lipids could be identified from these MSMS spectra.  The signal-to-noise ratio of the MS 
spectra obtained in the presence of lithium was reduced compared to spectra obtained in 
the absence of an added salt.  The addition of lithium meant that the population of each 
lipid was split between protonated, sodiated and lithiated ions, therefore reducing the 
signal-to-noise ratio for each adduct.   
The negative ions of a TLC plate on which the mouse lipid mixture had been 
separated were also analysed by MALDI imaging to see if any different lipids could be 
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identified, particularly those which might have had the same mass as phosphocholine 
lipids.  Very few non-matrix peaks were observed in the spectra obtained though, and 
none of these had sufficient intensity to allow MSMS to be carried out. 
DPPC was also the only lipid identified by MALDI-MSMS analysis of the mouse 
lipid mixture on the standard target plate in the presence and absence of Li+.  Table 2.27 
shows the fragments from which [DPPC + H]+ (m/z 734.6) and [DPPC + Li]+ (m/z 740.6) 
were identified during this analysis.  In each case, fragments were identified from which 
the palmitoyl chain and phosphocholine headgroup could be clearly identified. 
Table 2.27. Product ions observed in the MALDI-MSMS spectra of the unknown lipids with m/z 734.6 and m/z 
740.6 obtained from a standard MALDI target plate. 
m/z 734.6 m/z 740.6 
m/z Assignment m/z Assignment 
184.1 [OP(O)2CH2CH2NMe3]
+
 184.1 [OP(O)2CH2CH2NMe3]
+
 
478.2 [M – R16:0COO]
+ 
239.0 [R16:0CO]
+ 
496.2 [M – R16:0CO + 2H]
+
 425.1 [M – R16:0COO – NMe3 – H + Li]
+
 
551.2 [M – OP(O)2CH2CH2NMe3]
+
 478.2 [M – R16:0COO]
+
 
  484.2 [M – R16:0COO – H + Li]
+
 
  551.4 [M – OP(O)2CH2CH2NMe3]
+
 
2.2.6.6 Soybean PC 
Two TLC plates on which the soybean PC lipid mixture had been separated were 
analysed in the same way as the mouse lipid TLC plates, one in the absence of added 
salt and with LiCl added to the matrix solution.   
2.2.6.6.1 Analyses in the absence of added salt 
Figure 2.27 shows an MS spectrum recorded in the absence of added salt from a 
position on the TLC plate just above the point at which the lipid solution had been applied.  
The spectrum shows the same peaks as the spectrum of soybean PC analysed by 
MALDI-MS on the standard target plate (Figure 2.20A), the only differences being in the 
relative intensities of the peaks at m/z 780.5 and m/z 782.5 and the presence of a peak at 
m/z 776.6 in the spectrum recorded from the TLC plate which was not observed in 
spectrum obtained from the analysis on the target plate.  The lipid with m/z 758.5 was 
identified as 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine (PLPC) by MSMS 
analysis on the standard MALDI target plate.  MSMS analysis of the species with the 
same m/z value on the TLC plate produced a spectrum from which only the PC 
headgroup of PLPC could be identified, from peaks at m/z 184.0 and m/z 575.1 
corresponding to [OP(O)2CH2CH2NMe3]
+ and [M – OP(O)2CH2CH2NMe3]
+ respectively 
(Figure 2.28).  When the lipid mixture was analysed on the standard MALDI target plate it 
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was also possible to identify the lipid with m/z ([M + H]+ ion) 782.6 as 1,2-dilinoleoyl-sn-
glycero-3-phosphocholine (DLPC).  It was not possible to obtain product ion spectra of 
this or any of the other species observed in the analysis of the TLC plate. 
 
Figure 2.27.  MALDI-MS spectrum recorded from TLC plate after separation of soybean PC lipids (45 µL, 2 
mg/mL in CHCl3) with 25:25:25:10:9 ethyl acetate, propan-2-ol, CHCL3, MeOH, 0.25% (w/v) KCl.  The MALDI 
matrix was applied according to Section 2.2.6.3 method 2. 
 
Figure 2.28.  MALDI-MSMS spectrum of unknown lipid with m/z 758.5, suggested to correspond to [PLPC + 
H]
+
.  Spectrum recorded from TLC plate after separation of soybean PC (45 µL, 2 mg/mL in CHCl3) with 
25:25:25:10:9 ethyl acetate, propan-2-ol, CHCL3, MeOH, 0.25% (w/v) KCl.  The MALDI matrix was applied 
according to Section 2.2.6.3 method 2. 
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2.2.6.6.2 Analyses in the presence of lithium 
 An MS spectrum obtained in the presence of lithium from a TLC plate on which 
soybean PC had been separated is shown in Figure 2.29.  The spectrum was recorded 
from a region of the plate just above the point at which the lipid had been spotted.  The 
spectrum bears a close resemblance to that of soybean PC analysed in the presence of 
lithium on the standard MALDI target plate (Figure 2.20B).  When analysed on the 
standard MALDI target plate in the presence of LiCl, it was possible to identify the lipid 
with m/z 764.6 as the lithium adduct of 1-palmitoyl-2-linoleoyl-sn-glycero-3-
phosphocholine (PLPC) from the product ion spectrum.  It was not possible to fragment 
this species when analysis was carried out on the TLC plate.  It was not possible to obtain 
the product ion spectra of any other species on the TLC plate in the presence of lithium. 
 
Figure 2.29.  MALDI-MS spectrum recorded from TLC plate after separation of soybean PC lipids (45 µL, 2 
mg/mL in CHCl3) with 25:25:25:10:9 ethyl acetate, propan-2-ol, CHCL3, MeOH, 0.25% (w/v) KCl.  The MALDI 
matrix was applied according to Section 2.2.6.3 method 2 with the addition of 100 mM LiCl (EtOH). 
2.2.6.6.3 Discussion 
MALDI imaging of TLC plates on which soybean PC had been separated 
produced full scan MS spectra which included the same peaks as those observed when 
the lipid mixture was analysed on the standard MALDI target plate.  MSMS analysis on 
the TLC plate did not prove as informative as the MSMS analyses on the standard MALDI 
target plate in the presence of lithium or in the absence of added salt.  The product ion 
spectra recorded from the TLC plate in the absence of added salt did not provide 
information from which the acyl chains of any lipid could be identified, though peaks 
corresponding to the headgroup and the neutral loss of the headgroup of PLPC were 
observed.  It was not possible to obtain a product ion spectrum of the lithium adduct of the 
same lipid.  Overall less information could be gained from the lipid mixture after 
separation on the TLC plate than before separation, but the MS spectra which were 
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recorded suggest that if the method were refined it should be possible to obtain more 
informative MSMS spectra. 
2.3 Discussion 
2.3.1 Lipid analysis by MALDI-MS and MSMS 
Full scan MALDI-MS analyses of the positive ions of DOPC, DPPC, POPC, DPPE, 
POPE, DPPA, DOPS and POPG established that the information gained from this 
technique was insufficient for the identification of all of the lipids.  None of the 
phosphocholine lipids could be ionised in negative mode.  Since phosphocholine lipids 
are major components of mammalian cell membranes, this ruled out both MALDI-MS and 
MSMS analysis in negative mode for the analysis of unknown lipid mixtures.2  MALDI-
MSMS spectra of the positive ions of DOPC, DPPC, POPC, DPPE, POPE, DPPA, DOPS 
and POPG provided sufficient information to identify the headgroup and both acyl chains 
in all cases, though the intensity of some product ion peaks was very low. 
2.3.1.1 The effect of metal salts on the MALDI analysis of phospholipids 
The fragmentation of lithium and sodium adducted lipids was found to produce 
more useful product ion spectra, in terms of the number of fragmentations and the signal-
to-noise ratio, than that of protonated ions or calcium, copper, magnesium or zinc 
adducts.  The Li+ and Na+ adducts of POPC dissociated to give analogous product ions 
(Table 2.7), though the signal-to-noise ratio was better in the spectrum obtained in the 
presence of Li+.  The fragmentation of [POPE + Na]+ was similar to that of [POPC + Na]+ 
and [POPC + Li]+, but the product ion spectrum of [POPE + Li]+ gave only 6 peaks from 
which POPE could be identified, with only two of these corresponding to the neutral loss 
of an acyl chain (Table 2.6).  This may be attributable to the incomplete isolation of 
[POPE + Li]+, allowing the dissociation products of [POPE + 2Li – H]+ to be visible 
alongside those of [POPE + Li]+.  The product ion spectra of the Na+ adducts of POPC 
and POPE provided more information from which the identities of the acyl chains and 
headgroups could be determined than those of [POPC + Li]+ and [POPE + Li]+; therefore if 
positioning the acyl chains on the glycerol backbone is not required, the addition of NaCl 
to PC and PE lipids provides more useful product ion spectra in terms of lipid identification 
than the addition of LiCl, despite the lower signal-to-noise ratio in the product ion 
spectrum of the sodium adduct of POPE.   
It has been suggested that the different fragmentation of PC lipids observed in the 
presence of metal ions is due to the different ionic binding of protons and metal ions 
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(Scheme 2.1).  Protons bind tightly to the negatively charged oxygen of the 
phosphocholine headgroup, while metal cations are more free and can associate with 
different parts of the molecule, leaving the negatively charged oxygen able to carry out 
intermolecular attack.  This mechanism lends support to the product ion assignments of 
POPC made in Figure 2.8B, corresponding to [POPC – R2COO – NMe3 – H + Na]
+ and 
[POPC – R1COO – NMe3 – H + Na]
+ in Table 2.7.11  POPC was observed to dissociate in 
the same way in the presence of lithium (Figure 2.8C).  The mechanism also correlates 
with the observed fragmentation of [POPE + Na]+, which was analogous to that of [POPC 
+ Na]+ and [POPC + Li]+, as described in Figure 2.6 and Table 2.6.  POPE was observed 
to fragment differently in the presence of Li, with loss of (CH2)2NH3 and RxCOO rather 
than NH3 and RxCOO.  This type of fragmentation can not be explained by the 
mechanism of Al-Saad et al. (Scheme 2.1).   
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Scheme 2.1.  Fragmentation pathway proposed by Al-Saad et al. for the neutral loss of RxCOO and 
trimethylamine from PC lipids in the presence of Na
+
.
11
 
2.3.1.2 Identification of the acyl chain position of phospholipids 
The analysis of 24 samples of each of POPC, POPE and OPPC in the presence 
and absence of Li+ and Na+ has shown that reproducible results can be obtained for the 
relative intensities of the peaks corresponding to the loss of the acyl chain from the sn-1 
and sn-2 positions.  In the absence of added salt, the position of the acyl chains of POPC 
could only be determined from the [M – RxCO + 2H]
+ fragmentation.  The position of the 
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acyl chains on the glycerol backbone of POPE could be determined from the relative 
intensities of the [M – RxCOO]
+ and [M – RxCO + 2H]
+ fragmentations in the absence of 
added salt.  In both cases a preferential loss of the acyl chain from the sn-2 position was 
observed.  The [M – RxCOO – (CH2)2NH3 + H + Li]
+ fragmentation of [POPE + Li]+ 
revealed a clear preference for the cleavage of the chain from the sn-1 position, as did the 
[M – RxCO]
+, [M – RxCOO – H + Li]
+ and [M – RxCOO – NMe3 – H + Li]
+ fragmentations of 
[POPC + Li]+.  In the presence of Na+ a clear difference in relative intensities was 
observed for the [M – RxCOO – NH3 + 2H]
+ fragmentation of POPE and a slight difference 
for the [M – RxCOO – H + Na]
+ fragmentation of POPC.  As with the Li+ adducts, a 
preferential loss of the acyl chain from the sn-1 position of both POPC and POPE was 
observed in the presence of Na+.  When the relative intensities of the peaks 
corresponding to the loss of one or other acyl chain are included in the assessment of the 
improvement offered by the addition of the metal salts it is clear that the addition of LiCl 
provides an advantage in terms of lipid identification when compared to analysis in the 
absence of added salt and analysis in the presence of NaCl.  More fragments of [POPC + 
Li]+ than [POPC + H]+ or [POPC + Na]+ were identified  from which the position of the acyl 
chains on the glycerol backbone could be determined, and the difference in average 
relative intensities for cleavage at the sn-1 and sn-2 positions of  [POPC – ii – H + Na]+ 
was only slight.  The positions of the acyl chains of POPE could be determined in the 
presence or absence of Na or Li. 
When the dissociation of POPC and OPPC was compared, a greater loss of the 
acyl chain from the sn-2 position of both protonated parents and from the sn-1 position of 
both lithium adducts was observed.  The fragments of the lithium adducts corresponding 
to [RCO]+ were not in keeping with this pattern however.  The intensity of the peak 
corresponding to the palmitoyl chain was greater than that corresponding to the oleoyl 
chain whether it was fragmented from the sn-1 position of POPC or the sn-2 position of 
OPPC.  This suggests that the nature of this fragmentation mechanism is dependent on 
the acyl chain identity rather than the chain‟s position on the central glycerol.   
Different fragmentation mechanisms have been suggested to explain the 
preferential losses of the acyl chain from the sn-1 or sn-2 position, and the effects of the 
addition of alkali metal salts on this.  One mechanism was proposed from the results of 
MALDI-PSD analysis of PC lipids and based on the formation of 5- and 6-membered ring 
intermediates during the loss of an acyl chain.11  The authors reported no fragmentations 
involving the loss of an acyl chain in product ion spectra of protonated lipids, and 
therefore referred only to the fragmentation of sodium adducts.  They proposed that in the 
formation of [M – RxCOO – H + Na]
+ and [M – RxCOO – NMe3 – H + Na]
+ product ions, 
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decomposition goes via 6-membered (loss of R1COO) or 5-membered (loss of R2COO) 
intermediates, where the activation energy of the formation of the 6-membered ring is 
lower, therefore preferential loss of the chain from the sn-1 position is observed (Scheme 
2.2).  This correlates with the results discussed above for the lithium adducts of POPC 
and OPPC, but not with all of the results observed for dissociation of the sodium adduct of 
POPC.  In the presence of Na+, a very slight preference was observed for the cleavage of 
R1COO in the [POPC – RxCOO – H + Na]
+ fragmentation, but no preference could be 
observed for the loss of either chain in the [POPC – RxCOO – NMe3 + Na]
+ fragmentation.  
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Scheme 2.2.  Fragmentation pathway proposed by Al-Saad et al. for the neutral loss of R1COO and R2COO 
from [PC + Na]
+
 via 6- and 5-membered intermediates respectively.
11 
Al-Saad et al. also observed that where the metal ion was lost during 
fragmentation, producing [M – RxCOO + H]
+ fragments, there was no preference for 
cleavage at the sn-1 or sn-2 position, which they proposed was based on the equal 
probability of the Na+ ion associating with either acyl chain prior to fragmentation.  An 
equal likelihood of cleavage from the sn-1 and sn-2 positions was observed in the results 
discussed above for the [M – RxCOO + H]
+ fragmentation of POPC (Table 2.9), but a 
preferential cleavage of the chain from the sn-1 position was observed for this 
fragmentation of OPPC (Table 2.11).  Formation of the [RxCO]
+ fragment was not referred 
to in the mechanism described. 
 
  The identification of phospholipids by 
  mass spectrometry 
101 
 
Another set of proposed mechanisms is based on the suggestion that the α-
hydrogen atom on the sn-2 acyl chain is more labile than that at the sn-1 position.19, 49  
The mechanisms were developed from observation of fragmentation of lipids, some of 
them deuterium-labelled, by low energy CID after electrospray ionisation.  Similarly to Al-
Saad et al., Hsu and Turk reported the preferential cleavage of R1COO and R1COO + 
NMe3 or NH3 from alkali metal adducts of PC and PE (Scheme 2.3).  As described above, 
this does not fully correlate with the data presented above for POPC, POPE and OPPC.  
Observation of [RxCO]
+ fragments of the metal ion adducts was reported, but not their 
relative intensities. 
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Scheme 2.3.  Fragmentation pathway proposed by Hsu and Turk for the neutral loss of R1COO from [PC + 
Na]
+
 due to the α-hydrogen atom on the sn-2 acyl chain.
19   
 [M – RxCO + 2H]
+ product ions were reported by Hsu and Turk when PC lipids 
were analysed in the absence of an added salt, with preferential cleavage at the sn-2 
position.  This was again attributed to a more labile α-hydrogen at the sn-2 position than 
the sn-1 position (Scheme 2.4).  This is supported by the data for POPC and OPPC 
presented above.  The product ion spectra of protonated PE lipids recorded by Hsu and 
Turk were reported to be too weak for relative peak intensities to be determined.   
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+
, where preferential cleavage at the sn-2 position was attributed to the increased lability of the α-
hydrogen atom on the sn-2 acyl chain.
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When LIFT and CID experiments were compared for POPC, some differences 
were observed in the standard deviations of repeat measurements of the relative 
intensities of peaks corresponding to fragmentation at the sn-1 and sn-2 positions.  The 
same product ions involving the acyl chains were observed by each method, with similar 
average relative intensity values for each method, but the standard deviations of the set of 
repeat analyses were consistently larger for fragmentation by CID than by LIFT.  The 
average relative intensity of the peaks corresponding to [RC1O]
+ and [RC2O]
+ was 
0.61:0.39 for both CID and LIFT.  The error value for the 24 repeat analyses was ± 0.04 
for the LIFT product ions and ± 0.11 for the CID product ions, indicating a statistically 
preferential cleavage at the sn-1 position only when fragmentation was carried out by 
LIFT.  When [POPC + H]+ was fragmented by CID the position of the acyl chains on the 
glycerol backbone could only be determined from the [M – i + 2H]+ product ion.  When 
[POPC + Li]+ was fragmented by CID of [POPC + H]+ the acyl chain position could only be 
determined from the [M – ii – H + Li]+ product ion, and the preferential cleavage at the sn-
1 position for this product ion was only slight.  The greater variation in the CID results may 
be attributable to the increased fragmentation caused by CID compared to LIFT.  As 
shown in Figure 2.13A and B, a greater number of lower m/z product ions were observed 
in the CID product ion spectrum of [POPC + H]+ compared to LIFT.  This is a recognised 
consequence when comparing these two methods for the tandem mass spectrometry of 
peptides and proteins.50  The increased number of product ions in the lower m/z range is 
thought to arise from sequential fragmentation of primary fragments.  Secondary 
fragmentations involving the loss of the acyl chains is a likely cause of the greater 
standard deviations of the repeat measurements when analyses were carried out by CID 
compared to those of the LIFT analyses. 
2.3.2 The identification of unknown lipids by MALDI-MSMS 
One lipid, POPC, was identified from the MALDI-MSMS analysis of egg PC in the 
absence of an added salt, and a further, SOPC, was identified when LiCl was added to 
the sample.  The identities of the headgroup and both acyl chains, and the positions of the 
acyl chains of the glycerol backbone, were determined for both lipids.  POPC and SOPC 
are known to be major phosphocholine constituents of hen egg yolk. 
Two lipids, DLPC and PLPC, were identified during the analysis of soybean PC in 
the absence of lithium, and PLPC was identified in the presence of lithium.  Again it was 
possible to fully identify the constituent parts of the lipids and the positions of the acyl 
chains of PLPC.  The palmitoyl chain is known to only occur at the sn-1 position of lipids 
in soybean PC, which supports the identification of PLPC.  
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The complete identification of some unknown lipids in the soybean and egg PC 
mixtures has proven that the method of MSMS analysis of positive ions in the presence of 
lithium determined through the analyses described in Sections 2.2.3–2.2.5 can be applied 
to the identification of unknown lipids.  Figures 2.18 and 2.19 show that the signal-to-
noise ratio was better for the product ion spectra obtained in the presence of Li+ than in 
the absence of added salt, so in that respect the addition of the salt enhanced the 
identification.  One possible problem was identified with adding lithium salts.  In the full 
scan spectrum of egg PC analysed in the absence of an added salt there are peaks at 
m/z 782.6 and m/z 788.6.  The addition of Li+ to the sample would create a lithium adduct 
of the lipid with m/z 782.6 at m/z 788.6, and fragmentation of this mass would give a 
product ion spectrum containing peaks corresponding to both the lipid with m/z 788.6 for 
[M + H]+ and the lipid with m/z 788.6 for [M + Li]+, from which it is likely neither could be 
fully identified.  This highlights the need for separation of the lipids before analysis, such 
as on a TLC plate. 
2.3.3 MALDI imaging of TLC plates 
A method for analysing lipids on TLC plates was formed for the Autoflex II MALDI-
TOF/TOF instrument and was applied to the analysis of soybean PC and an extracted 
mixture of mouse lung lipids.  DPPC was identified from the mouse lung lipid mixture.  
When MSMS analysis was carried out on this lipid in the absence of added salt, the only 
identifiable peak in the product ion spectrum corresponded to the PC headgroup.  The 
sodium adduct of DPPC was also tentatively assigned from the full scan analysis and an 
MSMS spectrum, where again a peak corresponding to the PC headgroup was observed.  
Though previous analyses have shown that the addition of sodium to samples produced 
product ion spectra with a number of peaks from which lipids could be identified, in this 
case the sodium adduct came from just the small quantity of sodium naturally present in 
the sample and TLC plate, therefore there was only a small quantity of [DPPC + Na]+ 
present and the signal-to-noise ratio was not sufficient for achievable MSMS.  Only 
MSMS of the lithium adduct provided enough information to fully identify the lipid.  DPPC 
was also the only lipid which could be identified from MS and MSMS analysis of the 
mouse lung lipid mixture on the standard MALDI target plate in the presence and absence 
of Li+, so MALDI imaging of the TLC plate provided no more or less information than 
analysis of the lipid on the standard MALDI target.  In the absence of lithium however, the 
product ion spectrum obtained from the lipid on the TLC plate was less informative than 
that obtained on the standard MALDI target.   
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Soybean PC was also separated by TLC and analysed in the presence and 
absence of LiCl and the results compared to the analysis of the lipid mixture on the 
standard target.  The full scan MS spectra obtained in the presence and absence of 
lithium were very similar, but it was not possible to fully identify any species from MSMS 
spectra recorded from the TLC plates whereas two lipids were identified from the mixture 
analysed on the standard target plate in the absence of lithium and one in the presence of 
lithium.   
 Overall, the lipid mixtures which were separated on TLC plates gave less 
information than when analysed on the MALDI target plate.  The same peaks were 
observed in the full scan spectra of soybean PC on the standard target plate and on TLC 
plates, both in the presence and absence of lithium, but the signal was too low for 
achievable MSMS when analysis was carried out directly on the TLC plate.  
Fragmentation of the lithium adduct of DPPC on a TLC plate on which the mouse lipids 
had been separated produced a clear product ion spectrum from which the headgroup 
and palmitoyl chain could be identified.  These results suggest that with refinement of the 
method more information could be obtained. 
2.4 Future work 
The analyses of POPE, POPC and OPPC have shown that it is possible to identify 
the orientation of the acyl chains on the glycerol backbone when the methodology has 
been completely validated.  The correlation between the results reported herein and those 
reported in the literature is at times tentative however, and there are a number of other 
factors which may affect the relative intensities of peaks corresponding to cleavages at 
the sn-1 and sn-2 positions which should be evaluated using the same stringent 
repeatability experiments performed on POPE, POPC and OPPC.  The differences 
observed between the relative intensity results for POPC and OPPC, where the positions 
of two chains differing in length and degree of unsaturation are swapped, suggest three 
areas which could be investigated: The first is the influence of acyl chain length on the 
relative intensities of the product ions corresponding to the loss of an acyl chain from the 
sn-1 or sn-2 position.  There has been some research in this area reported in the 
literature which suggests that the preferential cleavage of the chain from one position 
holds until the chain at the sn-2 position is much shorter (≥ 6 CH2 difference in the paper 
referenced) than that at the sn-1 position, though the conditions of this analysis (FAB-
CAD MSMS in negative mode) were very different from those employed in the present 
research and, as shown by this work and a review of the literature, the conditions under 
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which such analyses are carried out have a large effect on the relative intensity values.  
The second is the influence of unsaturation, both the number of double bonds and their 
positions.  The same researchers reported that when the chain at the sn-2 position had 
more than 3 or 4 double bonds there was no longer preferential cleavage of the chain 
from the sn-2 position.  Again, this gives only an insight into the possible results which 
may be observed under different conditions.  The third analysis required would be a more 
detailed investigation into the influence of acyl chain position on the relative intensities.  
The results with POPC and OPPC suggest that the influence of chain length or 
unsaturation differs depending on the position at which the shorter or more unsaturated 
chain resides.  The effect of the headgroup needs to be explored also.  The results 
described herein suggest that the general preferences for the cleavage of a chain from 
the sn-1 or sn-2 position are the same for POPC/OPPC and POPE, but in order to fully 
analyse unknown lipid mixtures it would be necessary to determine if this held for other 
commonly occurring lipids such as phosphoglycerols. 
The idea of identifying lipid mixtures separated on TLC plates by MALDI imaging is 
fundamentally a good one, and the experiments described above produced encouraging 
preliminary results but did not reach the full potential of the technique.  Adapted MALDI 
target plates are now commercially available.  It was not possible to test whether the 
apparatus used for the experiments fully allowed high voltage to be conducted across the 
TLC plate inside the MALDI instrument, although resistance across the apparatus was 
checked with an ohmmeter to ensure there was some conductance between the metal 
plate and the TLC plate.  The use of the specific adapted target plate designed for the 
Autoflex would remove any potential problems caused by insufficient conductivity.  More 
conditions could be explored in order to obtain better results, including the use of high 
performance TLC (HPTLC) plates.  These are composed of silica particles which are 
around half the size of those in standard TLC plates, providing both a smoother surface 
(which may improve mass accuracy), and reducing the diffusion of samples as the plate is 
run.  This in particular could make a large difference to the analysis of lipid mixtures as 
the lipids will be concentrated in smaller areas after separation, which should increase the 
intensity of peaks in MS and MSMS spectra.  A TLC solvent solution which gave better 
separation of the PC lipids would also aid identification of mixtures with a high PC 
content.   
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3 THE CHEMICAL STABILITY OF PHOSPHOLIPIDS 
3.1 Introduction 
 The stability of liposomes after preparation has significance in two main areas; 
firstly, any changes in liposomes between their preparation and their use in peptide 
binding analyses may cause erroneous results, especially if these changes increase over 
time and the liposomes are not always stored for the same length of time before use.  
Secondly, liposomes are used as carriers for some drugs.  Examples of this include a 
tumour-targeting drug which is incorporated into liposomes composed of a 2:1 molar ratio 
of DSPC and cholesterol to improve delivery of the drug to the required area, and an 
inhaled mixture of the analgesic fentanyl in two forms.1, 2  The free form is absorbed 
immediately, while a liposome-encapsulated form is absorbed more slowly to give longer 
pain relief.  The stability of the liposomes has important implications for the shelf-life of 
these drugs. 
3.1.1 Chemical hydrolysis of lipids 
 Liposomal lipids have been shown to undergo acid- or base-catalysed hydrolysis 
to lysolipids and free fatty acids under certain conditions.  The most stable hydrolysis 
product is 1-acyl lysophosphocholine (Figure 3.1).  Hydrolysis has been observed to 
occur equally at both the sn-1 and sn-2 positions of the central lipid glycerol group, but 2-
acyl lysophosphocholines are rapidly converted through acyl migration to 1-acyl 
lysophosphocholines.3
 
Figure 3.1.  Lyso-MPC after hydrolysis of DMPC at the sn-2 position or after hydrolysis at the sn-1 position 
followed by acyl migration. 
The hydrolysis of liposomal lipids has been shown to be dependent on external 
factors including pH, temperature, buffer and ionic strength, and on the lipid headgroup 
and acyl chain length.3–10   
3.1.1.1 The effect of pH 
The slowest rate of hydrolysis of saturated soybean phosphocholine lipids has 
been shown to occur in liposomes buffered at pH 6.5, with sharp increases above and 
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below this pH.4  This is to be expected due to the hydrolysis occurring through acid or 
base-catalysed reactions.  Analysis of the rates of hydrolysis of mostly polyunsaturated 
phosphocholine and phosphoethanolamine lipids at pH 7.4 and pH 1.5 showed the effect 
of acidic media on the rate of hydrolysis.  After 24 hours at 25 °C and pH 7.4 the 
percentage by weight of lyso-PC in the sample had increased slightly, from 0.8 to 1.4%, 
as had the percentage lyso-PE (1.8 to 2.5%).  The lyso-PC content of the same lipid 
mixture at the same temperature at pH 1.5 increased from 0.8% to 3.3% in three hours, 
with the lyso-PE content increasing from 1.8% to 5.2%.5   
3.1.1.2 The effect of temperature 
When a sample of the same mostly polyunsaturated phosphocholine and 
phosphoethanolamine lipids was stored at pH 7.4 at 37 °C the lyso-PC content increased 
from 0.8% to 2.1% and the lyso-PE content increased from 1.8% to 5.5% in 24 hours, 
compared to increases of 0.6% and 0.7% respectively at 25 °C.  At pH 1.5 at 37 °C an 
even greater increase in the percentages of both lyso-lipids was observed in three hours, 
with lyso-PC increasing from 0.8% to 8.1% and lyso-PE increasing from 1.8% to 9.2%, 
compared to increases of 2.5% and 3.4% respectively at 25 °C.5  Increasing the 
temperature from 25 °C to 37 °C therefore had a clear effect on the hydrolysis of both the 
PC and PE lipids, which was stronger under acidic conditions. 
A longer-term study of hydrogenated soybean phosphocholines showed that after 
6 months storage in the dark at 4 °C only 5.4% of the lipids were lyso-PC (the lyso-PC 
content at the beginning of the study is not reported), while the same lipids stored at room 
temperature and in the daylight contained 14.2% lyso-PC after 6 months.6  It is unclear 
whether the temperature or UV light was the main factor in this increase in hydrolysis 
however. 
3.1.1.3 The effect of buffers 
Increasing buffer ionic strength has been shown to have no effect on the rate of 
hydrolysis of partially-hydrogenated egg phosphocholine lipids, due to PC lipids having no 
net charge.7  Reaction kinetics are only affected by ionic strength if a reaction occurs 
between two charged species, therefore at pH values where phosphocholine lipids have 
no net charge increasing the concentration of salts will not affect hydrolysis.3, 8   Changing 
the buffer does have an effect on the rate of hydrolysis, but the majority of the catalytic 
effect appears to still come from H+ or OH-.3 
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3.1.1.4 The effect of lipid composition 
A slight increase in the rate of hydrolysis has been observed with decreasing 
chain length of phosphocholine lipids from DPPC to DMPC to DLPC in mixed micelles 
with Triton X-100.  The increase was so small however that it was questioned whether it 
was meaningful.9  Marked differences were observed in the hydrolysis rates of egg lipids 
with phosphocholine and phosphoethanolamine headgroups however, with a rate 
constant of 14 x 103 s-1 M-1 observed for hydrolysis of phosphocholine in mixed micelles 
with Triton X-100 and a rate of 4.6 x 103 s-1 M-1 observed for hydrolysis of 
phosphoethanolamine lipids under the same conditions.  The phosphocholine 
components of mixed PE/PC micelles with Triton X-100 were hydrolysed faster than the 
phosphoethanolamine components of the same micelles, but the hydrolysis was slower 
than in pure micelles.  This was thought to be caused by the change in surface pH due to 
the PE lipids, which would be negatively charged due to the alkaline medium used for the 
experiments (pH 12.7).3, 9, 10   Hydrolysis of bilayers of PC and PG lipids has also been 
observed to be slower in alkaline media than in a neutral solution, again due to the 
surface pH.10 
3.1.1.5 Physical effects of hydrolysis 
The presence of lyso-PC and free fatty acids has a number of effects on liposome 
dispersions.  Liposomes composed of partially hydrogenated egg PC lipids, egg PG lipids 
and 15% lyso-PC were shown to decrease in size from 0.19 µm to 0.16 µm over 40 days 
stored at 40 °C.  This was attributed to rearrangement due to the release of lyso-PC, 
which spontaneously forms micelles in aqueous solution.11  The incorporation of free fatty 
acids into liposome bilayers has been observed to cause aggregation and fusion during 
storage below the phase transition temperature of the fatty acid/lipid mixed bilayer.  
Aggregation occurred rapidly below the phase transition temperature but was reversible if 
the dispersion was immediately reheated.  Fusion occurred by increasing degrees if the 
dispersion was kept below the phase transition temperature.12  The presence of lyso-
phospholipids in liposome bilayers also increases permeability, allowing small molecules 
to pass in and out of the liposomes.  Greater leak-in of calcein has been reported from 
liposomes to which lyso-PC has been incorporated into the bilayer compared to those 
containing lyso-PC and fatty acids that have been formed through hydrolysis however.  
Bilayers which contained up to 10% hydrolysis products showed less permeability than 
fresh liposomes, and equal permeability was reported with 15% hydrolysis products.  
Increased permeability was observed above this point.  Leak-in of calcein through lipid 
bilayers containing exogenous lyso-PC increased with increasing lyso-lipid 
concentration.11  Leakage of liposome contents through bilayers containing a proportion of 
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lyso-lipids was also observed to be temperature-dependant, depending on the fluidity of 
the bilayer.13 
3.1.2 Lipid oxidation 
Phospholipids are generally oxidised via one of two methods: 1) a free radical 
chain mechanism (also termed peroxidation or autoxidation); or 2) by ozonolysis.   
3.1.2.1 Free radical chain mechanism 
The free radical chain oxidation mechanism is composed of three stages: 
initiation, propagation, and termination (Scheme 3.1).  The mechanism is initiated by the 
loss of a hydrogen radical, which can be caused by heat, light, or the presence of trace 
metals, and leaves the lipid as a radical.14  The lipid radical then reacts with dissolved 
oxygen to form a peroxy radical in the first propagation step.  The peroxy radical can then 
react with more non-radical lipid molecules, removing H· and forming a hydroperoxide, 
the primary product of lipid peroxidation, and further propagating the reaction.   
Initiation: RH  H    R  
Propagation: R    O         
ROO    RH  R    ROOH  
Termination: 2ROO   [ROOOOR   nonradical products and O2 
Scheme 3.1.  Free radical peroxidation of lipids.
14
 
Lipids with polyunsaturated acyl chains are more likely to undergo free radical 
oxidation, due to the increased stability of the allyl radical through the ability to delocalize 
an unpaired electron, but lipids with monounsaturated chains also undergo peroxidation.  
Six hydroperoxide products of methyl oleate have been identified, and a mechanism of 
competing peroxyl rearrangement and H-atom abstraction proposed for their formation 
(Scheme 3.2). 
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R1 = C7H15, R2 = (CH2)6COOCH3, RH = methyl oleate 
Scheme 3.2.  The primary oxidation products of methyl oleate.  
The primary hydroperoxide oxidation products can degrade to secondary 
products.  These include allylic enones, saturated epoxy esters, unsaturated dihydroxy, 
saturated dihydroxy esters and aldehydes (Scheme 3.3).15–17   
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Scheme 3.3.  Secondary autoxidation products of methyl oleate.  A) Non chain-shortening products; B) chain 
shortening products.  Note from Scheme 3.2 that the initial oxygen radical can be situated on position 8, 9, 10 
or 11 of the chain, therefore on the ester or the tail side of the chain relative to the double bond, so different 
products are possible. 
Since peroxidation is initiated by light, heat or the presence of trace metal ions, the 
elimination of any of these reduces the chance of peroxidation.  Reducing the availability 
of oxygen by the presence of an inert atmosphere also lessens the likelihood of 
peroxidation occurring.3 
3.1.2.2 Ozonolysis 
Ozonolysis of fatty acid chains has been shown to initially cause formation of an 
aldehyde and a hydroxyl hydroperoxide.  The hydroxyl hydroperoxide then eliminates 
A 
B 
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H2O2, forming a second aldehyde.  Further oxidation of the aldehydes can cause 
formation of carboxylic acids (Scheme 3.4).18 
 
R2
H
R1
H O3
C
O
R H
+
CH
O
H R
O
H2O
C
OH
RH
HOO
C
OH
RH
HOO
C
O
H R
+ HOOH
C
O
H R
O3
C
O
HO R
+ O2
a)
b)
 
Scheme 3.4.  Ozonolysis of double bonds.  A) Initial reaction; B) oxidation of aldehyde product with second 
ozone molecule. 
3.1.2.3 Physical effects of oxidation 
The oxidation of phospholipids causes a number of chemical changes including 
the shortening of acyl chains (where aldehydes and carboxylic acids have been formed), 
a decrease in unsaturation and the addition of polar, and hydrogen-bonding, groups such 
as carbonyls, hydroxides and peroxides.  These have a number of physical effects on 
bilayer properties.  Analysis of mixed monolayers of DPPC with either 1-palmitoyl-2-(9´-
oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC) (Figure 3.2A) or 1-palmitoyl-2-
azelaolyl-sn-glycero-3-phosphocholine (PazePC) (Figure 3.2B) has shown that the 
presence of either causes an expansion of lipid monolayers.19  At high pressures, both 
are released from the monolayer and form micelles in the aqueous subphase.  It has also 
been proposed that the azelaolyl chain of PazePC bends back through the bilayer to 
enable the polar group to reside in the membrane-water interface rather than within the 
hydrophobic region of the bilayer.  This was suggested from data showing that bilayers 
containing PazePC interact with cytochrome c in similar way to vesicles composed of 
acidic lipids such as POPG (Figure 3.3).    
A 
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Figure 3.2.  A) PoxnoPC, B) PazePC 
 
 
Figure 3.3.  Proposed interaction of PazePC with cytochrome c. 
3.1.3 Melittin 
 Melittin is an α-helical antimicrobial peptide and is the main protein component of 
European honey bee (Apis mellifera) venom.  It has powerful hemolytic properties, 
causing the leakage of haemoglobin from erythrocytes at concentrations above 1 µg/mL.20  
Honey bee venom also contains the enzyme phospholipase A2 (PLA2).  PLA2 hydrolyses 
phospholipids at the sn-2 position.21  This hydrolysis requires catalysis by Ca2+.  
Commercially-supplied samples of natural melittin contain small amounts of this enzyme, 
and the observation of lipid hydrolysis in the presence of melittin is attributed to its 
presence, for example it is reported that the presence of melittin enhances the hydrolysis 
of lipids by PLA2 without suggesting that any hydrolysis might be caused by the melittin 
itself.22  The addition of 5 mM EDTA to buffers used for experiments involving natural 
melittin inhibits the action of PLA2 through chelation of Ca
2+.20  It has been proposed that 
melittin and PLA2 have a synergistic effect when acting on lipid bilayers.  This has been 
observed by different methods, including ac impedance analysis of supported bilayers on 
gold surfaces.23   This method allows sensitive detection of changes in conductance and 
capacitance caused by the formation of defects in lipid membranes.  The effect of natural 
melittin on a supported POPC bilayer was investigated in the presence and absence of 5 
A 
B 
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mM EDTA.  In the presence of EDTA, low concentrations (1.6 µM) of melittin caused a 
decrease in capacitance and conductance consistent with adsorption to the surface rather 
than penetration into the bilayer.  The capacitance and conductance were monitored and 
remained stable for 10 minutes.  Higher concentrations of melittin caused an increase in 
capacitance and conductance correlating to penetration of the peptide into the bilayer and 
the formation of defects.  These effects were small in comparison to those observed in the 
absence of EDTA however, where the addition of melittin at a low concentration (2 µM) 
caused an increase in capacitance and conductivity which continued linearly for over 2 
hours.  Pure PLA2 applied to the supported bilayer at a concentration comparable to those 
found in commercial samples (0.03 U mL-1) had only a slight effect on electrical 
parameters, and addition at a larger concentration (0.1 U mL-1) still had a much smaller 
effect than that observed for melittin in the absence of EDTA.   
3.1.4 Action of small molecules on liposomes 
3.1.4.1 Cationic amphiphilic drugs 
Cationic amphiphilic drugs have been shown to catalyse the hydrolysis of lipid 
membranes.24  Two examples of this class of compounds which have been studied in 
depth are haloperidol and spiperone (Figure 3.4).24, 25 
 
Figure 3.4.  A) Haloperidol, B) spiperone. 
Casey et al. postulated that the weakly acidic quaternary amines act as the source 
of protons for acid-catalyzed ester hydrolysis.25  The degradation of lipid bilayers into fatty 
acids and lyso-lipids is thought to provide a method of translocation and transport for the 
drug molecules.  The lyso-lipids bud off from the bilayer as micelles with drug molecules 
incorporated inside.  The micelles transport the molecules to neighbouring bilayers, bind, 
and allow the process to be repeated. 
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3.1.4.2 Alcohols 
Small alcohols such as trifluoroethanol (TFE) and 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP) have been shown to disrupt lipid bilayers, increasing lateral 
pressure and causing the leakage of liposome contents.26  This is thought to be caused 
by the insertion of the alcohol molecules in between the headgroups in the bilayer, 
increasing the lateral pressure in this region while decreasing it in the chain region.  HFIP 
was shown to have the greatest effect on bilayers out of methanol, ethanol, isopropanol, 
propanol, TFE, butanol and HFIP.26  This  supports the theory that the alcohol sits in the 
headgroup region, as the alcohol hydroxyl groups are thought to hydrogen bond to the 
phosphate oxygens, and HFIP is the best hydrogen-bond donor of the alcohols tested.27  
Ennaceur and Sanderson studied the effects of HFIP on lipid membranes in aqueous 
solution, finding a marked decrease in the stability of the bilayer with saturated lipids, 
which degraded to form mixed HFIP/lipid particles, though this was not observed with 
unsaturated lipids.27    They observed physical changes to the lipid membrane using a 
number of methods including small-angle X-ray scattering (SAXS), differential scanning 
calorimetry (DSC) and electron microscopy (EM).    
3.1.5 The limitations of current research and scope of this research 
The work in this section describes studies into the stability of liposomal 
phospholipids under certain conditions.  Having explored the use of MALDI-TOF and 
TOF/TOF for the identification of phospholipids, the technique was applied to the study of 
modified phospholipids, partly to complement and assist with the studies of melittin and 
other antimicrobial peptides by the group of Professor Alison Rodger, and partly to 
explore current theories as to the actions of certain species on lipids from a different 
angle.  Professor Rodger reported changes in the circular and linear dichroism spectra of 
antimicrobial peptides depending on the age of the liposomes to which they were binding, 
and proposed that this may be due to hydrolysis or oxidation of the liposomal lipids during 
storage.28   Analyses by MALDI-MS to look for any chemical changes to the lipids under 
the conditions applied were complemented by DLS and TEM to observe any physical 
changes such as aggregation, fusion or micellisation. 
3.1.5.1 Hydrolysis and oxidation 
The hydrolysis and oxidation of lipid acyl chains has been shown to be dependent 
upon a number of conditions (see Sections 3.1.1 and 3.1.2), making it hard to predict the 
stability of a specific liposome dispersion and what changes the liposomes may undergo 
before use in analyses.  Following Prof. Rodger‟s report, a number of experiments were 
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carried out in an attempt to identify any changes which may have been occurring within 
the liposomes to affect their stability and permeability. 
3.1.5.2 Melittin 
The hydrolysis of membrane lipids in the presence of melittin is generally 
attributed to the presence of PLA2.
22  No reference could be found in the literature which 
attributed hydrolysis to the effect of melittin itself on liposomal lipids.  The research 
described here aims to determine any chemical effect melittin may have on lipids in the 
absence of PLA2 and the extent of hydrolysis catalysed by PLA2. 
3.1.5.3 Small molecules 
The physical effect of HFIP on lipid bilayers has been well reported, but questions 
remain as to whether any chemical effects accompany them.  Since the hydrolysis effects 
of the cationic amphiphilic drug haloperidol on lipids has already been studied 
comprehensively, it was deemed to be a good model to support a study of the chemical 
stability of lipids under different conditions. 
3.2 Results and discussion 
3.2.1 Liposome stability in different buffers 
3.2.1.1 DOPC 
3.2.1.1.1 Bis-tris propane 
 The rate of hydrolysis of DOPC liposomes in water and bis-tris propane buffer (10 
mM, pH 7) was compared to determine whether the buffer had an effect on lipid 
hydrolysis.  Both samples were stored at 4 °C.  After preparation and after 2, 6, 7, 15, 18 
and 20 days a sample of each was removed and analysed by MALDI-MS.  Figure 3.5 
shows the intensity of the peak corresponding to [DOPC – RCO]+ normalised relative to 
the combined intensities of the peaks corresponding to [DOPC + H]+ and [DOPC – RCO]+.   
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Figure 3.5.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes in 10 mM bis-tris propane or water.  
Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised relative to the combined intensities of 
the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC liposomes in 10 mM bis-tris propane 
or water stored at 4 °C for 20 days.  Errors are estimated from the values obtained from repeat 
measurements. 
 The DOPC liposomes were not observed to have undergone any hydrolysis, within 
error, in bis-tris propane or in water over 20 days (Figure 3.5).   
3.2.1.1.2 Tris  
 DOPC was incubated at 4 °C in water and tris buffer (10 mM, pH 7.4) for 12 days 
with MALDI-MS analyses after preparation and after 2, 5, 7, 9 and 12 days.  No overall 
increase in lyso-PC could be observed over the analysis period in either sample (Figure 
3.6). 
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Figure 3.6.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes in 10 mM tris or water.  Intensity of 
the peak corresponding to [DOPC – RCO]
+
 was normalised relative to the combined intensities of the peaks 
corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC liposomes in 10 mM tris or water stored at 4 °C 
for 12 days.  Errors are estimated from the values obtained from repeat measurements. 
3.2.1.1.3 Phosphate and NaCl buffer with and without EDTA 
EDTA is added to buffers when natural melittin is analysed in order to chelate Ca2+ 
and prevent the activity of phospholipase A2, which is always present as a contaminant, 
from masking the actions of the peptide.  Figure 3.7 shows the intensity of the peak 
corresponding to [DOPC – RCO]+ normalised relative to the combined intensities of the 
peaks corresponding to [DOPC + H]+ and [DOPC – RCO]+ for DOPC liposomes stored at 
37 °C in a buffer of 10 mM phosphate and 150 mM NaCl (pH 7) with and without 1 mM 
EDTA.  Although the graph suggests a slight increase in lyso-PC over the first three days 
in both samples, the overall intensity of lyso-PC compared to DOPC remained very low 
over the course of the analysis period, and the variation is within an error of ± 1%.  There 
is no suggestion from the data that either the 10 mM phosphate and 150 mM NaCl buffer, 
the presence of 1 mM EDTA or storage at 37 °C enhances or inhibits lipid hydrolysis. 
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Figure 3.7.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes in 10 mM phosphate and 150 mM 
NaCl with and without 1 mM EDTA.  Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised 
relative to the combined intensities of the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for 
DOPC liposomes in 10 mM phosphate and 150 mM NaCl with and without 1 mM EDTA stored at 37 °C for 15 
days.  Errors are estimated from the values obtained from repeat measurements. 
3.2.1.2 DPPC 
3.2.1.2.1 Bis-tris propane 
 DPPC and DOPC differ in the length and degree of unsaturation of their acyl 
chains, and are in different phases at room temperature (Tm DOPC = -20 °C, Tm DPPC = 
41 °C).29  The acyl chains of DOPC are 18 carbon atoms long and contain a double bond, 
whereas the chains of DPPC are 16 carbons long and fully saturated.  DPPC liposomes 
were made and analysed in the same way as the DOPC liposomes in water and in bis-tris 
propane buffer (10 mM, pH 7), stored at 4 °C and analysed by MALDI-MS after 
preparation and 2, 6, 7, 15, 18 and 28 days after extrusion to look for an increase in lyso-
PC caused by hydrolysis.  As shown in Figure 3.7, no increase in lyso-PC was observed 
either in water or in bis-tris propane over the analysis period. 
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Figure 3.8.  MS intensity profile of [DPPC – RCO]
+
 for DPPC liposomes in10 mM bis-tris propane or water. 
Intensity of the peak corresponding to [DPPC – RCO]
+
 was normalised relative to the combined intensities of 
the peaks corresponding to [DPPC + H]
+
 and [DPPC – RCO]
+
 for DPPC liposomes in 10 mM bis-tris propane 
or water stored at 4 °C for 18 days.  Errors are estimated from the values obtained from repeat 
measurements. 
3.2.1.3 Discussion 
The results show that DOPC and DPPC are stable with respect to hydrolysis for at 
least two weeks in water and with a number of commonly used buffers, when stored in the 
fridge and at 37 °C.  This result correlates with literature reports of stability or instability of 
lipids with respect to hydrolysis.  The lipids both have neutral phosphocholine 
headgroups, which have been shown to make them less susceptible to hydrolysis than 
those with negatively charged phosphoethanolamine headgroups.3, 9, 10  The pH was 7 or 
7.4 in the buffered samples and 7 in the samples in water, which decreases the chance of 
acid- or base-catalysed hydrolysis.30  Storage at 37 °C has been shown to increase the 
rate of hydrolysis of some lipids,5 but no increase in hydrolysis was observed in these 
analyses. 
3.2.2 Lipid oxidation 
 All of the MALDI-MS spectra of the DOPC liposome samples and the DOPC lipid 
stock solution contained peaks at m/z 676.4 (Figure 3.10).  The intensity of the peak 
varied between spectra, with a maximum approximately half that of the protonated 
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molecular ion.  The peak was tentatively assigned as the protonated oxidation product 
OoxnoPC (Figure 3.9).  A weak peak was also observed at m/z 566.9 in the spectra of 
some samples (Figure 3.10), which was thought to correspond to the protonated doubly 
oxidised species DoxnoPC (Figure 3.9).  A peak, again of varying intensity, was observed 
at m/z 650.4 in the MALDI-MS spectra of POPC liposome solutions and lipid stock, which 
was thought to correspond to protonated PoxnoPC (Figure 3.9). 
 
 
 
Figure 3.9.  Proposed structures of single oxidation products of DOPC (OoxnoPC), POPC (PoxnoPC); and 
the double oxidation product of DOPC (DoxnoPC).  
a) Oxidation of OoxnoPC could occur on either chain 
 
Figure 3.10.  MALDI-MS spectrum of DOPC liposomes showing the singly and doubly oxidised lipid 
(OoxnoPC and DoxnoPC respectively).  The sample was prepared by mixing DOPC liposome dispersion (0.5 
mg/mL) 2:9 with DHB (30 mg/mL in 50:50 EtOH/water). 
OoxnoPCa 
PoxnoPC 
DoxnoPC 
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3.2.2.1 DOPC oxidation 
 The proposed DOPC oxidation product was analysed by MALDI-MSMS in the 
presence of Li+ and Na+ and in the absence of added salt in order to determine its 
structure (Figure 3.11A, B and C respectively and Table 3.1). 
 
Figure 3.11.  MALDI-MSMS spectra of proposed oxidation product of DOPC A) with Li
+
, B) with Na
+
 and C) in 
the absence of added salt.  The samples were prepared by mixing dispersions of the liposomes in water (0.5 
mg/mL) 2:9 (v/v) with solutions of DHB (30 mg/mL) in EtOH/H2O (50% v/v), for the protonated ion, or LiCl (100 
mM) or NaCl (100 mM) and DHB (30 mg/mL) in EtOH/H2O (50% v/v) for each of the salt adducts respectively. 
Table 3.1.  Product ions observed in the MALDI-MSMS spectra of the proposed DOPC oxidation product in 
the presence of Li
+
 and Na
+
 and in the absence of added salt. 
[OoxnoPC + Li]
+a 
[OoxnoPC + Na]
+ 
m/z Product ion m/z Product ion 
183.8 [OP(O)2OCH2CH2NMe3 + 2H]
+
 183.7 [OP(O)2OCH2CH2NMe3 + 2H]
+
 
264.5 [RCO]
+
 264.5 [RCO]
+
 
499.1 [OoxnoPC – OP(O)2OCH2CH2NMe3 – H + Li]
+
 356.8 [OoxnoPC – RCOO – NMe3 – H + Na]
+
 
503.2 [OoxnoPC – HC(O)(CH2)7COO]
+
 493.2 [OoxnoPC – OP(O)2OCH2CH2NMe3]
+
 
  512.2 [OoxnoPC – OP(O)2OCH2CH2NMe3 – H + Na]
+
 
  [OoxnoPC + H]
+
   
m/z Product ion   
183.9 [OP(O)2OCH2CH2NMe3 + 2H]
+
   
264.5 [RCO]
+
   
a) R corresponds to the non-oxidised acyl chain 
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The MALDI-MSMS spectrum of [OoxnoPC + Li]+ contained two peaks from which 
the oxidised and non-oxidised acyl chains could be identified (Figure 3.11A, Table 3.1).  
These were observed at m/z 264.5 and m/z 503.2, and corresponded to [RCO]+ and 
[OoxnoPC – HC(O)(CH2)7COO]
+ respectively.  Two peaks were observed which 
confirmed the identity of the molecule as a PC lipid, at m/z 183.8, m/z 499.1 
corresponding [OP(O)2OCH2CH2NMe3 + 2H]
+ and [OoxnoPC – OP(O)2OCH2CH2NMe3 – 
H + Li]+ respectively.  Similar fragments were identified in the fragmentation spectrum of 
the sodium adduct (Figure 3.11B, Table 3.1).  Two peaks were observed which allowed 
the identification of the oxidised and non-oxidised acyl chains, at m/z 264.5 and m/z 356.8 
corresponding to [RCO]+ and [OoxnoPC – RCO – NMe3 – H + Na]
+.  The PC headgroup 
was identified from peaks corresponding to [OP(O)2OCH2CH2NMe3 + 2H]
+, [OoxnoPC – 
OP(O)2OCH2CH2NMe3]
+ and [OoxnoPC – OP(O)2OCH2CH2NMe3 – H + Na]
+ at m/z 183.7, 
m/z 493.2 and m/z 512.2 respectively.  Little information about the structure of the 
proposed oxidation product could be determined from the MSMS spectrum of [OoxnoPC 
+ H]+ (Figure 3.11C, Table 3.1).  Only the PC headgroup and the oleoyl chain could be 
identified, from peaks at m/z 183.9 and m/z 264.5 corresponding to 
[OP(O)2OCH2CH2NMe3 + 2H]
+ and [RCO]+. 
The MALDI-MSMS spectra confirmed the identity of the oxidised species 
proposed in Figure 3.9.  The oxidised chain was identified through the loss of 
HC(O)(CH2)7COO; the intact acyl chain was identified through different peaks 
corresponding to the loss of RCOO and through peaks corresponding to [RCO]+.  The 
presence of the phosphocholine headgroup was also confirmed, through fragments 
involving its neutral loss and to the presence of peaks corresponding to 
[OP(O)2OCH2CH2NMe3 + 2H]
+ in all of the product ion spectra.  MALDI-MS analysis was 
carried out on an unopened batch of DOPC which was dissolved in CHCl3 immediately 
before analysis as opposed to the old sample which had been stored in the freezer as a 
solution in CHCl3 for a number of months.  Evidence of oxidation was also observed in the 
new batch (data not shown). 
 The identification of the oxidised DOPC molecule was further supported by 
accurate mass MS analysis.  A peak corresponding to the oxidised lipid was observed at 
m/z 676.45540.  An elemental composition search on this m/z value produced only one 
match with the correct P and N composition for a phospholipid, namely C35H67O9N1P1, 
with an error of -0.09 mmu.  This composition (with 1H subtracted to account for 
protonation) matches that of the suggested structure of OoxnoPC in Figure 3.9. 
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 The intensity of the peak corresponding to the proposed doubly oxidised species 
was too low for MALDI-MSMS or accurate mass analysis by FT-MS to be carried out, 
therefore its structure could not be conclusively identified. 
Proton NMR studies were carried out on a DOPC sample which, from MALDI-MS 
analysis, contained the oxidation product.  It was predicted that the oxidised species 
would cause a peak at 9.5–10 ppm corresponding to the aldehyde proton.  The NMR 
spectrum only showed peaks corresponding to the protons of DOPC however.  This 
suggests that, while the peaks are clearly visible in MALDI-MS spectra, there was very 
little of the oxidised species present in the lipid and liposome samples.  This implies that it 
is very easily ionised compared to the intact lipid and most of its other decomposition 
products.  It also explains why the intensity of the peak corresponding to the oxidation 
product is inconsistent from analysis to analysis.  If the concentration is extremely low yet 
a clear peak can be observed, very slight changes in the composition of each sample will 
have greatly magnified effects on the intensity of this peak. 
 
Figure 3.12.  The 
1
H NMR spectrum at 700 MHz in CDCl3 of a sample of DOPC from which OoxnoPC had 
been observed by MALDI-MS. 
ppm 
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3.2.2.2 POPC oxidation 
MALDI-MSMS was carried out on the possible analogous POPC oxidation product 
in the presence of lithium, sodium and in the absence of added salt. 
 
Figure 3.13.  MALDI-MSMS spectra of A)  [PoxnoPC + H]
+
, B) [PoxnoPC + Li]
+
 and C) [PoxnoPC + Na]
+
.  The 
samples were prepared by mixing solutions of the lipids in CHCl3 (1 mg/mL) 1:9 (v/v) with solutions of DHB 
(30 mg/mL) in EtOH/H2O (50% v/v), for the protonated ion, or LiCl (100 mM) or NaCl (100 mM) and DHB (30 
mg/mL) in EtOH/H2O (50% v/v) for each of the salt adducts respectively. 
 The MALDI-MSMS spectrum of [PoxnoPC + H]+ (Figure 3.13A) only allowed 
identification of the headgroup, from a peak corresponding to [OP(O)2OCH2CH2NMe3 + 
2H]+ at m/z 184.0.  Much more information could be gained from the MSMS spectrum of 
[PoxnoPC + Li]+ (Figure 3.13B, Table 3.2).  This spectrum allowed full identification of the 
oxidised species and confirmed its identity as PoxnoPC (Figure 3.9).  The oxidised oleoyl 
chain could be identified directly from the peak at m/z 155.0, corresponding to 
[HC(O)(CH2)7C(O)H]
+, and also from peaks corresponding to its loss (m/z 425.1, 
[PoxnoPC – HC(O)(CH2)7COO – NMe3 – H + Li]
+) and to the loss of the palmitoyl chain 
from the sn-1 position at m/z 341, m/z 394.0 and m/z 400.1, corresponding to  [PoxnoPC 
– R1COO – NMe3 – H + Li]
+, [PoxnoPC – R1COO]
+ and [PoxnoPC – R1COO – H + Li]
+ 
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respectively.  The peaks corresponding to the loss of the headgroup with and without Li+, 
[PoxnoPC – OP(O)2OCH2CH2NMe3]
+ and [PoxnoPC – OP(O)2OCH2CH2NMe3 – H + Li]
+ 
with m/z 467.2 and m/z 473.2 respectively, and to its presence ([OP(O)2OCH2CH2NMe3 + 
2H]+, m/z 183.8) support this identification.  The MSMS spectrum of [PoxnoPC + Na]+ was 
not as informative as that of [PoxnoPC + Li]+, but did show peaks corresponding to the 
headgroup and to its loss at m/z 183.9, m/z 467.2 and m/z 489.2 corresponding to 
[OP(O)2OCH2CH2NMe3 + 2H]
+, [PoxnoPC – OP(O)2OCH2CH2NMe3]
+ and [PoxnoPC – 
OP(O)2OCH2CH2NMe3 – H + Na]
+. 
Table 3.2.  Product ions observed in the MALDI-MSMS spectra of the proposed POPC oxidation product in 
the presence of Li
+
 and Na
+
. 
[PoxnoPC + Li]
+
 [PoxnoPC + Na]
+
 
m/z Fragment
a 
m/z Fragment 
155.0 [HC(O)(CH2)7CO + H]
+
 183.9 [OP(O)2OCH2CH2NMe3 + 2H]
+
 
183.8 [OP(O)2OCH2CH2NMe3 + 2H]
+
 467.2 [PoxnoPC – OP(O)2OCH2CH2NMe3]
+
 
238.6 [R1CO]
+
 489.2 [PoxnoPC – OP(O)2OCH2CH2NMe3 – H + Na]
+
 
341.0 [PoxnoPC – R1COO – NMe3 – H + Li]
+
   
394.0 [PoxnoPC – R1COO]
+
   
400.1 [PoxnoPC – R1COO – H + Li]
+
   
425.1 [PoxnoPC – HC(O)(CH2)7COO – NMe3 – H + Li]
+
   
467.2 [PoxnoPC – OP(O)2OCH2CH2NMe3]
+
   
473.2 [PoxnoPC – OP(O)2OCH2CH2NMe3 – H + Li]
+
   
a) R1 corresponds to the palmitoyl acyl chain at the sn-1 position 
 The structure of the oxidised POPC molecule was confirmed as that in Figure 3.9.  
Peaks were observed which corresponded to both the presence and the loss of the 
oxidised chain, such as that at m/z 154.9 corresponding to [HC(O)(CH2)7CO]
+ in the 
spectrum of [OoxnoPC + Li]+.  The intact palmitoyl chain was also identified, both through 
the fragment [R1CO]
+ and the loss of R1COO.  Finally, the molecule was identified as a 
PC lipid from the peak corresponding to the headgroup observed in all of the product ion 
spectra and the peaks corresponding to the loss of the headgroup observed in the spectra 
of [PoxnoPC + Li]+ and [PoxnoPC + Na]+. 
3.2.2.3 Investigation into method of oxidation 
The aldehyde oxidation products identified in samples of DOPC and POPC could 
have been caused by either ozonolysis or peroxidation.  In order to investigate the 
method of oxidation, DOPC and POPC were analysed by MALDI-MS for evidence of any 
other species which had undergone peroxidation or ozonolysis through which the 
mechanism of oxidation could be confirmed. 
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3.2.2.3.1 DOPC 
 Tables 3.3 and 3.4 show the theoretical products of the peroxidation or ozonolysis 
of DOPC and whether any evidence of these species were observed in the MALDI-MS 
spectrum of DOPC. 
Table 3.3.  Possible peroxidation products of DOPC and peaks observed in MALDI-MS spectrum of DOPC 
which may correspond to oxidation products.  Note the increase in mass of 1 Da for observed peaks 
compared to molecular weight of possible oxidation products due to protonation. 
DOPC peroxidation product
a 
Theoretical molecular 
weight (Da) 
Observed 
peak m/z 
Hydroperoxide (DOPC – H + OOH) 817.6 - 
Epoxide (DOPC + O) 801.6 - 
Saturated dihydroxy lipid (DOPC + 2OH) 819.6 - 
Unsaturated dihydroxy lipid (DOPC – 2H + 2OH) 817.6 - 
Dihydroperoxide (DOPC – 2H + 2OOH) 849.6 - 
Hydroxy hydroperoxide (DOPC – 2H + OH + OOH) 833.6 834.6 
Allylic enone (DOPC – 2H + O) 799.6 800.6 
Aldehyde (8) 661.4 - 
Aldehyde (9) 675.5 676.5 
Aldehyde (10) (unsaturated) 687.5 - 
Aldehyde (11) (unsaturated) 701.5 - 
a) The aldehydes are numbered according to the position of the aldehyde group, and therefore the 
point of cleavage of the acyl chain.  The unsaturated aldehydes incorporate one double bond. 
Table 3.4.  Possible ozonolysis products of DOPC and peaks observed in MALDI-MS spectrum of DOPC 
which may correspond to oxidation products.  Note the increase in mass of 1 Da for observed peaks 
compared to molecular weight of possible oxidation products due to protonation. 
DOPC ozonolysis product Theoretical molecular 
weight (Da) 
Observed 
peak m/z 
Aldehyde (9) 675.5 676.5 
Hydroxy hydroperoxide (9) 709.5 - 
Carboxylic acid (9) 691.4 692.5 
 
Three possible peroxidation products of DOPC were observed (Table 3.3) 
(including OoxnoPC).  It was not possible to fully identify these species, as they were not 
present in sufficient quantities to carry out MALDI-MSMS analysis.  No other aldehyde 
products were observed.  The proposed distribution of the hydroperoxide products of 
methyl oleate shown in (Scheme 3.2) has been suggested to be dependent on the 
concentration of the oleate if between 0.3 and 3 M.  Higher concentrations within this 
range cause higher quantities of the kinetic products, 8-cis, 9-trans, 10-trans and 11-cis 
hydroperoxides.  At lower concentrations the thermodynamic 8-trans and 11-trans 
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hydroperoxide products predominate.14  The lipid analysis was carried out on a solution of 
1.3 mM and the stock solution was 13 mM.  Though these concentrations are outside 
those in the work cited, the low concentrations suggest that the thermodynamic products 
8-trans and 11-trans hydroperoxide should predominate, thereby forming aldehydes at the 
8 and 11 positions of the oleate chain. 
 
Two possible ozonolysis products were observed, including OoxnoPC (Table 3.4).  
Again, it was not possible to carry out MALDI-MSMS analysis on the proposed carboxylic 
acid species to confirm its identity. 
 
Overall, the possible presence of oxidation products which could only be formed 
by peroxidation or ozonolysis suggests that both processes had occurred in the lipid 
during storage.  The fact that the aldehyde product observed was the only aldehyde which 
could be produced by ozonolysis and not the most likely aldehyde product of peroxidation, 
suggests that ozonolysis may be the primary cause of oxidation of the DOPC stock.  
Oxidation or photooxidation during MALDI analysis can be ruled out due to the vacuum in 
the sample chamber.  
3.2.2.3.2 POPC 
 Tables 3.5 and 3.6 show the theoretical products of the peroxidation or ozonolysis 
of DOPC and whether any evidence of these species were observed in the MALDI-MS 
spectrum of DOPC. 
Table 3.5.  Possible peroxidation products of POPC and peaks observed in MALDI-MS spectrum of POPC 
which may correspond to oxidation products.  Note the increase in mass of 1 Da for observed peaks 
compared to molecular weight of possible oxidation products due to protonation. 
POPC peroxidation product Theoretical molecular 
weight (Da) 
Observed 
peak m/z 
Hydroperoxide (POPC – H + OOH) 791.6 - 
Epoxide (POPC + O) 775.6 - 
Saturated dihydroxy lipid (POPC + 2OH) 793.6 - 
Unsaturated dihydroxy lipid (POPC – 2H + 2OH) 791.6 - 
Dihydroperoxide (POPC – 2H + 2OOH) 823.6 - 
Hydroxy hydroperoxide (POPC – 2H + OH + OOH) 807.6 808.5 
Allylic enone (POPC – 2H + O) 773.6 - 
Aldehyde (8) 635.4 - 
Aldehyde (9) 649.4 650.4 
Aldehyde (10) (unsaturated) 661.4 - 
Aldehyde (11) (unsaturated) 675.5 - 
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Table 3.6.  Possible ozonolysis products of POPC and peaks observed in MALDI-MS spectrum of POPC 
which may correspond to oxidation products.  Note the increase in mass of 1 Da for observed peaks 
compared to molecular weight of possible oxidation products due to protonation. 
POPC ozonolysis product Theoretical molecular 
weight (Da) 
Observed 
peak m/z 
Aldehyde (9) 649.4 650.4 
Hydroxy hydroperoxide (9) 683.4 - 
Carboxylic acid (9) 665.4 666.4 
 
Not including PoxnoPC, one peak was identified in the spectrum of POPC which 
may correspond to another peroxidation product (Table 3.5).  It was not possible to carry 
out MSMS analysis on this species, due to it being present at a low concentration.  A 
peak was also identified which may correspond to the carboxylic acid product of 
ozonolysis of POPC (Table 3.6).  The identity could not be confirmed due to its low 
concentration however.  As with DOPC, the results suggest that both peroxidation and 
ozonolysis have played a part in the oxidation of the POPC stock. 
3.2.3 Structural stability of liposomes 
3.2.3.1 TEM 
Electron microscopy was used to obtain images of the DOPC liposomes stored at 
4 °C in water and in bis-tris propane on the day they were prepared and after 9 days to 
see if any physical changes could be observed.   Images of the liposomes in bis-tris 
propane are shown in Figure 3.14.  The images show a range of liposomes of sizes 
above and below the extrusion membrane pore size of 100 nm, which is to be expected.  
No aggregation or micellization of any liposome samples could be observed in the 
micrographs after 9 days compared to those obtained on the day of preparation. 
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Figure 3.14.  TEM images of DOPC liposomes in bis-tris propane A) just after extrusion and B) 9 days after 
extrusion.  Liposomes, 5 mg/mL, diluted to 0.6 mM with water and stained with uranyl acetate. 
3.2.3.2 Dynamic light scattering 
The DOPC liposomes in water and bis-tris propane (10 mM, pH 7) were analysed 
by dynamic light scattering (DLS) after preparation and after 2, 5, 7, 9, 12 and 14 days of 
incubation at 4 °C to look for any size changes.  The polydispersity index (PdI) is a 
measure of the width of the distribution of sizes recorded.  The PdI can be used to give 
the percentage polydispersity (%Pd), where %Pd = PdI1/2 x 100, which gives a clearer 
indication of the width of the distribution.  The polydispersity index is in some ways more 
informative than the average diameter measurement, as the diameter measurement is 
intensity weighted, and therefore weighted towards the larger liposomes which scatter 
more, so if the liposomes were breaking down into smaller liposomes or micelles this 
would be visible more from the polydispersity than from the average diameter 
measurement.  Liposome fusion would have a significant effect on the diameter 
measurement as well as the polydispersity index.  The standard errors of the diameter 
measurements are also quoted, as these give an indication of the variation of the range of 
diameter values over 10 measurements. 
3.2.3.2.1 DOPC in water 
 The average diameter of the DOPC liposomes in water did not increase overall 
during the measurement period (Table 3.7).  The final measurement was the highest, but 
the increase was not great enough to suggest that liposome fusion had occurred, and the 
measurement after 12 days was the same as the first measurement within error.  The 
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polydispersity index also did not increase during the measurement period, so there was 
no significant increase in the distribution of the diameter measurements.   
Table 3.7.  The average diameter, PdI, %Pd and standard error values for DLS measurements of DOPC 
liposomes in water incubated for 14 days at 4 °C.  The diameter, PdI and %Pd values are an average of 10 
measurements. 
Time 
(days) 
Diameter 
(nm) 
PdI %Pd Std Error 
0 111.9 0.153 39.1 0.4 
2 113.4 0.139 37.3 0.4 
5 115.3 0.139 37.3 0.7 
7 113.7 0.143 37.8 0.6 
9 115.0 0.155 39.4 1.3 
12 112.6 0.180 42.4 1.4 
14 118.4 0.134 36.6 1.0 
 
3.2.3.2.2 DOPC in bis-tris propane 
 There was no significant increase in the average diameter measurements of the 
DOPC liposomes in bis-tris propane buffer, suggesting that no fusion was occurring.  The 
polydispersity index also did not increase significantly over the course of the 
measurements, suggesting that no micellisation occurred either. 
Table 3.8.  The average diameter, PdI, %Pd and standard error values for DLS measurements of DOPC 
liposomes in bis-tris propane buffer (10 mM, pH 7) incubated for 14 days at 4 °C.  The diameter, PdI and %Pd 
values are an average of 10 measurements. 
Time 
(days) 
Diameter 
(nm) 
PdI %Pd Std Error 
0 155.5 0.210 45.8 0.6 
2 151.8 0.216 46.5 0.9 
5 154.9 0.216 46.5 1.5 
7 156.1 0.214 46.3 1.4 
9 155.6 0.213 46.2 1.5 
12 154.2 0.219 46.8 1.1 
14 156.2 0.226 47.5 1.2 
 
3.2.3.3 Discussion 
 Overall, no evidence of aggregation or micellisation was observed in the DOPC 
liposomes in water or in buffer over 15 days.  This correlates with the observations from 
the TEM images. 
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3.2.4 The chemical effects of small molecules 
The chemical effects of two small molecules, 1,1,1,3,3,3-hexafluoroisopropanol 
(HFIP) and haloperidol, on DOPC hydrolysis were explored.  HFIP is known to affect the 
structure of lipid bilayers,27 and haloperidol has been observed to cause hydrolysis of 
phospholipid chains to form lyso-PC.24, 25 
3.2.4.1 HFIP 
 DOPC liposomes were incubated with 12.5 mM and 125 µM HFIP (10 moles and 
0.1 moles HFIP:1 mole DOPC) at 4 °C for 13 days.  On the day of preparation and after 2, 
5, 7, 9, and 12 days a sample was removed and analysed by MALDI-MS.  Figure 3.15 
shows the intensity of the peak corresponding to [M – RCO]+ normalised relative to the 
combined intensities of the peak corresponding to [DOPC – RCO]+ and that 
corresponding to [DOPC + H]+.  The graph shows that the presence of HFIP has no effect 
on the hydrolysis of the liposomes at either concentration.  
 
Figure 3.15.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes in water with 12.5 mM and 125 µM 
HFIP.  Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised relative to the combined 
intensities of the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC liposomes in water with 
12.5 mM and 125 µM HFIP stored at 4 °C for 12 days.  Errors are estimated from the values obtained from 
repeat measurements. 
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3.2.4.2 Haloperidol  
A solution of a haloperidol-TFA salt was prepared and added to DOPC liposomes 
in tris buffer (10 mM pH 7.4) in a 2:1 molar ratio of lipid to haloperidol ions, following the 
method described by Casey et al.25  The dispersion was stored at 37 °C and analysed 
regularly over the next 8 days by MALDI-MS.  The graph (Figure 3.16) shows that, within 
an error of ± 0.4%, there was no increase in lyso-PC in the sample.   
 
Figure 3.16.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes in tris buffer with haloperidol-TFA.  
Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised relative to the combined intensities of 
the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC liposomes in tris buffer (10 mM pH 
7.4) with haloperidol-TFA stored at 37 °C for 7 days.  Errors are estimated from the values obtained from 
repeat measurements. 
3.2.4.3 Discussion 
 No DOPC hydrolysis was observed in the presence of HFIP or haloperidol over 
the 12 and 8 day respective analysis periods.  The result of the HFIP experiment suggest 
that the effect of the alcohol on lipid bilayers is physical as opposed to chemical, as 
reported in the literature.  This was in contrast to literature reports for haloperidol salts 
however.  The most likely reason for this was the need to scale down the experiment 
compared to the method followed.  This meant that to obtain the same ratio and 
concentration as the literature method followed it was necessary to dissolve the lipid-
haloperidol mixture in just 7.5 µL buffer, giving a very small amount of a very concentrated 
viscous dispersion.  It is possible that the haloperidol and lipid could not mix sufficiently 
under these conditions for the lipids to be hydrolysed.  
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3.2.5 The effect of melittin on liposomes 
Experiments were carried out to study the lysis of the acyl chains of phospholipids 
in the presence of natural and synthetic melittin under different conditions and over 
different time-periods. 
3.2.5.1 Short term analysis of lipids in the presence of natural melittin 
Natural melittin was added to DMPC liposomes in 10 mM bis-tris propane in the 
absence of EDTA, and 1 µL aliquots were removed every 30 seconds and immediately 
mixed with a solution of DHB matrix.  Preliminary experiments had shown that addition to 
the matrix solution quenched the hydrolysis-catalysing effect of the enzyme PLA2 (data 
not shown).  MALDI-MS spectra were recorded for each aliquot and the intensity of the 
peak corresponding to lyso-MPC was normalised relative to the combined intensities of 
the peaks corresponding to [DMPC + H]+ and [DMPC – RCO]+.  Each sample was spotted 
on the MALDI target plate twice, and data were averaged over 4000 laser shots from 
each spot.  Figure 3.17 shows the relative intensity data.  Although the error at two times 
standard deviation over the two repeats is large, an increase in lyso-PC can clearly be 
observed over a period of 5 minutes. 
 
Figure 3.17.  MS intensity profile of [DMPC – RCO]
+
 for DMPC liposomes analysed at 30 s intervals after the 
addition of natural melittin.  Intensity of the peak corresponding to [DMPC – RCO]
+
 was normalised relative to 
the combined intensities of the peaks corresponding to [DMPC + H]
+
 and [DMPC – RCO]
+
 for MALDI-MS 
spectra of samples removed from liposome/peptide dispersion at 30 s intervals after the addition of natural 
melittin.  Errors are estimated from the values obtained from repeat experiments. 
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In the presence of 2 mM EDTA no increase in lyso-PC was observed over 9.5 
minutes after the addition of melittin to DMPC liposomes (data not shown).  This suggests 
that the rapid hydrolysis shown in Figure 3.17 is due to the presence of PLA2 in the 
sample.  The possibility of lipid hydrolysis promoted by melittin in the presence of EDTA 
or the absence of PLA2 was addressed in separate experiments with a longer timeframe. 
3.2.5.1.1 MALDI-MSMS analysis of lyso-MPC 
MALDI-MSMS analysis was carried out on the species identified as lyso-MPC in 
the MALDI-MS spectra in order to verify its identity.  The product ion spectrum produced a 
number of peaks from which the lyso-lipid could be identified, as shown in Figure 3.18 
and Table 3.9.  Peaks corresponding to fragments involving the loss of water from the 
protonated parent correlate with the presence of an OH group on the lyso-lipid due to the 
hydrolysis ([Lyso-MPC – OH – RCO + H]+, [Lyso-MPC – OH – NMe3]
+ and [Lyso-MPC – 
OH]+), while peaks corresponding to the loss of RCO confirm the presence of an 
unhydrolysed acyl chain on the lyso-lipid ([Lyso-MPC – OH – RCO + H]+, [Lyso-MPC – 
RCO + 2H]+).  Peaks were also observed which corresponded to the presence and 
neutral loss of the PC headgroup. 
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Figure 3.18.  MALDI-MSMS spectrum of [Lyso-MPC + H]
+
.  The sample was prepared by mixing the 
liposome/melittin dispersion (2.5 mg/mL DMPC, 0.1 mg/mL melittin, 10 mM bis-tris propane) 1:9 (v/v) with 
DHB (30 mg/mL) in EtOH/H2O (50% v/v). 
Table 3.9.  Product ions observed in the MALDI-MSMS spectrum of Lyso-MPC. 
m/z Fragment
a 
104.0 [OCH2CH2NMe3 + H]
+
 
184.0 [OP(O)2OCH2CH2NMe3 + 2H]
+
 
240.0 [Lyso-MPC – OH – RCO + H]
+
 
258.0 [Lyso-MPC – RCO + 2H]
+
 
285.1 [Lyso-MPC – OP(O)2OCH2CH2NMe3]
+
 
391.2 [Lyso-MPC – OH – NMe3]
+
 
450.3 [Lyso-MPC – OH]
+
 
a) R corresponds to the myristoyl hydrocarbon chain (CH3(CH2)12) 
3.2.5.2 Long-term analysis of lipids in the presence of natural melittin 
3.2.5.2.1 Natural melittin with DOPC liposomes and 1 mM EDTA 
DOPC liposomes were incubated at 37 °C in the presence of two concentrations 
of melittin, with 5:1 and 50:1 lipid:peptide molar ratios, in the presence of 1 mM EDTA, 
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which was thought to be sufficient to suppress PLA2 activity.
31  After 24 hours, strong 
peaks corresponding to lyso-OPC were observed in MALDI-MS spectra of both samples, 
while only a very small peak was observed in the spectrum of the control sample of 
DOPC without melittin which had also been stored at 37 °C.  Repeat analysis 24 hours 
later did not suggest that any further lyso-PC had been formed.  A large formation of 
Lyso-PC within 24 hours in the presence of EDTA was unexpected.32  It is now known that 
1 mM EDTA is not sufficient to completely suppress the activity of PLA2, and that 5 mM is 
recommended to ensure no PLA2 activity;
 20 therefore this lyso-PC formation was 
attributed to PLA2 due to incomplete chelation of Ca
2+.  It was concluded that the optimum 
way to be certain that PLA2 was having no effect on any hydrolysis observed would be to 
use synthetic melittin, where there could be no PLA2 contamination.   
3.2.5.2.2 MALDI-MSMS analysis of lyso-OPC 
MALDI-MSMS analysis was carried out on the species identified as lyso-OPC in 
the MALDI-MS spectra in order to verify its identity.  The product ion spectrum (Figure 
3.19 and Table 3.10) shows peaks corresponding to choline and phosphocholine and the 
neutral loss of phosphocholine ([OCH2CH2NMe3 + 2H]
+, [OP(O)2OCH2CH2NMe3 + 2H]
+ 
and [Lyso-OPC – OP(O)2OCH2CH2NMe3]
+), and to the neutral loss of the oleoyl chain 
([Lyso-OPC – RCO + 2H]+). 
 
Figure 3.19.  MALDI-MSMS spectrum of [Lyso-OPC + H]
+
.  The sample was prepared by mixing the 
liposome/melittin dispersion (0.27 mg/mL DOPC, 0.16 mg/mL melittin, 8 mM phosphate, 123 mM NaCl) 1:9 
(v/v) with DHB (30 mg/mL) in EtOH/H2O (50% v/v). 
 
 
 
 
 
  The chemical stability of phospholipids 
   
141 
 
Table 3.10.  Product ions observed in the MALDI-MSMS spectrum of Lyso-OPC. 
m/z Fragment
a 
104.2 [OCH2CH2NMe3 + H]
+
 
184.2 [OP(O)2OCH2CH2NMe3 + 2H]
+
 
258.3 [Lyso-OPC – RCO + 2H]
+
 
339.5 [Lyso-OPC – OP(O)2OCH2CH2NMe3]
+
 
a) R corresponds to the myristoyl hydrocarbon chain (CH3(CH2)12) 
3.2.5.3 Long-term analysis of lipids in the presence of synthetic melittin 
CID and ECD MSMS analyses were carried out on the synthetic and natural 
melittin samples in order to check the structure of the synthetic peptide, as any 
irregularities in the sequence could affect its interaction with lipids.  Figure 3.20 shows the 
sections of sequence identified from CID and ECD fragmentation spectra of samples of 
the natural and synthetic peptides.  Data were combined from different charge state 
deconvolutions and from different CID and ECD energies.  Figure 3.21 shows the types of 
fragmentation undergone by peptides during MSMS analysis.  „a‟, „b‟ and „c‟ ions are 
formed when the charge is retained on the N-terminal fragment, „x‟, „y‟ and „z‟ ions are 
formed when the charge is retained on the C-terminal fragment.33  Low-energy CID 
generally causes cleavage of the amide bond to give „b‟ or „y‟ ions,34 while ECD 
predominantly causes cleavage of the N – C(R)  bond to give „c‟ and „z‟ fragments.35 
 
Figure 3.20.  Diagram of sequence ions observed during CID and ECD analysis of natural and synthetic 
melittin.  All ECD fragments are c ions.  The C-terminal amide has been omitted for clarity. 
Figure 3.20 shows that, out of twenty five backbone bonds, only six cleavages 
were absent when the data from the two fragmentation methods were combined for the 
synthetic peptide, therefore we could be very confident that the sequence of the synthetic 
peptide was the same as that of the natural peptide. 
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Figure 3.21.   Nomenclature for sequence ions produced during MSMS analysis.  In a, b and c ions the 
charge is retained on the N-terminal fragment after cleavage; in x, y and z ions the charge is retained on the 
C-terminal fragment. 
DOPC liposomes were incubated at 37 °C in the presence of two concentrations of 
synthetic melittin, with 5:1 and 50:1 lipid:peptide molar ratios, for 16 days, along with a 
liposome sample with no melittin, and analysed regularly by MALDI-MS.  The intensity of 
the peak corresponding to [DOPC – RCO]+ was normalised relative to the combined 
intensities of the peaks corresponding to [DOPC + H]+ and [DOPC – RCO]+ for each 
spectrum and the results are shown in Figures 3.22 and 3.23.   
3.2.5.3.1 Low concentration melittin 
It can be observed from Figure 3.22 that over 15 days no acyl chain lysis of the 
DOPC lipids occurred in either the control liposomes or in the liposomes incubated with 
melittin at a 50:1 lipid:peptide molar ratio. 
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Figure 3.22.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes with synthetic melittin in a 50:1 
lipid:peptide molar ratio.  Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised relative to 
the combined intensities of the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC 
liposomes with synthetic melittin in a 50:1 lipid:peptide molar ratio in 10 mM phosphate and 147 mM NaCl (pH 
7) and in the absence of melittin stored at 37 °C for 15 days.  Errors are estimated from the values obtained 
from repeat measurements. 
3.2.5.3.2 High concentration melittin 
A clear increase in lyso-OPC was observed over 15 days in the sample with a 5:1 
lipid:peptide molar ratio (Figure 3.23).  Within 24 hours the relative intensity of [DOPC – 
RCO]+ observed when analysing the sample with melittin was greater than that observed 
in the control sample.  The amount of lyso-PC in the sample continued to increase rapidly 
over the next 24 hours, then more slowly over the rest of the analysis period.  This result 
suggests that melittin alone promotes the acyl chain lysis of lipids, though on a much 
slower timescale than catalysis in the presence of PLA2. 
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Figure 3.23.  MS intensity profile of [DOPC – RCO]
+
 for DOPC liposomes with synthetic melittin in a 5:1 
lipid:peptide molar ratio.  Intensity of the peak corresponding to [DOPC – RCO]
+
 was normalised relative to 
the combined intensities of the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC 
liposomes with synthetic melittin in a 5:1 lipid:peptide molar ratio in 8 mM phosphate and 123 mM NaCl and in 
the absence of melittin stored at 37 °C for 15 days.  Errors are estimated from the values obtained from 
repeat measurements. 
 Peaks were also observed at m/z 258.1 in the MALDI-MS spectra of the DOPC 
liposomes with melittin.  These were thought to correspond to the doubly hydrolysed 
species sn-glycero-3-phosphocholine (glycero-PC).  A graph of the intensities of [DOPC – 
RCO]+ and [DOPC – 2RCO]+ normalised relative to the combined intensities of the peaks 
corresponding to [DOPC + H]+, [DOPC – RCO]+ and [DOPC – 2RCO]+ (Figure 3.24) 
shows that the quantity of glycero-PC remained very low during the analysis period.  The 
relative intensity of the glycero-PC remained similar to the relative intensity of lyso-PC in 
the control sample, and did not increase over the analysis period within an error of ± 
1.5%.  No glycero-PC was observed in the control liposomes. 
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Figure 3.24.  MS intensity profiles of [DOPC – RCO]
+
 and [DOPC – 2RCO]
+
 for DOPC liposomes with 
synthetic melittin.  Intensities of the peaks corresponding to [DOPC – RCO]
+
 and [DOPC – 2RCO]
+
 were 
normalised relative to the combined intensities of the peaks corresponding to [DOPC + H]
+
, [DOPC – RCO]
+
 
and [DOPC – 2RCO]
+
 for DOPC liposomes with synthetic melittin in a 5:1 lipid:peptide molar ratio in 8 mM 
phosphate and 123 mM NaCl stored at 37 °C for 15 days.  Errors are estimated from the values obtained from 
repeat measurements. 
3.2.5.4 Thin layer chromatography of lipids in the presence of synthetic melittin 
 Thin layer chromatography was carried out on a sample of DOPC 17 days after 
the addition of synthetic melittin in a 5:1 lipid:peptide molar ratio, after the presence of 
lyso-PC had been confirmed by MALDI analysis.  The contents of the sample were 
compared with DOPC lipid and liposomes in the absence of melittin and a mixture of lyso-
PC and oleic acid.  The results (Figure 3.25) show clear evidence of lyso-PC in the 
sample of liposomes with melittin (lane D) and not in the DOPC lipid and liposome 
samples in the absence of melittin (lanes A and E respectively).  No oleic acid can be 
identified in the sample of DOPC in the presence of melittin, unlike in the mixture of oleic 
acid and lyso-PC (lane B).  The lack of free oleic acid accompanying the formation of 
lyso-PC suggests that the lysis process may involve the acylation of melittin rather than 
hydrolysis.  
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Figure 3.25.  TLC plate showing the presence of lyso-PC and absence of oleic acid in DOPC liposomes in the 
presence of synthetic melittin.  Lane A, DOPC spotted from a solution in CHCl3; lane B, lyso-OPC and oleic 
acid in CHCl3; lane C, 10 mM phosphate and 150 mM NaCl buffer; lane D, DOPC liposomes and melittin (5:1 
mol/mol) in 8 mM phosphate and 123 mM NaCl buffer 17 days after addition of; lane E, DOPC liposomes in 
10 mM phosphate and 150 mM NaCl buffer.  For lanes C, D and E, 30 µL of each sample was lyophilized and 
re-dissolved in 50:50 (v/v) MeOH/CHCl3 before application to the TLC plate.  The TLC plate was developed 
with 6:4:1 (v/v) CHCl3, MeOH and H2O and stained using phosphomolybdic acid (20 wt. % in EtOH) and heat. 
3.2.5.5 Long-term analysis of POPC with synthetic melittin 
 POPC was incubated at 37 °C with synthetic melittin, with a 5:1 lipid:peptide molar 
ratio, for 28 days, along with a liposome sample with no melittin, and analysed regularly 
by MALDI-MS.  A graph of the intensities of the peaks corresponding to the lysis of the 
palmitoyl chain ([POPC – R16:0CO]
+) and the oleoyl chain ([POPC – R18:1CO]
+) normalised 
relative to the combined intensities of the peaks corresponding to [POPC – R16:0CO]
+, 
[POPC – R18:1CO]
+ and [POPC + H]+ is shown in Figure 3.26.  An increase in the lysis of 
each chain was observed over 14 days.  This shows that melittin promotes the lysis of 
both acyl chains, unlike PLA2, which only catalyzes the hydrolysis of acyl chains from the 
sn-2 position of lipids.21 
Table 3.11 shows that the relative intensity of the peak corresponding to [POPC – 
R18:1CO]
+ was approximately twice that of the peak corresponding to [POPC – R16:0CO]
+ 
for every measurement.  No similar trend could be observed in the control liposomes, 
where the relative intensities of [POPC – R18:1CO]
+ and [POPC – R16:0CO]
+ were the same 
within error.  This suggests that melittin might be preferentially promoting the lysis of the 
oleoyl chain from the sn-2 position of the lipid. 
  The chemical stability of phospholipids 
   
147 
 
 
Figure 3.26.  MS intensity profiles of [POPC – R18:1CO]
+
 and [POPC – R16:0CO]
+
 for POPC liposomes with 
synthetic melittin.  Intensities of the peaks corresponding to [POPC – R18:1CO]
+
 and [POPC – R16:0CO]
+
 were 
normalised relative to the combined intensities of the peaks corresponding to [POPC + H]
+
, [POPC – 
R18:1CO]
+
 and [POPC – R16:0CO]
+
 for POPC liposomes with synthetic melittin in a 5:1 lipid:peptide molar ratio 
in 8 mM phosphate and 123 mM NaCl stored at 37 °C for 14 days. 
Table 3.11.  Intensities of peaks corresponding to [POPC – R18:1CO]
+
 and [POPC – R16:0CO]
+
 normalised 
relative to the combined intensities of the peaks corresponding to [POPC + H]
+
, [POPC – R18:1CO]
+
 and 
[POPC – R16:0CO]
+
 for POPC liposomes with and without synthetic melittin. 
Time / 
days 
Melittin 
relative intensity 
[POPC – R16:0CO]
+
 
Melittin 
relative intensity 
[POPC – R18:1CO]
+
 
Control 
relative intensity 
[POPC – R16:0CO]
+ 
Control 
relative intensity 
[POPC – R18:1CO]
+ 
0 0 0 0.0 0.2 
3 1.7 3.8 0.4 0.4 
4 1.2 2.2 0.2 0.2 
5 1.0 2.0 0.0 0.3 
14 7.2 14.6 0.1 0.2 
 
3.2.5.6 Discussion 
 The analyses of the DOPC and POPC liposomes after the addition of synthetic 
melittin showed a definite formation of lyso-PC.  This suggests that melittin itself can 
promote acyl chain lysis, though on a much slower timescale than in the presence of 
PLA2.  A small quantity of glycero-PC was also observed in the presence of synthetic 
melittin.  A clear difference was observed in the lysis of the palmitoyl and oleoyl chains of 
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POPC, with higher intensities of the peaks corresponding to cleavage of the oleoyl chain 
than those corresponding to the cleavage of the palmitoyl chain.     
3.2.6 The effect of metal salts on the lysis of the acyl chains of DOPC promoted by 
synthetic melittin 
A number of analyses were carried out to determine whether the presence of Ca2+, 
Zn2+ or Mg2+, the omission of NaCl from the buffer, or the addition of a haloperidol salt had 
an effect on the lysis of the acyl chains of DOPC in the presence of synthetic melittin.  
The concentrations of the metal salts were based on those in Dulbecco‟s buffer, a 
balanced salt solution developed for the preparation of cell cultures.  Dulbecco‟s buffer, 
and similar balanced salt solutions, are designed to perform four functions; 1) to maintain 
intra- and extracellular osmotic pressure; 2) to provide water and the bulk inorganic ions 
required for cell metabolism; 3) to provide energy for cell metabolism with the addition of a 
carbohydrate; 4)  to buffer the solution to the medium point in the physiological pH 
range.36   Dulbecco‟s buffer contains 0.133 g/L CaCl2, 0.1 g/L MgCl2, 0.2 g/L KCl, 8 g/L 
NaCl, 0.2 g/L KH2PO4 and 1.15% Na2HPO4.
36, 37  0.133 g/L CaCl2 correlates to 0.9 mM, 
therefore all salts, and haloperidol-TFA, were included in the buffers at this concentration, 
with final concentrations of 0.7 mM in each sample after the addition of melittin. 
It is clear from the data that quantitative comparisons of relative intensity values 
can only made between samples which were prepared and analysed on the same days.  
Less lysis was observed in later experiments than earlier ones, which is attributed to the 
age of the melittin stock at the time of the preparation of each set of samples.  The stock 
was stored in the freezer and defrosted and vortexed before use.  Slight variations in laser 
power were observed each day.  The same percentage of the total laser power was used 
for each analysis, but the total laser power was slightly variable and the laser was 
replaced between two sets of experiments.  The error bars account for any effect of slight 
day-to-day laser power variations within sets of analyses.  
3.2.6.1 Phosphate buffers containing ZnCl2 and NaCl, CaCl2 and NaCl, and no NaCl 
Figure 3.27 shows the intensity of the peak corresponding to lyso-PC normalised 
relative to the combined intensities of the peaks corresponding to the DOPC molecular 
ion and lyso-PC for DOPC liposomes with and without synthetic melittin under different 
salt conditions.  After 24 hours little acyl chain lysis could be observed in any sample, but 
from day 3 onwards clear differences could be observed between the levels of lyso-PC in 
the different samples.  In the absence of NaCl and any other added salts (Figure 3.27c), 
the relative intensity of lyso-PC at each analysis was similar to that observed in the 
absence of melittin.  When NaCl was present, acyl chain lysis was observed in both 
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samples with divalent metal cations and melittin.  The most lysis was observed in the 
sample with melittin, NaCl and ZnCl2 (Figure 3.27a), where a higher relative intensity of 
the peak corresponding to lyso-PC could be observed after 2 days, and after 14 days the 
relative intensity of the peak corresponding to lyso-PC was around twice that observed for 
the sample with CaCl2.  The increase in lyso-PC in the presence of melittin, NaCl and 
CaCl2 was slower than when ZnCl2 was present (Figure 3.27b), but after 8 days the 
relative intensity of the peak corresponding to lyso-PC was clearly greater than those of 
the control samples.  No acyl chain lysis, within error, was observed in the control 
samples (Figure 3.27d–f). 
 
 
Figure 3.27.  MS intensity profiles of [DOPC – R18:1CO]
+
 for DOPC liposomes with NaCl, ZnCl2 and synthetic 
melittin; NaCl, CaCl2 and synthetic melittin; synthetic melittin; NaCl and ZnCl2; NaCl, CaCl2; and no additions. 
Intensities of the peaks corresponding to [DOPC – RCO]
+
 were normalised relative to the combined intensities 
of the peaks corresponding to [DOPC + H]
+
 and [DOPC – RCO]
+
 for DOPC liposomes in phosphate buffer  
with a) NaCl, ZnCl2  and synthetic melittin; b) NaCl, CaCl2  and synthetic melittin; c)  synthetic melittin; d) NaCl 
and ZnCl2; e) NaCl, CaCl2 and f) no additions.  Errors are estimated from the values obtained from repeat 
measurements. 
 
Figure 3.28 shows data for DOPC liposomes in phosphate and NaCl buffer in the 
presence and absence of ZnCl2 and synthetic melittin which were prepared and analysed 
together.  For the first three days the rates of lysis in the presence of melittin were similar 
with and without Zn2+ (Figure 3.28a and b respectively), but lysis in the sample without 
Zn2+  appeared to stop at this stage, while in the presence of Zn2+ in continued until for the 
  The chemical stability of phospholipids 
   
150 
 
next 4 days.  No lysis, within error, was observed in the control samples (Figure 3.28c and 
d). 
 
 
Figure 3.28.  MS intensity profiles of [DOPC – R18:1CO]
+
 for DOPC liposomes with NaCl, ZnCl2 and synthetic 
melittin; NaCl and synthetic melittin; NaCl; and NaCl and ZnCl2.  Intensities of peaks corresponding to lyso-PC 
were normalised relative to those corresponding to DOPC for DOPC liposomes in phosphate buffer with a) 
NaCl, ZnCl2 and synthetic melittin; b) NaCl and synthetic melittin; c) NaCl and d) NaCl and ZnCl2.  Errors are 
estimated from the values obtained from repeat measurements. 
3.2.6.2 Phosphate and NaCl buffers containing MgCl2 and Haloperidol 
The formation of lyso-PC in DOPC dispersions in phosphate buffer with melittin 
was also followed in the presence of NaCl and MgCl2 and in the presence of NaCl and 
haloperidol.  The lyso-PC formation was compared to that in samples with melittin and 
NaCl and with each buffer without melittin.  With melittin, NaCl and either Mg2+ or 
haloperidol the increase in lyso-PC was similar to that observed with melittin and just 
NaCl for the first 7 days (Figure 3.29c, b and a respectively).  After this point there was 
little more acyl chain lysis in the sample with Mg2+.  Continued lysis was observed in the 
sample with melittin, NaCl and haloperidol after 7 days, but the rate was slower than in 
the phosphate buffer with just melittin and NaCl.  After 15 days the lyso-PC formation in 
the sample with melittin, NaCl and Mg2+ was the same as that in the control samples with 
NaCl and haloperidol and NaCl and Mg2+, in the absence of melittin.  After 3 days, only a 
weak peak corresponding to melittin was observed when the sample with melittin, NaCl 
and Mg2+ was analysed by MALDI, while when the other samples containing melittin were 
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analysed over the same mass range clear peaks corresponding to melittin could be 
observed.  When melittin was added to a buffer of phosphate, NaCl and MgCl2 without 
liposomes and analysed daily by MALDI-MS, a strong peak corresponding to melittin was 
observed at m/z 2845.7, along with one for the sodium adduct of the peptide at m/z 
2867.7 when the sample was analysed immediately after the addition of melittin.  After 24 
hours these peaks were weaker, and after 48 hours no peaks corresponding to melittin 
could be observed (Figure 3.30).  The reduction of the intensity of the peaks 
corresponding to melittin during MALDI analysis of the samples with melittin, NaCl and 
MgCl2 with and without liposomes is attributed to the precipitation of melittin/Mg 
complexes.  This also accounts for the level of lyso-PC in the sample with DOPC 
liposomes being similar to that in samples without melittin after 15 days. 
 
 
Figure 3.29.  MS intensity profiles of [DOPC – R18:1CO]
+
 for DOPC liposomes with NaCl and synthetic 
melittin; haloperidol, NaCl and synthetic melittin; MgCl2, NaCl and synthetic melittin; haloperidol and NaCl; 
MgCl2 and NaCl; and NaCl.  Intensities of peaks corresponding to lyso-PC were normalised relative to those 
corresponding to DOPC for DOPC liposomes in phosphate buffer with a) NaCl and synthetic melittin; b) 
haloperidol, NaCl and synthetic melittin; c) MgCl2, NaCl and synthetic melittin; d) haloperidol and NaCl; e) 
MgCl2 and NaCl and f) NaCl.  Errors are estimated from the values obtained from repeat measurements. 
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Figure 3.30.  MALDI-MS spectrum of synthetic melittin in 10 mM phosphate, 150 mM NaCl and 0.9 mM 
MgCl2 A) 0, B) 1 and C) 2 days after the addition of melittin.  The sample was prepared by mixing the sample 
1:9 (v/v) with DHB (30 mg/mL) in EtOH/H2O(50% v/v).  
3.2.6.3 Discussion 
As discussed in Section 3.2.5.3, the lysis of the acyl chains of DOPC in liposomes 
was promoted by the presence of synthetic melittin in 8 mM phosphate and 123 mM 
NaCl.  Altering the salt conditions in which synthetic melittin and DOPC liposomes were 
combined had a number of effects on the lysis.  In the absence of NaCl, no lysis was 
observed in the presence of melittin above that observed in the control samples.  The 
addition of ZnCl2, in the presence of melittin and NaCl, was shown to increase lyso-PC 
formation compared to that in the absence of ZnCl2.  Little lysis was observed in the 
sample containing melittin, NaCl and MgCl2.  The intensity of the peak corresponding to 
melittin also dropped sharply over 48 hours after preparation in samples with MgCl2 with 
and without liposomes.  This was attributed to the formation of insoluble melittin/MgCl2 
complexes. 
A 
B 
C 
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3.2.7 Acylation of melittin 
During the regular MALDI-MS analyses of the liposomes incubated with melittin it 
became clear that over time peaks were appearing at m/z 3110.0 and m/z 3132.1 in most 
of the spectra of samples of DOPC and melittin.  These corresponded to the molecular 
weights of [Melittin + R18:1CO]
+ and [Melittin + R18:1CO – H + Na]
+, where R18:1CO is the 
acyl chain of DOPC.  The molecular weight of [Melittin + R18:1CO]
+ takes into account the 
loss of H+ from a nucleophile on melittin (e.g. RNH2) during bonding to the acyl chain and 
the addition of H+ during ionisation.  This proposed identity was supported by the fact that 
after 28 days strong peaks could be observed at m/z 3084.0, m/z 3105.9, m/z 3110.0 and 
m/z 3132.0 in the spectrum of melittin with POPC, which corresponded to the molecular 
weights of [Melittin + R16:0CO]
+, [Melittin + R16:0CO – H + Na]
+, [Melittin + R18:1CO]
+ and 
[Melittin + R18:1CO – H + Na]
+ respectively (Figure 3.31) where R16:0CO is the palmitoyl 
chain of POPC and R18:1CO the oleoyl chain.  The first sign of the adduct in a sample of 
melittin and DOPC was observed after 4 days.  When analysing the sample with Zn+ in 
the buffer, and that without NaCl, a peak corresponding to the adduct was observed after 
6 days.  The first spectrum of the sample with Ca2+ which showed the adduct peak was 
recorded after 7 days.  Attempts were made to carry out MSMS on the acylated species in 
order to positively identify them.  It can be noted from Figure 3.32 that the intensities of 
the peaks corresponding to [Melittin + R18:1CO]
+ and [Melittin + R18:1CO – H + Na]
+ were 
greater than the intensities of those corresponding to [Melittin + R16:0CO]
+ and [Melittin + 
R16:0CO – H + Na]
+. 
 
Figure 3.31.  MALDI-MS spectrum of synthetic melittin in 8 mM phosphate and 123 mM NaCl 16 days after 
addition to DOPC liposomes.  The peaks at m/z 2845.7, m/z 2867.7, m/z 3110.0 and m/z 3132.0 correspond 
to [M + H]
+
, [M + Na]
+
, [M + R18:1CO]
+
 and  [M + R18:1CO – H + Na]
+
  The sample was prepared by mixing the 
melittin and liposome dispersion (1:5 peptide: lipid molar ratio) 1:9 (v/v) with DHB (30 mg/mL) in EtOH/H2O 
(50% v/v). 
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Figure 3.32.  MALDI-MS spectrum of synthetic melittin in 8 mM phosphate and 123 mM NaCl 28 days after 
addition to POPC liposomes.  The peaks at m/z 2845.7, m/z 2867.7, m/z 3084.0, m/z 3105.9, m/z 3110.0 and 
m/z 3132.0 correspond to [M + H]
+
, [M + Na]
+
, [M + R16:0CO]
+
, [M + R16:0CO – H + Na]
+
, [M + R18:1CO]
+
 and  
[M + R18:1CO – H + Na]
+
.  The sample was prepared by mixing the melittin and liposome dispersion (1:5 
peptide:lipid molar ratio) 1:9 (v/v) with DHB (30 mg/mL) in EtOH/H2O (50% v/v). 
MALDI-MSMS spectra of [melittin + R18:1CO]
+ from the sample with DOPC and 
[melittin + R18:1CO]
+ and [melittin + R16:0CO]
+ from the sample with POPC were obtained, 
from which it was possible to identify sections of sequence, including sections which 
appeared to include an acyl group.  Possible positions at which acylation could have 
occurred are the side chains of lysine, arginine, serine and tryptophan, the N-terminal 
amino group and the C-terminal amide (Figure 3.33).  Although threonine also has a 
nucleophilic hydroxyl group, acylation at this position was considered to be unlikely 
compared to acylation of serine, due to the increased steric hindrance caused by the 
additional methyl group on threonine.   
 
Figure 3.33.  Proposed product of addition of the oleoyl chain of DOPC to lysine. 
  The chemical stability of phospholipids 
   
155 
 
 Figure 3.34 shows all of the possible sites of acylation of melittin.  The molecular 
weights of all possible portions of sequence with an acyl group at one of these positions 
were calculated, including all internal fragments, a, b, c and y sequence ions and y ions 
where NH3 was also lost (y-17 ions); a, b, y and y-17 ions are the most likely to be 
produced under MALDI laser induced fragmentation.38   
 
Figure 3.34.  Possible sites of acylation of melittin.  The N-terminus, C-terminal amide, lysine, arginine, serine 
and tryptophan residues are shown in blue. 
 Only one acylation per section of sequence was accounted for, as the molecular 
mass of the parent ions only included one acyl group.  The m/z values of peaks in the 
product ion spectra of [melittin + R18:1CO]
+ from the sample with DOPC and [melittin + 
R18:1CO]
+ and [melittin + R16:0CO]
+ from the sample with POPC and were compared with 
the calculated molecular weights of all possible acylated sequence ions and internal 
fragments to identify product ions which were within ± 1.5 Da of the molecular weights of 
acylated sections of sequence.  The m/z values which corresponded to possible acylated 
sections of sequence were checked against all possible sequence ions and internal 
fragments of non-acylated melittin, to rule out misidentification.  All m/z values within ± 2 
Da of the molecular weight of a possible unmodified melittin fragment were ruled out to 
ensure confidence in the identification of any acylated fragments.  
 A number of peaks were observed in the product ion spectra of acylated melittin 
which corresponded to unmodified sequence ions, and comparison between the 
sequence coverage of modified and unmodified sequence ions provided further 
information from which the positions of acylation could be determined.  Figure 3.35 shows 
that when non-acylated melittin was fragmented by MALDI-MSMS in the same manner as 
the acylated species there was virtually full sequence coverage of a, b, or c-ions from the 
N-terminus and y or y-17 ions from the C-terminus, though a few sequence ions have the 
same molecular weights as possible internal fragments (shown in green).   
 
Figure 3.35.  Sequence ions identified from the product ion spectrum of non-acylated melittin.  Amino acids 
shown in blue are possible sites of acylation; sections of sequence marked in green are those which have the 
same molecular mass as possible internal fragments.  If peaks were observed corresponding to a number of 
cleavages at the same position, for example a1, b1 and c1, and at least one of these does not have the same 
molecular mass as a possible internal fragment the section of sequence will be marked in black. 
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3.2.7.1 DOPC 
3.2.7.1.1 Identification of acylated product ions 
 Table 3.12 and Figure 3.36 show all of the acylated product ions identified in the 
MALDI-MSMS spectrum of [melittin + R18:1CO]
+.  The spectrum is included as Appendix 
1A.  Some m/z values correspond to two or more possible fragments, as shown by the 
different colours in Figure 3.36, but others allowed specific sites of acylation to be 
identified.  Sequence ion b2 (m/z 435.3) could only have been acylated on the N-terminal 
amine, and in fragment KVLTT (m/z 808.3) acylation could only have occurred on K(7).  
No other specific sites of acylation could be identified, but all of the m/z values correspond 
to the molecular masses of at least one fragment containing a lysine residue or the N-
terminus.  Where a number of possible acylation sites could be identified within one 
fragment or different fragments with the same molecular mass lysine was the most likely 
point of acylation.  The ammonium group of lysine has a lower pKa than the other 
groups,39, 40 and though no reference could be found in the literature to non-enzymatic 
acylation of the epsilon amino group of lysine residues from esters, there are a number of 
examples of lysine acting as a nucleophile in the addition of reactive acylating agents both 
in vitro and in vivo.41–47  This is supported by the identification of melittin fragments on 
which acylation could only have occurred on K(7) and no fragments on which acylation 
had definitely not occurred on a lysine residue or the N-terminus.  If the fragments are 
analysed as if only a lysine residue or the N-terminus could be acylated there are three 
fragments from which acylation can be narrowed down to the N-terminus (b2, a3 and b4), 
one where acylation can only have occurred at K(7) (KVLTT), one where acylation can 
only have occurred at K(21) (WIK) and none where acylation can be isolated to K(23). 
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Table 3.12.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R18:1CO]
+
 
from melittin with DOPC.  Residues on which acylation might have occurred are shown in blue. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Calculated 
molecular mass 
(Da) 
Possible sites of 
acylation 
435.3 b2 577.3 435.4 N-terminus 
464.1 a3 454.1 464.4 N-terminus or S(18) 
 IS  465.4  
492.2 KV 4007.6 492.4 N-terminus or K(7) 
 b3  492.4  
563.2 b4 1544.6 563.4 N-terminus or W(19) 
 WI  564.4  
662.3 b5 274.2 662.5 N-terminus, K(21) or 
R(22)  IKR  662.5 
691.5 WIK 109.3 692.5 W(19) or K(21) 
808.3 KVLTT 281.2 807.6 K(7) only 
977.3 y22 208.1 978.7 C-terminus, K(7), 
K(21), K(23) or R(22)  LKVLTTG  977.7 
 KVLTTGL  977.7  
 WIKRK  976.7  
1003.3 b8 215.2 1002.7 N-terminus or K(7) 
1076.9 VLKVLTTG 104.7 1076.8 K(7), K(21), S(18) or 
W(19)  ALISWIK  1076.7 
1215.5 b10 229.3 1216.9 N-terminus, K(7), 
S(18) or W(19)  GLPALISWI  1215.8 
1758.0 LKVLTTGLPALISW 126.4 1758.2 K(7), K(21), S(18) or 
W(19)  KVLTTGLPALISWI  1758.2 
 VLTTGLPALISWIK  1758.2  
1941.6 a18 107.5 1941.3 N-terminus, K(7) or 
S(18)  
2835.7 b24 322.4 2836.9 N-terminus, K(7), 
K(21), K(23), S(18), 
W(19), R(22), R(24) 
 
 
Figure 3.36.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R18:1CO]
+
 
from melittin with DOPC.  A) Sequence ions; B) internal fragments.  Positions at which acylation might have 
occurred are shown in blue.  Sections marked in the same colour correspond to different fragments with the 
same molecular mass; sections marked in black are those for which only one type of fragment can be 
attributed to particular m/z value.  The C-terminal amide has been omitted for clarity.  
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3.2.7.1.2  Comparison of sequence coverage of modified and unmodified 
sequence ions 
 The product ion spectrum of [melittin + R18:1CO]
+ from the sample of melittin with 
DOPC revealed an unbroken series of non-acylated y or y-17-ions from y26 to y16, only 
three of which had molecular weights corresponding to possible internal fragments, as 
well as y14, y12, y11 and y1,  (Figure 3.37A and Table 3.13).  Only one acylated y-ion, 
y22, was identified (Figure 3.37B and Table 3.12).  Fragment y22 also has the same m/z 
value as a number of possible internal fragments.  This suggests that acylation did not 
occur at the C-terminus.  The lack of unmodified y-ions between y11 and y1 suggests that 
acylation of K(7), the only nucleophilic amino acid in this region, was likely, which 
correlates with the observation of internal fragment KVLTT, acylated on K(7).  A series of 
acylated and non-acylated a, b, and c-ions were observed up to b5 and a6 respectively 
from the N-terminus, supporting the conclusion that acylation occurred at the N-terminus 
and at K(7), though a number of these fragments share the same molecular weight with 
possible internal fragments.  The identification of unmodified fragments c11 and c12 
suggests that acylation was not isolated to the N-terminus and K(7), although fragment 
c11 has the same m/z value as two internal fragments.  The unmodified fragment b26 is 
likely to have formed through y-type cleavage of an added acyl chain and b-type cleavage 
of the C-terminal amide in a similar manner to that of internal fragments rather than b-type 
fragmentation of melittin with an acylated C-terminus.  There is no other evidence of 
acylation at the C-terminus, and it is an unlikely point of acylation.  The peak observed at 
m/z 2844.7 could correspond to c26 or y1 (molecular masses 2844.8 and 2845.7 
respectively).  Sequence ion y1 could form through y-type cleavage of an added acyl 
group from the N-terminus; fragment c26 could form through y-type cleavage of the acyl 
bond and c-type cleavage of the C-terminal amide.  Though it is possible that some of the 
other non-acylated fragments identified have undergone y-type fragmentation of an added 
acyl chain this is unlikely to have been the main factor in the presence of non-acylated 
sequence ions as a more even sequence coverage would be expected if this were the 
case. 
 
 
 
 
 
  The chemical stability of phospholipids 
   
159 
 
Table 3.13.  Non-acylated sequence ions identified from the product ion spectrum of [melittin + R18:1CO]
+
 from 
melittin with DOPC. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Possible internal 
fragment? 
Calculated molecular 
mass (Da) 
58.6 b1 360.2 No 58.0 
74.3 c1 553.8 No 75.1 
171.1 b2 647.1 Yes 171.1 
200.2 a3 479.9 Yes 200.1 
228.2 b3 1305.4 Yes 228.1 
299.2 b4 668.7 Yes 299.2 
370.0 a5 377.9 Yes 370.2 
398.2 b5 436.5 Yes 398.2 
482.1 a6 420.1 Yes 483.3 
1069.5 c11 262.5 Yes 1070.7 
1128.1 c12 376.0 No 1127.7 
2826.4 b26 316.1 No 2827.8 
2844.7 c26 376.8 No 2844.8 
129.1 y-17 26 3687.9 Yes 129.9 
256.1 y-17 25 474.5 No 257.1 
274.1 y25 812.1 Yes 274.2 
413.2 y-17 24 435.8 Yes 413.2 
430.1 y24 639.9 No 430.3 
541.0 y-17 23 330.0 Yes 541.3 
558.2 y23 501.1 No 558.3 
697.1 y-17 22 501.1 Yes 697.4 
714.1 y22 581.2 Yes 714.4 
825.1 y-17 21 401.4 Yes 825.5 
842.2 y21 425.9 No 842.5 
938.2 y-17 20 304.7 Yes 938.6 
955.3 y20 389.6 Yes 955.6 
1141.4 y19 428.4 No 1141.7 
1228.7 y18 179.1 No 1228.7 
1341.5 y17 165.2 No 1341.8 
1438.5 y-17 16 173.1 Yes 1437.9 
1606.1 y-17 14 217.6 Yes 1606.0 
1622.6 y14 287.3 Yes 1623.0 
1775.8 y-17 12 127.3 Yes 1776.1 
1793.6 y12 210.1 No 1793.1 
1877.2 y-17 11 206.5 No 1877.1 
2844.7 y1 376.8 No 2845.7 
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Figure 3.37.  Non-acylated and acylated sequence ions identified from the product ion spectrum of [melittin + 
R18:1CO]
+
 from melittin with DOPC.  A) Non-acylated sequence ions; B) acylated sequence ions.  Amino acids 
shown in blue are possible sites of acylation; sections of sequence marked in green are those which have the 
same molecular mass as possible internal fragments (non-acylated or acylated for Figures 3.37A and B 
respectively).  If peaks were observed corresponding to a number of cleavages at the same position, for 
example a1, b1 and c1, and at least one of these does not have the same molecular mass as a possible 
internal fragment the section of sequence will be marked in black. 
3.2.7.2 POPC palmitoyl chain 
3.2.7.2.1 Identification of acylated product ions 
 Similarly to the analysis of [melittin + R18:1CO]
+, some peaks observed in the 
MSMS spectrum of [melittin + R16:0CO]
+ from melittin with POPC correspond to two or 
more possible fragments (Figure 3.38, Table 3.14 and Appendix 1B), but acylation could 
be isolated to the N-terminal amine, from the fragment with m/z 382.1 (a2).  No other 
specific sites of acylation could be identified, but all of the m/z values corresponded to at 
least one fragment containing lysine or the N-terminus.  If only acylation of lysine or the N-
terminal amine are considered, there is one fragment in which acylation can only have 
occurred on the N-terminus (a2) and three (two of which have the same molecular mass) 
for which acylation can only have occurred on K(21) or K(23) (IKRKR and KRKR or 
RKRQ).  
 Two peaks corresponding to possible acylated species were observed in the 
product ion spectra of both [melittin + R16:0CO]
+ and [melittin + R18:1CO]
+ from the sample 
of melittin with POPC.  These peaks were observed at m/z 409.3 and 537.2 in the product 
ion spectrum of [melittin + R16:0CO]
+, with possible identities of b2 and b4 respectively.  In 
the product ion spectrum of [melittin + R18:1CO]
+ they were observed at m/z 410.0 and 
537.1, possibly corresponding to y26 and y25 or SW respectively.  They were discounted 
from the results as it was likely that they were caused by incomplete isolation of one or 
other acylated melittin parent ions.  Peaks were not observed at these m/z values in the 
product ion spectrum of [melittin + R18:1CO]
+ from the sample of melittin with DOPC, which 
suggests that they did not arise from the [melittin + R18:1CO]
+ parent from the sample with 
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POPC.  All but one of the other species identified in the product ion spectrum of [melittin + 
R18:1CO]
+ from the sample of melittin with POPC were also observed in the spectrum of 
melittin with DOPC. 
Table 3.14.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R16:0CO]
+
 
from melittin with POPC.  Residues on which acylation might have occurred are shown in blue. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Calculated 
molecular mass 
(Da) 
Possible sites of acylation 
382.1 a2 1439.4 381.3 N-terminus 
466.2 b3 13559.6 466.4 N-terminus or K(7) 
 KV  466.4 
636.2 b5 1024.3 636.5 N-terminus, K(21), R(22) 
  IKR  636.5  
808.2 KRKR 716.7 807.6 K(21), K(23), R(22) or R(24) 
  RKRQ  807.6 
  ALISW  809.6  
921.3 IKRKR 511.3 920.7 K(21), K(23), S(18), W(19), 
R(22) or R(24)   ALISWI  922.6 
976.2 b8 1081.0 976.7 N-terminus or K(7) 
1742.2 b16 403.5 1743.2 N-terminus or K(7) 
2840.5 y-17 4 1629.3 2839.9 C-terminus, K(7), K(21), 
K(23), S(18), W(19), R(22), 
R(24) 
2938.1 b25 494.6 2938.9 N-terminus, K(7), K(21), 
K(23), S(18), W(19), R(22), 
R(24) 
2957.0 c25 1282.0 2955.9 N-terminus, K(7), K(21), 
K(23), S(18), W(19), R(22), 
R(24) 
3010.2 y-17 2 6488.1 3010.0 C-terminus, K(7), K(21), 
K(23), S(18), W(19), R(22), 
R(24) 
 
 
Figure 3.38.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R16:0CO]
+
 
from melittin with POPC.  A) Sequence ions; B) internal fragments.  Positions at which acylation might have 
occurred are shown in blue.  Sections marked in the same colour correspond to fragments with the same 
molecular mass; sections marked in black are those for which only one type of fragment can be attributed to 
particular molecular mass.  The C-terminal amide has been omitted for clarity. 
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3.2.7.2.2 Comparison of sequence coverage of modified and unmodified sequence 
ions 
 A long series of unmodified y and y-17-ions were identified from the product ion 
spectrum of [melittin + R16:0CO]
+ (Figure 3.39A and Table 3.15), with only one missed 
cleavage between y26 and y11, with three ions which have the same molecular masses 
as internal fragments, compared with only two modified y or y-17 ions (Figure 3.39B and 
Table 3.14), both of which were close to the N-terminus.  Similarly to the results for 
[melittin + R18:1CO]
+ with DOPC, this suggests that the C-terminal amide was not acylated.  
The lack of unmodified ions between y11 and y1 suggests acylation of K(7), the only 
nucleophilic species within this section of sequence.  The acylated ions b2, a3 and b5 
indicate acylation at the N-terminus, and for ions b8 and b16 acylation could have 
occurred at the N-terminus or K(7). The unbroken series of non-acylated a, b and c ions 
from c1 to b6 suggest acylation on K(7), but the presence of non-acylated b7, b8 and c12 
ions indicates that acylation was not restricted to the N-terminus and K(7).  The peak 
observed at m/z 2828.8 could correspond to sequence ions b26 or y-17 1, and the peak 
at m/z 2846.5 could correspond to ions c26 or y1.  As described in section 3.2.7.4.1, the 
non-acylated fragments b26 and c26 could have formed through an internal-like 
fragmentation involving y-type cleavage of an acyl chain and b or c-type cleavage at the 
C-terminus.  The y1 and y-17 1 fragments could have occurred from y-type cleavage of 
an acylated N-terminal amide with or without an additional loss of NH3. 
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Table 3.15.  Non-acylated sequence ions identified from the product ion spectrum of [melittin + R16:0CO]
+
 from 
melittin with POPC. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Possible internal 
fragment? 
Calculated molecular 
mass (Da) 
74.8 c1 2211.3 No 75.1 
143.2 a2 938.8 No 143.1 
171.2 b2 4039.7 Yes 171.1 
200.2 a3 2266.5 Yes 200.1 
228.2 b3 8587.2 Yes 228.1 
246.2 c3 1666.4 No 245.2 
272.2 
 
a4 2716.0 Yes 271.2 
 
299.1 
 
b4 2407.9 Yes 299.2 
 
369.1 a5 3693.2 Yes 370.2 
398.1 b5 2187.1 Yes 398.2 
482.1 a6 2478.1 Yes 483.3 
511.1 b6 976.1 Yes 511.3 
640.1 
 
b7 781.2 No 639.4 
 
737.3 
 
b8 616.8 No 738.5 
 
1128.3 
 
c12 1014.0 No 1127.7 
 
2827.9 
 
b26 1666.7 No 2827.8 
 
2843.9 
 
c26 1473.8 No 2844.8 
 
129.2 
 
y-17 26 29170.8 Yes 129.9 
 
146.2 
 
y26 1066.0 No 146.1 
 
256.2 
 
y-17 25 2169.3 No 257.1 
 
274.1 
 
y25 4925.7 Yes 274.2 
 
413.1 y-17 24 2058.1 Yes 413.2 
430.1 y24 1710.0 No 430.3 
541.1 y-17 23 1746.9 Yes 541.3 
558.1 y23 1620.3 No 558.3 
697.1 y-17 22 1711.8 Yes 697.4 
714.1 y22 1971.8 Yes 714.4 
825.2 y-17 21 1205.7 Yes 825.5 
842.3 y21 1124.1 No 842.5 
955.1 y20 1908.5 Yes 955.6 
1124.7 y-17 19 883.4 No 1124.7 
1211.2 y-17 18 466.2 No 1211.7 
1228.4 y18 625.7 No 1228.7 
1325.0 y-17 17 347.1 No 1324.8 
1341.7 y17 350.1 No 1341.8 
1438.3 y-17 16 360.1 Yes 1437.9 
1454.8 y16 389.8 No 1454.9 
1605.9 y-17 14 799.2 Yes 1606.0 
1622.5 y14 727.9 Yes 1623.0 
1777.1 y-17 12 473.9 Yes 1776.1 
1794.1 y12 478.7 No 1793.1 
1894.7 y11 513.8 No 1894.2 
2827.9 
 
y-17 1 1666.7 No 2828.8 
 
2846.5 
 
y1 507.7 No 2845.8 
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Figure 3.39.  Non-acylated and acylated sequence ions identified from the product ion spectrum of [melittin + 
R16:0CO]
+
 from melittin with POPC.  A) Non-acylated sequence ions; B) acylated sequence ions.  Amino acids 
shown in blue are possible sites of acylation; sections of sequence marked in green are those which have the 
same molecular mass as possible internal fragments (non-acylated or acylated for Figures 3.39A and B 
respectively).  If peaks were observed corresponding to a number of cleavages at the same position, for 
example a1, b1 and c1, and at least one of these does not have the same molecular mass as a possible 
internal fragment the section of sequence will be marked in black. 
3.2.7.3 POPC oleoyl chain 
3.2.7.3.1 Identification of acylated product ions 
 The MSMS spectrum of [melittin + R18:1CO]
+ from melittin with POPC revealed a 
number of acylated product ions (Figure 3.40, Table 3.16 and Appendix 1C).  The majority 
of the m/z values correspond to two or more possible acylated fragments, but acylation 
could be isolated to the N-terminal amine, from the fragment with m/z 435.0 (b2).  No 
other specific sites of acylation could be identified, but all of the m/z values corresponded 
to at least one fragment containing a lysine residue or the N-terminus.  If only the 
possibility of lysine of N-terminal acylation is considered, acylation can be isolated to the 
N-terminus from three fragments (b2, a3 and b4) and to either K(21) or K(23) from one 
fragment (y-17 13). 
Table 3.16.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R18:1CO]
+
 
from melittin with POPC.  Residues on which acylation might have occurred are shown in blue. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Calculated 
molecular mass 
(Da) 
Possible sites of 
acylation 
435.0 b2 324.0 435.4 N-terminus 
464.1 a3 428.6 464.4 N-terminus or S(18) 
 IS  465.4  
492.2 b3 2294.5 492.4 N terminus or K(7) 
 KV  492.4  
563.2 b4 1179.3 563.4 N-terminus or W(19) 
 WI  564.4  
663.2 b5 342.8 662.5 N terminus, K(21) or R(22) 
 IKR  662.5  
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1982.5 y-17 13 176.3 1983.2 C-terminus, K(21), K(23), 
S(18), W(19), R(22), R(24) 
2837.6 b24 262.0 2836.8 N-terminus, K(7), K(21), 
K(23), S(18), W(19), R(22), 
R(24) 
 
 
 
Figure 3.40.  Possible acylated fragments identified from the MALDI-MSMS spectrum of [melittin + R18:1CO]
+
 
from melittin with POPC.  A) Sequence ions; B) internal fragments.  Positions at which acylation might have 
occurred are shown in blue.  Sections marked in the same colour correspond to fragments with the same 
molecular mass; sections marked in black are those for which only one type of fragment can be attributed to 
particular molecular mass.  The C-terminal amide has been omitted for clarity. 
3.2.7.3.2 Comparison of sequence coverage of modified and unmodified sequence 
ions 
 The product ion spectrum of [melittin + R18:0CO]
+ revealed a long series of 
unmodified y or y-17 ions from y-17 26 to y11 with only two missed cleavages and five 
ions which could also correspond to internal fragments (Figure 3.41 and Table 3.17), 
suggesting that the C-terminus was not acylated.  The lack on unmodified fragments 
between y11 and y2 suggests acylation of K(7), the only likely site of acylation in this 
section of sequence.  One modified y-ion, y-17 13, was identified (Figure 3.41 and Table 
3.16), indicating that there was at least one point of acylation other than the N-terminus or 
K(7).  Acylated and non-acylated a, b and c ions were observed up to b5 and b6 
respectively, suggesting that acylation may have occurred on K(7).  The next cleavages 
were b24 and c12 for acylated and non-acylated fragments respectively.  The modified 
and unmodified sequence ions indicate that the N-terminus, K(7) and at least one other 
position were acylated.  Peaks corresponding to unmodified fragments b26 and y-17 1, 
and c26 and y1 were also observed.  As described in sections 3.2.7.4.1 and 3.2.7.4.2, the 
non-acylated b26 and c26 fragments could have formed through y-type cleavage of an 
acyl chain and b or c-type cleavage at the C-terminus.  The y1 and y-17 1 fragments 
could have occurred through y-type cleavage of an acylated N-terminal amide with or 
without an additional loss of NH3. 
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Table 3.17.  Non-acylated sequence ions identified from the product ion spectrum of [melittin + R18:1CO]
+
 from 
melittin with POPC. 
Observed 
m/z 
Fragment Peak intensity 
(a.u.) 
Possible internal 
fragment? 
Calculated molecular 
mass (Da) 
74.0 
 
c1 642.9 No 75.1 
171.1 b2 631.5 Yes 171.1 
200.1 a3 364.0 Yes 200.1 
228.1 b3 1670.1 Yes 228.1 
272.2 
 
a4 562.4 Yes 271.2 
 
299.1 b4 881.5 Yes 299.2 
 
369.0 a5 780.1 Yes 370.1 
398.1 b5 617.3 Yes 398.1 
482.1 
 
a6 476.7 Yes 483.3 
1128.2 
 
c12 725.9 No 1127.7 
 
1520.5 
 
c16 177.8 Yes 1522.0 
 
2827.5 
 
b26 182.0 No 2827.8 
 
2845.1 
 
c26 442.7 No 2844.8 
 
129.1 
 
y-17 26 3367.7 Yes 129.9 
 
256.1 
 
y-17 25 437.3 No 257.1 
 
274.0 
 
y25 809.0 Yes 274.2 
 
413.0 y-17 24 441.8 Yes 413.2 
430.1 y24 705.6 No 430.3 
540.9 y-17 23 462.9 Yes 541.3 
558.1 y23 627.1 No 558.3 
697.2 y-17 22 427.0 Yes 697.4 
714.1 y22 897.5 Yes 714.4 
825.1 y-17 21 503.6 Yes 825.5 
842.2 y21 609.2 No 842.5 
938.2 y-17 20 471.5 Yes 938.6 
 
955.3 y20 1016.5 Yes 955.6 
1124.5 y-17 19 168.5 No 1124.7 
1210.7 y-17 18 191.8 No 1211.7 
1229.0 y18 176.4 No 1228.7 
1342.5 y17 167.9 No 1341.8 
1520.5 y16 177.8 Yes 1454.9 
1607.0 y-17 14 169.8 Yes 1606.0 
1623.5 y14 258.7 Yes 1623.0 
1793.3 y12 211.9 No 1793.1 
1893.9 y11 126.5 No 1894.2 
2771.5 y-17 2 97.2 No 2771.7 
 
2827.5 
 
y-17 1 182.0 No 2828.8 
 
2845.1 
 
y1 442.7 No 2845.8 
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Figure 3.41.  Non-acylated and acylated sequence ions identified from the product ion spectrum of [melittin + 
R18:1CO]
+
 from melittin with POPC.  A) Non-acylated sequence ions; B) acylated sequence ions.  Amino acids 
shown in blue are possible sites of acylation; sections of sequence marked in green are those which have the 
same molecular mass as possible internal fragments (non-acylated or acylated for Figures 3.41A and B 
respectively).  If peaks were observed corresponding to a number of cleavages at the same position, for 
example a1, b1 and c1, and at least one of these does not have the same molecular mass as a possible 
internal fragment the section of sequence will be marked in black. 
3.2.7.4  Summary of melittin acylation 
 The MSMS analyses of [melittin + R18:1CO]
+ from the samples of melittin with 
DOPC and POPC and [melittin + R16:0CO]
+ from the sample with POPC all showed that 
acylation had occurred on the N-terminal amino group.  The addition of an oleoyl chain 
was also identified at K(7) of melittin from the sample with DOPC.  There were no cases 
identified where fragmentation definitely occurred at a position other than the N-terminus 
or a lysine residue.  When the acylated fragments were reviewed in terms of just acylation 
of the N-terminal amine or a lysine residue, acylation was identified on the N-terminal 
amine for each acylated parent ion.  Acylation could be identified on K(7) and K(21) from 
the product ion spectrum of [melittin + R18:1CO]
+ from melittin with DOPC, and on either 
K(21) or K(23) for the oleoyl and palmitoyl adducts of melittin with POPC.  Comparison 
between the acylated and non-acylated sequence ions identified from each acylated 
parent ion showed that C-terminal acylation was unlikely to have occurred and showed 
that acylation was likely to have occurred at the N-terminus, K(7) and at least one other 
position. 
3.3 Conclusions 
3.3.1 Lipid stability 
 A number of analyses were carried out with the aim of determining the stability of 
DOPC and DPPC liposomes with respect to hydrolysis and fusion or micellisation.  Prof.  
Rodger reported changes in the binding of antimicrobial peptides to liposomes depending 
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on how long after preparation the liposomes were used, and hydrolysis, fusion or 
micellisation had been proposed as possible reasons for this.28 No changes to any of the 
liposome samples were observed.  These results are encouraging in that they show that 
the liposomes are stable with respect to hydrolysis over the course of 2–3 weeks, and 
they showed that hydrolysis, fusion and micellisation were not the cause of the changes 
noted by Prof. Rodger. 
 In the course of these analyses it became apparent that a certain amount of 
oxidised lipids were present in both the DOPC and POPC stocks.  Comparison between a 
new batch of DOPC, which was stored at -20 °C as a powder up until analysis, and a 
batch which had been stored at -20 °C as a solution in CHCl3 for a number of months 
showed that storage in CHCl3 was not the cause of the oxidation.  It was not possible to 
observe an increase in oxidation products in the liposome samples analysed, as the 
peaks corresponding to the oxidation products in the MALDI-MS spectra obtained were 
variable in intensity.  This observation was supported by the fact that no oxidation product 
of DOPC was observed by 1H NMR analysis of a sample of the same stock solution which 
gave intense peaks corresponding to the oxidation product in MALDI-MS spectra, 
suggesting that the actual concentration of the oxidation product was very low, below the 
detection limit of the 700 MHz NMR spectrometer used, and that it must be very easily 
ionisable to be observed so strongly in the mass spectra.  The presence of a very small 
concentration of oxidised lipid in the liposomes used in peptide binding experiments is 
unlikely to have had a significant effect on peptide binding experiments, and any effect will 
have been consistent due to the presence of the oxidised species in the lipid stocks rather 
than forming during liposome storage. 
3.3.2 The effect of small molecules on DOPC liposomes 
The observation that HFIP did not cause the hydrolysis of DOPC liposomes is in 
keeping with the model proposed in the literature, where the alcohol inserts between lipid 
headgroups in a bilayer, increasing the lateral pressure in the headgroup region and 
decreasing it in the chain region, thereby causing permeability through physical disruption 
of the bilayer rather than chemical disruption. 
The results of the analysis of haloperidol with liposomes, intended as a test of the 
use of MALDI-MS to plot the hydrolysis of liposomes over time, was unexpected, but can 
most likely be attributed to the very small sample quantity and its sticky consistency 
limiting the mixing of the drug and the lipid molecules.  The sample may also have 
evaporated partly, due to the very small quantity in a 1 mL sample vial, leaving few water 
molecules to carry out the hydrolysis.  The analysis of the samples of DOPC with melittin 
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showed that the lyso-lipids could be detected by MALDI-MS however, and that qualitative 
increases in their concentration could be monitored. 
3.3.3 The effect of melittin on lipid bilayers 
3.3.3.1 Acyl chain lysis in the presence of melittin  
DMPC liposomal lipids were observed to undergo rapid acyl chain lysis over 5 
minutes in the presence of natural melittin and the absence of EDTA and no acyl chain 
lysis over 10 minutes in the presence of 2 mM EDTA.  Some hydrolysis of DOPC was 
observed after 24 hours in the presence of natural melittin and 1 mM EDTA.  The lysis in 
these samples was attributed to hydrolysis by PLA2 in the sample, due to incomplete 
chelation of Ca2+ when only 1 mM EDTA was used, as a concentration of 5 mM is 
required for complete chelation of Ca2+.20  These results were consistent with those 
reported in the literature.21, 22  For the first 24 hours after addition, no acyl chain lysis was 
observed of DOPC liposomes in the presence of synthetic (and therefore PLA2-free) 
melittin.  After 48 hours however it became clear that with a 5:1 lipid:peptide molar ratio 
lyso-PC was being formed compared to the control sample to which melittin had not been 
added.  A small amount of sn-glycero-3-phosphocholine was also observed.  These 
results suggest that melittin does promote the lysis of the acyl chains of phospholipids, 
though over a much slower timescale than in the presence of PLA2.  The two likely 
explanations for the observed acyl chain lysis are a) hydrolysis, caused by the 
perturbation of the liposome bilayer by melittin allowing water to access the core of the 
bilayer, thereby permitting hydrolysis to occur, and/or b) acyl transfer occurring from the 
lipids to nucleophilic groups of melittin when inserted in the bilayer.  TLC analysis of a 
sample of DOPC 17 days after the addition of synthetic melittin showed the presence of 
lyso-PC but not oleic acid.  This suggests that the mechanism of acyl chain lysis involved 
acyl chain transfer to melittin rather than hydrolysis. 
A clear increase in acyl chain lysis was observed in the presence of melittin and 
Zn2+.  The presence of low concentrations of Zn2+ (up to approximately 1 mM) has been 
found to increase the percentage lysis of liposomes composed of PC or PC/PS (85:15) 
when compared with liposomes prepared in the absence of Zn2+.48  This is thought to be 
due to binding of the metal ions to the surface of the membrane promoting the binding of 
melittin.  This enhancement of liposome lysis in the presence of Zn2+ correlates with the 
results reported herein for acyl chain lysis in the presence of Zn2+.  The increased lysis in 
the presence of Zn2+ may reflect increased melittin binding, supporting either the acyl 
transfer or the melittin-promoted hydrolysis mechanisms, or may be due to the catalysis of 
ester hydrolysis by Zn2+ acting as a Lewis acid. 
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Melittin did not promote acyl chain lysis when NaCl was excluded from the buffer.  
This observation is likely to be due to the different conformations of melittin, which are 
known to be affected by the ionic strength of the buffer.  At a neutral or basic pH and in 
the presence of buffer salts (e.g. 300 mM NaCl), melittin has been shown to form 
tetrameric aggregates.49  In lower ionic strength buffers (e.g. 150 mM NaCl), melittin 
exists as a monomer, but has a rigid α-helical secondary structure.  In the absence of 
added salt, melittin exists as a flexible random coil monomer.50–52  Red edge excitation 
shift (REES) analysis of membrane-bound melittin in the presence and absence of NaCl 
has shown that in the absence of NaCl the water molecules around the tryptophan 
residue of melittin are rapidly reorienting, giving no REES and suggesting that the residue 
is not buried in the membrane.  In the presence of up to 150 mM NaCl a red-edge shift 
was reported, suggesting that the tryptophan residue was localised inside the 
membrane.53  If melittin does not insert into the membrane in the absence of NaCl, as 
reported in the literature, this would explain the lack of lysis observed in the absence of 
NaCl.  This supports either model of acyl chain lysis: membrane perturbation by melittin 
allowing water to access the hydrophobic core of the bilayer for hydrolysis to occur, or 
acyl transfer to nucleophilic groups of melittin when the peptide is inserted in the 
membrane. 
 
The MALDI-MS spectrum of POPC to which melittin had been added showed a 
greater intensity of the peak corresponding to a loss of the oleoyl chain from the sn-2 
position than that corresponding to the loss of the palmitoyl chain from the sn-1 position.  
Reports of acid and alkali catalysed hydrolysis of POPC in the literature state that equal 
hydrolysis of the palmitoyl and oleoyl chains was observed, therefore the unequal levels 
of lysis at the sn-1 and sn-2 positions must be accounted for by some other mechanism.9, 
54   
3.3.3.2 Melittin acylation in liposomal membranes  
MALDI-MS analyses of the samples of melittin with DOPC and POPC liposomes 
showed addition of the oleoyl chain of DOPC and the palmitoyl and oleoyl chains of 
POPC to the peptide.  It was established through MSMS analysis that in each case acyl 
transfer was occurring on the N-terminal amine of melittin.  Fragments were also identified 
in which oleoyl chain of DOPC had added to K(7).  There were no cases where acylation 
definitely occurred at a position other than the N-terminus or a lysine residue.  A number 
of m/z values corresponded to more than one acyated fragment, but in each case there 
was at least one fragment containing a lysine residue or the N-terminus.  In some cases 
there were a number of possible sites of acylation within one fragment or within fragments 
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with the same molecular weight.  As stated in section 3.2.7.1.1, the N-terminus and lysine 
residues are the most likely points of acylation.  When other acylation sites were 
discounted, the addition of an acyl chain to the N-terminus and to K(7) could be identified 
from the product ion spectra of [melittin + R18:1CO]
+ from DOPC and POPC and from the 
product ion spectrum of [melittin + R16:0CO]
+ from POPC.  The addition of the oleoyl chain 
of DOPC to K(21) was identified, along with oleoyl and palmitoyl adducts of melittin with 
POPC in which acylation had occurred at K(21) or K(23).  There was no evidence that 
acylation had definitely occurred on K(23).  When the sequence coverage of acylated and 
non-acylated sequence ions was compared for each acylated parent ion it was 
established that acylation was unlikely to have occurred at the C-terminus and in each 
case was likely to have occurred on the N-terminal amine, K(7) and on at least one other 
residue.  The results of melittin acylation reported herein are consistent with reports of the 
structure, orientation and location of melittin within lipid membranes.  It is assumed that 
under the conditions in which melittin became acylated the peptide had an α-helical 
structure, due to the presence of 150 mM NaCl in the buffer.53  Solid-state NMR analysis 
has shown that melittin is also helical in the presence of lipid.55  Hristova et al. established 
from oriented circular dichroism (OCD) analysis that melittin helices bind parallel to DOPC 
membranes.56  They followed this with x-ray diffraction, from which the location of a 
melittin helix within a DOPC bilayer could be determined.  The helix was found to be 
centred close the glycerol groups of the lipids, 17.5 Å from the centre of the bilayer.  The 
edge of the helix extended to the depth of the oleoyl double bonds.  This position within 
the membrane is entirely consistent with membrane acylation.  The presence of acylated 
melittin shows that the formation of lyso-PC is at least partially due to acyl transfer to 
melittin, and the observed absence of oleic acid in the TLC analysis of DOPC liposomes 
after the addition of synthetic melittin (Figure 3.25) suggests that acyl transfer is the 
principle cause of the formation of lyso-PC.   
 
The peak corresponding to [melittin + R18:1CO]
+ had a greater intensity than that 
corresponding to [melittin + R16:0CO]
+ in all of the MALDI analyses of samples of melittin 
and POPC.  This is likely to account for the greater intensity of the peaks corresponding 
to lyso-PPC compared to those corresponding to lyso-OPC which gave the appearance of 
increased hydrolysis at the sn-2 position of POPC, as more acyl transfer was occurring 
from the sn-2 position than the sn-1 position and giving a greater quantity of lyso-PPC 
than lyso-OPC. 
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3.4 Future work 
The formation of lyso-lipids discussed above has been followed by MALDI-MS 
using the intensity of the lyso-PC normalised relative to the combined intensities of the 
peaks corresponding to the lyso-lipid and the molecular ion.  Although this method 
allowed the lyso-lipid formation to be followed qualitatively, the results had a poor signal 
to noise ratio with a large margin of error.  More accurate data could be provided from 
LCMS analysis of the liposome/melittin dispersion, as the LC trace would provide a 
quantitative analysis of the lyso-lipid content if compared to standards.  The trade-off for 
this increase in accuracy would be the need to find a different buffer system which was 
compatible with chromatography, as sodium phosphate buffer is non-volatile and would 
contaminate the mass spectrometer,57 and the requirement for a much larger sample 
volume.  The formation of lyso-lipids is likely to be accompanied by the generation of 
detergent micelles, the formation of which could be monitored by dynamic light scattering 
to provide a fuller picture of the process and the timescale upon which it was occurring. 
  
 The MALDI-MS analysis of the acyl adducts of melittin did not provide a clear 
indication as to the quantity of adducts formed.  Separation of melittin and the adduct by 
liquid chromatography may allow the adduct to be quantified and therefore give an idea 
as to the extent of melittin modification occurring. 
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4 THE MEMBRANE BINDING OF DEFENSIN HNP-2 
4.1 Introduction 
4.1.1 The defensin family 
The defensins are a family of peptides found in plant, invertebrate and vertebrate 
species.  They are small (3–5 kDa), arginine-rich, cationic peptides, with predominately β-
sheet structures stabilised by 3–4 disulphide bonds.1  There are three subtypes of 
vertebrate defensins: α, β and θ, along with insect and plant subtypes (Table 4.1).  The α, 
β and θ-defensins are categorised by their disulphide bond pairing and distance between 
cysteine residues.2  α-Defensins have six cysteine residues, paired Cys 1 – Cys 6, Cys 2 
– Cys 4 and Cys 3 – Cys 5.3  β-Defensins also contain six cysteines, but they are paired 
Cys 1 – Cys 5, Cys 2 – Cys 4 and Cys 3 – Cys 6.3 All α and β mammalian defensins 
identified so far have been shown to have three-stranded antiparallel β-sheet structures, 
though they differ in the percentage of β-sheet, for example human neutrophil defensin-3 
(HNP-3) (an α-defensin) is 53% β-sheet,4 rabbit kidney defensin-1 (RK-1) (α) is  40%  β-
sheet and human β defensin-3 (HBD-3) (β) is only 28% β-sheet.5, 6  There is only one 
known θ-defensin, rhesus theta defensin-1 (RTD-1), an 18 amino acid cyclic peptide 
stabilised by three disulphide bonds, found in the leukocytes of rhesus macaques.7, 8 
 
Figure 4.1.  The crystal structures of A) HBD-3 (closest to average NMR structure), B) HNP-2 (X-ray; D-
Ala(17)-HNP-2), C) HNP-3 (X-ray) and C) RK-1 (lowest energy NMR structure).  Entries 1KJ6, 1ZMH, 1DFN 
and 1EWS  respectively in the Protein Data Bank.
 5, 9, 4, 6
  Disulphide bonds shown in red. 
There are six α-defensins, human neutrophil peptides 1-4 (HNP-1-4) and human 
defensins 4 and 5 (HD-5, HD-6), and eleven β-defensins, human β-defensins 1–6 and 
25–29 (HBD-1–6 and 25–29), known to be present in humans, as described in Table 
4.2.10 
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4.1.2 Human α-defensin structures 
 The crystal structures of all six human α-defensins have been determined (HNP-2 
was crystallised as D-Ala(17)-HNP-2, with the second Gly residue replaced with D-Ala), 
along with solid and solution state NMR structures of HNP-1.4, 9, 11–15  They have very 
similar triple stranded β-sheet structures connected through tight turns and a β-hairpin.  
All of the human α-defensins crystallised as dimers, and the solution state NMR analysis 
of HNP-1 also showed it to have a dimeric structure.  HNP-1–3 have primary structures 
which only differ by one residue (Table 4.2).  The secondary structures of HNP-1–3 have 
been shown to be essentially identical, with three strands of antiparallel β-sheet involving 
sections „YCR‟, „RYATCIY‟ and RLWAFC‟ of the sequence of each peptide, two hydrogen 
bonded turns involving residues „AG‟ and „QG‟ and, like all α-defensins, disulphide bonds 
between Cys 1 and Cys 6, Cys 2 and Cys 4 and Cys 3 and Cys 5 (Figure 4.2).  The three 
dimer crystal structures only show small differences in the sections where no specific 
secondary structure can be assigned (Figure 4.3).4, 9, 14  It is therefore possible to combine 
some structural information which has been gained for each of them individually.  The 
numbering of the amino acids in Section 4.2.1 has been determined by designating the 
first residue in the peptide referred to at the time as residue 1.  This may differ from 
numbering in the references, where the amino acids have been numbered such that 
conserved residues have the same number in each peptide, i.e. the first residue of HNP-2 
would be labelled C(2) when compared to the other human neutrophil defensins, and C(3) 
when compared to rabbit neutrophil peptide-2 (NP-2).9  D-Ala(17)-HNP-2 is modified on 
the 16th residue if the sequence is numbered in isolation (Figure 4.2). 
 
Figure 4.2.  The DSSP secondary structure assignment of D-Ala(17)-HNP-2.
9, 16
  = β strand;  = 
hydrogen bonded turn;  = no secondary structure assigned; cysteine residues are circled in green; red, 
green and blue lines linking cysteines show arrangement of disulphide bonds. 
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Figure 4.3.  The crystal structures of dimers of HNP 1-3 (A–C respectively).  Entries 3HJ2, 1ZMH and 1DFN 
respectively in the RSCB Protein Data Bank.
4, 9, 14 
4.1.2.1 HNP-1 
The structure of HNP-1 was initially determined using solution state NMR.11 Clear 
evidence was observed for the existence of defensin dimers in solution.  Eighteen slowly 
exchanging protons were observed on the HNP-2 monomers, twice as many as on the 
homologous rabbit NP-2 peptide (Figure 4.4), which has been shown not to dimerise.  
The exchange rate of amide protons is slowed when they are not accessible by the 
solvent, either due to hydrogen-bonding or being buried in the peptide.  Some of the 
protons of interest appeared to be on the surface of the monomer and should have been 
freely accessible by solvent.  This suggests strongly that the peptide was present as 
either a dimer or an aggregate.   
 A C  Y  C  R  I  P  A  C  I  A  G  E  R  R  Y  A  T  C  I  Y  Q  G  R  L  W  A  F  C  C    
V  V  C  A  C  R  R  A  L  C  L  P  L  E  R  R  A  G  F  C  R  I  R  G  R  I  H  P  L  C  C  R  R  
 
Figure 4.4.  The sequences of HNP-1 and NP-2. 
The data did not allow the distinction between a symmetrical dimer and an 
asymmetric dimer where the monomer and aggregate were exchanging fast on the NMR 
chemical shift timescale.  It was also not possible to determine whether the peptide was 
present as dimers or higher-order aggregates, as the amide proton of residue 26, which 
was not on the surface thought to lie between the two monomers, was also slowly 
exchanging, suggesting aggregation.  Further evidence which suggested either 
A 
B C 
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dimerisation or aggregation included larger average proton line widths than those in the 
spectra of monomeric rabbit NP-2, lower signal-to-noise ratios for cross peaks in the 
COSY spectra and higher signal-to-noise ratios for cross peaks in the 2-dimentional NOE 
spectra, all consistent with longer rotational correlation times caused by aggregation.  The 
x-ray crystal structure of an HNP-1 dimer has also been determined. 
4.1.2.2 HNP-2 
Three x-ray crystal structures of D-Ala(17)-HNP-2 (residue Gly(16) replaced with 
D-Ala) have been determined.  The peptide crystallised as a dimer, and a number of 
interactions between the monomers were identified.  Four main-chain N–H---O hydrogen 
bonds were identified between the Thr(17) and Ile(19) residues of each monomer, along 
with hydrophobic contacts between Phe(27) and the sulphur atoms of Cys(3) and Cys(18) 
(which share a disulphide bond) and, in some cases, hydrogen bonds between the Cys(1) 
residues on each monomer.  The monomers participating in dimerisation were shown to 
have different relative locations, suggesting asymmetry.9 
4.1.2.3 HNP-3 
HNP-3 also crystallised with two monomers in close contact related by a two-fold 
rotation axis, as shown in Figure 4.5.  Four direct hydrogen bonds were identified in the 
same positions as those observed during the analysis of the HNP-2 crystal (between 
residues numbered 19 and 21 in Figure 4.5), along with two indirect hydrogen bonds 
through water molecules (between residues numbered 17 and 23 in Figure 4.5).  
Hydrophobic interactions were observed between residues Cys(4), Cys(19), Tyr(21), and 
Phe(28) (labelled 5, 20, 22 and 29 respectively in Figure 4.5) of each monomer.  
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Figure 4.5.  Pattern of hydrogen bonding in the HNP-3 dimer.
4
  Reproduced with permission from the 
American Association for the Advancement of Science, license no. 2362010971233. 
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  Type Species Disulphide Bonds Target Location Ref 
Human 
neutrophil 
peptide (HNP) 
1–4 
α Human Cys 1 – Cys 6, Cys 2 – Cys 4, Cys 3 – Cys 5 Gram +ve and Gram -ve 
bacteria, fungi, enveloped 
viruses, yeast 
Neutrophils 1, 13, 17–20 
Human 
defensin (HD) 
5–6 
α Human Cys 1 – Cys 6, Cys 2 – Cys 4, Cys 3 – Cys 5 Gram +ve and Gram -ve 
bacteria, fungi, yeast 
Small intestine (paneth 
cells; granulocytes) 
13, 18 
Neutrophil 
peptide NP 1–
5 
α Rabbit Cys 1 – Cys 6, Cys 2 – Cys 4, Cys 3 – Cys 5 Gram +ve and Gram -ve 
bacteria, fungi, enveloped 
viruses 
Neutrophils 21–24 
Macrophage 
cationic 
peptide (MCP) 
1–2 
α Rabbit Cys 1 – Cys 6, Cys 2 – Cys 4, Cys 3 – Cys 5 Gram +ve and Gram -ve 
bacteria, fungi, enveloped 
viruses 
Lung machrophages 21–24 
Cryptidins α Mouse, 
rat 
Cys 1 – Cys 6, Cys 2 – Cys 4, Cys 3 – Cys 5 Gram +ve and Gram -ve 
bacteria, fungi, protozoans 
Small intestine (paneth 
cells) 
24–27 
Human β 
defensin (HBD) 
1–6, 25–29 
β Human Cys 1 – Cys 5, Cys 2 – Cys 4, Cys 3 – Cys 6 Gram -ve bacteria Various 28–37 
Tracheal 
antimicrobial 
peptide (TAP) 
β Cattle Cys 1 – Cys 5, Cys 2 – Cys 4, Cys 3 – Cys 6 Gram +ve and Gram -ve 
bacteria, fungi 
Tongue 38 
Rhesus θ 
defensin  
(RTD) 1 
θ Rhesus 
Macaque 
Cys 1 – Cys 6, Cys 2 – Cys 5, Cys 3 – Cys 4 Gram +ve and Gram -ve 
bacteria, fungi 
Leukocytes 7, 8 
4 kDa defensin Insect Scorpion Cys 1 – Cys 4, Cys 2 – Cys 5, Cys 3 – Cys 6 Primarily Gram +ve bacteria Hemolymph 39 
Defensin-1 Plant Garden 
pea 
Cys 1 – Cys 8, Cys 2 – Cys 5, Cys 3 – Cys 6, 
Cys 4 – Cys 7 
Fungi Epidermis and vascular 
bundles 
40 
Table 4.1.  Examples of defensin peptides. 
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  Type Sequence Target Location Ref 
HNP-1 α ACYCRIPACIAGERRYGTCIYQGRLWAFCC Gram +ve and Gram -ve bacteria, fungi, enveloped viruses, yeast Neutrophils 1, 17–19 
HNP-2 α CYCRIPACIAGERRYGTCIYQGRLWAFCC Gram +ve and Gram -ve bacteria, fungi, enveloped viruses, yeast Neutrophils 1, 18–20 
HNP-3 α DCYCRIPACIAGERRYGTCIYQGRLWAFCC Gram +ve and Gram -ve bacteria, fungi, enveloped viruses, yeast Neutrophils 18, 19 
HNP-4 α VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV Gram +ve and Gram -ve bacteria, fungi, yeast Neutrophils 13, 17, 18 
HD-5 α ATCYCRTGRCATRESLSGVCEISGRLYRLCCR Gram +ve and Gram -ve bacteria, fungi, yeast Small intestine (paneth cells; 
granulocytes) 
13, 18 
HD-6 α AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL Very low activity against Gram +ve and Gram -ve bacteria; HIV-1 Small intestine (paneth cells; 
granulocytes) 
13, 18 
HBD-1 β DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK  Gram -ve bacteria Various, including plasma and 
kidney  
28–30 
HBD-2 β GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKC
CKKP 
 Gram +ve and Gram -ve bacteria, yeast Various, including skin, lung, 
trachea 
31 
HBD-3 β GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRG
RKCCRRKK 
 Gram +ve and Gram -ve bacteria, yeast Various, including skin, lung, 
trachea and kidney 
32 
HBD-4 β ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLR
K 
 Gram +ve and Gram -ve bacteria, yeast Mainly testis and gastric antrum 33 
HBD-5 β GLDFSQPFPSGEFAVCESCKLGRGKCRKECLENEK
PDGNCRLNFLCCRQRI  
Unknown Epididymis 34 
HBD-6 β FFDEKCNKLKGTCKNNCGKNEELIALCQKSLKCCRTI
QPCGSIID 
Gram -ve bacteria Epididymis 34, 35 
HBD-25 β SFEPQKCWKNNVGHCRRRCLDTERYILLCRNKLSC
CISIISHEYTRR 
Unknown Not trachea or skin 36 
HBD-26 β NWYVKKCLNDVGICKKKCKPEEMHVKNGWAMCGK
QRDCCVPAD 
Unknown Epididymis 36, 37 
HBD-27 β QLKKCWNNYVQGHCRKICRVNEVPEALCENGRYCC
LNIKELEAC 
Unknown Not trachea or skin 36, 37 
HBD-28 β ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCA
NDEEEKKHVSFKKPHQHSGEKLSVLQDYIILPTITIFT
V 
Unknown Not trachea or skin 36 
HBD-29 β EFIGLRRCLMGLGRCRDHCNVDEKEIQKCKMKKCCV
GPKVVKLIKNYLQYGTPNVLNEDVQEMLKPAKNSSA
VIQRKHILSVLPQIKSTSFFANTNFVIIPNATPMNSATI
STMTPGQITYTATSTKSNTKESRDSATASPPPAPPPP
NILPTPSLELEEAEEQ 
Unknown Epididymis 36 
Table 4.2.  Human defensin peptides. 
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4.1.3 Membrane binding and activity 
 Research to date suggests that defensins act through permeabilization of 
microbial cell membranes causing leakage of the contents.19, 41–43 
4.1.3.1 Lipid specificity of HNP-2 
HNP-2 has a net charge of +3 at pH 7, making it unsurprising that the peptide will 
bind to lipid bilayers containing a proportion of negatively charged lipids, due to 
electrostatic attractions.44  The extent of binding of HNP-2 (14.5 µM) to vesicles 
composed of POPG and POPC (10 mM) has been shown to have a sigmoidal 
dependency on the concentration of POPG.  No binding was observed in the absence of 
POPG (100% POPC).  Approximately 20% of HNP-2 was observed to have bound with 
10% POPG and approximately 60% of the HNP-2 was bound with 20% POPG.  Maximum 
binding (more than 90% of added HNP-2 bound to the vesicles) did not occur until around 
70% of the lipid was negatively charged, though nearly 90% of the peptide was bound at 
50% POPG.45  This suggests that HNP-2 specifically binds to bacterial cells, which 
contain negatively charged lipids, over erythrocyte cells, which contain mostly neutral 
lipids.  After binding, it has been shown that HNP-2 causes lysis of the membrane.  This 
has been observed with both negatively charged vesicles and with the inner and outer 
membranes of Escherichia coli (E. coli) (Gram-negative bacteria) cells.20, 46  The lack of 
binding of HNP-2 to neutral membranes is in contrast to the binding of some other 
antimicrobial peptides, such as melittin.  Melittin has a net charge of +5 at pH 7 and binds 
preferentially to negatively charged lipids, but melittin also binds to neutral liposomes, and 
causes a greater degree of lysis of neutral liposomes than of those composed of 
negatively charged lipids.47 
HNP-2 has been shown to cause fusion and aggregation of vesicles under certain 
conditions.  Wimley et al. reported aggregation only with lower concentrations of vesicles 
(1 mM as opposed to 10 mM) and at least 40% POPG (60% POPC).  They observed that 
with pure POPG liposomes aggregation was rapid as soon as the molar ratio of POPG 
lipid to HNP-2 dropped below 100:1, which suggests that the aggregation was caused by 
electrostatic interactions.20  HNP-1 has also been observed to cause fusion of liposomes 
containing 25% DOPS in DPPC.43 
4.1.3.2 Buffer and ionic strength effects 
Human neutrophil peptides have been shown to be strongly affected by the ionic 
strength of buffers.43  In 5 mM phosphate buffer, HNP-1 caused greater than 50% lysis of 
3:1 DPPC/DOPS liposomes and 20–50% fusion of the same liposomes.  In 100 mM NaCl 
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and 25 mM phosphate no lysis was observed and the amount of fusion dropped.  The 
results of a sucrose gradient lipid binding assay showed a higher lipid:peptide molar ratio 
for HNP-1 bound to DPPC/DOPS liposomes in 100 mM NaCl and 25 mM phosphate than 
in 5 mM phosphate (20:1 mol/mol and 13:1 mol/mol respectively), showing that the 
binding was weaker in the presence of NaCl and a higher concentration of phosphate.  It 
has been suggested that the decrease in binding at a high salt concentration is due to 
ions in solution shielding the charges on the peptide from the charged lipid headgroups.  
The higher concentration buffer had no effect on the liposome binding of rabbit NP-1, 
which has a much higher net charge of +9 at pH 7 and therefore may not have been 
shielded so well.  
The antimicrobial activity of HNP-1 against Gram negative (E. coli) and Gram 
positive (Listeria monocytogenes) bacteria has been shown to be greatly inhibited by 
buffers of even medium ionic strength.  The minimum inhibitory concentration (MIC) (the 
lowest peptide concentration at which bacterial cell growth was inhibited) of HNP-1 
against E. coli in 10 mM phosphate buffer was 1.9 µg/mL.  In a 10 mM phosphate buffer 
with 50 mM or 100 mM NaCl the MIC was over 50 µg/mL.  Similarly, with L. 
monocytogenes the MIC in the absence of NaCl was 5.8 µg/mL, and with 50 mM or 100 
mM NaCl it was over 50 µg/mL.48 
4.1.4 Binding models 
On publishing the crystal structure of HNP-3, Hill et al. proposed three models for 
the interaction between the peptide and lipid membranes.4  The structure they found 
(Figure 4.6) was that of a basket-shaped dimer, with an apolar base and polar top, held 
together through hydrogen bonds.  The centre of the basket was found to contain the 
hydrophobic amino acids, and a ring of six positively charged arginine side chains was 
observed around the basket.  A mini-channel was observed running through the centre of 
the dimer (Figure 4.6B). The two strands of β-sheet were found to be linked by hydrogen 
bonds through ordered solvent molecules in this channel. 
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Figure 4.6.  Schematic representations of HNP-3 dimer in binding models and how they relate to crystal 
structure. 
The three binding models proposed by Hill et al. were: 
4.1.4.1 Wedge model 
The first model suggested was that of a wedge, with the basket sitting in, and 
disrupting, the outer leaflet of the membrane.4  The hydrophobic base of the basket is 
buried in the hydrophobic centre of the bilayer and the arginine residues are able to 
interact with the negatively charged lipid headgroups. 
4.1.4.2 Multiple dimer pore model 
The second model proposed was that of a pore composed of at least four dimers 
arranged with their polar tops facing into the centre of the pore and their hydrophobic 
bases facing outwards into the bilayer.4  The arginine side chains were suggested to be 
flexible enough to bind the lipid headgroups from this orientation. 
4.1.4.3 Two dimer pore model 
The final model involved the formation of a two dimer pore within the membrane, 
with the polar tops of the dimers facing each other at the centre of the pore and the 
hydrophobic bases facing outwards towards the lipid acyl chains at the centre of the 
bilayer.  The arginine side chains are again able to interact with the lipid headgroups.  The 
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dimers are rotated by 90° compared to the other models to allow the pore to be spanned 
by the solvent mini channel in the top of the basket.4 
  
Figure 4.7.  HNP-3 binding models proposed by Hill et al.
4
  A) wedge model; B) multiple dimer pore model; C) 
two dimer pore model.  The relationship between the schematic images of the peptide dimer and the crystal 
structure is shown in Figure 4.6. 
4.1.4.4 Proposed model for HNP-2 membrane binding 
Wimley et al. used the HNP-3 crystal structure and applied it to experimental data 
for HNP-2 to develop a proposed model for the membrane binding of the latter peptide.20  
The HNP-3 structure was used because HNP-2 had not been crystallised at that time.  
They initially studied the effect of the addition of HNP-2 to POPG vesicles containing a 
mixture of fluorescent 8-aminonaphthalene-1,3,6 trisulfonic acid (ANTS) and the quencher 
p-xylene-bis-pyridinium bromide (DPX) in 50 mM KCl, with the expectation of observing 
an increase in ANTS fluorescence on lysis of the vesicles due to dilution. On addition of 
HNP-2 an increase in fluorescence was observed.  The release of the vesicle contents 
appeared to start immediately after addition of the peptide, and then to increase 
exponentially on a timescale of minutes, with a half time of the leakage being around 2 
minutes with 1.45 µM HNP-2.   
Further work was then carried out to determine if the fluorophore leakage was due 
to a graded process where all of the vesicles released some of their fluorophores, or an 
„all-or-none‟ process where a portion of the vesicles released all of their contents and the 
rest remained intact.  The process was found to be all-or-none.  An all-or-none leakage 
A B 
C 
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process is caused by either complete destruction of some of the vesicles or the formation 
of pores. In order to determine the process occurring, HNP-2 was added to vesicles 
containing a mixture of ANTS/DPX and the fluorescent dextrans FD-4 (fluorescein 
isothyocyanin-labelled dextran, molecular weight 4,400 Da) and FD-20 (fluorescein 
isothyocyanin-labelled dextran, molecular weight 18,900 Da).  At two different 
concentrations of HNP-2, 100% of the ANTS/DPX was released, 64% of the FD-4 and 
24% of the FD-20.  This suggested that pores were being formed, which were large 
enough to allow ANTS/DPX and FD-4, but too small for FD-20.  Through the quantity of 
defensin added and the proportion of vesicles in which pores were formed, Wimley et al. 
estimated that the pores were composed of 6-8 dimers, and from the size of the dextrans 
that the maximum pore radius was 25 Å.  From all of this, they proposed a pore 
composed of 6 dimers, with an internal radius of 20 Å (Figure 4.8).20  This pore model is 
similar to the second of those proposed by Hill et al. for HNP-3, described in Section 
4.1.4.3.4 
Wimley et al. proposed that the polar region at the top of the dimer baskets would 
face into the centre of the pore and the hydrophobic bases would face the hydrophobic 
lipid chains.  The dimers would be oriented such that the arginine residues lay parallel to 
the bilayer normal in two planes.  The furthest distance between the ends of the arginine 
groups in each plane, and therefore the maximum width of the pore, would then be 25–27 
Å, which is approaching the thickness of a fully hydrated bilayer, where the distance 
between the phosphate groups of a DPPC bilayer is 37 Å.49  The thickness of the 
hydrophobic portion of a DPPC bilayer is 26 Å, but the hydrophobic region of the 
proposed pore would only have a width of 15 Å.  The authors suggested that the bilayer 
might adapt its width to match the width of the pore, as had been proposed for gramicidin 
A channels.20 
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Figure 4.8.  A top-down view of the multimeric pore proposed by Wimley et al.
20 
4.1.4.5 Proposed model for defensin-induced liposome fusion 
 Fujii et al. used the HNP-3 crystal structure to propose a model for HNP-1-induced 
liposome fusion.43  The fusion was measured using fluorescence resonance energy 
transfer (FRET) between two types of fluorescent probes.   Liposomes were prepared 
with a small proportion of each of the donor N-(7-nitro-2,1,3-benzodiazol-4-yl)-
phosphatidylethanolamine (NBD-PE) and the acceptor N-(Lissamine Rhodamine B 
sulfonyl)-phosphatidylethanolamine (Rh-PE).  The addition of HNP-1 caused fusion 
between labelled and unlabelled liposomes, leading to dilution of the fluorophores and a 
reduction in fluorescence emission from Rh-PE and increase in fluorescence emission 
from NBD-PE.  Using the HNP-3 crystal structure, they speculated that defensin dimers 
would associate through the hydrophobic regions at the bases of their „baskets‟ and that 
the three arginine residues on each side of the basket would associate with the negatively 
charged lipid headgroups on the surface of the membrane, allowing the following process: 
A) Two defensin dimers associate with each other through their hydrophobic residues 
and with the surface of the bilayer through electrostatic interactions. 
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B) The surface of another liposome is attracted electrostatically and associates with the 
arginine residues on the other side of the dimer pair. 
C) The membranes are destabilised by disruption of the hydration shells surrounding 
them.  The lipids are able to exchange between bilayers due to the lack of 
hydrophobic shell, initiating fusion.  The fused bilayers eventually reform as a larger 
bilayer. 
 
Figure 4.9.  The three stages of HNP-1-mediated liposome fusion proposed by Fujii et al.
43 
4.1.5 Comparison of human and rabbit α-defensin binding 
 A number of studies have looked at the action of rabbit α-defensins on liposomes 
in comparison with the human neutrophil peptides.42, 43, 50  The solution state NMR 
structures of rabbit neutrophil defensins NP-2 and NP-5 and the crystal structure of rabbit 
kidney defensin RK-1 show no evidence of dimerisation or higher order aggregation, even 
at high peptide concentrations (25 mg/mL).6, 10 ,11, 51  Certain differences have been 
observed between the binding of the human and rabbit α-defensins, which have been 
attributed in part to their respective dimer/monomer formation.  The effects of six rabbit 
defensins on leakage from vesicles have been examined and compared to the all-or-none 
leakage observed for HNP-2.20, 42  Firstly, it was observed that the rabbit defensins NP-2 
and NP-5 only bound to liposomes composed of a proportion of negatively charged lipids, 
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as was found for HNP-2.42  The proportion of POPG required varied with the peptide‟s 
charge however, with 100% binding of NP-2 (net charge +8 at pH 7) observed with just 25 
mol% POPG in POPC vesicles, and 50 mol% POPG required for 100% binding of NP-5 
(net charge +4 and pH 7).  This supports the electrostatic explanation for binding 
described in Section 4.1.3.1.  Much higher concentrations of the rabbit defensins were 
required for liposome permeabilization than HNP-2, and the leakage was much slower, 
although NP-4 did not cause membrane permeabilization at all.  The leakage of vesicle 
contents was found to be graded rather than all-or-none, suggesting that the rabbit 
defensins did not form the same stable pores in the bilayer that HNP-2 has been 
suggested to form.  This difference was attributed to the monomer/dimer difference, and it 
was suggested that the features which caused HNP-2 dimer assembly were also required 
for the formation of the larger HNP-2 structures proposed to be responsible for pore 
formation.   
 In other experiments, rabbit NP-1 was found cause fusion of 3:1 
DPPC:Cholesterol liposomes, though not to permeabilize them.43  HNP-1, NP-1 and NP-5 
were observed to cause lysis of 3:1 DPPC:DOPS vesicles.  A sucrose density gradient 
assay was used to study the strength of the binding between the different defensin 
peptides and DPPC/DOPS liposomes. HNP-1 binding was observed to bind strongly, with 
a low lipid:peptide ratio (13:1 mol/mol), while the binding of NP-1 and 2 was much weaker 
(lipid:peptide ratios of 90:1 and 60:1 (mol/mol) respectively).43  It was proposed that the 
higher net charge of NP-1 (+9 at pH 7) made it more stable in aqueous solution, therefore 
more lipid was required for it to bind. 
4.1.6 The scope of this research 
 A number of important features of the action of defensin HNP-2 on membranes 
have been determined, as discussed above.  It is known to lyse membranes, but only 
those with a proportion of negatively charged lipids, and the crystal structure has shown 
that the peptide exists as a dimer under at least some conditions.   
The lysis has been shown to have an all-or-none effect on leakage from vesicles, 
suggesting that pores are formed rather than more random permeabilization of the 
bilayer.  It has also been observed that only markers of certain sizes are able to escape 
through these pores, giving a suggestion of their size. 
 The proposal that the dimeric form of HNP-2 causes membrane lysis is supported 
by a comparison with the effects of rabbit NP-2 and NP-5 on membranes.42  Structural 
analysis of the rabbit neutrophil peptides suggests that they only exist as monomers, 
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despite their sequence similarities with the human neutrophil peptides.6, 10, 11, 51  These two 
peptides cause a graded release of vesicle contents during permeabilization rather than 
the all-or-none effect caused by the human neutrophil peptides, suggesting that they 
cannot form the same stable pores, which is proposed to be due to their lack of 
dimerisation.42  Hill et al. proposed that the presence of an invariant Gly residue at 
position 17 of HNP-3 also suggests that the peptide acts on membranes as a dimer, as 
replacement of this residue by any other would cause the Cβ atom to overlap with the O 
atom on residue 19 of the neighbouring monomer (labelled 18 and 20 in Figure 4.5).4  
Again, there is good evidence for the peptide binding as a dimer, though this is 
inconclusive and does not explain whether the peptide is present as a monomer at lower 
concentrations and dimerises on the surface of the membrane or during pore formation. 
The multimeric pore model for the binding of HNP-2 to membranes is, to quote the 
authors, “highly speculative... it is only presented to demonstrate that a physically rational 
structure can be made that is both consistent both with the experimental data and with the 
known structures of human defensins and phospholipid bilayers”.20  There is no direct 
evidence for the pore being as proposed, especially concerning the orientation of the 
dimers.  Hill et al. propose a pore model where the dimers sit at 90° to those in the 
Wimley model, also with rational arguments for how the dimers can interact with 
themselves and the bilayer.   
Little is known about the kinetics of the binding of HNP-2, apart from the vesicle 
leakage half times reported by Wimley et al.  They observed that the half time increased 
from around 11 minutes with 0.3 µM HNP-2 to around 2 minutes with 0.9 µM, 1.2 µM and 
1.5 µM HNP-2.20   
There are therefore two main features of the action of HNP-2 which require 
investigation: 
1) The organisation of the peptide after binding to the membrane and whether it 
correlates with any of the models proposed. 
2) The mechanism of this binding. 
 
In order to investigate these two areas, the work described in this chapter was 
concentrated around determining the kinetics of binding, by recording a series of 
fluorescence and linear dichroism spectra over 5 hours under different conditions, and 
studying the orientation of the peptide during and after binding using linear dichroism.  By 
combining these results, a model could be proposed for the mechanism and organisation 
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of the binding of HNP-2.  Analyses were carried out with different lipids and at different 
temperatures in order to gain wider information as to the nature of binding, and further 
investigations were carried out to ensure that the data obtained was from HNP-2 binding 
and not affected by other actions such as liposome fusion. 
4.2 Results and discussion 
4.2.1 Background to HNP-2 analyses 
4.2.1.1 Liposome composition 
 The liposome mixtures used in the HNP-2 binding analyses were chosen for a 
number of reasons.  As stated previously, HNP-2 is known to only bind to liposomes 
containing a proportion of negatively charged lipids, with approximately 90% of the 
peptide reported to bind with 50% POPG (with 50% POPC) at a peptide:lipid ratio of 
1.5:1000 (mol/mol).  With a peptide:lipid ratio of 1.5:100 (mol/mol) 75% of the peptide was 
reported to bind to 50:50 (w/w) POPG/POPC membranes.45    The majority of linear 
dichroism analyses using the flow cell have been carried out using PC liposomes, often 
soybean PC, and little research has been carried out into the behaviour of liposomes 
composed of different lipid types in the flow cell.52  For initial experiments 50:50 (w/w) 
negative lipid:PC mixtures were therefore used to minimise the risk of unexpected 
liposome behaviour affecting the results.  Preliminary analyses were carried out using 
50% egg or soybean PC lipids, with either POPG or soybean PS but for later analyses 
DOPC or DMPC lipids were chosen for the PC component and POPG, DMPG or DOPS 
for the negative component to ensure reproducibility and to remove any possible artifacts 
from the non-PC lipids known to be present in the natural mixtures, or variation in 
composition between batches.53 
 
 The lipid:peptide ratio and overall concentrations used for analyses were selected 
partly due to analytical factors such as necessary minimum peptide concentrations for 
signal detection or maximum lipid concentrations, and partly from the work of Wimley et 
al.,20 who determined the lipid:peptide ratios and concentrations which cause aggregation.  
Initial LD analyses confirmed that the minimum HNP-2 concentration necessary to obtain 
a good signal was 15 µM.  As discussed previously (Section 4.1.3.1), Wimley et al. 
determined that peptide/lipid aggregates were formed when HNP-2 was added to 
liposomes containing a minimum of 40% POPG at a concentration of 1 mM lipid, but no 
aggregation was observed when the lipid concentration was increased to 10 mM, 
regardless of POPG concentration.  They also observed aggregation with pure POPG 
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liposomes at lipid:peptide ratios below 100:1.  A lipid:peptide ratio of approximately 100:1 
was therefore used for the experiments described herein, with the understanding that 
aggregation is thought to be caused by electrostatic forces between the POPG and HNP-
2; therefore these forces would be lessened by the presence of only 50% POPG in the 
liposomes.  This gave an overall lipid concentration of approximately 1.4 mM.  At 1 mM 
lipid with 50% POPG in the liposomes some aggregation had been observed by Wimley 
et al., but with a slightly higher lipid concentration it was hoped that this could be 
minimised.  Wimley et al. observed the leakage of fluorescent markers and different sized 
fluorescent dextran molecules from liposomes with lipid concentrations of 300 µM and 
peptide concentrations of 1.5 µM or 5.8 µM.  A lipid concentration of 300 µM is 
approximately 20% of the absolute lipid concentration used in the binding experiments 
described in this chapter, but the lipid to peptide ratios, 200:1 and 52:1 respectively, are 
either side of the ratio used. 
4.2.1.2 The temperature of LD and CD analyses 
During the investigation into HNP-2 binding, another user of the LD and CD 
spectrophotometer discovered that for LD measurements the user-inputted temperature 
and the actual sample temperature differed, with the difference increasing with distance 
from room temperature in either direction.  This was attributed to the distance between 
the peltier heating unit and the sample in the LD cell.  Little difference between the set 
and actual temperature was observed for CD, as the heating unit is much closer to the 
sample cell in the CD cell holder.  This means that for some of the analyses the 
temperatures at which the LD and CD measurements were carried out differ slightly 
where it was intended that complementary data would be obtained on both instruments 
under the same conditions. The affected analyses were those using POPG/DOPC and 
DOPS/DOPC liposome mixtures, both of which have phase transition temperatures well 
below the analysis temperatures, therefore it was assumed that the small differences 
between measurement temperatures of the CD and LD spectra would not affect the 
understanding of the results.  Table 4.3 shows the set and actual temperatures for the 
affected measurements.  The CD and LD measurements using the DMPG/DMPC 
liposome mixture were both carried out at 17 °C and 33 °C. 
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Table 4.3.  Set and actual temperatures of LD analyses.
¤
 
Sample Set temperature (and 
temperature of CD 
measurements) (°C) 
Sample temperature of 
LD measurements (°C) 
POPG/DOPC 30 
DOPS/DOPC 30 
30 28.7 
POPG/DOPC 40 40 36.8 
POPG/DOPC 53 53 47.3 
 
The temperatures of the analyses with DMPG and DMPC liposomes were chosen 
so as to obtain data above and below the phase transition temperature of the lipids.  The 
temperatures of the other analyses were chosen to determine and compare behaviour 
over a range, including temperatures above and below 37 °C, which would be presumed 
to be the optimum temperature for a human peptide. 
4.2.1.3 Phase transition of DMPG/DMPC liposome dispersion  
In order to study the binding of HNP-2 to liposomes composed of a mixture of 
DMPC and DMPG lipids it was first necessary to establish the gel to liquid crystalline 
phase transition temperature (Tm) of the mixture.  This was required to ensure that binding 
studies were carried out at temperatures outside the region during which the phase 
transition was occurring.  This analysis was carried out using dynamic light scattering 
(DLS), following a method developed by N. Michel et al. which uses changes in liposome 
size and shape caused by the lipid phase transition to determine the temperature at which 
it occurs.54  This method has the advantage of being carried out on small quantities of the 
same liposome dispersions that have been prepared for binding analyses, as opposed to 
differential scanning calorimetry (DSC), the standard technique for determining lipid 
phase transition temperatures.  The liposomes were all prepared by extrusion through 
polycarbonate membranes with 100 nm diameter pores. 
Before the phase transition analyses were carried out, the temperature of the 
contents of a cuvette was checked over a range of inputted temperatures to ensure the 
accuracy of the temperature setting.  A linear relationship was observed between the 
inputted and measured temperatures, as shown in Equation 4.1, where Tc is the 
temperature in the sample cell and Ts is the temperature reported by the DLS instrument.  
                                               
¤ Sample temperatures were determined using the conversion factor in Equation F1, where Tc is the sample 
temperature and Ts the temperature set on the instrument.  The conversion factor was determined by Emma 
Gilroy from repeat measurements at a number of set temperatures using a thermocouple probe to record the 
sample temperatures. 
                            F1 
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At 25 °C the temperature inside the sample cell was the same as the user-inputted 
temperature. 
 
                           (4.1) 
 
Table  4.4.  Recorded variation between user-inputted temperature and sample temperature for dynamic light 
scattering measurements. 
Set  
temperature (°C) 
Sample 
temperature (°C) 
10 11.3 
15 15.9 
20 20.5 
25 25.0 
30 29.6 
35 34.0 
40 38.6 
45 43.4 
50 47.6 
 
Figure 4.10 shows plots of the intensity weighted mean hydrodynamic diameter (z-
average diameter) of liposomes composed of DMPG, DMPC and 50:50 (w/w) 
DMPG/DMPC lipids against temperature.  The main transition of DMPG was observed 
between 20.5 °C and 23 °C (20.8 °C and 23.1 °C after conversion using Equation 4.1).  
The second transition is attributed to the presence of Na+ in the sample.  DMPG was 
supplied as a sodium salt due to its inherent negative charge, and the presence of Na+ is 
known from literature on differential scanning calorimetry to split the phase transition of 
lipids due to the different transition temperatures of the salt adducted and protonated 
species, with the intensity and position of secondary peaks relative to the transition of the 
protonated species dependant on the concentration of the Na+.55  DSC analysis of DMPG 
produced a plot with two transitions and a shoulder, due to the presence of Na+, the main 
transition being observed at 22.5 °C (Figure 4.10).  DMPC was observed from the DLS 
analysis shown in Figure 4.10 to undergo the transition between 22 °C and 24 °C (22.2 °C 
and 24.0 °C after conversion using Equation 4.1).  The literature value for the main phase 
transitions of DMPG and DMPC in the absence of added salt is 23 °C.56  The liposomes 
composed of a 50:50 (w/w) mixture of DMPC and DMPG underwent a phase transition 
between 18 °C and 25 °C (18.6 °C and 25.0 °C after conversion using Equation 4.1), 
again with a second transition due to the presence of Na+.  On the basis of these results, 
                                               
 Sample temperatures were determined using the conversion factor in Equation 4.1, where Tc is the sample 
temperature and Ts the temperature set on the instrument.  The conversion factor was determined from repeat 
measurements at a number of set temperatures using a thermometer to record the sample temperatures.   
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CD and LD analyses of the binding of HNP-2 to 50:50 (w/w) DMPG/DMPC liposomes 
were carried out at 17 °C and 33 °C, above and below the phase transition temperature 
the lipid mixture. 
 
Table 4.5.  Phase transition temperatures of liposome dispersions identified from DLS analysis. 
Liposome 
composition 
Main transition 
range (°C)
a 
Secondary transition 
range (°C)
a 
DMPG 20.8–23.1 29.9–34.9 
DMPC 22.2–24.0 - 
50:50 (w/w) 
DMPG/DMPC 
18.6–25.0 28.1–31.3 
a) Temperatures have been converted from observed temperatures to actual temperatures using 
Equation 4.1.  
 
 
Figure 4.10.  Intensity weighted mean hydrodynamic diameter (z-average diameter) measurements of 
liposomes composed of DMPG (blue), DMPC (red) and 50:50 (w/w) DMPG/DMPC recorded between 10 °C 
and 40 °C.  All liposomes were extruded through polycarbonate membranes with pores of 100 nm diameter 
during preparation. 
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Figure 4.11.  Differential scanning calorimetry heating scan of DMPG sodium salt in water. 1.204 mg sample; 
H = 14.2 kJmol
-1
. 
 
For comparison, liposomes composed of 50:50 (w/w) POPG/DOPC were also 
analysed by DLS between 10 °C and 60 °C to determine whether they underwent any 
size changes.  It was not expected that any phase transitions would be observed, as 
POPG and DOPC have phase transition temperatures of -20 °C and -2 °C respectively.56 
As shown in Figure 4.12, the POPG/DOPC liposomes underwent only a gradual increase 
in diameter of approximately 6 nm between 10 °C and 35 °C, unlike the DMPG, DMPC 
and DMPG/DMPC liposomes, which decreased in size by 6–15 nm over temperature 
ranges of 2 °C to 7 °C during phase transition.  The slight increase in size of the DOPC 
liposomes is likely to have been caused by thermal fluctuations. 
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Figure 4.12.  Intensity weighted mean hydrodynamic diameter (z-average diameter) measurements of 
liposomes composed of 50:50 (w/w) POPG/DOPC recorded between 10 °C and 40 °C.  All liposomes were 
extruded through polycarbonate membranes with pores of 100 nm diameter during preparation. 
4.2.2 Analysis of HNP-2 by fluorescence spectroscopy  
4.2.2.1 Binding constant for dimerisation of HNP-2 
The crystal and NMR structures described in the literature for the HNP1–3 have 
shown them all to have dimeric structures.  These structures were generally obtained 
from analysis of solutions at much higher concentrations than those suitable for 
membrane binding studies however, for example HNP-2 was crystallised from a 15 
mg/mL solution and the solution state NMR structure of HNP-2 determined from a 2 
mg/mL solution.9, 10  Although HNP-1–3 are reported to have dimeric structures in 
literature discussing their action on membranes, no measurements of dimer binding 
constants have been reported; therefore it cannot be stated with certainty that HNP-2 is 
predominately in the dimeric form at the concentrations at which binding studies are 
carried out.20, 57 
Fluorescence spectroscopy can be used to study the insertion of antimicrobial 
peptides into a lipid bilayer.  The three aromatic amino acids tryptophan, tyrosine and 
phenylalanine contribute to the fluorescence of proteins (Table 4.6).   
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Table 4.6.  The spectral properties of tryptophan, tyrosine and phenylalanine in proteins in aqueous solution 
at pH 7.
58 
 Emission maximum (nm) Quantum yield
a 
Tryptophan 350 0.13 
Tyrosine 303 0.14 
Phenylalanine 282 0.03 
a) λex tryptophan = 280 nm; λex tyrosine = 275 nm; λex phenylalanine = 260 nm 
The emission spectra of peptides and proteins are often recorded after excitation 
at 280 nm, at which wavelength tryptophan and tyrosine are both excited but 
phenylalanine is not.  Tryptophan fluorescence generally dominates the fluorescence 
spectra of peptides and proteins regardless of the number of other fluorescent amino 
acids they contain, due to its relatively high extinction coefficient and the fact that it often 
absorbs energy from phenylalanine and tyrosine residues by fluorescence resonance 
energy transfer (FRET).58  Tryptophan fluorescence is very sensitive to its environment.  
In peptides and proteins the quantum yield varies above and below the figure for the free 
amino acid due to factors such as quenching by proton or electron transfer from 
neighbouring amines, amides or carboxyl groups or disulphide bonds, or resonance 
energy transfer between tryptophan and tyrosine residues, depending on the structure of 
the peptide or protein.58   The emission wavelength is very sensitive to the hydrophobicity 
of the tryptophan environment, due to both the location of the residue on the structure and 
the environment around the peptide or protein.  This makes tryptophan fluorescence in 
bulk solvent a useful probe for the location of the tryptophan residues, whether they are 
solvated or embedded in the hydrophobic environment at the centre of the lipid bilayer.   
A series of fluorescence measurements were obtained from solutions of increasing 
(1 µM – 39 µM) and decreasing (1.5 µM – 0.013 pM) HNP-2 concentration in order to 
study the self-association of the peptide.  The tryptophan fluorescence spectrum of HNP-
2 shows two emission maxima (Figure 4.13) at all concentrations down to 0.046 µM, 
where no more signal could be observed.  This suggests two populations of tryptophan 
within the HNP-2 solution.  A cross section was plotted of the average of the fluorescence 
intensities at 324 nm, 324.5 nm, 325 nm, 325.5 nm and 326 nm, the wavelength of the 
emission maximum.  This plot shows that the intensity began to decrease sharply at 
around 2 µM (Figure 4.14), which was attributed to dissociation of the defensin dimers. 
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Figure 4.13.  Fluorescence emission spectrum of HNP-2 in water at concentrations of 0.4 µM – 39 µM. λex = 
280 nm. 
Least squares fitting was used to determine the binding constant, Ka (Equation 
4.3), for the equilibrium between the monomer (P) and dimer (D) from the data obtained 
over the range of 0.012 µM to 6.2 µM.   
               (4.2) 
   
   
    
          (4.3) 
An equation was determined for the concentration of the dimer ([D]) in terms of Ka and the 
total peptide concentration ([P]t) (Equation 4.9) by substituting Equation 4.3 for the 
concentration of the monomeric peptide ([P]) in Equation 4.5 and rearranging to give 
Equation 4.6. 
                      (4.4) 
                      (4.5) 
                 
         (4.6) 
Equation 4.6 was then rearranged to give Equation 4.7 
          
                   
       (4.7) 
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and formed into a quadratic equation:  
        
                    
        (4.8) 
and solved using the quadratic formula to give Equation 4.9. 
    
                     
 
     
     
 
   
       (4.9) 
 At any time, the observed fluorescence emission signal, Sobs is a combination of 
the emission from tryptophan residues in the monomers and the emission from tryptophan 
residues in the dimers: 
                          (4.10) 
where Sx is the fluorescence emission per monomer or dimer and Fx is the fraction of 
peptide in either a monomeric or a dimeric state, were Fm + Fd = 1.  Equation 4.11 was 
gained from substituting Equation 4.5 into Equation 4.10.  
        
         
    
     
    
    
        (4.11) 
Substitution with Equation 4.12 gave Equations 4.13 and 4.14.   
         
           (4.12) 
        
           
 
    
     
      
 
    
        (4.13) 
     
      
    
  
      
         
    
        (4.14) 
Equation 4.14 was then rearranged to give: 
     
      
        
    
           (4.15) 
Least squares fitting was carried out on Equation 4.15 to give calculated 
fluorescence values at each [P]t, changing the parameters Sm, Sd and Ka.  [P] and [D] 
were calculated for each [P]t using Equations 4.5 and 4.9 respectively. The best fit was 
produced with Sm = 1778 ±178, Sd = 114256 ± 11426 and Kd = 3.8 x 10
-6 ± 4 x 10-7 M-1.  
This suggests that at the peptide concentration used in the binding analyses (15 µM) the 
majority of the peptide will be present as dimers.  The fit between the experimental and 
calculated fluorescence (Figure 4.14) is moderate, but this is understandable due to the 
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weak fluorescence emission at the HNP-2 concentrations over which the analysis was 
carried out.   
 
Figure 4.14.  Experimental and calculated fluorescence emission of HNP-2 in water at 325 nm.  Experimental 
data are presented as points and the profile calculated from non-linear regression as a line.   λex = 280 nm. 
 The magnitude of Sd was more than two times that of Sm.  This can be explained 
by studying the crystal structure of an HNP-2 dimer (Figure 4.15), which shows that the 
distances between Trp(26) on one monomer and Tyr(16), Tyr(3) and Tyr(21) on the other 
monomer are 10.6, 12.2 and 14.4 Å respectively.  These distances are close enough for 
fluorescence resonance energy transfer (FRET) to occur from the tyrosine residues to the 
tryptophan residue across the dimer.59  The same effect has been observed for Human 
Recombinant Interferon γ, a peptide which exists as a dimer in its biologically active form.  
Each monomer contains one tryptophan and four tyrosine residues.  On dissociation of 
the dimer the quantum yield of tryptophan drops significantly due to the loss of FRET from 
tyrosine residues on one monomer to tryptophan on the other.60 
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Figure 4.15.  Crystal structure of HNP-2 showing distances between tryptophan and tyrosine residues on 
neighbouring subunits of the dimer.  Distances measured and structures displayed using The PyMOL 
Molecular Graphics System, Version 1.2r1, Schrödinger, LLC (www.pymol.org). 
4.2.2.2 Fluorescence in water and MeOH 
The fluorescence spectrum of HNP-2 in water (Figure 4.13) shows two emission 
maxima, both of which appear to be blue-shifted relative to the expected emission 
wavelength of tryptophan in water (350 nm).58  This suggests that there are two 
populations of tryptophan residues.  A fluorescence spectrum was recorded in 75% (v/v) 
MeOH/H2O, a more hydrophobic environment than water, to mimic the hydrophobic 
region of the lipid bilayer to see if a further blue-shift would be observed (Figure 4.16).61  
The change from water to MeOH had no effect on the position of either emission 
maximum.  The two emission maxima were less resolved in the spectrum in MeOH.  This 
is attributed to the fact that the instrument used to obtain the spectra of the peptide in 
water used an array photon multiplier tube (PMT), which gives more sensitive detection 
than the mesh PMT in the instrument used to record the spectrum in 75% MeOH.   
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Figure 4.16.  Fluorescence emission spectrum of HNP-2 (15 µM) in 75% (v/v) MeOH/H2O.  λex = 280 nm. 
The two populations of tryptophan observed in the fluorescence spectra can be 
explained by studying the crystal structure of HNP-2 and the solid state NMR (SSNMR) 
structures of HNP-1.15  Each HNP-2 monomer contributes one tryptophan residue, three 
tyrosine residues and one phenylalanine residue to the dimer.  The crystal structure of an 
HNP-2 dimer reveals that, although the backbone of the dimer is symmetrical, the two 
tryptophan side chains are not in equivalent environments relative to nearby tyrosine side 
chains, and that the tryptophan and tyrosine residues are close enough for excimer 
coupling to occur (Figure 4.17).  This suggests that there are at least two low energy 
interactions between tryptophan and neighbouring tyrosine residues which can contribute 
to the tyrosine emission.  
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Figure 4.17.  Structure of HNP-2 dimer showing different orientations of tryptophan relative to neighbouring 
tyrosine residues and the closest C–C contact distances.  Distances measured and structures displayed using 
The PyMOL Molecular Graphics System, Version 1.2r1, Schrödinger, LLC (www.pymol.org). 
The published SSNMR analysis of HNP-1 produced 10 minimum energy 
structures of peptide monomers within dimers in which there was little variation in the 
orientations of the backbone or tyrosine residues but a large degree of variation in the 
orientation of the tryptophan residue.  Two main tryptophan rotamers can be 
distinguished, as shown in Figure 4.18A and B.  In Figure 4.18A the closest C–C contact 
distance between Trp(26) and Tyr(21) is 4.1 Å, and in Figure 4.18B the closest C–C 
distance between Trp(26) and Tyr(21) is also 4.1 Å.  This is close enough for aromatic–
aromatic interactions to occur.62, 63   
 
Figure 4.18.  Interactions between A) Trp(26) and Tyr(21) and B) Trp(26) and Tyr(3) in HNP-1 showing the 
two main rotamers of Trp(26).  Residues are labelled according the sequence of HNP-1 and correspond to 
Tyr(2), Tyr(15), Tyr(20), Trp(26) and Phe(27) of HNP-2. Structures displayed using The PyMOL Molecular 
Graphics System, Version 1.2r1, Schrödinger, LLC (www.pymol.org). 
Trp(26) 
– Tyr(21)  
3.1 Å  
Trp(26) – 
Tyr(21)   
3.4 Å 
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4.2.2.3 HNP-2 fluorescence in a liposome dispersion 
Figure 4.19 shows a time series spectrum of HNP-2 in 50:50 (w/w) POPG/DOPC 
liposomes recorded at 2.5 minute intervals for five hours, with just the first, 60th, and final 
spectra shown together in Figure 4.20.  Two pieces of information can be drawn from the 
shapes of the spectra in Figure 4.20.  Firstly, there is no evidence of blue-shifting during 
binding compared to the spectra of the peptide in water and in MeOH, though the 
tryptophan fluorescence emission is blue-shifted in water, MeOH and in liposomes 
relative to the expected emission wavelength of tryptophan in water. Secondly, the two 
emission maxima became more resolved during the course of the analysis, as shown by 
their clarity in spectra B and C in Figure 4.20 compared to spectrum A.  This suggests 
that the peptide was binding to the membrane and that when the peptide is bound the 
tryptophan residues exchange more slowly between the two main conformations.  Cross 
sections of the time series spectra at 330 nm and 340 nm (Figure 4.21) show changes in 
fluorescence intensity, from which the binding kinetics of HNP-2 can be studied (Section 
4.2.6). 
 
Figure 4.19.  Time series fluorescence emission spectrum of HNP-2 (15 µM) in 50:50 (w/w) POPG/DOPC 
liposomes (1.4 mM) acquired over a 5 hour period.  Spectra were recorded at 2.5 minute intervals.  λex = 280 
nm. 
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Figure 4.20.  Spectra A, B and C recorded after 0, 147.5 and 297.5 minutes respectively from combined 
fluorescence emission spectrum of HNP-2 (15 µM) in 50:50 (w/w) POPG/DOPC liposomes (1.4 mM).  Spectra 
recorded every 2.5 minutes for 5 hours.  λex = 280 nm. 
 
Figure 4.21.  Evolution of the fluorescence emission intensity of HNP-2 (15 µM) in 50:50 (w/w) POPG/DOPC 
liposomes (1.4 mM) at A) 330 nm and B) 340 nm.  Spectra were recorded at 2.5 minute intervals for 5 hours.  
λex = 280 nm. 
 There was no real change in the wavelength of the tryptophan emission maxima 
between water, 75% MeOH and the liposome dispersions.  If the tryptophan residues in 
the dimer were exposed to the solvent or liposomes a blue-shift would be expected in less 
polar, more hydrophobic, environments.  The fact that this was not observed suggests 
that the tryptophan residues are not exposed to the environment surrounding the peptide 
dimer.  This was confirmed by examining space-filling models of the two main HNP-1 
rotamers identified in Figure 4.18 (Figure 4.22), which show that in both conformations the 
A B 
  The membrane binding of defensin HNP-2 
208 
 
tryptophan residue is not freely solvated.  The blue-shift of the tryptophan emission in all 
of the spectra is due to the interactions between tryptophan and tyrosine. 
 
Figure 4.22.  Space-filling models of HNP-1 showing the two main rotamers of tryptophan.  Residues shown 
in white, orange, red, blue and yellow correspond to residues Tyr(2), Tyr(15), Tyr(20), Trp(25) and Phe(27) of 
HNP-2.  Structures displayed using The PyMOL Molecular Graphics System, Version 1.2r1, Schrödinger, LLC 
(www.pymol.org). 
4.2.3 Linear dichroism analyses 
A series of LD spectra were obtained in order to determine the peptide orientation 
with relation to the lipid bilayer during binding and the kinetics of binding (Figure 4.23).  
Sixty scans were recorded at 5 minute intervals for each of the analyses to produce time 
series spectra. 
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Figure 4.23.  Selected linear dichroism spectra of HNP-2 with POPG/DOPC, DOPS/DOPC or DMPG/DMPC 
liposomes.  HNP-2 (15 µM) was added to A) 50:50 (w/w) POPG/DOPC (1.4 mM) at 30 °C; B) 50:50 (w/w) 
POPG/DOPC (1.4 mM) at 40 °C; C) 50:50 (w/w) POPG/DOPC (1.4 mM)  at 53 °C; D) 50:50 (w/w) 
DOPS/DOPC (1.05 mM) at 30 °C; E) 50:50 (w/w) DMPG/DMPC (1.4 mM) at 17 °C; F) 50:50 (w/w) 
DMPG/DMPC (1.4 mM) at 33 °C.  Sixty scans were recorded at 5 minute intervals, the legends show the 
starting times of the included spectra in minutes. 
 The LD spectra show clear changes in intensity over time, suggesting changes in 
orientation which allow the binding kinetics to be followed (Section 4.2.6).  Figure 4.24 
shows the cross section at 200 nm of the spectra obtained with POPG/DOPC at 30 °C. 
A B 
D 
F 
C 
E 
  The membrane binding of defensin HNP-2 
210 
 
 
Figure 4.24.  Evolution of the LD signal at 200 nm over 5 hours after the addition of HNP-2 (3 µM) to 50:50 
(w/w) POPG/DOPC (280 µM) at 30 °C. 
4.2.4 The effect of HNP-2 on liposomes and liposome stability 
4.2.4.1 Fluorescence resonance energy transfer studies of liposome fusion 
Fluorescence resonance energy transfer (FRET) was used to determine whether 
HNP-2 was causing liposome fusion under the conditions employed for the other 
analyses.  The FRET experiment was carried out using POPG/DOPC liposomes with 0.5 
mol% of each of the donor N-(7-nitro-2,1,3-benzodiazol-4-yl)-phosphatidylethanolamine 
(NBD-PE) and the acceptor N-(Lissamine Rhodamine B sulfonyl)-
phosphatidylethanolamine (Rh-PE).  If liposomes composed of these two species are 
excited at around 460 nm (the excitation wavelength of NBD-PE), emission is observed 
from both species (λem NBD-PE = 540 nm, λem Rh-PE = 590 nm).  If these liposomes are 
mixed with unlabelled liposomes and a species added which causes fusion or exchange 
between the labelled and unlabelled liposomes, an increase in the NBD-PE emission and 
decrease in the Rh-PE emission will be observed due to dilution.64  
 
HNP-2 was added to a 3:1 mixture of unlabelled 50:50 (w/w) POPG/DOPC 
liposomes and NBD-PE/Rh-PE labelled POPG/DOPC liposomes to give the same 
peptide:lipid ratio as in the peptide binding experiments, and 60 fluorescence spectra 
recorded at 5 minute intervals (λex 450 nm, λem 470–650 nm) (Figure 4.25) over 5 hours.  
A spectrum was also recorded of the same ratio of liposomes to which a 0.1% solution of 
Triton X-100 had been added.  Triton X-100 is a detergent which causes lysis and 
aggregation of liposomes.65  No Rh-PE emission was observed after the addition of Triton 
X-100, showing that the liposomes had been broken up and the donor NBD-PE and 
  The membrane binding of defensin HNP-2 
211 
 
acceptor Rh-PE lipids separated.  A baseline spectrum of non-labelled liposomes in the 
absence of HNP-2 and triton X-100 was subtracted from all spectra. 
 
 
Figure 4.25.  Time series FRET spectrum of HNP-2 with unlabelled and labelled POPG/DOPC liposomes.  
HNP-2 (15 µM) was added to 3:1 (v/v) unlabelled 50:50 (w/w) POPG/DOPC liposomes and 50:50 (w/w) 
POPG/DOPC liposomes with 0.5 mol% of each of Rh-PE and NBD-PE (1.4 mM total lipid concentration) and 
fluorescence analyses recorded over 5 hours at 5 minute intervals.  λex = 450 nm. 
The ratio of NBD-PE fluorescence to Rh-PE fluorescence was calculated to see if 
it was changing over time using Equation 4.16.   
 
        
        
            (4.16) 
 
Fx, λ1 and λ2 are described in Equations 4.17 and 4.18, where (F1)0 data were 
obtained from the spectrum of 3:1 (v/v) labelled:unlabelled liposomes recorded in the 
absence of HNP-2; (F1)t data were taken from the spectra with obtained with 3:1 (v/v) 
labelled:unlabelled liposomes and HNP-2; and (F2)0 and (F2)t data were taken from the 
spectra obtained with Triton X-100 without and with HNP-2 respectively. 
 
   
         
         
          (4.17) 
                         
                        
        (4.18) 
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         was calculated for each of the 60 spectra, and then a graph of Equation 
4.16 produced (Figure 4.26).  The time t of each scan at a given wavelength (λt) was 
calculated using Equation 4.19, where λs is the starting wavelength of each scan, n 
corresponds to the number of completed scans and s corresponds to the scan rate 
(nm/minute).  The scan rate is multiplied by 2.5 due the interval between scans. 
  
 λ  λ  
 
              (4.19) 
 
Figure 4.26.  Ratio of NBD-PE fluorescence to Rh-PE fluorescence against time, calculated using Equation 
4.16 from time series fluorescence analysis of HNP-2 (15 µM) with 3:1 (v/v) unlabelled 50:50 (w/w) 
POPG/DOPC liposomes and 50:50 (w/w) POPG/DOPC liposomes with 0.5 mol% of each of Rh-PE and NBD-
PE (1.4 mM total lipid concentration) recorded over 5 hours at 5 minute intervals.  λex = 450 nm.   
No change can be observed in the plot of the ratio of NBD-PE fluorescence to Rh-
PE fluorescence over five hours after the addition of HNP-2 to the liposomes (Figure 
4.26), confirming that there was no exchange of lipids between the labelled and 
unlabelled liposomes and therefore no fusion occurring. 
4.2.4.2 Dynamic light scattering 
Dynamic light scattering (DLS) was used to determine of the average size of the 
liposomes before and after the addition of HNP-2, which would show the effects of any 
fusion, aggregation, micellization or increase in size due to the addition of peptide.   
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 Liposome dispersions were analysed in the absence of HNP-2, diluted to the 
same concentration as those in the presence of HNP-2, and in the presence of HNP-2 
after each 5-hour LD analysis.  All DLS measurements were recorded at 21 °C regardless 
of the temperature of the LD analysis.  The diameter was averaged over 74 
measurements.  The diameter measurement used was the „z-average‟, the intensity 
weighted average of the distribution of liposome sizes.  The polydispersity index (PdI) is a 
measure of the width of the distribution of sizes recorded.  The PdI can be used to give 
the % polydispersity (%Pd) (Equation 4.20), which gives a clearer indication of the width 
of the distribution.   
                             (4.20) 
The data (Table 4.7) show that there was no real change in the diameter of the liposomes 
before and after the addition of HNP-2. 
Table 4.7.  Diameter and polydispersity measurements of liposomes before and after the addition of HNP-2.   
Name Diameter (nm)
a 
Average PdI %Pd 
POPG/DOPC Blank 119 0.067 26 
POPG/DOPC HNP-2 30 °C 110 0.078 28 
POPG/DOPC HNP-2 40 °C 113 0.071 27 
POPG/DOPC HNP-2 53 °C 111 0.082 29 
DMPG/DMPC Blank 83 0.193 44 
DMPG/DMPC HNP-2 17 °C 92 0.258 51 
DMPG/DMPC HNP-2 33 °C 82 0.188 43 
DOPS/DOPC Blank 122 0.077 28 
DOPS/DOPC HNP-2 30 °C 115 0.070 27 
a) Each value is an average of 74 individual measurements 
4.2.5 Binding kinetics 
 The results of the fluorescence and linear dichroism analyses both showed 
changes in signal over time, which enabled the binding kinetics of HNP-2 to be 
determined.  The combined data from the two techniques were analysed using different 
binding models in order to determine which best described the binding of HNP-2. 
4.2.5.1 Two-state model 
4.2.5.1.1 Fluorescence data 
 Cross sections of the time series fluorescence spectra at 330 nm and 340 nm 
(Figure 4.27) suggest an initial binding stage during the first 50 minutes, followed by either 
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a second, slower, binding stage or an increase in scattering due to the settling and 
grouping of the liposomes due to the lack of stirring, and then a drop-off in signal which is 
attributed to photobleaching of the samples.   
 
Figure 4.27.  Evolution of the fluorescence emission intensity of HNP-2 (15 µM) in 50:50 (w/w) POPG/DOPC 
liposomes (1.4 mM) at A) 330 nm and B) 340 nm.  Spectra were recorded at 2.5 minute intervals for 5 hours.  
λex = 280 nm. 
 
Figure 4.28. Semi-log plots of the evolution of the fluorescence emission intensity of HNP-2 (15 µM) in 50:50 
(w/w) POPG/DOPC liposomes (1.4 mM) at A) 330 nm and B) 340 nm.  Spectra were recorded at 2.5 minute 
intervals for 5 hours.  λex = 280 nm. 
 Semi-log plots of the evolution of the fluorescence intensity at 330 and 340 nm 
over the first 80 minutes (Figure 4.28A and B respectively) suggest that the binding was 
pseudo-first order with respect to HNP-2.  Pseudo-first order kinetics are reasonable 
given the large excess of lipid, but they also suggest that the mechanism being followed 
did not involve multimer formation.  Plots of fluorescence intensity against time and the 
reciprocal of fluorescence intensity against time (data not shown) ruled out zero and 
second order binding, as they were not linear.  It was not possible to study the kinetics 
after 80 minutes due to the drop in signal at around 200 nm, which meant that the end of 
the process could not be modelled.  The gradient of the semi-log plots can be used to 
approximate the reaction rate.  From Figure 4.28A and B, the gradients of the semi-log 
A B 
A B 
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plots are initially 0.048 minutes-1 and 0.046 minutes-1 at 330 nm and 340 nm respectively, 
corresponding to half lives of approximately 15 minutes. This initial process was followed 
by one with a much slower rate, with gradients of 0.005 minutes-1 and 0.004 minutes-1 at 
330 nm and 340 nm respectively, corresponding to half lives of 173 minutes.  Due to the 
very shallow gradient of this stage, the binding was initially just fitted to a two state model, 
treating the slight increase in signal after 20 minutes as negligible.  It was assumed that 
the majority of the peptide was present, and binding, in the dimeric form, due to the 
binding constant established in Section 4.2.2.1.  The two-state model described the 
binding of free peptide dimers to give one bound peptide state, as shown in Figure 4.29, 
where Pf and Pm correspond to free and bound peptides dimers respectively. 
 
Figure 4.29.  The two state kinetic model used for analysis of the LD and fluorescence data. 
At any time, the observed fluorescence intensity, Fobs was a combination of the 
fluorescence from the peptides in state Pf and those in state Pm (Equation 4.21). 
          
  
    
       
  
    
         (4.21) 
[P]f and [P]m correspond to the concentrations of the peptides in states Pf and Pm 
respectively, [P]t corresponds to the total peptide concentration and Ff and Fm correspond 
to the fluorescence from each peptide in state Pf and Pm respectively.   
The time series data from each experiment were analysed using weighted least 
squares fitting to determine the rate constant, k.  The time t of each scan at a given 
wavelength (λt) could be calculated using Equation 4.22, where λs is the starting 
wavelength of each scan; n corresponds to the number of completed scans and is 
multiplied by 2.5 due to the 2.5 minute interval between scans. The scan rate, in 
nm/minute, is represented by s.   
  
 λ  λ  
 
              (4.22) 
The concentrations [P]f and [P]m were calculated at each time t using equations 4.23 and 
4.24. 
          
            (4.23) 
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                       (4.24) 
The fluorescence intensity corresponding to these values, Fcalc, was then calculated at 
each time point (Equation 4.25).   
         
    
    
     
    
    
         (4.25) 
Weighted non-linear least squares fitting was performed simultaneously on data at 
330 nm and 340 nm.  The least squares values were weighted by multiplication by 
 
  
 to 
give a better fit over the whole data range.  As shown in Table 4.8, the rate constant 
correlated closely with the gradients of the semi-log plots at 330 nm and 340 nm. 
Table 4.8.  Rate constant and half-life calculated from fitting of fluorescence analysis of HNP-2 binding to 
50:50 (w/w) POPG/DOPC liposomes. 
Liposomes Temperature 
(°C) 
k (minute
-1
) t1/2 (minutes) 
POPG/DOPC 30 0.043 ± 0.004 16.3 ± 1.6 
 
4.2.5.1.2 LD data 
Semi-log plots of the cross sections of the linear dichroism data at major peaks 
and negative bands also suggested a 1st order binding model, with a fast binding stage 
followed by a levelling off of the signal (Figure 4.30).  The gradients of these semi-log 
plots suggested rate constants of around 0.150 minutes-1, corresponding to half lives of 
around 5 minutes.  Plots of intensity against time and the reciprocal of intensity against 
time were not linear, which ruled out zero or second order binding models (data not 
shown). 
  The membrane binding of defensin HNP-2 
217 
 
 
Figure 4.30.  Semi-log plots of the evolution of the LD signal over 5 hours after the addition of HNP-2 to 
POPG/DOPC, DOPS/DOPC or DMPG/DMPC liposomes.  HNP-2 (14 µM) was added to A) 50:50 (w/w) 
POPG/DOPC (1.4 mM) at 30 °C (200 nm); B) 50:50 (w/w) POPG/DOPC (1.4 mM) at 40 °C (198 nm); C) 
50:50 (w/w) POPG/DOPC (1.4 mM) at 53 °C (228 nm); D) 50:50 (w/w) DOPS/DOPC (1.05 mM) at 30 °C (225 
nm); E) 50:50 (w/w) DMPG/DMPC (1.4 mM) at 17 °C (215 nm) and F) 50:50 (w/w) DMPG/DMPC (1.4 mM) at 
33 °C (194 nm).  Sixty scans were recorded at 5 minute intervals. 
An LD signal is only observed when the peptides in the sample are oriented, 
therefore the LD signal, LDobs, will only include LD signals from peptides which are bound 
to the oriented liposomes, in state Pm (Equation 4.26).     
           
   
    
          (4.26) 
The LD data were fitted to the same 2-state binding model as the fluorescence data 
(Figure 4.29), and the equations for the concentrations of free and bound peptide ([P]f and 
[P]m respectively) were the same as those used to analyse the fluorescence data 
A B 
C D 
E F 
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(Equations 4.23 and 4.24).  The time t of each scan at a given wavelength (λt) could be 
calculated using Equation 4.27, where λs and λe are the starting and final wavelengths of 
each scan respectively; n corresponds to the number of completed scans and is multiplied 
by 5 due to the 5 minute interval between scans.  The scan rate, in nm/minute, is 
represented by s.  
  
 λ  λ  
 
            (4.27)  
The LD signal corresponding to the bound peptide, LDcalc was calculated at each time 
using Equation 4.28.  
            
   
    
          (4.28) 
Weighted non-linear least squares fitting was performed.  Global fitting was carried 
out on each set of data using data from 2–5 wavelengths simultaneously.  Each set of 
experimental data was truncated at scan 21 (t ≈ 100 mins) or scan 31 (t ≈ 150 mins) 
depending on the time when the binding process which was being fitted could be 
observed to have completely finished and the curve had levelled out. 
It was not possible to obtain a good fit between the experimental and calculated 
LD data from this model.  The calculated plots gave a very poor match to the 
experimental plots.  Though it was possible to fit the two-state model to the fluorescence 
data, since it did not fit the LD data it was clear that it did not correctly describe the 
binding of HNP-2.  More models were applied to the data to seek one which would 
describe the binding correctly.  Three-state binding models were initially applied to the 
fluorescence and LD data for binding to 50:50 (w/w) POPG/DOPC liposomes at 30 °C to 
find a model which fitted both sets of data. 
4.2.5.2 Three-state binding models 
4.2.5.2.1 Three-state binding model: Treatment one 
The three-state binding model explored involved three states, free peptide and two 
bound states (Figure 4.31).   
 
Figure 4.31.  The three state kinetic model used for analysis of the LD and fluorescence data. 
The LD signal at any time was calculated using Equation 4.29.   
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        (4.29) 
As described in Section 4.2.6.1.2, only bound peptide dimers would be oriented and 
contribute to the observed LD signal but it was necessary to take the concentration of free 
peptide (Equation 4.23) into account when determining the concentration of peptide in the 
two bound states ([P]m1 and [P]m2 in Equation‟s 4.31 and 4.32).   
                              (4.30) 
      
        
           
     
        (4.31) 
              
    
        
     
     
         (4.32) 
Equation 4.33 was fitted to the fluorescence data, as the fluorescence emission from the 
free peptide contributes to the total fluorescence intensity.  The concentration of free 
peptide and of peptide in the two bound states was determined using Equations 4.23, 
4.31 and 4.32 respectively.  The least squares values were weighted by multiplication by 
 
  
 to give a better fit over the whole data range. 
         
    
    
      
     
    
      
     
    
       (4.33) 
The calculated rate constants and half lives from this fit are shown in Table 4.9. 
Table 4.9.  Parameters calculated from non-linear least squares fitting of fluorescence and LD analyses of 
HNP-2 binding to 50:50 (w/w) POPG/DOPC liposomes using 3-state binding model described by Equations 
4.29–4.32 or 4.30–4.32 and 4.33 for LD and fluorescence data respectively. 
 k1         
(minute
-1
) 
t1/2  
(minutes) 
k2               
(minute
-1
) 
t1/2 
(minutes) 
Fluorescence 2.57 ± 0.26 0.27 ± 0.03 0.080 ± 0.008 8.6 ± 0.9 
LD 3.74 ± 0.37 0.19 ± 0.02 0.128 ± 0.013 5.4 ± 0.5 
 
4.2.5.2.2 Three-state binding model: Treatment two 
The scan speed for the fluorescence analysis was four times that of the LD 
analyses (200 nm/minute and 50 nm/minute respectively), and fluorescence spectra were 
recorded every 2.5 minutes and LD data recorded every 5 minutes.  The value for k1 
calculated from the fluorescence data using the second 3-state binding model is therefore 
likely to be more accurate due improved sampling of the initial stages of binding.  The LD 
data were therefore refitted using the second 3-state binding model using Equations 
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4.29–4.32 but with k1 fixed at the value calculated from analysis of the fluorescence data 
(Table 4.9).  The rate constant for the second binding step, k2, was calculated as 0.137 
minutes-1, corresponding to a half life of 5.1 minutes.  There was a good match between 
the experimental and calculated data (Figure 4.32) and the calculated LDm1 and LDm2 
values, shown as plots in Figure 4.33, were within a sensible range. 
 
Figure 4.32.  Experimental and calculated LD signal for HNP-2 in 50:50 POPG/DOPC liposomes at 200 nm 
(■), 225 nm (□) and 245 nm (▲).  Experimental data are presented as points and the profiles calculated from 
fitting Equation 4.29 to the experimental data by non-linear regression as lines. 
 
Figure 4.33.  LD spectra of the Pm1 and Pm2 states of HNP-2 (15 µM) binding to 50:50 (w/w) POPG/DOPC 
(1.4 mM) at 30 °C described by Equation 4.29. 
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4.2.5.3 Analysis of all LD data using the 3-state model 
 The three-state model described by Equations 4.29–4.32 was fitted to the data 
from each of the other LD analyses using weighted least squares fitting to find LDm1, 
LDm2, k1 and k2.  Global fitting was carried out on each set of data using data from 2–5 
wavelengths simultaneously.  Each set of experimental data was truncated at scan 21 (t ≈ 
100 mins) or scan 31 (t ≈ 150 mins) depending on the time when the binding process 
which was being fitted could be observed to have completely finished and the curve had 
levelled out.  The calculated rate constants are shown in Table 4.10, and examples of the 
correlation between the experimental and calculated data for each experiment are shown 
in Figure 4.34.  The concentration of the free peptide, [P]f, 100 minutes after mixing the 
peptide and liposomes was negligible in each case. 
Table 4.10.  Parameters calculated from non-linear least squares fitting of LD analyses of HNP-2 binding to 
50:50 (w/w) POPG/DOPC, DOPS/DOPC and DMPG/DMPC liposomes using 3-state binding model described 
by Equations 4.29–4.32. 
 T  
(°C) 
k1 
(minute
-1
) 
t1/2  
(minutes) 
k2 
(minute
-1
) 
t1/2  
(minutes) 
POPG/DOPC 30 2.57 ± 0.26 0.27 ± 0.03 0.137 ± 0.014 5.06 ± 0.51 
POPG/DOPC 40 2.60 ± 0.26 0.27 ± 0.03 0.222 ± 0.022 3.11 ± 0.31 
POPG/DOPC 53 3.43 ± 0.34 0.20 ± 0.02 0.194 ± 0.019 3.57 ± 0.36 
DOPS/DOPC 30 0.727 ± 0.07 0.95 ± 0.10 0.231 ± 0.023 3.00 ± 0.30 
DMPG/DMPC 17 1.40 ± 0.14 0.50 ± 0.05 0.047 ± 0.005 14.9 ± 1.49 
DMPG/DMPC 33 1.03 ± 0.10 0.67 ± 0.07 0.117 ± 0.012 5.93 ± 0.59 
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Figure 4.34.  Experimental and calculated LD signal for HNP-2 binding to A) 50:50 (w/w) POPG/DOPC 
liposomes at 40 °C at 230 nm; B) 50:50 (w/w) POPG/DOPC liposomes at 53 °C at 228 nm; C) 50:50 (w/w) 
DOPS/DOPC liposomes at 30 °C at 224 nm; D) 50:50 (w/w) DMPG/DMPC liposomes at 17 °C at 196 nm and 
E) 50:50 (w/w) DMPG/DMPC liposomes at 33 °C at 198 nm.  Experimental data are presented as points and 
the profiles calculated from non-linear regression as lines. 
 The quality of the fits of the 3-state model to the LD and fluorescence data were 
determined by plotting the residual () (Equation 4.34) against time at each of the 
wavelengths used for the fits.  The plots of the residuals showed some noise, but were all 
linear or close to linear across the time period analysed, showing a good fit across the 
range of the data (Appendix 2).  
                       (4.34) 
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4.2.5.4 Binding model revealed by kinetics 
 All of the sets of LD data fitted to a 3-state model with a fast first binding stage 
followed by a slower reorientation (Table 4.10).  Due to the fast rate of the first binding 
stage compared to the interval between LD scans it is likely that the error in the value for 
k1 is greater than 10%.   
4.2.5.4.1 Binding to 50:50 POPG/DOPC liposomes 
 k1 was essentially the same for the three analyses of HNP-2 binding to the 
POPG/DOPC liposomes at different temperatures.  The second stage of the binding to 
the POPG/DOPC liposomes was slowest at 30 °C.  At 40 °C and 53 °C the rates of the 
second stage of the binding were almost the same within an error of 10%.   
4.2.5.4.2 Binding to 50:50 DOPS/DOPC liposomes 
 The first stage of the binding of the DOPS/DOPC liposomes was slower than 
binding to the POPG/DOPC liposomes, but the second stage of the binding had 
essentially the same rate as the binding to the POPG/DOPC liposomes at 40 °C.  
4.2.5.4.3 Binding to 50:50 DMPG/DMPC liposomes 
 The rate of the first stage of binding to the DMPG/DMPC liposomes was 
essentially the same at 17 °C and 33 °C.  The clearest difference was observed when 
comparing the rates of the second stage of the binding however.  At 33 °C, above the 
phase transition temperature of DMPG and DMPC, k2 was only slightly lower than for 
binding to the POPG/DOPC liposomes.  When binding occurred at 17 °C, below the 
phase transition of the lipids, the second stage of binding was much slower.  This is to be 
expected given the increased order of the lipids in the membrane below the phase 
transition temperature; insect defensin and colicin A have been shown to not insert at all 
into lipid membranes below the phase transition temperature.66, 67 
 Figure 4.35A–F shows the calculated LD spectra corresponding to HNP-2 in the 
first and second membrane bound states, Pm1 and Pm2 respectively.  All of the spectra 
except those for the binding of HNP-2 to DOPS/DOPC at 30 C show some changes in the 
spectral shape between the two membrane bound states consistent with a change in the 
orientation of the peptides.  The faster kinetics of the first stage of binding and slower 
second stage suggests that the peptide dimers initially bind rapidly and weakly to the lipid 
bilayer, then more slowly reorient and insert into the membrane.  This mechanism is 
supported by the very similar k1 values for binding to DMPG/DMPC above and below the 
phase transition temperature of the lipids, where the state of the lipids did not affect the 
rate, followed by a much smaller k2 value for the second stage of binding to the liposomes 
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below the phase transition temperature than above it, consistent with a difficulty in 
insertion when the lipids were ordered.  The pseudo 1st order kinetics observed for these 
stages suggest that multimeric pores are not formed during the two binding stages 
identified here, as the formation of multimeric pores is likely to involve higher order rate 
constants.  The binding model which has been fitted to the data implies irreversible 
binding of HNP-2 to the membrane.  Similar irreversible kinetic models have been applied 
successfully to other peptides, and in others where a reversible model has been used the 
backwards rate constants have been found to be negligible for all stages of binding.68, 69   
 
 
Figure 4.35.  LD spectra of the Pm1 and Pm2 states of HNP-2 as described by Equation 4.29.  Spectra 
calculated for HNP-2 (15 µM) binding to A) 50:50 (w/w) POPG/DOPC (1.4 mM) at 40 °C; B) 50:50 (w/w) 
POPG/DOPC (1.4 mM)  at 53 °C; C) 50:50 (w/w) DOPS/DOPC (1.05 mM) at 30 °C; D) 50:50 (w/w) 
DMPG/DMPC (1.4 mM) at 17.4 °C; E) 50:50 (w/w) DMPG/DMPC (1.4 mM) at 33 °C. 
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4.2.6 Entropy and enthalpy of HNP-2 binding to POPG/DOPC liposomes 
 The rate constants determined for binding to POPG/DOPC liposomes at 30, 40 
and 53 °C allowed a semi-quantitative assessment of the entropic and enthalpic 
contributions to the binding to be made.  The Eyring equation and its linear form are 
shown as Equations 4.35 and 4.36.  An Eyring plot of ln(k/T) against 1/T produces a 
straight line of the form y = mx + c, where the gradient gives  H‡/R and the y-intercept 
gives ln(kB/h) + S
‡/R (Figure 4.36).   
  
   
 
  
   
   
   
          (4.35) 
   
 
  
   
 
 
 
 
   
  
 
 
   
 
        (4.36) 
The free energy of activation, G‡, was calculated using Equation 4.37. The enthalpy and 
entropy of activation are represented by H‡ and S‡ respectively, R is the universal gas 
constant and kb the Boltzmann constant.  The activation parameters for the binding of 
HNP-2 to POPG/DOPC (50:50 (w/w) liposomes are shown in Table 4.11.   
                     (4.37) 
 
Figure 4.36.  Temperature dependence of A) the first rate constant and B) the second rate constant for the 
binding of HNP-2 to 50:50 (w/w) POPG/DOPC liposomes shown as an Eyring plot.  The error bars were 
propagated from an error of ± 10% in the value of k. 
Table 4.11.   Activation parameters for HNP-2 binding to POPG/DOPC (50:50 (w/w)) liposomes. 
 H
‡
 (kJmol
-1
) S
‡
 (kJK
-1
mol
-1
) G
‡
 (kJmol
-1
)
a 
k1 8.0 ± 5.0 -0.20 ± 0.01 68.3 ± 5.9 
a) G
‡
 was calculated at 303 K 
b) Errors were propagated from the uncertainties in the gradient and y-intercept determined from linear 
regression analysis 
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 The activation parameters were determined from the gradient and y-intercept of a 
line of best fit through only three data points.  The line of best fit in the Eyring plot of the 
first rate constants is within the error bars, calculated from propagating an error of 10% in 
the value of k1, and therefore though the errors in the values calculated for the enthalpy 
and entropy are high, the results can be used to determine whether the entropy and 
enthalpy changes are favourable or not.  The line of best fit through the Eyring plot of the 
second rate constants is outside the error bars for two of the points and just inside error 
for the third.  Activation parameters calculated using the gradient and intercept of this line 
are unlikely to be meaningful.  The positive H‡ value for the first binding step suggests 
an electrostatic energy barrier, due to factors such as the desolvation of the peptide 
before binding and breaking van der Waals forces between the lipids during insertion into 
the membrane.  Positive H‡ values are to be expected for elementary reaction steps due 
to the energy required to partially break bonds to give the activated intermediate 
complex.70  The negative, unfavourable, entropy is due to a decrease in rotational, 
translational and possibly vibrational degrees of freedom of the peptide and lipids when 
the peptide binds.  For some protein folding reactions the Eyring plots can be curved 
rather than linear, as the rate constant increases with increasing temperature until a 
maximum, where it then decreases.  The initial increase in rate with increasing 
temperature gives a positive enthalpy value, as expected for the majority of chemical 
reactions.  The decrease in rate with increasing temperature after this point can be due to 
different factors such as temperature-induced changes of the peptide in the ground state 
and changes in the heat capacity in the activated complex, or a temperature-induced 
change in the rate limiting step.  
4.2.7 Orientation  
4.2.7.1 Qualitative analysis of orientation 
 As described in Section 1.3.4.2, linear dichroism probes the orientation of 
transition moments relative to an axis system by measuring the difference in absorbance 
of parallel and perpendicular linearly polarised light by an oriented sample.  As shown in 
Figure 4.37, in this analysis we define the long axis of the liposome as the x-axis, which is 
parallel to the surface of the membrane.  The z-axis is perpendicular to the membrane 
and to the incident light.  If a transition moment is aligned with the x-axis a peak will be 
observed in the LD spectrum.  If a transition is aligned with the z-axis a negative band will 
be observed. 
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Figure 4.37.  Orientation of the LD experiment.
¥  
 The LD spectrum of HNP-2 is expected to show contributions from the transitions 
of β-sheets, tryptophan, tyrosine and phenylalanine, and possibly from the disulphide 
bonds.  As shown in Figure 4.38, a signal from the π–π* transition of the backbone amide 
bonds is expected at around 195 nm (see Figure 1.10 for amide bond transitions).  The 
opposing polarisations of the amide n–π* transition at 219 nm and 221 nm usually cancel 
each other out in LD spectra of β-sheet peptides.73   Tryptophan has three transitions in 
the region between 200 and 320 nm: Bb at 220 nm, La at 270 nm and Lb at 280 nm.  
Tyrosine has two transitions in this region: La at 230 nm and Lb at 275 nm.  Of the two 
transitions of phenylalanine in this region, the Lb transition at 260 nm is not expected to be 
observed due to its very low extinction coefficient compared to the other transitions.  The 
phenylalanine La transition at 210 nm is expected to contribute to the LD spectrum.
74  Any 
band from the disulphide bonds is also likely to be weak.75  The wavelength at which 
signals corresponding to the side chains are observed is strongly dependant on their 
environment, for example the Lb transition of tyrosine has been observed to be shifted to 
lower wavelengths in the LD spectra of peptides with high aromatic content.76  The crystal 
structure of HNP-2 (Figure 4.17) shows that the two tryptophan residues are both close 
                                               
¥ The axis system in Figure 4.37 differs from the standard axis system commonly referred to when discussing 
LD experiments, where the z-axis is the long axis of the liposome and the x-axis normal to membrane 
surface.
71
  This is due to the fact that Dichrocalc uses the standard LD equation (Equation F2) where β is the 
angle between the transition polarization direction and the flow direction  For analyses of binding to liposomes 
the equation required is Equation F3, where α is the angle between the membrane normal and the 
polarization direction.
72
  The molecule‟s orienting force is the membrane, which is perpendicular to the flow 
direction.  In order to interpret the Dichrocalc results correctly it was necessary to describe the results in term 
of the axis system in Figure 4.41 and invert the spectra produced by the Dichrocalc calculations.   
    
 
 
          ) F2 
    
 
 
            F3 
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enough to tyrosine residues for excimer coupling to occur.  This would cause a tryptophan 
or tyrosine transition to be split to give an in phase and an out of phase contribution, 
which would be observed as a peak and negative band centred on the wavelength of the 
transition.77 
 
Figure 4.38.  The transition moments of A) amide bonds in β-sheets; B) tyrosine C) tryptophan and D) 
phenylalanine. 
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Figure 4.39.  LD spectra of the Pm1 and Pm2 states of HNP-2 (15 µM) binding to A) 50:50 (w/w) POPG/DOPC 
(1.4 mM) at 30 °C; B) 50:50 (w/w) POPG/DOPC (1.4 mM) at 40 °C; C) 50:50 (w/w) POPG/DOPC (1.4 mM)  at 
53 °C; D) 50:50 (w/w) DOPS/DOPC (1.05 mM) at 30 °C; E) 50:50 (w/w) DMPG/DMPC (1.4 mM) at 17.4 °C; F) 
50:50 (w/w) DMPG/DMPC (1.4 mM) at 33 °C.  The black lines show the positions of transitions discussed in 
Section 4.2.8. 
4.2.7.1.1  Backbone amide transitions 
 All of the LD spectra of the two bound states of HNP-2 (Figure 4.39) show peaks 
at 195 nm, regardless of membrane composition or temperature.  The π–π* transitions of 
the backbone amide bonds are therefore parallel to the surface of the membrane.   
4.2.7.1.2  Exciton coupling 
 The spectra of the first and second bound states of HNP-2 with POPG/DOPC 
liposomes at 53 °C and DOPS/DOPC liposomes at 30 °C (Figure 4.39C and D) both show 
splitting of the Bb transition of tryptophan due to exciton coupling.  The Bb band, expected 
at 220 nm, has been split to give a peak at 230 nm and a negative band at 205 nm.   
A B 
C D 
E F 
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4.2.7.1.3 Transitions of tyrosine 
 The peaks attributed to exciton coupling in the spectra of the first and second 
bound states of HNP-2 with POPG/DOPC liposomes at 53 °C and DOPS/DOPC 
liposomes at 30 °C (Figure 4.39C and D) at 230 nm may also incorporate a peak 
corresponding to the La transition of tyrosine oriented parallel to the membrane.  A peak 
or shoulder at 230 nm corresponding to the La band of tyrosine is also observed in the 
spectra of HNP-2 binding to DMPG/DMPC liposomes at 17 °C and at 33 °C (Figure 4.39E 
and F).  Negative bands can be observed at the same wavelengths in the spectra of HNP-
2 with POPG/DOPC liposomes at 30 °C and 40 °C (Figure 4.39A and B).  The spectra of 
both membrane bound states of HNP-2 binding to POPG/DOPC and DOPS/DOPC 
liposomes at 30 °C (Figure 4.39A and D) show peaks at 245 nm.  These are attributed to 
the tyrosine Lb transition, which has been observed to be shifted to lower wavelengths in 
the spectra of peptides with a high aromatic content, oriented parallel to the membrane.83  
The first membrane bound state of HNP-2 binding to POPG/DOPC liposomes at 40 °C 
(Figure 4.39B) shows no signal at 245 nm, suggesting that the tyrosine Lb transition is 
oriented close to 54.7°.  The spectrum of the second membrane bound state shows a 
weak peak at 245 nm, suggesting that the transition reoriented towards being parallel with 
the surface of the membrane.  In the case of binding to DMPG/DMPC liposomes at 33 °C 
(Figure 4.39F) a weak peak is observed in the spectrum of the second membrane bound 
state and no signal in the first membrane bound state.  Neither of the spectra of HNP-2 
binding to POPG/DOPC liposomes at 53 °C (Figure 4.39C) show a signal at 245 nm, and 
no clear peak or shoulder can be observed at 245 nm in the spectra of binding to 
DMPG/DMPC liposomes at 17 °C (Figure 4.39E), though a signal may be masked by 
scattering. 
4.2.7.1.4 Transitions of tryptophan 
 In the spectrum of the first membrane bound state of HNP-2 binding to 
DMPG/DMPC liposomes at 33 °C a peak can be observed at 220 nm corresponding to 
the Bb transition of tryptophan oriented parallel to the surface of the membrane.  In the 
spectrum of the second membrane bound state of HNP-2 with DMPG/DMPC liposomes at 
33 °C (Figure 4.39F), and in both membrane bound states when binding to POPG/DOPC 
liposomes at 30 °C and 40 °C (Figure 4.39A and B), the signal at 220 nm is zero, 
suggesting that the Bb transition is oriented close to 54.7° relative to the membrane 
normal.  When the transition is oriented at 54.7° relative to the membrane normal the LD 
signal is zero.  This can be explained by referring to the LD equation (Equation 4.38), 
where  is the angle between the transition moment and the membrane normal,  is the 
transition moment and S is the scaling factor. 
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        (4.38) 
 No clear shoulder or negative band corresponding to the Bb band can be observed 
in the spectra of either bound state of HNP-2 with DMPG/DMPC liposomes at 17 °C 
(Figure 4.39E).  It is likely that there is no signal in these spectra at this wavelength, with 
the transition oriented close to 54.7° relative to the membrane normal, and that this is 
masked by the large amount of scattering.  The scattering in the spectrum is attributed to 
the lipids being in the gel phase.  The intensity of light scattered from liposomes drops 
sharply when they are heated above the phase transition temperature.78 
4.2.7.1.5 Transitions of phenylalanine 
 The negative band of the split tryptophan Bb band at 205 nm in the spectra of 
HNP-2 with POPG/DOPC liposomes at 53 °C and DOPS/DOPC liposomes at 30 °C 
(Figure 4.39C and E) may incorporate a negative band at around 210 nm from the La 
band of phenylalanine oriented perpendicular to the membrane.  In the spectra of HNP-2 
with POPG/DOPC liposomes at 30 °C (Figure 4.39A) and in the spectrum of the first 
membrane bound state of HNP-2 binding to DMPG/DMPC liposomes at 33 °C (Figure 
4.39F) the LD signal is positive at 210 nm which may be due to the La band of 
phenylalanine being oriented parallel to the membrane, or the phenylalanine transition 
may be masked by the π–π* transition of the backbone amide bonds.  No signal can be 
observed at the same wavelength in the spectrum of the second membrane bound state 
of HNP-2 binding to DMPG/DMPC liposomes at 33 °C, suggesting that the La transition is 
oriented close to 54.7°.  A negative band can be observed at 210 nm in the spectrum of 
the first membrane bound state of HNP-2 binding to POPG/DOPC liposomes at 40 °C 
(Figure 4.39B), and a positive band in the spectrum of the second membrane bound 
state, suggesting that the transition reorients from parallel to the membrane to 
perpendicular to it when changing between the two states.  No clear shoulder or negative 
band corresponding to the La band can be observed in the spectra of either bound state of 
HNP-2 with DMPG/DMPC liposomes at 17 °C (Figure 4.39E). 
4.2.7.1.6 Other transitions 
 No signal can be observed from the La or Lb transitions of tryptophan in any of the 
spectra.  This could be due to the transitions being oriented close to 54.7°.  No clear band 
can be observed at 260 nm corresponding the disulphide bonds or to the Lb band of 
phenylalanine, but this was expected due to the weak nature of these absorptions. 
4.2.7.1.7 Comparison between spectra of first and second membrane bound states 
 The spectra of HNP-2 binding to POPG/DOPC membranes at all temperatures 
and DMPG/DMPC membranes at 17 °C (Figure 4.39A–C and E) increase in intensity 
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between the first and second membrane bound states.  The signal strength of a transition 
gets weaker as the transition moment is oriented further away from being oriented parallel 
or perpendicular to the membrane, with no signal being observed when it is oriented at 
54.7° to the membrane normal.  This suggests that the backbone in the second 
membrane bound state is oriented so that the π–π* transition of the backbone amide 
bonds are oriented closer to parallel to the membrane surface in the second membrane 
bound state than in the first.  There is no real change in intensity between the spectra of 
the first and second membrane bound states of HNP-2 when binding to DOPS/DOPC 
liposomes at 30 °C (Figure 4.39D), suggesting that there is little change in orientation 
between the two membrane bound states.  The spectrum of the second membrane bound 
state of HNP-2 binding to DMPG/DMPC liposomes at 33 °C (Figure 4.39F) is much 
weaker than the first membrane bound state, suggesting that the backbone is oriented 
closer to 54.7° in the second membrane bound state than in the first.   
4.2.7.2 Discussion of qualitative analysis of LD spectra  
 All of the spectra discussed in Section 4.2.8.1 suggest that the π–π* transitions of 
the backbone amide bonds are parallel to the surface of the membrane.  When the HNP-2 
dimer is examined it is clear that the β-sheet portions are twisted and therefore the 
orientations of the dimer in which the β-sheets are oriented with the π–π* transitions 
mostly parallel to the membrane cannot be determined by eye.  In order to determine the 
true orientation of the peptide it was necessary to analyse the spectra quantitatively 
through fitting spectra of HNP-2 in known orientations to them. 
 A qualitative analysis of the spectra provides more information on the orientation 
of the phenylalanine, tryptophan and tyrosine side chains.  In Section 4.2.2.2 it was noted 
that the fluorescence spectrum of HNP-2 reveals that the tryptophan residues within the 
dimer occupy two distinct environments due to their proximity to and interaction with 
tyrosine residues.  Furthermore, the distance between the tryptophan and tyrosine 
residues was close enough for coupling to occur.  The LD spectra of HNP-2 binding to 
POPG/DOPC at 53 °C and to DOPS/DOPC at 30 °C (Figure 4.39C and D) show evidence 
of excimer coupling between at least one of the tryptophan residues and a neighbouring 
tyrosine residue, causing a peak and a negative band to be observed centred on the 
wavelength of the tryptophan Bb transition.  In most of the other spectra no signal can be 
observed from this transition, although a peak was observed at 220 nm in the spectrum of 
the first membrane bound state of HNP-2 binding to DMPG/DMPC at 33 °C (Figure 
4.39F) suggesting that the tryptophan residues are oriented with the Bb transition parallel 
to the membrane surface.  The orientations of the other side chain transitions appeared to 
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vary for binding to the different liposomes at different temperatures.  The variation 
observed in the orientation of the side chains shows the rotational freedom of these 
residues and suggests that the orientation of the aromatic side chains may be 
independent of the backbone orientation. 
4.2.7.3 Quantitative analysis of orientation 
 The orientation of the β-sheet backbone in the two membrane bound states was 
determined using a set of model spectra.  These were obtained using Dichrocalc, a 
program which calculates the linear dichroism spectra of peptides and proteins from 
oriented PDB files.79–82  The software has an “orientation search” function, which takes the 
inputted oriented peptide through a series of rotations about two axes, calculating a 
spectrum at each new orientation.  One of these axes is defined as the tilt axis and one as 
the rotation axis (Figure 4.40).  The interval and total rotation about each axis can be 
specified.  The peptide is initially taken through the specified rotation about the rotation 
axis.  The peptide and the rotation axis are then both tilted about the tilt axis by a 
specified angle, before the rotation is repeated around the tilted rotation axis. 
 
Figure 4.40.  Explanation of the “orientation search” feature of the Dichrocalc program. 
 The aim of the quantitative analysis was to determine the orientation of the peptide 
in relation to rotation around the x and y-axes.  A reference peptide orientation was 
established, as shown in Figure 4.41. 
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Figure 4.41.  The orientation of the peptide dimer in the reference state.  
 LD spectra were calculated for the peptide dimer oriented as in Figure 4.41 and 
from starting structures rotated by increments of 9° around either the x or y-axis (or = 
0, 9, 18, 27, 36, 45, 54, 63, 72, 81 and 90) relative to the reference state.   In order to take 
account of the fact that the peptide could bind in any orientation relative to rotation about 
the z-axis, and could be at any position around the cylindrical surface of the shear-
deformed liposome a series of spectra obtained at 30° rotations about the z-axis and 30° 
tilt angles about the x-axis were averaged for each starting structure (Figure 4.40).  The 
reference orientation was chosen due to the C2 symmetry around the z-axis, and spectra 
were calculated for rotations of up to 90° around the x- and y-axes due to symmetry; a 
calculated spectrum of the peptide rotated by 170° around the x-axis would be the same 
as that of the peptide rotated by 10°, for example. 
 The peptide dimer incorporates a number of different transitions, as discussed in 
Section 4.2.8.1, with transition dipoles polarized in different directions.  As shown in 
Figure 4.42, rotation about the y-axis keeps the transition moments, y, polarized along 
the y-axis constant (where y is the sum of the vectors aligned along the y-axis), but 
varies the rest of the transition moments as a function of  (and ).  Similarly, rotation 
about the x-axis keeps the transition moments polarized along the x-axis, x, constant, but 
varies the other transition moments as a function of  (and ).   
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Figure 4.42.  Specific geometrical parameters for the determination of the orientation of a peptide in relation 
to rotation about the x and y-axes. x and y are the sum of the vectors aligned along the x and y-axes 
respectively and 1 and 2 are the transition moment vectors, with the subscripts 1 and 2 relating to analysis 
of the orientation in relation to rotation about the x and y-axes respectively. 
The angle of  about the z-axis is .  In the reference state we can define  = i0, 
therefore Equations 4.39 and 4.40 apply (Figure 4.42B and C).  In the reference state  
and  = 0°. 
                 (4.39) 
                 (4.40) 
As described in Section 1.3.4.2, LD is the difference in absorbance of light oriented 
parallel and perpendicular to an oriented sample.  This can also be written in terms of the 
x and y components of the transition dipole, x and y, as described in Equation 4.41, 
where S is a scaling factor. 
             
    
          (4.41) 
Two axis systems can be used to describe the LD experiment.71  The {x, y, z} axis system 
defines the coordinates in relation to the long axis of the liposome, where the z/y plane is 
perpendicular to this (the axis system in Figure 4.37).  The {X, Y, Z} system defines the 
B C 
A 
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coordinates in relation to the bilayer and the analyte, where the analyte can be at any 
position around the surface of the liposome and Z is the normal to the cylinder surface 
that passes through the origin of the analyte.  The long axis of the liposome is the same in 
both axis systems, x = X.  Equation 4.41 can be rewritten as Equation 4.43, which 
describes the LD signal in terms of rotation about the x-axis.  For rotation about the x-
axis, x is constant. y is calculated as the dot product of the transition moment vector, 1, 
with the y-axis vector in the {X, Y, Z} system (Equation 4.41), and changes with rotation 
about the x-axis. 
                                                   
                                          (4.42) 
The angle between the projection of  onto the X/Y plane and the Z-axis is represented by 
v (Figure 4.43) and  can take any value between 0 and 2π The scaling factor has been 
omitted for clarity. 
 
Figure 4.43.  Geometrical parameters relating the transition dipole to the {x, y, z} axis system. 
       
    
     
                             
     (4.43) 
      
    
                       
                                (4.44) 
Equation 4.44 can be developed to give Equation 4.44 be averaging  and  over 0 to 2π 
radians.   
      
    
                            (4.45) 
Equation 4.45 is developed through Equations 4.46 and 4.47 to give Equation 4.48. 
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                       (4.46)        
      
        
                       (4.47) 
      
        
                     (4.48) 
Rotation about the y-axis is treated in a similar fashion, starting with Equation 4.49, where 
y is treated as a constant. 
       
    
     
            
    
       (4.49) 
v in Equation 4.49 is averaged over 0 to 2π radians to give Equations 4.50. 
         
         
         (4.50) 
This is developed to give: 
         
             
         (4.51) 
Equations 4.45 and 4.51 are then modified to take into account the transition moment 
dipole in the reference state and the scaling factor reintroduced, producing Equations 
4.52 and 4.53. 
        
        
                       (4.52) 
           
                   
        (4.53) 
 For each starting orientation the values of x or y, io and  or  would be the 
same at each wavelength regardless of the angle of  and , allowing non-linear least 
squares fitting to be performed simultaneously on the calculated data at each wavelength 
to determine these parameters by fitting Equations 4.52 and 4.53 to the data from the 
Dichrocalc calculations. 
 Equations 4.52 and 4.53 were then fitted to the LD data calculated for HNP-2 in 
the first and second membrane bound states (Pm1 and Pm2 in Figure 4.31) in Section 
4.2.6.3, using the values of x or y, io and  or  calculated from fitting the Dichrocalc 
data, in order to determine the values of  or  for which the best fit could be obtained 
between the calculated and experimental data.  It is likely that a number of possible 
orientations could be fitted to the data, including individual rotations involving just  or 
,and combinations of rotations around both axes.  The experimental and fitted spectra 
are included as Appendix 3, and an example is shown in Figure 4.44.  None of the fits 
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between the experimental and calculated data matched well above approximately 220 
nm.  This can be explained by the fact that the orientation of the aromatic transition 
moments in the bound state will differ more significantly than those of the amide 
backbone from the x-ray structure.  It also appears that the coupling between the 
tryptophan and tyrosine residues, which caused splitting in some of the LD spectra as 
discussed in Section 4.2.8.1, has not been accounted for in the calculated spectra. 
 
Figure 4.44.  LD spectrum of the Pm1 state of HNP-2 binding to 50:50 (w/w) POPG/DOPC at 40 °C (purple) 
and closest-fit calculated spectrum determined through least squares fitting using Equation 4.53 (green). 
 The scaling factors and rotations about  and  determined from fitting the 
calculated data to the data from the first and second membrane bound states of HNP-2 
are listed in Table 4.12.  It was not possible to fit the spectra of HNP-2 binding to 
DMPG/DMPC liposomes below the phase transition temperature due to the high degree 
of scattering in the spectra.  The calculated rotation angles in Table 4.12 are likely to be 
the maximum extents of the peptide tilt, and a large degree of error will be present for 
each angle due both to the mathematical error inherent in least squares fitting (10%) and 
due to modelling dynamic systems using a static structure.   
 
 
 
 
  The membrane binding of defensin HNP-2 
239 
 
Table 4.12.  Parameters obtained from fitting Equations 4.52 and 4.53 to data for the first and second 
membrane bound states (Pm1 and Pm2 (Figure 4.31)) of HNP-2 binding to POPG/DOPC, DMPG/DMPC and 
DOPS/DOPC liposomes at different temperatures. 
  S (°) (°) 
POPG/DOPC  
30 °C 
 
Pm1 1.1 10  
0.9  8 
Pm2 0.6 -18  
0.8  19 
POPG/DOPC  
40 °C 
 
Pm1 0.9 16  
0.6  0 
Pm2 0.6 -16  
0.9  22 
POPG/DOPC  
53 °C 
 
Pm1 0.8 17  
0.5  0 
Pm2 0.6 -2  
0.8  28 
DOPS/DOPC   
30 °C 
 
Pm1 1.6 18  
1.0  0 
Pm2 0.2 -33  
0.2  2 
DMPG/DMPC  
33 °C 
 
Pm1 2.2 -21  
2.1  0 
Pm2 0.2 -16  
0.4  28 
  
4.2.7.4 Discussion of results of quantitative analysis of binding 
 The data in Table 4.12 suggest that the peptide sits on or partially inserted into the 
surface of the liposome with a tilt of up to 33° around the x or y-axes as defined in Figure 
4.41.  Figures 4.45A–I show the furthest extent of the tilts around the y and x-axes in first 
and second membrane bound states.   
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Figure 4.45.  Orientations of HNP-2 in the first and second membrane bound states.  A–C) The furthest 
extent of the tilts around the x-axis in the first and second membrane bound states of HNP-2 binding to 50:50 
(w/w) POPG/DOPC at any temperature or to 50:50 (w/w) DOPS/DOPC at 30 °C compared to the peptide in 
the reference state (18°, 0° and -33° respectively); D–F) the furthest extent of the tilts around the x-axis in 
the first and second membrane bound states of HNP-2 binding to 50:50 (w/w) DMPG/DMPC at 33 °C 
compared to the peptide in the reference state (21°, 0° and -16° respectively);  G–I) the furthest extent of 
the tilts around the y-axis in the first and second membrane bound states of HNP-2 binding to any of the 
liposomes under any conditions compared to the peptide in the reference state (8°, 0° and 28° 
respectively).  The plane of the membrane, though not necessarily the position of the surface of the 
membrane relative to the peptide dimers, is indicated by hashed line. 
4.2.7.4.1  Binding to 50:50 (w/w) POPG/DOPC liposomes 
 When binding to POPG/DOPC liposomes in the first membrane bound state the 
peptide as shown in Figure 4.45B is tilted between 10° and 17° clockwise around the x-
axis and/or between 0° and 8° clockwise around the y-axis looking towards the origin in 
Figure 4.45H.  In the second membrane bound state the peptide is tilted between 2° and 
33° clockwise around the x-axis and/or between 19° and 28° around the y-axis.  The tilts 
A B C 
D E F 
G H J 
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around the x-axis in the first membrane bound states are very similar, essentially the 
same within error, while the tilts around the y-axis are the same within 10% when binding 
to POPG/DOPC at 40 °C and 53 °C, but lower at 30 °C.  In the second membrane bound 
state the extent of the tilt around the x-axis decreases with temperature, while the tilt 
around the y-axis increases with increasing temperature. 
4.2.7.4.2 Binding to 50:50 (w/w) DOPS/DOPC liposomes 
 The angles at which the peptide inserts into DOPS/DOPC membranes at 30 °C, 
and the changes between the peptide in the two membrane bound states are similar to 
those for binding to POPG/DOPC membranes.  The angles of HNP-2 in the first 
membrane bound state are within 10% of those of the peptide in the first membrane 
bound state when binding to POPG/DOPC liposomes at 53 °C.  The tilt around the x-axis 
in the second membrane bound state is greater than for binding to POPG/DOPC 
membranes at any temperature, while the tilt around the y-axis is lower than observed for 
binding to the POPG/DOPC liposomes.  Rotation about both axes increases between the 
two membrane bound states. 
4.2.7.4.3 Binding to 50:50 (w/w) DMPG/DMPC liposomes 
 When binding to DMPG/DMPC liposomes above the phase transition temperature 
a rotation of 21° anticlockwise around the x-axis, looking towards the origin, compared to 
Figure 4.45E was calculated for HNP-2 in the first membrane bound state, which is 
different from the orientation observed in the first membrane bound state when binding to 
the other liposomes at any temperature.  In the second membrane bound state this tilt is 
reduced to 16°, which is the same as calculated for binding to POPG/DOPC liposomes at 
40 °C.  In the first membrane bound state there is no tilt around the y-axis, as observed 
for POPG/DOPC at 40 °C and 53 °C and DOPS/DOPC at 30 °C, and in the second 
membrane bound state a tilt of 28° clockwise around the y-axis, looking towards the 
origin, compared to Figure 4.45H is observed, which correlates with that observed for 
POPG/DOPC at 53 °C. 
4.2.8 Binding model for defensin HNP-2 
 Combining the information gained from determining the kinetics and orientation of 
HNP-2 binding to membranes allows us to propose a model for the nature of the binding 
of this peptide to membranes.  The first stage of the binding has a very fast rate constant, 
and leaves the peptide in an orientation where it is generally tilted only slightly away from 
being normal to the membrane surface.  This is consistent with the peptide initially binding 
rapidly to the surface of the membrane.  The initial tilt of 10–18° around the x-axis in the 
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first membrane bound state when binding to POPG/DOPC or DOPS/DOPC membranes 
(Figure 4.45A), or 21° when binding to DMPC/DMPC membranes (Figure 4.45D) can be 
explained by the presence of 6 arginine residues around the middle of the dimer (Figure 
4.46).  In Figure 4.46A and B it is clear that a tilt around the x-axis would allow at least 
one of these positively charged residues to interact with the negatively charged lipid 
headgroups in the membrane.  Figure 4.46C shows that the arginine residues are mainly 
located on two sides of the membrane, and that rotation about the y-axis would not allow 
the arginine residues to interact with the membrane, which may explain why initially little 
or no rotation around this axis is observed in the first membrane bound state.  The H‡ 
value determined for the first binding step (Section 4.2.7) was found to be positive, which 
is consistent with partial desolvation of the peptide and lipids and breaking van der Waals 
forces between the lipids in the transition state during insertion.  The entropy of activation 
for the first stage of binding, S‡, was found to be unfavourable, due to the decrease in 
rotational freedom of the peptide and the freezing out of motion of the lipids, which 
correlates with a binding processing occurring. 
 
 
Figure 4.46.  Orientation of HNP-2 dimers in first membrane bound state.  A)  = 10°; B)  = -21° and C)  = 
0°.  Arginine residues are shown in purple. 
 The second membrane bound state is formed more slowly and involves a tilt 
around both the x- and y-axes of between 2° and 33°.  In this orientation it is unlikely that 
the dimer is completely buried in the membrane, but it is likely to have inserted slightly 
into the membrane.  This is consistent with the much slower rate for the second stage of 
binding to the DMPG/DMPC liposomes below the phase transition temperature compared 
A B C 
  The membrane binding of defensin HNP-2 
243 
 
to above the phase transition temperature, in contrast to the first stage, where it is likely 
that only an interaction with the surface was occurring, where the rates were similar.  
There are four hydrophobic residues at the base of the HNP-2 dimer, two glycine and two 
leucine residues, which create a hydrophobic region of 344 Å2 on the base of the dimer 
(Figure 4.47).  This is likely to be positioned inside the hydrophobic core of the membrane 
if the dimer is bound in a stable position.  The slight tilts around the x and y-axes may 
occur to allow more arginine residues to interact with the PG headgroups than if the dimer 
inserted vertically.  The distance between the hydrophobic base of an HNP-2 dimer to the 
backbone carbon of an arginine residue is approximately 9 Å and the distance longest 
between the base of the peptide dimer and the guanidinium group of an extended 
arginine residue is approximately 18 Å.  When this is compared to the thickness of one 
leaflet of a DOPC bilayer, where the hydrophobic portion is 16 Å thick and the interface 
region, incorporating the rest of the lipid and the waters of hydration, 15 Å,83  it is clear 
that a dimer could partially insert into one leaflet with the base within the hydrophobic 
region and the guanidinium groups able to interact with the lipid headgroups. 
   
Figure 4.47.  Proposed orientation of HNP-2 in second membrane bound state showing maximum rotations 
about the x and y-axes where  A)  = -33°, and where  = 28 viewed along B) the y-axis and C) the x-axis.  
Arginine residues are shown in purple; glycine and leucine residues are shown in orange. 
A 
B C 
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4.2.8.1 Comparison between results and proposed literature models 
 As described in Section 4.1.4, three models were proposed for the binding of 
HNP-2 to lipid membranes by Hill et al. in their paper describing the crystal structure of 
HNP-3: the wedge model, the multiple dimer pore (or multimeric pore) model and the two 
dimer pore model, and Wimley et al. carried out binding experiments using HNP-2 from 
which they proposed that the multiple dimer pore model best fitted to their results.4, 20  The 
binding of HNP-2 in the analyses reported herein displayed first-order kinetics, ruling out 
the formation of multimeric pores during the time period of the analyses.  Nevertheless, 
models of the two dimer pore and multiple dimer pore were analysed using Dichrocalc to 
determine what their calculated LD spectra would be and to see how they differed from 
the experimental spectra and the fitted spectra.  In each case a series of calculated 
spectra obtained at 30° rotations about the z-axis and 30° tilt angles about the x-axis were 
averaged to account for the possibility of the pores being situated at any position on a 
shear-deformed liposome and to have any orientation with relation to rotation about the z-
axis.  The resulting spectra are compared with the spectrum of the second membrane 
bound state of HNP-2 binding to POPG/DOPC membranes at 30° and to the spectra 
where  = 198 and  = 19 (Figure 4.48), which were found to correlate most closely with 
the spectrum of HNP-2 in the second membrane bound state.  It is clear from Figure 4.48 
that the spectra of the two pore models are very different from the spectrum of the second 
membrane bound state and from the spectra fitted to spectrum of HNP-2 in the second 
membrane bound state.  This is not surprising, but reinforces the orientation which we 
propose for the second membrane bound state. 
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Figure 4.48.  Calculated LD spectra of a multimeric pore (blue), a two dimer pore (purple) and HNP-2 dimers 
oriented as in Figure 4.41 where  = 198 (grey) and  = 19 (orange).  These are compared to the spectrum of 
the second membrane bound state of HNP-2 binding to 50:50 (w/w) POPG/DOPC at 30. 
 The orientation of HNP-2 in the second membrane bound state resembles the 
„wedge model‟ proposed by Hill et al and shown in Figure 4.7A, and suggests that the 
peptide acts on membranes through a carpet-type mechanism, when a large number of 
peptides bind to the membrane surface and cause it to weaken and become permeable 
through a detergent-like action, rather than through the formation of pores.  Hill et al.  
suggested that the wedge model would disrupt the bilayer by distorting interactions 
between the lipids through burying the dimer into the outer leaflet of the membrane and 
allowing the arginine residues to interact with the negatively charged PG or PS 
headgroups.4  In proposing the multimeric pore model Wimley et al. studied the release of 
fluorescent markers from liposomes after the addition of HNP-2 and determined that it 
occurred through an all-or-none mechanism which was indicative of the presence of pores 
in the membrane.20  It is possible for artifacts to be observed which suggest all-or-none 
release but are actually due to inefficient mixing immediately after the addition of the 
peptide to the liposomes causing transient high local peptide concentrations.  The data 
Wimley et al. used to propose all-or-none release of fluorescent markers was also re-
analysed by some of the authors of the original paper at a later date using an extended 
model for analysing the data.  They determined from this more comprehensive data 
analysis that the original data could be interpreted as all-or-none or as graded release 
with a very high preference of ANTS leakage over DPX, though they argued that the latter 
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was unlikely due to the observation of the release of large dextrans after the addition of 
HNP-2.84  Peptides which have been suggested to act through carpet-type mechanisms 
have been shown to cause the release of large markers however.85,  86  It is also possible 
that HNP-2 acts in a 2-state model which has been used to describe the some 
antimicrobial peptides, including the helical antimicrobial peptide magainin, where below a 
certain peptide-to-lipid ratio the peptides adsorb to the surface and above this ratio they 
insert into the membrane to form toroidal pores.87, 88  Wimley et al. carried out analyses at 
peptide:lipid ratios half and twice those used for the experiments reported in this chapter, 
with little difference between the results for the two concentrations, and observed the 
release of large markers within two hours of the addition of HNP-2 to liposomes, so it is 
unlikely that they observed a different binding process to that observed in these 
experiments.  The degree of binding of HNP-2 to liposomes composed of 50:50 (w/w) 
POPG/DOPC reported by Wimley et al. (75% with 14.5 µM HNP-2 and 1 mM lipid) is also 
inconsistent with the results of the experiments reported herein, where the concentration 
of free peptide 100 minutes after mixing HNP-2 (15 µM) with 50:50 (w/w) POPG/DOPC, 
DOPS/DOPC or DMPG/DMPC liposomes (1.4 or 1.05 mM) was found to be negligible.45 
4.3 Future and other work 
Preliminary experiments were carried out using a cross-linking method and 
neutron reflectivity to further explore the membrane binding of HNP-2.  Neither were taken 
to completion, but the experiments and the information they were designed to provide are 
outlined. 
4.3.1 Cross-linking 
The photo-induced cross-linking of unmodified proteins (PICUP) method, 
developed by Fancy and Kodadek,89 involves photolysis of ruthenium(II) tris-bipyridyl 
dication (Ru(II)bpy3
2+) to give an excited state of ruthenium, which donates an electron to 
a persulphate ion (present as ammonium persulphate), causing the O–O bond to break.  
This leaves Ru(III)bpy3
3+ and a sulphate radical, which cause cross-linking between the 
tyrosine side chains of neighbouring peptides.  The exact cross-linking method is not 
known, but the two mechanisms proposed by Fancy and Kodadek, on which the method 
was designed, are shown in Scheme 4.1. 
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Scheme 4.1.  Mechanisms proposed by Kodadek and Fancy for the PICUP process. 
Experiments were carried out with the aim of using this method to cross-link HNP-
2 peptides at different times during their insertion into POPG liposomes, to give a „snap-
shot‟ of the insertion process and to hopefully identify the arrangement of the peptides 
during and after binding.  Analyses were carried out using MALDI-MS and sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with the aim of observing 
the size of any groups of peptides linked together, where small groups would support the 
proposed multimeric pore binding method while larger aggregates would suggest 
something more like the carpet mechanism. 
It was not possible to observe defensin multimers by any analysis method.  
Different ratios of reagents were tested, with different peptide:lipid ratios and cross-linking 
at different times after the addition of the cross-linking reagent.  The initial experiments 
were thought to be unsuccessful due to the use of a buffer containing 150 mM NaCl, a 
known inhibitor of defensin binding, but even in the absence of added salt and just 5 mM 
phosphate buffer it was not possible to observe any cross-linking. 
Two main theories were proposed for the lack of observation of multimers.  The 
first was the low concentration of peptide used in the experiments.  It was proposed that if 
the peptide formed oligomers these would each be present at too low a concentration to 
observe.  It was hoped that an antibody could be obtained to enhance detection of the 
peptide.  With antibodies, Western Blotting could be carried out, as this is more sensitive 
than silver or Coomassie blue staining, due to the 10-fold increase in peptide mass when 
it is bound by an antibody causing a 10-fold increase in sensitivity towards amino acid 
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detection.  The antibodies could also be labelled, for example with colloidal gold, which 
can be viewed by TEM without staining, facilitating identification of the resulting pictures 
as only the antibody (attached to the peptide) would be visible.  The other likely cause of 
the lack of observed oligomers is the position of the tyrosine residues within the peptide 
dimer.  Tyr(20) sits in the centre of the HNP-2 dimer and has been said to participate in 
the binding through hydrophobic interactions.  The other two tyrosine residues sit at the 
top and side of the dimer, and may not be in suitable positions for cross-linking after the 
formation of a multimeric pore or carpet-like aggregation. 
4.3.2 Neutron reflectivity 
Neutron reflectivity (NR) allows the study of nature of peptide binding through 
analysing changes in lipid bilayers after the addition of peptides.  Features which can be 
studied include the depth of bilayer penetration, the orientation of the bound peptide and 
the nature of any pore formed.  Deuterium labelled lipids are deposited on silicon crystals 
via the adsorption and rupture of liposomes.  The peptide is then added and the nature of 
the disruption of the bilayer studied.90  Washing with H2O and D2O can be used to reveal 
pores in the bilayer.91  Preliminary experiments explored methods of obtaining a bilayer 
with a high enough percentage of negatively charged DMPG lipid for HNP-2 to bind.  The 
binding of lipids to hydrophobic surfaces is strongly affected by the lipid charge, but this 
can be overcome by varying the ratio of neutral and negative lipid and by the addition of 
Ca2+ salts.92  A bilayer was formed when 80:20 (w/w) dDOPC/DMPG in 10 mM CaCl2 was 
left for 2 hours to adsorb onto the surface.  It is hoped that further neutron reflectivity 
experiments would reveal more information about the depth and orientation of HNP-2 in 
membranes to compliment the results of the linear dichroism experiments. 
4.3.3 Future work 
The results of the analyses of HNP-2 have suggested that the peptide acts on 
membranes via a carpet mechanism under the conditions used, rather than the pore 
model which has been proposed to explain the action of HNP-2.  Further LD analyses of 
the binding at different peptide:lipid ratios would establish whether the peptide reorients to 
form toroidal pores through the membrane at higher concentrations in a similar way to the 
model which has been proposed for magainin.   Further information about the binding 
process could be obtained by measuring the enthalpy, through measuring the heat 
released after the addition of HNP-2 to liposomes. 
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5 CONCLUSIONS 
5.1 The identification of phospholipids by mass spectrometry 
 The objective of the study of phospholipids was to establish a validated protocol 
for identifying unknown phospholipids in mixtures, which could ultimately be applied to the 
analysis of lipid bilayers and lipid mixtures separated on TLC plates.   
 After analyzing the positive and negative ions of a number of different lipids by 
MALDI-MS and MSMS it was established that only MSMS analysis of the positive ions 
could provide enough information to identify the acyl chains and headgroups of all of the 
lipids studied.  The addition of Li+ or Na+ was shown to improve the MSMS spectra of 
POPC and POPE in terms of signal to noise ratio and number of useful product ions, with 
the product ion spectra in the presence of Na+ providing the most information from which 
the identities of the acyl chains and headgroups could be determined.  Repeat MSMS 
analyses of POPE, POPC and OPPC in the presence of Li+ or Na+ and in the absence of 
added salt found clear preferences for the loss of the acyl chain from the sn-2 position in 
some product ions of POPE, POPC and OPPC in the absence of added salt, and from the 
sn-1 position in the presence of Li+ or Na+.  Analysis of POPC in the presence of Li+ was 
shown to give a greater difference in relative intensity of peaks corresponding to the loss 
of the acyl chain from the sn-1 and sn-2 positions compared to analysis in the presence of 
Na+ or in the absence of added salt, while analysis of POPE in the presence of Na+ or Li+ 
and in the absence of added salt gave information from which the position of the acyl 
chains could be clearly determined.  Comparison between the analyses of POPC and 
OPPC validated the method of identifying the position of acyl chains on the glycerol 
backbone through the relative ease with which they are cleaved during MSMS analysis 
through showing that for all but one fragment the position of the acyl chain and not its 
identity controlled the ease with which it was fragmented.  The standard deviations of 
repeat measurements of the relative intensities of peaks corresponding to fragmentation 
at the sn-1 and sn-2 positions were consistently larger for fragmentation by CID than by 
LIFT, which was attributed to secondary fragmentations of the primary fragments from 
which the relative intensities were determined.   
 The protocol established for lipid analysis was applied to the analysis of unknown 
PC lipids and enabled some to be completely identified including the position of the acyl 
chain on the glycerol backbone.  Preliminary MALDI imaging of TLC plates on which lipid 
mixtures had been separated produced full-scan MALDI spectra but in most cases the 
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signal was too low for achievable MSMS.  It was possible to identify DPPC on a TLC plate 
on which mouse lung lipids had been separated from a clear product ion spectrum 
produced in the presence of Li+.  With refinement of the method it is likely that much more 
information could be obtained from MALDI imaging of TLC plates on which lipid mixtures 
have been separated. 
5.2 The chemical stability of phospholipids 
 The techniques identified from the analyses of phospholipids were applied to the 
study and identification of lipids modified by actions such as hydrolysis and oxidation, 
both under normal conditions for membrane binding experiments and after the addition of 
melittin or small molecules. 
  
 Professor Alison Rodger reported changes in the CD and LD spectra of 
antimicrobial peptides depending on the age of the liposomes with which they were 
mixed.  MALDI-MS analyses of liposomes composed of DOPC or DPPC under a number 
of conditions, including different buffers and temperatures, revealed no hydrolysis over at 
least 2 weeks after liposome preparation.  Electron microscopy and dynamic light 
scattering analyses showed that the liposomes were not undergoing any physical 
changes consistent with aggregation or micellization.  Evidence of oxidation was found in 
all stocks of DOPC and POPC lipid, whether stored as a solid or as a solution in CHCl3.  
The results of MS and MSMS analyses of these lipids suggested that both peroxidation 
and ozonolysis were contributing to this oxidation.  The concentration of oxidized DOPC 
in the stock was found to be very low, below the detection limit when the lipid was 
analysed by 1H NMR, and was therefore unlikely to have had a significant effect on 
peptide binding experiments.  The presence of oxidized lipid in the stock solutions rather 
than its formation during liposome storage would mean that any effects on peptide binding 
should be consistent regardless of the age of the liposomes. 
 
 HFIP was not shown to cause hydrolysis of DOPC liposomes, which correlated 
with proposals in the literature that HFIP causes membranes to become permeable 
through physical disruption rather than through causing chemical changes to the 
membrane lipids. 
 
 Lysis of the acyl chains of liposomal lipids was observed in the presence of both 
natural and synthetic melittin.  Hydrolysis in the presence of natural melittin is well-
documented and attributed to contamination with phospholipase A2, which is present in all 
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natural melittin.  No reference could be found in the literature to the lysis of the acyl 
chains of liposomal lipids in the presence of synthetic melittin, i.e. when there could be no 
possible PLA2 contamination.  The rate of lysis in the presence of synthetic melittin was 
much slower than with natural melittin, but was found to be enhanced by the presence of 
Zn2+ and to be inhibited when NaCl was excluded.     
 
 The addition of acyl chains to melittin from both POPC and DOPC was observed a 
few days after mixing the peptide and liposomes.  MALDI-MSMS analysis identified the N-
terminus as a site of acylation by the oleoyl chains of DOPC and POPC and the palmitoyl 
chain of POPC, and acylation was observed on K(7) from the oleoyl chain of DOPC.  
Acylation was likely to have occurred on K(21) and possibly also on K(23).  There was no 
case in which acylation could be confirmed at a position other than the N-terminus or a 
lysine residue.  When samples where melittin had been added to POPC liposomes were 
analysed, a greater transfer of the oleoyl chain from the sn-2 position of the lipid was 
observed, which is consistent with the observation of higher intensities of lyso-PPC than 
lyso-OPC.  The observation of acylated melittin, along with the lack of free oleic acid after 
acyl chain lysis suggests that the formation of lyso-PC in the presence was primarily due 
to acyl transfer to melittin. 
5.3 The membrane binding of defensin HNP-2 
 Fluorescence analyses were carried out on HNP-2 over a range of concentrations 
in order to determine the dimer binding constant and confirm whether the peptide would 
be predominately in a monomeric or dimeric form during the liposome binding analyses.  
The binding constant was found to be 3.8 µM-1.  All of the binding analyses were carried 
out using 15 µM HNP-2, therefore the observed results could be attributed to the actions 
of HNP-2 dimers.  Comparison between fluorescence analyses of HNP-2 in water, 75:25 
(v/v) MeOH/water and in 50:50 (w/w) POPG/DOPC liposomes showed that no blue shift 
occurred in the emission wavelengths of the tryptophan residues when the peptide was in 
a more hydrophobic environment, suggesting that these residues were shielded from the 
solvent.  Two peaks were observed in all of the fluorescence spectra, which was 
indicative of the presence of two tryptophan environments within the dimer.  This was 
confirmed through reference to the solid state NMR structures of HNP-1, which showed 
two main tryptophan rotamers, each interacting with a different tyrosine residue.  When 
fluorescence spectra of HNP-2 in 50:50 (w/w) POPG/DOPC liposomes were recorded 
every 2.5 minutes for 5 hours changes in shape and fluorescence intensity were observed 
over time which suggested that the peptide was binding to the membrane. 
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 Linear dichroism analyses of HNP-2 with POPG/DOPC, DMPG/DMPC or 
DOPS/DOPC at different temperatures showed that HNP-2 was changing orientation over 
5 hours after its addition to liposome dispersions. 
 
 Fluorescence resonance energy transfer and dynamic light scattering analyses 
were carried out to study the effects of HNP-2 on the liposomes following binding.  
Fluorescence analysis of labelled liposomes over 5 hours after the addition of HNP-2 
showed that no mixing of lipids between liposomes was occurring, and that therefore 
HNP-2 was not causing aggregation or fusion.  Liposome samples were analysed by DLS 
before the addition of HNP-2 and after each 5-hour LD analysis to look for any changes in 
size which would indicate that HNP-2 was causing aggregation, fusion or micellization.  
No changes consistent with any of these processes were observed.  
 
 The fluorescence and LD data were found to fit to a 1st order 3-state binding model 
with the binding mechanism involving free peptide and two membrane-bound states.  The 
first stage of binding was found to be fast, with the rate constants varying a little for 
binding to the different liposomes but similar for binding to the same liposomes at different 
temperature.  This was consistent with an interaction with the surface of the membrane 
but no insertion.  The second stage of the binding was slower and had some dependence 
on the temperature at with the binding took place, particularly the binding to 50:50 (w/w) 
DMPG/DMPC, where the second stage of binding was much slower below the phase 
transition temperature of DMPG and DMPC than above it.  This suggests that the peptide 
dimer was inserting into the membrane to some extent during the second stage of 
binding.  The orientation of the dimer in the second membrane bound state and the 1st 
order binding kinetics were consistent with a carpet-type binding mechanism with partial 
insertion of the peptide dimer into the bilayer, and not the formation of multimeric pores. 
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6 Materials and methods 
6.1 Materials 
 Unless otherwise stated, all chemicals were used as received.  1,1,1,3,3,3-
hexafluoroisopropanol was obtained from Apollo Scientific Ltd., Stockport, UK and 
distilled before use.  All other reagents were reagent grade and obtained from Fisher 
Scientific, Loughborough, UK, and used without further purification.  Water was purified 
using a Milli-Q Direct Q system from Millipore (UK) Ltd., Watford, UK, with a resistivity of 
18.2 MΩ/cm.  2,5-dihydroxybenzoic acid (DHB) and α-cyano-4-hydroxycinnamic acid (α-
CHCA) were purchased from Sigma-Aldrich, Dorset, UK. 
 All metal salts and buffer salts were obtained from Sigma-Aldrich.  Buffer solutions 
were prepared in Milli-Q water and the pH adjusted with concentrated aqueous HCl. 
 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-
phosphoserine (DOPS), 1-oleoyl-2-palmitolyl-sn-glycero-3-phosphocholine (OPPC), egg 
phosphocholine from hen egg yolk (egg PC, product P2772, ≥ 99% purity) and soybean 
phosphocholine (soybean PC, product P3644, ≥ 30% purity) were Fluka brand, obtained 
from Sigma-Aldrich.  1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine (DPPE) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) were purchased from Bachem (UK) Ltd., St. Helens, UK.  1-palmitolyl-2-oleoyl-
sn-glycero-3-phosphoethanolamine (POPE), 1-palmitolyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) and 1-palmitolyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) 
were obtained from Avanti Polar Lipids through Instruchemie B.V., The Netherlands.  
DMPG was Alexis brand, obtained from Enzo Life Sciences (UK) Ltd., Exeter, UK.  N-
(Lissamine Rhodamine B sulfonyl)-phosphatidylethanolamine (Rh-PE) and N-(7-nitro-
2,1,3-benzoxadiazol-4-yl)-phosphatidylethanolamine (NBD-PE) were Molecular Probes 
brand, from Invitrogen, Paisley, UK.  All lipids except POPG, soybean PC and egg PC 
were obtained as lyophilised solids.  POPG and egg PC were obtained as solutions in 
CHCl3 and soybean PC was obtained as a waxy solid.  The mouse lipids were extracted 
from the lung tissue of freshly culled CD-1 mice by Helen McPhee.  The tissue was frozen 
in liquid nitrogen and homogenized with a 2:1 (v/v) solution of CHCl3/MeOH using a pestle 
and mortar, before filtering (Whatman grade no. 1 paper).  The biphasic mixture was 
washed with 1–2 ml distilled water and the organic phase separated off.  The interfacial 
liquid was washed again with water and a small quantity of CHCl3/MeOH, which was 
separated off and added to the original organic phase.1  All lipids were stored at -20 °C as 
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solids (DPPC, DPPE, DOPE, soybean PC) or solutions in CHCl3 (POPG, POPC, DOPC, 
egg PC, mouse lipids, Rh-PE, NBD-PE) or CHCl3/MeOH (10:2 (v/v)) (DMPG). 
 Defensin human neutrophil peptide-2 (HNP-2) was obtained from Bachem.  
Natural melittin was from Sigma-Aldrich and synthetic melittin Alexis brand from Enzo Life 
Sciences.  All were obtained as lyophilised solids.  HNP-2 was stored as a solid at -20 °C 
or as a solution in water at 4 °C.  Melittin was stored as a solid or a solution in water at -
20 °C.  Haloperidol was obtained from Sigma-Aldrich and stored as a solid at -20 °C. 
6.2 General methods 
Unless otherwise stated, the following standard protocols were used. 
6.2.1.1 MALDI-MS and MSMS analyses 
MALDI-TOF-MS and MSMS analyses were carried out using an Autoflex II MALDI-
TOF/TOF spectrometer with 337 nm nitrogen laser (Bruker Daltonics Ltd., Coventry, UK).  
The instrument was calibrated for MS analysis with the sodium adducts of poly(ethylene 
glycol) 600.  A ground steel target plate was used, and cleaned with methanol and 
acetone before use.  Positive and negative ion MS analyses were made using the 
reflectron.  Positive ion MSMS experiments were made using the LIFT capability in the 
absence of a collision gas and at a source pressure of around 2.5 x 10-7 mBar.  Data were 
analysed with Flex Analysis version 3.0 (Bruker Daltonics Ltd).  DHB was used as a 
matrix for all MALDI experiments unless otherwise stated.  In the absence of added salt 
DHB was prepared at 30 mg/mL in EtOH/H2O (50:50 v/v).  For experiments in the 
presence of lithium or sodium, DHB was prepared at 30 mg/mL in solutions of 100 mM 
LiCl or NaCl in EtOH/H2O (50% (v/v)).  Matrix solutions were mixed 9:1 (v/v) with lipid 
samples and 9:2 (v/v) with liposome samples, and 1 µL applied to a ground steel target 
plate and allowed to air dry.  In order to achieve a thicker sample layer, for automated 
runs 2 x 0.5 µL were spotted on top of each other and allowed to air dry between 
applications. 
6.2.1.2 Liposome preparation 
Liposomes were prepared by evaporation of a solution of the lipid in CHCl3 or 
CHCl3/MeOH (10:2 (v/v)) to a thin film inside a round bottomed flask in vacuo.  Lipid films 
were placed in a vacuum desiccator for a minimum of 2 hours before the addition of water 
or buffer.  The flask was then vortexed and 5 freeze-thaw cycles carried out using liquid 
nitrogen and warm water.  The lipid suspensions were extruded 10 times through laser-
etched polycarbonate membranes (Whatman) with 100 nm pores using a LIPEX 
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thermobarrel extruder (Northern Lipids Inc., BC, Canada).  The extruder was warmed to a 
temperature above the phase transition temperature of the lipids being prepared. 
6.2.1.3 Least squares fitting 
 Non-linear least squares curve fitting was performed using the Solver function in 
Excel (Office 2007, Microsoft Corp.).  Where weighted fitting is stated, the least squares 
value was weighted by multiplication by 
 
  
, where t is the time of each scan at a given 
wavelength. 
6.2.1.4 Preparation of images and manipulation of pdb files 
 Images of peptides were prepared using Pymol (DeLano Scientific, Palo Alto, CA, 
USA., (http://www.pymol.org/) and the orientation of HNP-2 dimers was manipulated 
using Pymol and Swiss-PdbViewer for use in Dichrocalc calculations.2 
6.3 The identification of phospholipids by mass spectrometry 
6.3.1 MSMS analyses 
MSMS analyses using the collision-induced decay (CID) capability were carried 
out using argon as collision gas at a source pressure of approximately 8.5 x 10-7 mBar.  
MSMS experiments were carried out using the LIFT capability unless otherwise stated.  
Isolation of the protonated and sodium adduct parents was sufficient with instrument 
default settings.  For LIFT of the lithium adducts of POPC and POPE, the isolation 
windows were set to exclude the protonated ion, and in the case of POPE the [POPE – H 
+ 2Li]+ ion also.  For the automated LIFT analysis of [POPE + Li]+ it was necessary to 
widen the window slightly to ensure fragmentation of the parent.  For CID and for the LIFT 
analyses of OPPC the precursor ion isolation window could not be altered from the default 
setting of ± 1% of the parent m/z value due to constraints included in an upgrade of the 
software.  The isolation windows are summarised in Table 5.1.  
 
Table 5.1.  Summary of precursor ion isolation windows for automated MSMS analyses.  
 [POPC + H]
+
 
(Da) 
[POPC + Na]
+
 
(Da) 
[POPC + Li]
+
 
(Da) 
[OPPC + H]
+
 
(Da) 
LIFT ± 15 ± 15 + 9, – 5 ± 8 
CID ± 8 n/a ± 8 n/a 
 [OPPC + Li]
+
 
(Da) 
[POPE + H]
+
 
(Da) 
[POPE + Na]
+ 
(Da) 
[POPE + Li]
+
 
(Da) 
LIFT ± 8 ± 14 ± 14 + 6, – 7 
CID n/a n/a n/a n/a 
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For experiments in the presence of lithium, DHB was prepared at 30 mg/mL in 
solutions of LiCl (5 to 100 mM in EtOH/H2O (50% v/v)).  Where added, LiCl was used at a 
concentration of 100 mM unless otherwise stated.  For experiments in the presence of 
other salts, DHB was prepared at 30 mg/mL in solutions of NaCl (100 mM), CaCl2 (4.5 
mM), CuCl2 (100 mM), MgCl2 (100 mM) or ZnCl2 (100 mM) in EtOH/H2O (50% (v/v)).   
6.3.2 MALDI imaging 
For the MALDI imaging of thin layer chromatography (TLC) plates, 35 µL DOPC (1 
mg/mL in CHCl3) or 45 µL extracted mouse lung lipid (2 mg/mL in 50:50 MeOH/CHCl3 
(v/v)) or soybean PC (2 mg/mL in CHCl3) were spotted onto aluminium-backed silica TLC 
plates (Merck brand from Sigma-Aldrich) and run in 25:25:25:10:9 (v/v) ethyl 
acetate/propan-2-ol/CHCL3/MeOH/0.25% (w/v) KCl.  A channel was ground out of a 
microscope-sized slice of steel to the combined depth of the TLC plate and double-sided 
adhesive carbon sheets (Agar Scientific, Essex, UK).  TLC plates were allowed to dry for 
at least 30 minutes before cutting to size and sticking into the channel of the steel plate 
with a strip of adhesive tape.  DHB matrix was dissolved at 100 mg/mL in ACN/H2O (50% 
v/v), 100% EtOH, 100% MeOH or 100 mM LiCl in 100% EtOH.  The matrices were 
generously applied to the plates by pipette, ensuring thorough coverage, quickly dried 
under a stream of argon, then another layer applied.  The plates were allowed to dry 
thoroughly before MALDI analysis.  TLC plates not analysed by MALDI were visualised by 
dipping in phosphomolybdic acid (20 wt. % in EtOH), allowing to air dry and heating until 
the appearance of spots. 
6.4 The chemical stability of phospholipids 
6.4.1 Preparation 
DOPC and DPPC liposomes were prepared as in Section 5.2.1.2 in 10 mM bis-tris 
propane (pH 7), 10 mM tris (pH 7.4), Milli-Q water or 10 mM phosphate and 150 mM NaCl 
with and without 1 mM EDTA.  Liposomes in 10 mM bis-tris propane (pH 7) or 10 mM tris 
(pH 7.4) were stored at 4 °C; liposomes in 10 mM phosphate and 150 mM NaCl with and 
without EDTA were stored 37 °C. 
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6.4.2 MS and MSMS analyses 
MALDI-MS analyses of liposomes in the absence of melittin were carried out as 
described in Section 6.2.1.1. 
The MALDI-MS analysis of the short-term action of natural melittin was carried out 
on an Ultraflex II MALDI-TOF/TOF spectrometer with 337 nm nitrogen laser (Bruker 
Daltonics Ltd.).  The target plate and calibration were as in Section 6.2.1.1.  1 µL aliquots 
of a solution of DMPC liposomes (2.5 mg/mL in 10 mM bis-tris propane pH 7) with melittin 
concentration (0.1 mg/ml) were removed at 30 second intervals after the addition of the 
melittin and were immediately mixed with a solution of DHB (30 mg/mL in EtOH/H2O (50% 
v/v)) to quench the hydrolysis.  1 µL aliquots of each sample/matrix solution were then 
spotted on the target plate and allowed to air dry.  The information from 4000 laser shots 
was averaged for each sample spot. 
For the long-term analyses of the effects of natural melittin on liposomes, melittin 
was mixed with DOPC liposomes (5:1 and 50:1 lipid:peptide (mol/mol)) in 10 mM 
phosphate and 150 mM NaCl (pH 7) with 1 mM EDTA to give final concentrations of 8 
mM phosphate, 123 mM NaCl, 1 mM EDTA, 0.27 mg/mL DOPC and 0.16 mg/mL melittin 
with a 5:1 lipid:peptide molar ratio, and 10 mM phosphate, 147 mM NaCl, 1 mM EDTA, 
0.32 mg/mL DOPC and 0.02 mg/mL melittin with a 50:1 lipid:peptide molar ratio.  The 
samples were incubated at 37 °C and analysed as described in Section 6.2.1.1.  A control 
sample was prepared in the absence of melittin and stored and analysed in the same way 
as the samples containing melittin. 
For initial long-term analyses of the effects of synthetic melittin on liposomes, 
melittin was mixed with DOPC liposomes (5:1 and 50:1 lipid:peptide mol/mol) in 10 mM 
phosphate and 150 mM NaCl (pH 7) to give final concentrations of 8 mM phosphate, 123 
mM NaCl, 0.27 mg/mL DOPC and 0.16 mg/mL melittin with a 5:1 lipid:peptide molar ratio, 
and 10 mM phosphate, 147 mM NaCl, 0.32 mg/mL DOPC and 0.02 mg/mL melittin with a 
50:1 lipid:peptide molar ratio.  The samples were incubated at 37 °C.  Further analyses 
were carried out using 5:1 lipid:peptide (mol/mol) with DOPC or POPC liposomes in 8 mM 
phosphate and 123 mM NaCl (pH 7), 8 mM phosphate, 123 mM NaCl and 0.7 mM CaCl2, 
ZnCl2 or MgCl2, or 10 mM phosphate (pH 7). In the presence of haloperidol-TFA (0.7 mM, 
pH 7), the buffer was 7 mM phosphate and 113 mM NaCl.  Control samples were 
prepared in the absence of melittin.  All samples were stored at 37 °C and analysed as 
described in Section 6.2.1.1. 
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For the MSMS analyses of melittin and modified melittin, samples were mixed 1:9 
(v/v) with solutions of α-CHCA (20 mg/mL in 30:70 (v/v) ACN/H2O (0.1% TFA)).  MS 
analyses in the mass region of melittin were calibrated with the sodium adducts of 
poly(propylene glycol) 3000.  All other details of the MALDI analyses were as described in 
Section 6.2.1.1. 
The normalised intensity of the peak corresponding to lyso-PC was calculated 
using Equation 6.1 for DOPC 
                                 6.1 
and Equations 6.2 and 6.3 for POPC 
                                    6.2 
                                    6.3 
where Ilipid, IOPC and IPPC are the absolute intensities of the peaks corresponding to the lipid 
molecular ion, lyso-OPC and lyso-PPC respectively and InOPC and InPPC are the normalised 
intensities of lyso-OPC and lyso-PPC respectively. 
6.4.3 1H NMR 
 The 1H NMR spectrum of DOPC was recorded at 700 MHz on a 10 mg sample 
dissolved in CDCl3 using a Varian 700 NMR spectrometer (Varian, Inc., Palo Alto, USA). 
6.4.4 Electron microscopy 
 Transmission electron microscopy (TEM) analysis was carried out using a Hitachi 
TEMH7600 transmission electron microscope in high resolution mode with an 
accelerating voltage of 80–100 kV.  Liposome solutions were diluted to 0.5 mg/mL with 
Milli-Q water then 5 µL deposited on 400 mesh carbon film coated copper grids (Agar 
Scientific).  After approximately 1 minute, the droplet was soaked up with filter paper from 
the edge of the grid.  The process was repeated with 5 µL 1% uranyl acetate negative 
stain solution. 
6.4.5 Dynamic light scattering 
 Dynamic light scattering (DLS) analyses were carried out using a ZetaPlus Zeta 
Potential Analyzer (Brookhaven Instruments Corporation, Holtsville, USA) in a 10 mm 
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pathlength cell.  The liposome solutions were analysed without dilution and the diameter 
value is an average of the results of ten one minute runs. 
6.4.6 Haloperidol-trifluoroacetic acid preparation and analysis with lipid 
 Haloperidol-trifluoroacetic acid was prepared according to the method of Casey et 
al.3  Haloperidol (40 mg) was dissolved in TFA/DCM (4 mL) and stirred at room 
temperature for 1 hour.  The solvents were removed under vacuum.  DOPC (2.5 mg in 
CHCl3) was dried to a thin film in vacuo in a round bottomed flask then placed in a 
vacuum desiccator overnight.  Haloperidol-TFA (0.8 mg) was dissolved in 50:50 (v/v) 
MeOH/CHCl3 (513 µL) and 50 µL of this solution (0.16 µmoles) used to dissolve the 
DOPC film.  The solution was diluted with 150 µL 50:50 (v/v) MeOH/CHCl3 and 
transferred to a 1 mL sample vial before drying to a film under vacuum and storing in a 
vacuum desiccator overnight.  The film was rehydrated with 7.5 µL tris buffer (10 mM pH 
7.4) and vortexed for 5 x 30 seconds to homogenise. 
6.4.7 Thin layer chromatgraphy 
 For the TLC analysis of DOPC liposomes 17 days after the addition of melittin, 
DOPC liposomes with melittin (30 µL, 5:1 lipid:melittin molar ratio in 10 mM phosphate 
and 150 mM NaCl buffer), DOPC liposomes (30 µL, 0.33 mg/mL in 10 mM phosphate and 
150 mM NaCl buffer), prepared and stored with melittin sample, and an aliquot of 
phosphate buffer (30 µL, 10 mM with 150 mM NaCl) were lyophilized and each 
redissolved in 15 µL MeOH/CHCl3 (50:50 (v/v)).  All of each redissolved sample was 
applied drop-wise to an aluminium-backed silica TLC plate (Merck brand from Sigma-
Aldrich).  DOPC lipid (5 µL, 0.5 mg/mL in CHCl3) and a mixture of lyso-PC and oleic acid 
were also applied to the TLC plate in separate lanes.  The TLC plate was run in 6:4:1 (v/v) 
CHCl3, MeOH and H2O and stained with phosphomolybdic acid (20 wt. % in EtOH) and 
heat. 
6.5 The membrane binding of defensin HNP-2 
6.5.1 Protein concentration determination 
 The concentration of HNP-2 was determined before each set of experiments using 
UV analysis.  A blank spectrum was recorded of 3 mL water in a quartz cuvette from 200-
350 nm.  Four additions of 5 mL HNP-2 were made to the 3 mL water and a spectrum 
recorded after each addition.  The concentration of the peptide was then calculated using 
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the absorbance at 280 nm using the following equations, where A is the observed 
absorbance at 280 nm and Acorr is the corrected absorbance allowing for the change in 
volume after each addition of peptide solution.  V0 is the initial volume of water in the 
cuvette and V is the volume of peptide solution added. 
        
    
  
          (6.4) 
The concentration of the peptide solution, x, is then given by Equation 6.5, where c is the 
overall concentration in the cuvette. 
    
 
  
           (6.5) 
Equation 6.5 can be rearranged to give Equation 6.6. 
  
  
  
           (6.6) 
This can then be combined with the Beer–Lambert law to give Equation 6.7, where ε is 
the extinction coefficient of the peptide. 
      
   
  
          (6.7) 
A plot of Acorr against V has a gradient of      .  This allows x to be calculated, provided ε 
and V0 are known.  The extinction coefficient of HNP-2 was calculated using the 
ProtParam tool from the ExPASy Proteomics Server.4  The ProtParam tool calculates 
extinction coefficients using the equation 
                                                           
           (6.8) 
where ε(Tyr) =1490, ε(Trp) = 5500 and ε(cystine) = 125 M-1 cm-1, noting that in HNP-2 all 
cysteine residues are involved in disulphide bonds and are therefore present as half 
cystines, and N corresponds to the number of each residue.  The extinction coefficient of 
HNP-2 was calculated as 10345 M-1 cm-1. 
6.5.2 Dynamic light scattering 
DLS experiments were carried out using a Zetasizer Nano ZS (Malvern 
Instruments Ltd., Malvern, UK) with a 3 mm pathlength cell.  For the determination of the 
phase transition temperature, 50 µL aliquots of liposome solutions (2 mg/ml, H2O) were 
heated from 10 °C to 40 °C or 60 °C at 0.5 °C intervals.  The samples were equilibrated 
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for 5 minutes before the start of the analyses, then for 1 minute at each temperature.  The 
attenuator, sample position and number of repeat analyses (within a range of 15–17) 
were automatically optimised at each temperature.  A fresh aliquot of liposome solution 
was used for each set of measurements.  Diameter measurements before and after the 
addition of defensin were averaged from 71 individual measurements at 21 °C on the 
same instrument. 
6.5.3 Differential scanning calorimetry 
 DSC analysis of DMPG was carried out using a PerkinElmer Pyrus 1 calorimeter 
(PerkinElmer, Cambridge, UK).  Solid DMPG (1.204 mg) was sealed in an aluminium pan 
with a drop of water and taken through three heating and cooling cycles between 0 and 
60 °C, heating at 4 °C/minute. 
6.5.4 Dimer binding analysis 
 The dimer binding equilibrium was calculated from data obtained on an ISA Jobin-
Yvon Spex Fluorolog-3 luminescent spectrometer (Horiba Jobin Yvon Ltd., Middlesex, 
UK) with an array photon multiplier tube using DataMax v2.20 software.  The data for 1–
39 µM HNP-2 was collected by adding 30 aliquots of 2 µL HNP-2 to 60 µL H2O Two 
spectra were recorded after each addition with the results averaged.  For the lower 
concentration range, a solution of 1.5 µM HNP-2 was increasingly diluted by the addition 
of H2O and the data from two spectra averaged at each concentration.  All analyses were 
carried out with an excitation wavelength of 280 nm, 3 nm excitation and emission 
bandwidths and a 3 mm pathlength.   
6.5.5 Fluorescence resonance energy transfer 
 The FRET experiment was carried out using an LS 55 fluorimeter (Perkin Elmer, 
Cambridge, UK) with a mesh photomultiplier tube with FL Winlab 95 software.  The 
excitation and emission bandwidths were 2.5 nm and the pathlength was 3 mm.  50:50 
(w/w) POPG/DOPC liposomes and 50:50 (w/w) POPG/DOPC liposomes with 0.5 mol % 
each of Rh-PE and NBD-PE were prepared at 4 mg/mL in H2O as in Section 6.2.1.2.  
Labelled and unlabelled liposomes were mixed 3:1 (v/v) for analyses and used at a final 
concentration of 1.4 mM.   60 measurements were made at 5 minute intervals in the 
presence and absence of 15 µM HNP-2.  45 µL of a 0.1% solution of Triton X-100 was 
added to 1.4 mM liposomes with and without 15 µM HNP-2 to give a final concentration of 
1.2 mM Triton X-100 for the spectra of lysed liposomes.  A baseline spectrum of 
unlabelled liposomes was recorded and subtracted from all other measurements.   
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6.5.6 Fluorescence analysis in MeOH and kinetic analysis 
 HNP-2 (15 µM) in 75% MeOH was analysed on a Jasco FP-6500 fluorimeter 
(Jasco UK, Great Dunmow, UK)  with 2.5 nm excitation and emission bandwidths and a 3 
mm pathlength.  The kinetic analysis was also performed using the FP-6500 fluorimeter.  
HNP-2 (15 µM) and 50:50 (w/w) POPG/DOPC liposomes (1.4 mM) were analysed at 2.5 
minute intervals for 5 hours with a scan speed of 200 nm/min with excitation at 280 nm 
and a 3 mm pathlength.   
6.5.7 Linear dichroism 
Linear dichroism (LD) measurements were performed using a Jasco J-815 
spectropolarimeter (Jasco UK) using Jasco Spectra Manager version 1.53.01 software, in 
a microvolume Couette flow cell (Crystal Precision Optics, Rugby, UK; now available from 
Kromatek Ltd., Great Dunmow, UK).5  The Couette cell was rotated at ~3000 rpm (3.0 V).  
Analyses were carried out with 15 µM HNP-2 and 1.4 mM (50:50 (w/w) POPG/DOPC and 
DMPG/DMPC) or 1.05 mM (50:50 (w/w) DOPS/DOPC) liposomes.  Spectra were 
recorded at 5 minute intervals over 5 hours at a scan speed of 50 nm/minute with a 
response time of 2 seconds and a data pitch of 0.2 nm. 
Model LD spectra of HNP-2 were obtained using Dichrocalc v3.3 software through 
the web interface (http://comp.chem.nottingham.ac.uk/dichrocalc/).6–9  All model spectra 
were inverted before comparison with measured spectra as explained in Section 4.2.8.1. 
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A)  MALDI-MSMS spectrum of [melittin + R18:0CO]
+
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Appendix 1: MALDI-MSMS spectra of acylated melittin 
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B) MALDI-MSMS spectrum of [melittin + R16:1CO]
+
 from melittin with POPC.  The sample was prepared by mixing the melittin and liposome dispersion (1:5 peptide:lipid molar 
ratio) 1:9 ( v/v) with solutions of α-CHCA (20 mg/mL in 30:70 (v/v) ACN/H2O (0.1% TFA)). 270 
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C) MALDI-MSMS spectrum of [melittin + R18:0CO]
+
 from melittin with POPC.  The sample was prepared by mixing the melittin and liposome dispersion (1:5 peptide:lipid molar 
ratio) 1:9 ( v/v) with solutions of α-CHCA (20 mg/mL in 30:70 (v/v) ACN/H2O (0.1% TFA)). 271 
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Appendix 2: Residuals of the least-squares fitting of LD data to the 3-state kinetic 
model 
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Appendix 2.  Residuals of the least-squares fitting of LD data to the 3-state kinetic model described in 
Section 4.2.6.2.  A–C) 50:50 (w/w) POPG/DOPC 30 °C at 200, 225 and 245 nm; D–E) 50:50 (w/w) 
POPG/DOPC 40 °C at 230 and 245 nm; F–G) 50:50 (w/w) POPG/DOPC 53 °C at 206 and 228 nm; H–J) 
50:50 (w/w) DOPS/DOPC 30 °C at 194, 209 and 224 nm; K–M) 50:50 (w/w) DMPG/DMPC 17 °C at 196, 215 
and 235 nm and N–P) 50:50 (w/w) DMPG/DMPC 33 °C at 188, 194 and 198 nm. 
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Appendix 3: LD spectra of the Pm1 and Pm2 states of HNP-2 with closest-fit 
calculated spectra 
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Appendix 3.  LD spectra of the Pm1 and Pm2 states of HNP-2 (blue) with closest-fit calculated spectra 
determined through least squares fitting using Equation 4.52 (red). A–D) Spectra of Pm1 with best fit spectra 
for rotation around  and  and spectra of Pm2 with best fit spectra for rotation around  and  respectively for 
binding to 50:50 (w/w) POPG/DOPC at 30 °C; E–H) Spectra of Pm1 with best fit spectra for rotation around  
and  and spectra of LDm2 with best fit spectra for rotation around  and  respectively for binding to 50:50 
(w/w) POPG/DOPC at 40 °C; I–L) Spectra of LDm1 with best fit spectra for rotation around  and  and spectra 
of Pm2 with best fit spectra for rotation around  and  respectively for binding to 50:50 (w/w) POPG/DOPC at 
53 °C; M–P) Spectra of Pm1 with best fit spectra for rotation around  and  and spectra of Pm2 with best fit 
spectra for rotation around  and  respectively for binding to 50:50 (w/w) DOPS/DOPC at 30 °C and Q–T) 
Spectra of Pm1 with best fit spectra for rotation around  and  and spectra of Pm2 with best fit spectra for 
rotation around  and  respectively for binding to 50:50 (w/w) DMPG/DMPC at 33 °C. 
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